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ABSTRACT 
Joshua William Heyen 
 
COMPARATIVE ANALYSIS OF THE DISCORDANCE BETWEEN THE GLOBAL 
TRANSCRIPTIONAL AND PROTEOMIC RESPONSE OF THE YEAST 
SACCHAROMYCES CEREVISIAE TO DELETION OF THE F-BOX PROTEIN, 
GRR1 
  
 The Grr1 (Glucose Repression Resistant) protein in Saccharomyces 
cerevisiae is an F-box protein for the E3 ubiquitin ligase protein complex known 
as the SCFGrr1 (Skp, Cullin, F-box).  F-box proteins serve as substrate receptors 
for this complex and in this capacity Grr1 serves to promote the ubiquitylation 
and subsequent proteasomal degradation of a number of intracellular protein 
substrates.  Substrates of SCFGrr1 include the G1-S phase cyclins, Cln1 and 
Cln2, the Cdc42 effectors and cell polarity proteins, Gic1 and Gic2, the FCH-bar 
domain protein, Hof1, required for cytokinesis, the meiosis activating 
serine/threonine protein kinase, Ime2, the transcriptional regulators of glucose 
transporters, Mth1 and Std1, and the mitochondrial retrograde response inhibitor 
Mks1.  Stabilization of these substrates lead to pleiotrophic phenotypic defects in 
grr1Δ strains including resistance to glucose repression, accumulation of grr1Δ 
cells in G2 and M phase of the cell cycle, sensitivity to osmotic stress, and 
resistance to divalent cations.  However, many of these phenotypes are not 
reflected at the gene expression level.  We conducted a quantitative genomic 
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and proteomic comparison of 914 loci in a grr1Δ and wild-type strain grown to 
early log-phase in glucose media.  These loci encompassed 16.7% of the 
Saccharomyces proteome of which 22.3% exhibited discordance between gene 
and protein expression.  GO process enrichment analysis revealed that 
discordant loci were enriched in the processes of “trafficking”, “mitosis”, and 
“carbon/energy” metabolism.  Here we show that these instances of discordance 
are biologically relevant and in fact reflect phenotypes of grr1Δ strains not 
evident at the transcriptional level.  Additionally, through combined biochemical 
and network analysis of discordant loci among “carbon and energy metabolism” 
we were able to not only construct a model for central carbon metabolism in 
grr1Δ strains but also were able to elucidate a novel molecular event that may 
serve to regulate glucose repression of genes needed for respiration in response 
to changes in glucose concentration. 
 
 
 
 Mark G. Goebl, Ph.D., Chair 
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SUMMARY OF PROPOSED RESEARCH 
The goal of my thesis project was to develop and apply a global 
proteomics strategy to discover novel mechanisms by which the Saccharomyces 
cerevisiae F-box protein, Grr1, acts to regulate multiple cellular processes in 
Saccharomyces.  The Grr1 protein is a member of a class of proteins known as 
F-box proteins.  F-box proteins are found in all eukaryotic organisms and serve to 
regulate multiple cellular processes such as development, endocytosis, 
transcription, translation, and targeted protein degradation.  Many of these 
essential functions for the F-box proteins are carried out through a conserved 
mechanism by which the F-box protein serves as a receptor to target various 
protein substrates for ubiquitin modification.  Most F-box proteins discovered to 
date facilitate protein ubiquitylation in conjunction with a well conserved complex 
of proteins collectively known as the SCF (Skp, Cullin, F-box).  The archetype of 
the SCF complex is the S. cerevisiae SCF composed of the proteins Skp1, 
Cdc53, Rbx1, Cdc34, and a variable F-box protein.  Multiple F-box proteins can 
associate with this core group of four SCF components adding modularity to the 
complex and the ability to recognize multiple cellular substrates.  The attachment 
of ubiquitin to SCF substrates has been extensively shown to result in the 
substrate’s degradation.  It is through this targeted degradation that the SCF can 
control numerous cellular processes including transcription (by targeting 
transcription factors for degradation), translation, and cell signaling.  As one can 
imagine the function of this complex is critical to the cell and alterations in its 
function could lead to disease and indeed diseases such as Parkinson’s, 
Huntington’s, and Alzheimer’s have all been linked to defects in the ubiquitylation 
machinery. 
The importance of the SCF complex in maintaining cellular homeostasis 
underscores the need to characterize each of its components as they relate to 
the cell as a whole.  Recently, through the development of global assays and 
screens the molecular toolbox available to biologists has expanded allowing 
researchers to begin to probe the cell and measure its molecular response on a 
global system wide level.  Micro-arrays allow for the measurement of all actively 
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transcribed genes in a cell providing a snapshot of the cell at the transcriptional 
level.  This valuable tool allows scientists to probe the transcriptional framework 
that dictates genes expression; however the molecular state of the cell at the 
protein level can only be inferred.  Thus, a method to assay global protein 
expression is needed to complement the gene expression data.  Consistencies 
and paradoxes between these two data sets will aid in our understanding of the 
cell on a system wide level.   
Global proteomic strategies based on liquid chromatography followed by 
mass spectrometry have really just begun to be used as a method to analyze 
complex protein mixtures.  Development in this field has been rapid, still major 
hurdles are yet to be overcome.  First, researchers are still unable to detect and 
quantify the entire proteome of an organism reliably.  This is due to limitations 
with the current resolving power of liquid chromatography and the sensitivity of 
widely available mass spectrometers.  Second, scoring algorithms for accurately 
matching experimental MS/MS spectra to the correct peptide are inefficient, 
leaving many spectra unidentified, and sometimes inaccurate, containing many 
false positives.  Third, quantification of a peptide and/or protein is limited by the 
fact that post-translational modification of a peptide can skew the relative ratios 
obtained for the peptide resulting in inaccurate quantification.  Finally, software to 
efficiently and effectively mine the results of the data generated to arrive at 
interesting biological discoveries are in short supply and those that are available, 
though useful, fall short of the mark.   
Thus, a significant part of my thesis will detail the development of a global 
proteomics strategy that generates valid and accurate LC-MS based results and 
allows for the efficient and effective analysis of this data to uncover novel 
scientific discoveries.  This method will be applied to discovering novel roles for 
the F-box Grr1 in S. cerevisiae cell biology.  For my thesis I hope to contribute to 
the development of LC-MS based global proteomic strategies and apply these 
developments to a significant biological question (the system wide role of the F-
box protein Grr1) using the biology to validate my strategy and the strategy to 
uncover novel biological roles for SCF based functions. 
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CHAPTER 1:  INTRODUCTION TO UBIQUITYLATION AND GRR1 
 
1.1.  The Process of Ubiquitylation and its Multifarious Role in Eukaryotes 
The molecular regulatory process of ubiquitylation, as the name implies, is 
ubiquitously conserved in all eukaryotic cells.  Defects in this process in 
mammalian cells lead to the manifestation of complex human diseases.  In 
mammalian cells, ubiquitylation plays a critical role in axonal morphogenesis in 
the brain 1, the control of cellular aging 2, innate and adaptive immunity 3, 
angiogenesis 4, and many other processes.  Given the eclectic nature of 
ubiquitylation, it is not surprising that multiple diseases are intimately linked to 
defects in the molecular machinery that carry out the reactions of ubiquitylation 
(for review, see 5).  Breast, ovarian 6,7, colorectal 8-10, as well as HPV linked 
cervical cancers 11,12 display alterations in the ubiquitylation system.  Viruses 
such as HIV 13-18 and HSV 19-22 possess genes that encode components of the 
ubiquitylation machinery.  Finally, the development of neurodegenerative 
diseases such as Alzheimer’s 23-26, Parkinson’s 27,28,26, and Huntington’s 29,30 has 
been linked to defects in components of the ubiquitylation system. 
The multitude of processes that rely on a functional ubiquitylation system 
and the prevalence of diseases caused by a defective ubiquitylation system 
underscore the need to understand not only the molecular mechanism of protein 
ubiquitylation but also the cellular response to perturbations of this system.  The 
fact that the core molecular mechanism of ubiquitylation is conserved in the 
yeast, Saccharomyces cerevisiae, enables researchers to utilize this single 
celled eukaryote as a model system for studying this process.  The ease with 
which S. cerevisiae can be grown in the laboratory and manipulated genetically, 
as well as its eukaryotic nature has made this organism a vital contributor to our 
understanding of many cellular processes, not the least of which is ubiquitylation.  
It is through research using this organism that much of our current understanding 
of the molecular processes necessary for a proteins ubiquitylation were revealed.   
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1.2.  Ubiquitin and the Molecular Mechanism of Ubiquitylation 
Ubiquitin is a 76 amino acid protein.  In 1980, it was discovered as an 
essential post-translational modification necessary for the targeted degradation 
of many intracellular protein substrates by the 26S proteasome 31,32.  Since that 
time, we have found that the role ubiquitin plays in the biology of eukaryotic cells 
is vast and it is clear that the nature of the ubiquitin modification and the 
processes it facilitates are far more diverse than first hypothesized.  Classically, 
ubiquitin has been defined by its role in targeting protein substrates for 
degradation by the 26S proteasome.  Targeting of substrates to the 26S 
proteasome occurs through the oligomeric addition of ubiquitin moieties to the 
protein substrate in the form of lysine 48 linked ubiquitin chains 33.  It was later 
shown that the multimeric addition of at least four covalently linked ubiquitin 
molecules facilitated the efficient degradation of modified substrates 34.  Ubiquitin 
chains are formed by covalent attachment of the C-terminal glycine of a free 
ubiquitin to an acceptor lysine on the substrate associated ubiquitin 35.  Initial 
investigations primarily focused on the mechanism of lysine 48 linkage 
formations but it soon became clear that other lysine residues on the ubiquitin 
molecule could also serve as acceptor sites for chain formation.  These various 
chains facilitate diversified cellular processes and this fact emphasizes the 
multifarious role of ubiquitin in cell biology. 
Ubiquitin contains eight lysines available for chain formation and three 
(Lysine 48, 63, and 29) have been found to form multi-ubiquitin chains 36.  
Additionally, ubiquitin can be added to substrates without forming a chain.  Each 
of these types of ubiquitin modifications has been shown to participate in unique 
intracellular processes.  Lysine 63 linked ubiquitin chains are necessary for DNA 
repair, mitochondrial DNA inheritance, ribosome function, stress adaptation, and 
endocytic trafficking of some integral membrane proteins 37.  Lysine 29 linked 
ubiquitin chains have been shown to play a role in the UFD (Ubiquitin Fusion 
Degradation) pathway 38 and mono-ubiquitylation is necessary for retroviral 
budding, endocytosis, and histone regulation 39.  Thus, each of these different 
ubiquitin modifications has been shown to facilitate distinct cellular processes 
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and thus the nature of the ubiquitin modification determines to some extent the 
effect that ubiquitin attachment will have on a protein substrate (Figure 1.1).  
However, in all cases the purpose of ubiquitylation is to promote protein/protein 
interactions that commonly culminate in the altered sub-cellular localization of the 
protein substrate. 
It is clear that these different ubiquitin modifications are critical to 
facilitating the diverse cellular functions in which ubiquitin participates.  However, 
the eclectic nature of the ubiquitin signal is not solely explained by the presence 
of its alternative forms.  Mechanistic studies have revealed that various modular 
complexes of proteins interchangeably work together to facilitate substrate 
recognition, ubiquitin attachment, and chain formation.  Even though the nature 
of the ubiquitin modification and the cellular fate of the substrates modified by 
this protein are highly variable, remarkably, the core mechanism of ubiquitin 
attachment is highly conserved. 
Through an enzymatic cascade involving three essential enzyme types, 
free intracellular ubiquitin is activated and covalently attached to a protein 
substrate (Figure 1.1).  First, an E1 ubiquitin activating enzyme catalyzes, in an 
ATP dependent manner, the covalent attachment of ubiquitin to itself through 
formation of a thiolester bond between the C-terminal glycine of ubiquitin and the 
catalytic cysteine of the E1 40.  Three gene products in S. cerevisiae have been 
classified as E1s, however only the product of the essential UBA1 gene 
participates in ubiquitin activation 41.  Following ubiquitin activation, transfer of 
ubiquitin to an E2 conjugating enzyme is facilitated by an ATP dependent 
transacylation reaction.  Eleven E2’s have been discovered to catalyze ubiquitin 
modifications in S. cerevisiae, each thought to be required for ubiquitin 
modification of different intracellular substrates in different intracellular locations.  
However, hundreds or possibly thousands of different proteins are modified by 
ubiquitin in S. cerevisiae and the nature of the ubiquitin modification for each of 
these substrates varies. 
To enable the modification of multiple substrates by a specific E2, the E2 
enzymes associate with different complexes of proteins collectively known as E3 
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ubiquitin ligases.  Together a particular E3 complex and the E2 recognize and 
ubiquitylate specific substrates.  Therefore, the number of substrates 
ubiquitylated by a specific E2 is often substantial since one E2 can associate with 
multiple different E3 ubiquitin ligases.  The number of E3 ubiquitin ligases in 
yeast and humans is unknown since little sequence homology exists between the 
constituent proteins in these complexes.  However, known E3 complexes can be 
broadly divided into two categories based on the presence of a RING (really 
interesting new gene) finger domain or a HECT (homologous to E6-AP carboxyl 
terminus) domain containing protein in the complex 37.  Perhaps the best 
characterized of these complexes is the RING Finger E3, SCF (Skp1, 
Cdc53/Cullin, and F-box receptor) complex. 
 
1.3.  The SCF (Skp, Cullin, F-Box) Complex 
The S. cerevisiae SCF complexes consist of five proteins that each 
facilitates specific aspects of SCF function (Figure 1.2).  Cdc53, Skp1, Rbx1, and 
F-box proteins work in collaboration with the E2, Cdc34, which together are 
responsible for the recognition and ubiquitylation of protein substrates.  Domain 
characterization of the Skp1 protein has emphasized its role as a molecular 
bridge (or chaperone) linking F-box proteins to the core enzymatic proteins, 
Cdc53 and Rbx1 42.  The Cdc53 protein contains three domains which enable its 
interaction with Skp1, the RING Finger protein Rbx1, and the E2 ubiquitin 
conjugating enzyme Cdc34, respectively 43,44.  A scaffolding role for Cdc53 in the 
SCF complex is well established but limiting Cdc53 to this functional definition 
seems premature at this time.  The extreme C-terminus of Cdc53 is the most 
conserved region of the protein and serves as the site of Rub1 (an ubiquitin-like 
protein) modification, yet no functional significance to this region has been 
assigned 45.  The RING Finger protein, Rbx1, directly interacts with Cdc53, 
Cdc34, and the F-box protein 46.  Rbx1 is essential to the SCF for ubiquitylation 
of substrates.  The RING Finger motif of Rbx1 promotes interaction with the E2; 
Cdc34.  Rbx1 is thought to position Cdc34 next to the substrate, promoting 
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Figure 1.1.  Ubiquitylation in Saccharomyces cerevisiae.  The intracellular pool of 
ubiquitin is supplied by four genes in yeast.  Free ubiquitin is then activated by Uba1 and 
transferred to any one of 13 E2 enzymes which in conjunction with a RING Finger or HECT type 
complex from an E3 ubiquitin ligase.  The E3 then recognizes and catalyzes the ubiquitylation of 
the protein substrate.  Alternative ubiquitin modifications can be appended on the substrate and 
have been shown to be important for diversified cellular processes.
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efficient substrate modification 44.  Substrate recognition is the responsibility of a 
class of proteins called the F-box proteins.  These proteins serve as adapters for 
the core SCF complex enabling multiple substrates to be ubiquitylated by the 
same core machinery.  Cdc4, Grr1, and Met30 are three such proteins that have 
been identified in S. cerevisiae and each promotes the ubiquitylation and 
subsequent degradation of unique substrates. 
 
1.4.  F-Box Proteins 
The F-box proteins comprise a growing class of proteins detected in 
multiple eukaryotic organisms.  Members of this class of proteins are similar in 
that they possess a highly conserved domain termed the F-box.  Mutations in this 
F-box region abrogate interaction with Skp1 47 supporting the role of this domain 
in promoting F-Box protein association with the SCF.  Multiple F-box proteins can 
associate interchangeably with the core SCF components.  Thus, the SCFs are 
considered modular complexes and the associated F-box defines the repertoire 
of substrates that may be ubiquitylated.  Hence, many different SCF complexes 
are possible and are usually distinguished by a nomenclature that denotes the F-
box associated, for example SCFCdc4 indicates the Cdc4 associated complex.  
Factors regulating the temporal and spatial association of different F-box proteins 
with the core SCF complex have not been identified. 
A C-terminal truncation of an F-box protein results in the inability to 
degrade the appropriate substrate and thus has been determined to mediate F-
box substrate interactions 48.  The presence of WD-40 or leucine-rich repeats in 
the C-termini of most F-box proteins initially suggested the presence of two 
distinct signals mediating F-box/substrate interaction.  However, both regions 
have been found to recognize phosphorylated substrates and no conserved 
recognition sequences have been found that would distinguish the substrates of 
these two domains 49.  In fact, phosphorylation of the target protein is required to 
initiate most interactions between substrate and F-box proteins 50. 
Seventeen F-box proteins exist in S. cerevisiae 51, but only three have 
been extensively characterized both biochemically and genetically.  Through 
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these studies it became apparent that a single F-box protein can promote the 
ubiquitylation of multiple substrates resulting in yet another level of SCF 
modularity.  Among the Saccharomyces E3’s, more substrates have been 
discovered for the SCFGrr1 than any other SCF complex.  The reason for this 
partially stems from the fact that S. cerevisiae cells harboring null mutations at 
the GRR1 locus are viable (null mutations of CDC4 as well as MET30 are lethal) 
making grr1Δ cells particularly amenable to biochemical and genetic analysis.  
Substrates for the SCFGrr1 complex include the cyclins, Cln1 and Cln2 52, the 
meiosis activating kinase Ime2 53, the Hof1 protein required for cytokinesis 54, the 
Cdc42 effectors Gic2 and Gic1 55, the glucose responsive transcriptional 
repressors, Mth1 and Std1 56, the retrograde signaling regulator Mks1 57, and the 
Snf1 kinase interacting protein Gis4 58.  Additionally, Grr1 has been shown to be 
indirectly involved in controlling the targeted degradation of nutrient transporters 
59,60 and to be required for SPS (Ssy1, Ptr3, Ssy5) signaling in response to 
external amino acids 61-63 suggesting that more substrates have yet to be 
uncovered.   
 
1.5.  Grr1 
Much of what is known about the role of Grr1 in yeast physiology has 
been discovered either directly or indirectly through characterization of yeast 
strains containing deleted (grr1Δ) or crippled alleles of the GRR1 gene.  Yeast 
deleted for GRR1, remarkably, remain viable despite pleiotrophic defects.  
Originally, mutations in GRR1 (glucose repression resistant) were isolated in 
1982 64 and subsequently characterized in 1984 as mutations conferring 
resistance to glucose repression 65.  Concurrently, as GRR1 mutant alleles were 
isolated and characterized it was also noted that these strains possess a distinct 
multiple elongated bud morphology.  Cloning of the GRR1 gene allowed for a 
more thorough investigation of grr1Δ strains that revealed a number of additional 
phenotypic defects.  Strains fully deleted for GRR1 display a decreased rate of 
growth on glucose media 66,67, a severely decreased rate of respiratory growth 68, 
defects in high affinity glucose transport 69,70, defects in divalent cation 
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Figure 1.2.  The SCFGrr1 Complex, Substrates, and Regulated Processes.  The SCFGrr1 E3 ubiquitin ligase consists of the cullin, 
Cdc53, Skp1, the Ring Finger, Rbx1, the E2, Cdc34, and the F-box protein, Grr1.  Together these proteins recognize and catalyze the covalent 
attachment of ubiquitin to a protein substrate.  Grr1 is the substrate receptor for the SCFGrr1 and has been shown to mediate the ubiquitylation and 
subsequent degradation of nine protein substrates involved in various cellular processes.  Additionally, Grr1 has been shown to positively regulate 
SPS signaling through an unknown mechanism as well as Snf1 signaling by mediating ubiquitin dependent stabilization of Gis4.  All SCFGrr1 
substrates must be phosphorylated to be recognized by the leucine rich repeat domain of Grr1 and are shown in orange.  Vertical bars indicate 
Grr1 dependent inhibition of the substrate through enhanced protein degradation while arrows indicate Grr1 dependent activation.
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transport 71, defects in amino acid transport 72, defects in cytokinesis 73, and 
resistance to mating pheromone 74.  They also are sensitive to osmotic 66 and 
oxidative 75 stresses as well as the microtubule destabilizing drug benomyl 76.  
Furthermore, in multiple studies it has been noted that grr1Δ cells accumulate 
with 2N DNA 77,78 with 10% of the cells undergoing defective nuclear segregation 
78,76.  The pleiotrophic defects exhibited by grr1Δ cells underscore the 
multifarious roles of Grr1 in the molecular biology of Saccharomyces. 
As indicated in Section 1.4, Grr1 has been discovered to target a number 
of intracellular proteins for proteasomal degradation and the molecular functions 
of these substrates are in many cases consistent with the observed phenotypes 
of grr1Δ cells (Figure 1.2).  For instance, the observed slow growth on glucose 
and high affinity glucose transport defects in grr1Δ cells have been attributed to 
stabilization of Mth1 and Std1; two membrane-bound proteins responsible for 
transcriptional repression of hexose transporter genes in the absence of glucose.  
Additionally, as seen in Figure 1.2, the Cln’s as well as the Gic’s are SCFGrr1 
substrates that are positively involved in bud emergence.  Expression of 
stabilized forms of these proteins causes hyperpolarized growth, resembling that 
seen in grr1Δ strains.  Though a direct substrate for the SCFGrr1 complex linking 
its function to the control of amino acid transport has not been found, it is well 
known that SCFGrr1 is required for transcriptional expression of amino acid 
transporters through the membrane bound sensor known as the SPS (Ssy1, 
Ptr3, and Ssy5).  Defects in respiratory metabolism in grr1Δ may partially be due 
to the inability to degrade the negative regulator of the retrograde response, 
Mks1.  Finally, at least some of the defects in cytokinesis observed in grr1Δ 
strains are explained by a role for Grr1 in degrading Hof1. 
The various roles that Grr1 plays in the molecular biology of 
Saccharomyces present a high level of complexity when attempting to delineate 
the direct causality of its pleiotrophic defects.  As indicated above, a number of 
phenotypes are readily explainable in the context of known Grr1 substrates; 
however the nuclear segregation defects, the sensitivity to osmotic and oxidative 
stresses, as well as the sensitivity to benomyl observed in grr1Δ cells are not 
 10 
 
easily linked to known substrates of SCFGrr1, suggesting that undiscovered 
substrates for SCFGrr1 exist.  Additionally, conflicting evidence exists that 
suggests that the role of Grr1 in glucose signaling may not be limited to its role in 
the Snf3/Rgt2 pathway.  In order to delineate these discrepancies it is first 
necessary to understand what is already known about Grr1.  With this in mind the 
remaining sections will be dedicated to describing the known roles for Grr1 in the 
context of its characterized substrates.  Since the role of Grr1 in glucose 
repression is the central subject of this volume its role in this process will be 
reserved for Chapter 2.  
 
1.6.  The Role of Grr1 in the G1 to S Phase Transition through Targeted 
Degradation of the G1 Cyclins, Cln1 and Cln2 
The propagation of viable offspring in all eukaryotic cells occurs through a 
sequential process known as the cell cycle (Figure 1.3).  Through this process 
genetic as well as biosynthetic material necessary for life are replicated and 
segregated to spawn an independent daughter cell.  The successful execution of 
the cell cycle relies on the temporal and spatial perpetration of consecutive 
molecular events and as a result can be divided into four phases known as G1, 
S, G2, and M.  These four phases have been defined through biochemical, 
genetic, and cytological assays that permitted the elucidation of the chronological 
order of key molecular events such as DNA replication and chromosome 
condensation.  At the molecular level, the chronological initiation of each of these 
events is tightly controlled through a control system that monitors and integrates 
environmental and intracellular cues to insure cell cycle fidelity.   
The initial phase of the cell cycle is considered to be “Gap 1” or G1 and is 
the phase in which Saccharomyces spends most of its time.  During G1 yeast 
cells undergo cell growth in response to the availability and type of nutrients 
present in the environment.  In the absence of essential nutrients yeast cells in 
G1 phase can enter a differentiated state termed quiescence.  Additionally, if 
yeast cells of opposite mating type are present, yeasts in G1 will respond to 
mating pheromone and will enter another differentiated process known as  
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Figure 1.3.  The Saccharomyces Cell Cycle.  A.  The cell cycle can be divided into 
four distinct phases known as G1, S, G2, and M.  Normally, the longest phase of the cell cycle in 
Saccharomyces is G1 (Green).  Once cells progress past START (Red) they are committed to 
cell division and must wait until the next G1 phase to enter into differentiated cell fates such as 
mating.  B.  Each phase of the cell cycle is marked by distinct physiological events.  In G1 phase 
of the cell cycle the cell grows to a cell size defined by quality of external nutrients.  Once the 
optimal cell size is reached the cell passes START and shortly thereafter DNA replication is 
initiated, the bud begins to emerge, and the spindle pole body is duplicated.  The cell is now in S 
phase where DNA replication and spindle pole migration proceed.  After S phase the cell enters 
G2.  In G2 the spindle pole migrates to the mother bud neck.  Once the spindle pole reached the 
mother bud neck, mitosis or M phase begins.  In this phase the spindle elongates, segregating 
chromosomes to mother and bud.  The end of M phase and the beginning of G1 of the next cell 
cycle is marked by cytokinesis and cell separation.  C.  Progression through the cell cycle is 
regulated by modulating the kinase activity of the cyclin dependent kinase, Cdc28, by altering its 
association with any of the nine cyclins in Saccharomyces. At the beginning of G1, Cdc28 
associates with the G1 cyclin, Cln3 (not shown), which drives the transcriptional expression of the 
G1-S phase cyclins, Cln1 and Cln2.  Cln1 and Cln2 protein levels abruptly accumulate at START 
at which time Cln associated Cdc28 kinase activity peaks and catalyzes the phosphorylation of 
the cyclin dependent kinase inhibitor, Sic1.  Phosphorylation of Sic1 results in Sic1 ubiquitylation 
by the SCFCdc4 and its degradation by the proteasome which results in the activation of Clb5/6-
Cdc28 kinase activity and the initiation of DNA replication.  Cln1/2/3-Cdc28 activity during G1 is 
required for spindle pole body duplication, bud emergence, and DNA replication.  Premature 
accumulation of Cln1 and Cln2 and thus premature progression through START is prevented by 
maintaining low levels of Cln protein through SCFGrr1 dependent ubiquitylation which promotes 
Cln degradation.  The SCFGrr1 is stimulated by glucose to promote Cln ubiquitylation and thus 
prolong G1 phase to promote cell growth.  Throughout S phase, Cdc28 is primarily associated 
with Clb3 and Clb4 and then subsequently associates with Clb2 and Clb1 to promote G2 to M 
phase progression.  Clb2-Cdc28 activity is required for M phase but must be inactivated to 
promote mitotic exit.  Inactivation of Clb2-Cdc28 activity is achieved through ubiquitylation of Clb2 
by the E3 ubiquitin ligase, anaphase promoting complex, and its subsequent degradation in the 
proteasome. 
 
mating.  In environmentally favorable nutrient conditions and in the absence of 
mating pheromone, wild-type yeast will progress through G1 past START, a point 
at which the cell is committed to DNA replication and cell division.  Once past 
START, the cell cannot enter the quiescent or mating state until the subsequent 
G1 phase of the next cell cycle.  Progression through START in yeast is marked 
phenotypically by resistance to mating pheromone, spindle pole body duplication, 
bud emergence, inactivation of B-type cyclin proteolysis, and the initiation of DNA 
replication.   
Progression through START is driven by the kinase activity of the cyclin 
dependent kinase, Cdc28.  Cdc28 is the central kinase that drives almost all 
stages of the cell cycle in S. cerevisiae and given this function Cdc28 protein 
levels remain constant throughout the cell cycle.  Control of this kinase is 
achieved through post-translational modification and its association with any of 
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the nine cyclins present in S. cerevisiae (Cln1-3, Clb1- 6).  Cdc28 interacts with 
each of these cyclins in a highly coordinated temporal manner which is achieved 
through timed regulation of cyclin transcription and perhaps more importantly 
cyclin degradation.  Therefore, precise control of Cdc28 activity is achieved 
through its association with different cyclins and the availability of these cyclins to 
Cdc28 is a result of coordinately controlled cyclin synthesis and degradation.  At 
the G1 to S phase transition, Cdc28 associates with the G1 cyclins, Cln1, Cln2, 
and Cln3.  These cyclins have half lives in the range of 3 to 10 minutes, 
emphasizing the transient association of these proteins with Cdc28 79-81.  
Deletion of any two of these cyclins is permitted; however in the absence of all 
three, yeast cells arrest at START 82-84.  Association of the Cln proteins with 
Cdc28 activates its kinase activity at START which initializes the post START 
processes of budding 85, spindle pole body duplication, and DNA replication 1.  
Initialization of DNA replication is realized through Cln-Cdc28 dependent 
phosphorylation of the Clb-Cdk inhibitor, Sic1.  Phosphorylation of Sic1 leads to 
its ubiquitylation by the SCFCdc4 complex and subsequent degradation of Sic1 by 
the 26S proteasome, which activates Clb-Cdc28 kinase activity 87.  Thus active 
Cln-Cdc28 kinase activity promotes a cascade of events that ultimately drive the 
cell past START and into S-phase of the cell cycle. 
The association of the Clns with Cdc28 in late G1 is primarily controlled by 
their ubiquitylation by the SCFGrr1 which targets them for degradation by the 26S 
proteasome.  Evidence supporting this role for Grr1 is provided by the fact that 
Cln1 and Cln2 protein levels, which normally accumulate sharply at the G1 to S 
phase transition and abruptly drop ten minutes later 88, are stabilized in a GRR1 
deleted strain 78.  Similar results were found for yeast strains harboring 
temperature sensitive mutations in CDC34, CDC53, and SKP1 implicating the 
SCFGrr1 complex in controlling the regulated degradation of Cln1 and Cln2 89-92.  
Additionally, Cln1 and Cln2 degradation by SCFGrr1 can be reconstituted in vitro 
93,94.  Degradation of Cln1 and Cln2 by SCFGrr1 requires their phosphorylation 
through a Cdc28 dependent mechanism in regions of the proteins known as 
PEST sequences 81,80,90.   
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The role of Grr1 in G1 phase of the cell cycle through ubiquitylation and 
degradation of the Clns plays a role in coupling nutrient sensing 
(specifically glucose) to progression through the cell cycle.  In a rich nutrient 
environment, both haploid and diploid yeast cells grow and divide at rates 
specific to the available nutrient profile.  Thus, yeast not only coordinate growth 
and division strictly to the availability of nutrients but also to the quality of these 
nutrients.  For example, the average doubling time of yeast grown in the 
presence of glucose (high quality carbon source) is ~75 minutes with cell 
volumes reaching ~38um3 before the transition from G1 to S.  However, the 
average doubling time on glycerol (low quality carbon source) is ~160 minutes 
with cell volumes reaching ~23um3 before transition from G1 to S 95,96.  Thus, an 
inverse correlation between doubling time and the extent of growth is observed 
as the quality of nutrients available depreciates.  A number of observations 
suggest that the role of Grr1 in degrading the Clns is important in the coupling of 
nutrient signals to progression through the cell cycle.  First, Grr1 interaction with 
Skp1 is enhanced approximately four fold by high glucose 97 suggesting that 
glucose somehow promotes Grr1 interaction with the SCF which would 
presumably lead to enhanced Cln instability.  Second, cells expressing stabilized 
forms of Cln2 cause shortened G1 phases, premature progression through 
START, a decreased ability to arrest in response to mating pheromone and 
nitrogen deprivation, and an increased percentage of cells with 2N DNA content 
82.  Most of these phenotypes have been described for grr1Δ cells 98,77,74 and 
thus it is highly likely that grr1Δ cells also exhibit premature progression through 
START.  Finally, Grr1 function is required for multiple nutrient signaling pathways 
including Snf3/Rgt2 glucose signaling 99,56, amino acid signaling through the SPS 
sensor 63, and mitochondrial retrograde response 57.  Each of these functions for 
Grr1 will be discussed in later sections. 
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1.7.  The Role of Grr1 in Bud Emergence and Polarity through Targeted 
degradation of Cln1,2 and Gic1,2 
For some time the role of Grr1 in cell cycle progression was believed to be 
limited to its control of G1 to S phase progression; however, it has become clear 
that there is a definitive role for Grr1 in the processes of budding and cytokinesis.  
Upon the transition from G1 to S phase of the cell cycle yeast cells begin to 
polarize the actin cytoskeleton to produce the daughter cell.  This process is 
highly regulated and mainly facilitated by the small GTPase known as Cdc42 100.  
Through a signaling cascade that remains enigmatic the Cln1/2/3-Cdc28 
complex stimulates the formation of the active GTP bound Cdc42 protein, 
promoting its binding to an effector known as Gic2 101.  This active Cdc42/Gic2 
complex is thought to be important for the initiation of bud formation and appears 
to need only be active for a small window of time to perform this function 101,102.  
Cells that harbor a stabilized form of Gic2 exhibit defects in cytoskeletal 
polarization with some of these cells possessing multiple buds 55.  A similar 
phenotype is exhibited in GRR1 deleted strains and it has been shown that Gic2 
protein levels which normally abruptly disappear after bud emergence are 
stabilized in the absence of SCFGrr1 55.  The phosphorylation of Gic2 has also 
been shown to be necessary for Gic2 destabilization, but the mechanism of Gic2 
action and its regulation have yet to be discovered.  Interestingly, as stated 
previously, the Cln1/Cln2-Cdc28 protein kinase complex has been shown to 
induce polarization of the actin cytoskeleton through an unknown mechanism 
affecting Cdc42 activity 103,104 and thus would indirectly control Gic2 activity since 
it is downstream effector of Cdc42.  It is not known how Grr1 can serve to 
promote degradation of both the cyclins and a downstream effector of the cyclins 
but nonetheless this interaction suggests that the processes of cell cycle 
progression and bud emergence are intimately coordinated through the SCFGrr1 
complex. 
 
 
 
  
16 
 
wild-type        grr1Δ 
Figure 1.4.  Morphology of wild-type and grr1Δ Yeast.  Phenotype of wild-type (left) and grr1Δ (right) cells grown on YPD-2% 
glucose media.  As can be seen, the grr1Δ strains exhibit multiple hyperpolarized buds that remain attached.  This morphology is most likely a 
manifestation of a corollary of defects associated with stabilization of substrates normally targeted for ubiquitylation by the SCFGrr1.
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1.8.  The Role of Grr1 in Cytokinesis through Targeted Degradation of Hof1  
Before the mother cell can re-enter G1 of the cell cycle, separation of the 
mother from the daughter cell must occur through cytokinesis.  Most eukaryotic 
cells facilitate cytokinesis through the formation of an actomyosin-based 
contractile ring, however S. cerevisiae possesses a cell wall and cytokinesis can 
occur through the formation of a chitin septum as well 105,106.  The protein Hof1 
has been shown to be necessary for both of these processes in S. cerevisiae 73 
and over-expression of this protein interferes with cell separation in S. pombe 107.  
Hof1 localizes to the bud neck during cytokinesis 108, a cellular location shared by 
Grr1 at this stage of the cell cycle 73.  This observation led to the implementation 
of a two hybrid screen where Grr1 was found to bind with Hof1 73.  In this same 
study it was found that Hof1 protein stability is regulated in a SCFGrr1 dependent 
manner since Hof1 is stabilized in grr1Δ, cdc53-1, and cdc34-2 strains.  It is 
interesting to note that grr1Δ strains exhibit multiple elongated buds that contain 
independent nuclei (Figure 1.4).  This phenotype is probably a result of impaired 
cytokinesis due to Hof1 stabilization and hyper-polarization due to Gic2 
stabilization. 
The substrates identified for the SCFGrr1 complex involved in cell cycle 
progression implicate Grr1’s role in the cell cycle as diversified and complicated.  
Despite the complicated nature of the role of Grr1 in the cell cycle it has been 
hypothesized that the sequential and timely degradation of each of these 
substrates is necessary to coordinate the appropriate sequence of events that 
are required to efficiently and correctly divide.  However, this coordination must 
not be essential since GRR1 deleted strains are still viable.  These mutants are, 
however, slow to divide with doubling times more than twice that of wild-type 
strains and these mutant strains seem to be inefficient at adapting to changing 
nutrient environments 78,66,109.  This has led many to hypothesize that Grr1 may 
be involved in regulating the cell cycle in response to external nutrient conditions 
and that the delayed division times and inefficient adaptability exhibited by GRR1 
deleted strains is a result of an impaired ability to change a subset of transporters 
and metabolizing enzymes necessary to efficiently utilize nutrients available in 
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the environment.  Evidence supporting this hypothesis is best supplied by 
elaborating on the other known Grr1 substrates.  It is indeed observed that the 
remaining substrates are involved in coupling external and internal nutrient 
sensing to the transcriptional and post-transcriptional regulatory machinery. 
 
1.9.  The Role of Grr1 in Amino Acid Signaling Through the SPS Sensor 
The yeast S. cerevisiae possesses the ability to synthesize all twenty 
amino acids necessary for protein biosynthesis but when amino acids are 
present in the environment Saccharomyces will first utilize the extra-cellular 
amino acid supply in order to conserve the cellular energy and co-factors needed 
for their synthesis.  Additionally, Saccharomyces can also utilize a large subset of 
amino acids as sources of ammonia for the biosynthesis of other amino acids 
and metabolites.  The ability to utilize extra-cellular sources of amino acids 
directly for protein biosynthesis and/or as sources of ammonia is dependent on 
Saccharomyces’ ability to sense and respond appropriately to the particular 
amino acid(s) present.  The appropriate transport proteins and metabolic 
enzymes must be coordinately regulated in response to the extra-cellular 
nitrogen composition to ensure efficient utilization of the available nutrients.  This 
coordinate regulation is in part realized through a plasma membrane localized 
amino acid sensor known as the SPS (Ssy5, Ptr3, and Ssy1).  Through this 
sensor, external amino acids stimulate a signaling cascade that culminates in the 
transcriptional regulation of amino acid permeases and catabolic enzymes 
needed for their metabolism.  Grr1 plays an essential role in propagating this 
response and thus the absence of Grr1 leads to an inability to respond to extra-
cellular amino acids through this pathway.  Therefore, the mechanism of SPS 
signaling and the consequences of defective SPS signaling will be discussed in 
the following section. 
The presence of extra-cellular amino acids is initially sensed through a 
plasma membrane localized amino acid sensor known as Ssy1.  Similar to the 
glucose sensors, Rtg2 and Snf3, Ssy1 was revealed as an amino acid sensor 
based on its similarities and marked differences to the amino acid permease 
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family 110.  Ssy1 is comprised of 12 transmembrane-spanning domains flanked 
by a large N-terminal cytoplasmic region not found in the 17 remaining amino 
acid permease family members 111.  This N-terminal extension is required for 
Ssy1 function 112 and strains harboring non-functional SSY1 alleles were initially 
shown to exhibit defects in amino acid uptake 110.  The induced expression in 
response to extra-cellular amino acids occurs for genes encoding both broad 
specificity and high affinity amino acid permeases.  Agp1, Bap2, Bap3, Gnp1, 
Tat1, Tat2, and Mup3 as well as the peptide transporter, Ptr2, have been shown 
to be dependent on Ssy1 (Figure 1.5) 111,112,110.  This dependency does not rely 
on facilitated amino acid transport by Ssy1 and occurs specifically in response to 
extra-cellular amino acids 110,111. 
The mechanism for sensing extracellular amino acids by Ssy1 remains a 
mystery; however the intracellular events that occur in response to amino acid 
sensing have begun to be revealed.  What is known about the molecular events 
that facilitate amino acid dependent induction of amino acid permeases through 
the SPS is summarized in Figure 1.5 and briefly discussed here.  Disruption of 
PTR3 or SSY5, like SSY1, leads to defects in amino acid uptake attributable to 
the inability to induce expression of amino acid permeases in these cells 112,113.  
It was subsequently shown that the cytoplasmic N-terminal extension of Ssy1 
physically interacts with both Ptr3 and Ssy5, suggesting that these three proteins 
together comprise the functional amino acid sensor responsible for transcriptional 
regulation of amino acid permease genes (hence the name SPS for Ssy1, Ptr3, 
Ssy5) 114,112.  The N-terminal association of Ptr3 with Ssy1promotes hyper-
phosphorylation of Ptr3 by the plasma membrane bound casein kinases, Yck1 
and Yck2, in response to the presence of extra-cellular amino acids.  Hyper-
phosphorylation of Ptr3 is essential for sensor signaling and has been shown to 
require Ssy1, at least one functional, and Grr1 114.  The role of Grr1 in this 
pathway is ill-defined but like ssy1Δ, ptr3Δ, or ssy5Δ strains, grr1Δ cells exhibit 
amino acid uptake defects and complete loss of SPS signaling 111.  Through an 
unknown mechanism, hyper-phosphorylated Ptr3 stimulates cleavage of the 
inhibitory Ssy5 N-terminal pro-domain.  Cleavage of the pro-domain is believed 
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to activate the C-terminal chymotrypsin-like serine protease activity of Ssy5 115.  
This protease activity is required for release of two functionally redundant, 
plasma membrane bound, transcription factors, known as Stp1 and Stp2, through 
cleavage of their N-terminal membrane targeting sequences.  Interestingly, 
cleavage of Stp1 and Stp2 is also dependent on phosphorylation by Yck1 or 
Yck2 116,117.  Finally, cleaved Stp1 and Stp2 are free to translocate to the nucleus 
where, in conjunction with Uga35/Dal81, they induce the transcription of amino 
acid permeases 118,119. 
Deletion of GRR1 or SSY1 leads to complete loss of amino acid induced 
signaling through the SPS and this deficiency culminates at the physiological 
level with the inability to transport certain amino acids effectively across the 
plasma membrane.  However, in the absence of GRR1 or SSY1, the general 
amino acid transporter, Gap1, can support, to a limited extent, uptake of all 
amino acids for protein synthesis and nitrogen supplementation 111,120,121,72.  
Therefore, Grr1 as well as Ssy1 specific effects on amino acid transport were 
revealed by characterizing gap1Δ, grr1Δ gap1Δ, and ssy1Δ gap1Δ cells on 
multiple single amino acid nitrogen sources 111,72.  Through these studies it was 
revealed that Grr1 and Ssy1 are required for Gap1 independent transport of 
isoleucine, leucine, valine, phenylalanine, tyrosine, tryptophan, and methionine at 
1mM concentrations.  However, growth of ssy1Δ gap1Δ strains was restored on 
leucine, valine, methionine, and phenylalanine at 10mM 111 whereas no growth of 
the grr1Δ gap1Δ strain was supported on 10mM leucine or methionine 72.  
Additionally, grr1Δ gap1Δ strains exhibited no growth on 1mM threonine whereas 
ssy1Δ gap1Δ strains grew robustly.  Together, these data indicate that Grr1 is 
not only required for SPS mediated amino acid permease induction in response 
to external amino acids but also SPS independent control of amino acid 
transport.
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Figure 1.5.  Amino Acid Signaling through the SPS (Ssy1, Ptr3, Ssy5) 
Sensor.  Through an unknown mechanism, the presence of extracellular amino acids is 
believed to induce a conformational change in the integral plasma membrane sensor of the SPS 
known as Ssy1.  This conformational change promotes phosphorylation of Ptr3 by either of the 
plasma membrane bound casein kinases, Yck1 or Yck2.  Ptr3 is bound to the C-terminal 
cytoplasmic tail of Ssy1 along with the serine protease, Ssy5.  Phosphorylation of Ptr3 leads to 
autocatalytic cleavage of the inhibitory domain of Ssy5 which activates its serine protease activity 
towards two redundant, plasma membrane bound, transcription factors, known as Stp1 and Stp2.  
Interestingly, Stp1 and Stp2 also must be phosphorylated by either of the Ycks in order to be 
proteolytically cleaved by Ssy5.  Cleavage of Stp1 and Stp2 leads to their translocation to the 
nucleus where they, in conjunction with the Uga35/Dal81 transcription factor, induce or repress a 
number of amino acid transporters and genes involved in allantoin, allantoate, and urea 
metabolism, respectively.  The role of Grr1 in SPS signaling is ill defined but it is known that Grr1 
is required for phosphorylation of Ptr3 by the Ycks.  Transcriptional control of all SPS targets in 
response to amino acids is non-functional in grr1Δ strains.  
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1.10.  The Role of Grr1 in Mitochondrial Retrograde Signaling through 
Targeted Degradation of Mks1 
In response to mitochondrial dysfunction, mitochondria influence nuclear 
gene expression in order to promote adaptation to decreased respiratory 
capacity.  Decreased respiratory capacity can be attributable to defects in TCA 
cycle or respiratory protein function, changes in intracellular ion pools, or 
decreases in other cofactors needed by the mitochondrial respiratory chain such 
as ubiquinone.  In Saccharomyces, these deficiencies indirectly influence nuclear 
gene expression through a signaling pathway known as the retrograde response 
pathway 122.  The repertoire of nuclear encoded genes affected by this pathway 
is extensive and includes genes of enzymes needed to provide necessary 
metabolites that are normally provided by the TCA cycle, which would fail to 
function as a full cycle in respiratory deficient mitochondria since succinate would 
fail to be oxidized to fumarate.  Thus, genes of anapleurotic pathways that 
function to supply mitochondria with TCA cycle intermediates such as 
oxaloacetate, acetyl-CoA, and malate are all induced through the retrograde 
signaling pathway.  These genes include enzymes of the glyoxylate cycle, 
peroxisomal enzymes, and enzymes involved in fatty acid oxidation 123.  A key 
metabolite provided by the TCA cycle is glutamate and respiratory deficiencies 
that compromise flux through the TCA cycle lead to decreased intracellular 
glutamate pools 124.  Therefore, an essential function of the retrograde response 
is to increase expression of genes needed to provide intracellular glutamate, 
which is synthesized from the TCA cycle intermediate, α-ketoglutarate.  
Consistent with this function, the retrograde response pathway is strongly 
activated by glutamate starvation 125. 
Much of what is known about Saccharomyces retrograde signaling has 
been revealed through gene expression analysis of the CIT2 gene 126.  CIT2 
encodes the peroxisomal citrate synthase in Saccharomyces and catalyzes the 
peroxisomal condensation of oxaloacetate and acetyl-CoA to form citrate.  Thus, 
CIT2 activity provides an alternative source of citrate through fatty acid oxidation 
in the peroxisome.  Since CIT2 expression is primarily controlled through the 
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retrograde pathway, many of the proteins responsible for retrograde signaling 
have been revealed by studying the effects of their mutation on CIT2 expression. 
CIT2 expression is controlled directly by Rgt1 and Rgt3, which are basic 
helix-loop-helix-leucine zipper transcription factors that bind as a hetero-dimer to 
R box (GTCAC) sequences present in the promoters of retrograde pathway 
regulated genes 127.  Transcriptional activity of the hetero-dimer is regulated 
through both phosphorylation of Rtg3 and sequestration of Rtg1/3 in the 
cytoplasm.  In the absence of retrograde signaling, Rtg3 is hyper-phosphorylated 
and both Rtg1 and Rtg3 are sequestered in the cytoplasm 128.  Activation of 
retrograde signaling requires the partial de-phosphorylation of Rtg3 which results 
in the nuclear accumulation of both Rtg1 and Rtg3, where the hetero-dimer is 
free to bind to R box sites of retrograde regulated genes.  The kinase(s) and 
phosphatase(s) acting to regulate Rtg3 have not been identified; however the 
phosphorylation state and intracellular location of Rtg3 is intimately controlled by 
another retrograde protein, Rtg2 124.  Cells deleted for RTG2 contain 
hyper-phosphorylated Rtg3.  Thus, the Rtg1/3 hetero-dimer remains cytoplasmic 
and as a result, retrograde signaling is defective in rtg2Δ cells 129.  Therefore, the 
key event regulating retrograde control of gene expression is the positive control 
of Rgt1/3 localization to the nucleus by Rtg2. 
The molecular events that act to regulate Rtg2 and thus Rtg1/3 nuclear-
cytoplasmic distribution have begun to be elucidated.  Rtg2 has been found to 
interact with the retrograde signaling negative regulator, Mks1, when the 
retrograde signaling pathway is on 129.  When the pathway is off, Mks1 no longer 
interacts with Rtg2 but interacts with the 14-3-3 proteins, Bmh1 and Bmh2 129.  
Deletion of MKS1 results in constitutive activation of retrograde response genes 
such as CIT2 and gene expression is insensitive to glutamate repression 124.  
Thus, Mks1 in complex with Bmh1/2 inhibits Rtg3 de-phosphorylation and/or 
promotes Rtg3 hyper-phosphorylation resulting in sequestration of Rtg1/3 in the 
cytoplasm when glutamate is plentiful or when respiratory competence is normal. 
In response to glutamate depletion and/or respiratory deficiency, the Mks1 
phospho-protein becomes de-phosphorylated promoting interaction of Mks1 with 
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Figure 1.6.  Mitochondrial Retrograde Signaling in Saccharomyces.  Mitochondrial dysfunction promotes changes in nuclear 
gene expression necessary for adaptation to respiratory deficiency through the retrograde signaling pathway.  Multiple intracellular nutrient cues 
act through unknown mechanisms to control retrograde signaling.  Normally, during periods of respiratory competence and adequate glutamate 
concentrations, two transcription factors, Rtg1 and Rtg3, are sequestered in the cytoplasm resulting in the inability of these two transcription 
factors to induce retrograde target gene expression.  Sequestration of Rtg1 and Rtg3 in the cytoplasm correlates with Rtg3 hyper-phosphorylation.  
Localization of Rtg1 and Rtg3 is controlled through an unknown mechanism mediated by the dynamic interplay between Rtg2, Mks1, and Bmh1/2.  
In nutrient replete conditions in the absence of mitochondrial dysfunction Mks1 is hyper-phosphorylated which promotes Mks1 interaction with 
Bmh1/2.  Bmh1/2-Mks1 inhibits retrograde signaling by promoting the hyper-phosphorylation and cytoplasmic retention of Rtg3.  In respiratory 
deficient cells, Mks1 is de-phosphorylated which promotes its interaction with Rtg2.  Rtg2 inhibits Mks1 interaction with Bmh1/2 and thus inhibits 
the ability of Bmh1/2-Mks1 to inhibit de-phosphorylation and nuclear translocation of Rtg1 and Rtg3.  Bmh1/2 interaction with Mks1 prevents Mks1 
ubiquitylation by SCFGrr1 which promotes degradation of Mks1 and subsequent activation of the retrograde signaling pathway.
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Rtg2.  De-phosphorylated Mks1 is also subject to SCFGrr1 dependent 
ubiquitylation and subsequent degradation by the 26S proteasome 57.  Consistent 
with the requirement for Grr1 in positively regulating the retrograde response, 
dominant mutations in GRR1 bypass the requirement for Rtg2 in retrograde 
signaling and deletion of GRR1 in rtg2Δ cells exacerbates the growth defect of 
rtg2Δ cells on synthetic minimal media lacking glutamate 57.  The kinases and 
phosphatases which regulate the phosphorylation state of Mks1 are currently 
unknown.  Additionally, the molecular events leading to Mks1 degradation by 
SCFGrr1 are also currently unknown; however hypo-phosphorylated Mks1 
recognition by the SCFGrr1 complex is most likely not bridged by Rtg2 as SCFGrr1 
dependent ubiquitylation of Mks1 is not specific for Rtg2-Mks1 but for unbound 
Mks1 57.  Thus, many of the details regarding retrograde signaling regulation 
through Rtg2, Mks1, Rtg1/3, and SCFGrr1 remain to be determined; nevertheless, 
the role for Grr1 in this signaling pathway is well substantiated. 
The intracellular signals which indicate mitochondrial dysfunction and/or 
glutamate starvation and lead to activation of the retrograde signaling pathway 
have not been deciphered.  Most likely, multiple intracellular signals act through 
different retrograde signaling proteins to modulate the response.  Rgt2 contains 
an ATP binding domain that is required for Rtg2 interaction with Mks1 129.  Thus, 
the intracellular ATP/ADP ratio may influence retrograde response activation 
through Rtg2.  Rapamycin inhibition of the PI kinase related kinase, Tor1 and 
Tor2, also promotes induction of the retrograde signaling response.  Activation of 
retrograde signaling through Tor inhibition requires Rtg2 130 and Tor dependent 
inactivation of retrograde signaling promotes Mks1 hyper-phosphorylation 131.  
Tor kinase activity is regulated by multiple nutritional cues including the 
intracellular concentration of glutamate 132,133.  Thus, glutamate deficiency may 
induce retrograde signaling through inactivation of the Tor kinase.  It is 
interesting to speculate that glucose dependent regulation of Grr1 interaction with 
Skp1 and the SCF may serve as an additional regulatory mechanism to control 
retrograde signaling.  Grr1 interaction with Skp1 is enhanced four fold in the 
presence of glucose 97 which would most likely promote enhanced degradation of 
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Mks1.  Thus, regulation of the retrograde response is highly complex with 
multiple nutrient signals acting through multiple regulatory proteins to fine tune 
the molecular response to mitochondrial dysfunction.   
The role of Grr1 in Saccharomyces physiology is extremely complex.  This 
complexity is underscored by the eclectic substrates targeted for ubiquitylation by 
the SCFGrr1.  However, as illustrated throughout this chapter, the roles for Grr1 in 
Saccharomyces fall into two major categories; cell cycle related processes and 
nutrient signaling processes.  The multifaceted role for Grr1 in regulating multiple 
aspects of these processes suggests that Grr1 function is intimately involved in 
coordinating progression through the cell cycle in response to various alterations 
of the extracellular and intracellular nutrient profile.  Consistent with this role, 
grr1Δ cells are additionally resistant to the repressive affects of glucose on the 
expression of genes needed for the utilization of alternative carbon sources.  The 
molecular response of yeast to the presence of glucose underlies the ability of 
Saccharomyces to preferentially ferment glucose to ethanol, an attribute of yeast 
that has been exploited by man for centuries.  Given this attribute, much attention 
has been devoted to determining the molecular events that dictate 
Saccharomyces response to glucose and thus the literature encompassing this 
subject is vast.  Therefore the following chapter will be devoted to this subject 
and the role of Grr1 in the process of glucose repression 
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CHAPTER 2:  GLUCOSE TRANSPORT, SIGNALING, AND METABOLISM IN 
SACCHAROMYCES 
 
2.1.  Introduction to Glucose Signaling and Metabolism 
Unlike mammalian cells, the preferred metabolic pathway to generate ATP 
in the yeast, S. cerevisiae, is through aerobic fermentation of glucose.  Once 
glucose has been transported into the cell it is converted to two pyruvates 
through a series of enzymatic reactions that together comprise a nearly 
universally conserved metabolic pathway, termed glycolysis.  In mammalian cells 
and other respiratory organisms, pyruvate is funneled into the citric acid cycle to 
produce electron carriers which are subsequently utilized to generate a proton 
gradient and produce ATP through oxidative phosphorylation.  This process is 
efficient, since 32 ATPs are generated from one molecule of glucose.  
Saccharomyces, on the other hand, during growth on glucose, preferentially 
converts pyruvate to ethanol which produces only two ATPs for every molecule 
of glucose catabolized.  Though inefficient, fermentive growth is fast, supporting 
a growth rate of 0.34 doublings per hour whereas the growth rate on galactose or 
ethanol is 0.26 and 0.087 doublings per hour, respectively 134.  Despite its 
inefficiencies, the preference to ferment glucose to ethanol most likely evolved in 
Saccharomyces to establish a competitive advantage in the environment.  The 
fast growth rate allows for yeast to keep pace with faster growing microbes and 
the production of ethanol concurrently decreases the growth rate of these 
microbes as most are ethanol intolerant. 
After the complete consumption of glucose, Saccharomyces will begin to 
utilize other fermentable carbon sources and finally non-fermentable carbon 
sources in order to maintain viability.  A good example of Saccharomyces 
preference for glucose and its nutrient adaptability can be seen in the 
fermentation profile presented in Figure 2.1.  When yeast is gown in the 
presence of glucose and maltose at equal concentrations (% weight to volume), 
the glucose is fermented first and completely before the maltose begins to be 
metabolized.  After complete utilization of glucose Saccharomyces prefers to 
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ferment other hexose sugars, such as maltose.  In the absence of other 
fermentable sugars, as maltose is depleted, Saccharomyces diverts more and 
more pyruvate generated from glycolysis away from ethanol production to the 
TCA cycle where it is respired to produce ATP more efficiently.  Finally, after 
complete utilization of fermentable sugars Saccharomyces once again alters its 
metabolism to utilize C2 and C3 carbon sources such as ethanol and glycerol. 
The versatility of yeast to grow on a wide variety of carbon sources is 
facilitated by their ability to reprogram their metabolic state.  Metabolic state, as 
used here, is defined by the active subset of transporters and enzymes needed 
to metabolize a given carbon source for energy production.  Though this re-
programming occurs at all molecular regulatory levels the alterations in the 
transcriptional profile of yeast in batch culture as they progress from fermentative 
to respiratory based growth provides a descriptive representation of this complex 
process 135.  In the presence of glucose, multiple molecular pathways responsive 
to both internal and external glucose concentrations act to both repress (glucose 
repression) and inactivate genes and proteins responsible for the metabolism of 
other “non-preferred” carbon sources and to induce and activate genes and 
proteins needed for glucose fermentation.  As seen in Figure 2.1 B, on glucose, 
genes and proteins needed for maltose utilization as well as respiration are 
suppressed in order to favor ethanol production from glucose.  As glucose is 
usurped the regulatory pathways acting to repress maltose transporters and 
enzymatic proteins are de-activated allowing for fermentation of maltose (Figure 
2.1 C).  The depletion of a fermentable sugar (in this case maltose) leads to a 
gradual increase in respiratory genes needed to support ATP production as the 
metabolic flux through glycolysis is reduced (Figure 2.1 D).  Finally, the complete 
depletion of maltose leads to de-repression of genes involved in the glyoxylate 
cycle, gluconeogenesis, and respiration in order to support growth on C2 and C3 
carbon sources such as ethanol. 
 The ability to reprogram the metabolic state is conferred by the concerted 
action of a network of regulatory pathways that act to coordinate transcriptional 
and post-transcriptional processes in response to the internal and external 
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nutrient composition.  Among the different carbon sources, the molecular 
response of yeast to glucose has drawn the most attention and as a result the 
regulatory pathways which facilitate the molecular response to glucose have 
been extensively characterized, especially at the level of gene expression 
135,136,67,137-140.  Three regulatory pathways with seemingly redundant and non-
redundant functions contribute to the transcriptional and post-transcriptional re-
programming of the metabolic state of the cell in response to glucose.  First, 
activation of the Ras/cAMP/PKA pathway has been shown to result in the 
activation and inactivation of almost the entire subset of glucose responsive 
genes through a mechanism that most likely is initiated by the phosphorylation of 
glucose to glucose-6-phosphate by one of the hexose kinases (Hxk1, Hxk2, or 
Glk1) 141.  The Snf3/Rgt2 pathway has been shown to almost exclusively regulate 
the transcriptional de-repression of hexose transporters in response to external 
glucose concentrations 142-144.  Finally, the Glc7/Snf1 pathway regulates the 
transcriptional induction of MAL (maltose), GAL (galactose), and SUC (sucrose) 
genes 145,146 as well as genes involved in gluconeogenesis, respiration, and the 
glyoxylate cycle in response to glucose depletion 147-151.  Inhibition of Snf1 
catalytic activity in the presence of glucose is also dependent on Hxk2 activity 152-
156,136.  Through integration of these three regulatory pathways the molecular 
response to glucose is elicited. 
 
2.2.  Grr1 and Glucose Repression  
Mutant alleles of GRR1 were first isolated when ethylmethanesulfonate 
(EMS) mutagenized yeast were screened for mutations that conferred resistance 
to 2-deoxyglucose 65.  2-Deoxyglucose is a non-metabolizable glucose analogue 
that retains the ability to exert glucose repression 157.  Thus, wild-type yeast 
strains lack the ability to grow on media containing non-glucose carbon sources 
in the presence of 2-deoxyglucose because the production of the enzymes 
necessary for utilization of these carbon sources is inhibited by glucose 
repression while 2-deoxyglucose itself cannot be metabolized to produce energy.   
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However, multiple non-allelic mutations have been isolated that abrogate the 
sensitivity of S. cerevisiae to 2-deoxyglucose and thus, these strains grow 
robustly on non-glucose carbon sources in its presence.  The resistance to 2-
deoxyglucose displayed by these mutants is conferred by their ability to produce 
the enzymes needed to grow on non-glucose carbon sources despite the 
presence of a signal to induce glucose repression and as a result yeast strains 
harboring these mutations have been deemed glucose repression resistant.  
Yeast deficient for the GRR1 gene exhibit this glucose repression resistance and 
as a result this gene was aptly named for the phenotype it conferred (Glucose 
Repression Resistant). 
A diverse array of glucose repressed transcripts is observed to exhibit 
glucose insensitive expression in grr1Δ strains.  Invertase (SUC2), maltase 
(MAL12, 22, 32, 42, 62), galactokinase (GAL1), and cytochrome c oxidase (COX 
genes) were among the first genes characterized to be insensitive to glucose 
repression in grr1Δ strains 64,158; however micro-array analysis of grr1Δ strains 
reveal that a large number of glucose repressed transcripts are actively 
expressed despite the presence of glucose.  Enzymes needed for the utilization 
of other fermentable carbon sources (i.e. maltose, galactose, and sucrose) as 
well as respiratory, gluconeogenic, and glyoxylate cycle genes needed for growth 
on C2 and C3 carbon sources (i.e. glycerol, ethanol, and acetate) all show 
increased gene expression in grr1Δ strains (159 and present study).  Additionally, 
previous studies revealed that Grr1 activity was necessary for induction of a 
number of glucose transporters in response to the presence of glucose in the 
external environment 69,56,160.  The signaling mechanism for the control of these 
transporters has been eloquently revealed and it is now known that defects in 
hexose transporter induction in grr1Δ strains is a result of the positive role of Grr1 
in glucose signaling through the Snf3/Rgt2 pathway 161-165.  Thus, the glucose 
repression resistant effects of a GRR1 deletion influence genes under the control 
of both the Snf3/Rgt2 pathway and the Hxk/Glc7/Snf1 pathway. 
Currently, the lack of glucose repression exerted on genes under the 
control of the Hxk2/Glc7/Snf1 pathway in grr1Δ strains is hypothesized to be an
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Figure 2.1.  Metabolic States of Saccharomyces throughout the 
Fermentation Process.  A.  Fermentation profile of a wild-type Saccharomyces strain 
grown in batch culture in YP 1% glucose 1% maltose.  Panes B-E represent simplified schematic 
diagrams of the metabolic state of the cell at the times on the fermentation profile as indicated.  
Green boxes in the panels encapsulate the metabolic pathway of greatest flux at the time point 
indicated while red dashed boxes represent repressed metabolic pathways.  Red lines represent 
glucose repressed pathways.  B.  Saccharomyces prefers to ferment glucose before any other 
carbon/energy source.  This preference for glucose is realized at the molecular level through 
integration of multiple signaling pathways which ultimately repress genes necessary for the 
utilization of other carbon sources (in this case maltose) and respiration.  C.  As glucose is 
usurped, the repression of genes needed for fermentation of secondary sugars such as maltose 
is lifted while repression of TCA cycle and respiratory genes is maintained.  D.  As 
Saccharomyces usurps all the fermentable sugars, repression of respiratory and TCA cycle 
genes is gradually lifted and coordinately more pyruvate generated from glycolysis is diverted 
from ethanol production to respiratory metabolism in order to support the energy demands of the 
cell.  E.  Once all fermentable sugars have been utilized, Saccharomyces goes through a 
dramatic alteration in its metabolic state known as the diauxic shift where fermentive growth is no 
longer supported.  At this point, TCA cycle, respiratory, gluconeogenic, and glyoxylate cycle 
genes are completely de-repressed and Saccharomyces growth is fully supported through 
utilization of C2 and C3 carbon energy sources (in this case ethanol). 
 
indirect consequence of defective glucose transport 69,70,67,166,167.  Defective 
glucose transport in grr1Δ strains is attributed to an inability to de-repress hexose 
transporter gene expression in response to glucose due to the positive role of 
Grr1 in relieving HXT repression through Snf3/Rgt2 167,168,56.  It is thought that 
defective glucose transport in grr1Δ strains results in decreased flux through the 
glycolytic pathway which thereby releases glucose repression of genes affected 
by the Hxk2/Glc7/Snf1 pathway through an unknown mechanism 69,169,67.  
However, a number of observations suggest that this explanation is not sufficient 
to explain the glucose repression defects of grr1Δ strains.  First, though grr1Δ 
strains do show defects in high affinity glucose transport (needed for growth on 
low glucose), only a 30% reduction in low affinity transport (needed for growth on 
moderate to high glucose) has been observed and transcriptional studies 
measuring glucose insensitive expression of gluconeogenic and glyoxylate cycle 
genes have been performed utilizing samples from grr1Δ strains grown on 
moderate to high glucose concentrations (~1-2%) 159.  A number of studies 
suggest that a 30% transport reduction is insufficient to de-repress the 
gluconeogenic genes observed to be expressed in grr1Δ strains 170-173.  Second, 
grr1Δ strains are observed to have increased doubling times on glucose media 
which has been hypothesized to be a consequence of increased respiratory 
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metabolism in these strains 174.  However, while fermentation profiles performed 
on grr1Δ strains in glucose media have revealed decreased glucose uptake in 
these strains, they have not revealed significant decreases in ethanol yield 67.  
These observations present a number of questions regarding the role of Grr1 in 
glucose signaling and metabolism.  First, are the changes in gene expression 
observed for the HXTs as well as the MAL, GAL, SUC, respiratory, and 
gluconeogenic genes reflected at the protein level?  Second, if so, how do grr1Δ 
cells maintain glucose fermentation despite increases in enzymes that would 
divert pyruvate from ethanol production and into respiratory metabolism?  Lastly, 
does the decrease in glucose flux associated with the decreased glucose uptake 
in grr1Δ cells lead to de-repression of the internal glucose sensing pathway 
(Hxk/Glc7/Snf1) or is there an additional direct role for Grr1 in the internal 
glucose signaling pathway?  In order to answer these questions it is first 
necessary to understand the mechanisms by which glucose is transported in 
wild-type yeast as well as the signaling pathways which affect their regulation 
and the regulation of other normally glucose repressed genes.  Additionally, it is 
necessary to understand the current knowledge pertaining to the role of Grr1 in 
these processes.  With this in mind, in the following sections, a detailed 
description of glucose transport and control of glucose transporter transcription 
through the Snf3/Rgt2 pathway will be presented.  The role of Grr1 in this 
pathway as well as the phenotypes exhibited by grr1Δ cells as a result of 
defective signaling through this pathway will be emphasized.  Additionally, 
glucose signaling through the internal Hxk/Glc7/Snf1 pathway will be reviewed.   
 
2.3.  Glucose Transport in S. cerevisiae 
There are 20 genes in the S. cerevisiae genome that encode products 
with similarities to glucose transporters (HXT1-HXT17, GAL2, SNF3, and RGT2) 
underscoring the importance of glucose to Saccharomyces 175.  Interestingly, 
only Hxt1, Hxt2, Hxt3, Hxt4, Hxt6, and Hxt7 have been shown to be necessary 
for glucose transport since a yeast strain deleted for all six of these transporters 
(known as the hxt null, hxt1-hxt7Δ) exhibits no glucose uptake and no growth on 
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glucose media 176,177.  GAL2 encodes for the galactose transporter, but GAL2 
over-expression restores normal glucose transport to the hxt null strain 177.  
However, expression of this gene is regulated dualistically through glucose 
repression and galactose dependent induction and is therefore not actively 
expressed in media devoid of galactose.  The physiological role of the remaining 
hexose transporter genes (HXT8-HXT17) has yet to be determined but it has 
been hypothesized that these genes may encode for transporters specific to 
other sugars 178.  Thus, the primary hexose transporters responsible for glucose 
transport under normal laboratory conditions (~1% glucose or above) are 
encoded by HXT1-HXT7 and what is known about their transport kinetics, 
transcriptional regulation, and post-transcriptional regulation will be discussed 
further. 
S. cerevisiae possesses the ability to grow on a variety of glucose 
concentrations and this ability is conferred by multiple transport systems with 
varying affinities for glucose 179.  Originally, two glucose uptake systems were 
described for S. cerevisiae; a constitutive low affinity uptake system acting on 
moderate to high glucose concentrations and a glucose repressible high affinity 
system acting at low glucose concentrations 180.  Genetic as well as biochemical 
characterization of yeast expressing only one of the seven hexose transporters at 
a time in the hxt null strain showed that each of these strains exhibited varying 
abilities to grow at different glucose concentrations 176 and that each of these 
transporters possesses a distinct affinity for glucose 173,181.  HXT1, HXT3, or 
HXT4 expressing strains exhibited normal growth on high glucose concentrations 
(5%, or 278mM) but have impaired growth on low glucose concentrations (0.1% 
or 5.5mM).  The growth defect on low glucose was especially pronounced in 
HXT1 strains with a growth defect obvious at even 1% (55.5mM) glucose.  This 
phenotype is explained by the fact that the Hxt1 transporter shows the lowest 
affinity for glucose (Km = ~107mM), implicating Hxt1 in the transport of glucose 
at high extra-cellular glucose concentrations.  HXT3 and HXT4 growth defects on 
0.1% glucose were more subtle and these phenotypes were consistent with their 
measured affinities (measured Km-values of ~28mM and 6mM respectively) and 
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thus Hxt3 and Hxt4 are also considered moderate to low affinity glucose 
transporters.  Three of the remaining individual hexose transporter strains (HXT2, 
HXT6, or HXT7 expressing) display opposite growth properties from the low 
affinity hexose transporters, exhibiting wild-type growth on low glucose 
concentrations and growth defects on high glucose concentrations.  Thus, Hxt2, 
Hxt6, and Hxt7 were characterized as high affinity transporters with Km values 
for glucose of ~4mM, .9mM, and 1.3mM respectively.  Finally, the HXT5 
expressing strain did not restore glucose transport to the hxt null and thus was 
deemed to possess no glucose transport capacity 173,176.  Thus, the combined 
action of these various glucose transporters enables yeast to support growth on 
fluctuating glucose concentrations. 
 
2.4.  Transcriptional Expression of Glucose Transporter Genes in 
Response to Fluctuating Glucose Concentrations 
Over a broad range of glucose concentrations it has been observed that 
the maximal rates of glucose transport remain constant yet the affinity for glucose 
increases as the glucose concentration decreases for S .cerevisiae 182.  This 
ability to maintain relatively steady glucose influx over varying glucose 
concentrations is the manifestation of a corollary of regulatory mechanisms that 
modulate the transport capacity of S. cerevisiae in response to the external 
glucose concentration.  These regulatory mechanisms ultimately control the 
subset of active glucose transporters present at the plasma membrane and their 
transport activities by directly controlling the transcriptional expression of hexose 
transporter genes and the stability, localization, and activity of Hxt proteins.  Thus 
through the integration of these regulatory mechanisms yeast cells only actively 
express the subset of hexose transporters appropriate for growth on the actual 
external glucose concentration.   
Though regulation of each of the hexose transporters is ultimately 
achieved by integration of transcriptional and post-transcriptional regulatory 
mechanisms the majority of work has been devoted to understanding the factors 
contributing to HXT gene regulation.  Through this work, it was established that 
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the transcriptional regulation of each of the hexose transporters in response to 
glucose is consistent with the measured uptake kinetics for each transporter 181.  
Thus, for HXT1, a low affinity glucose transporter, gene expression increases 
linearly with increasing glucose concentrations reaching maximal expression at 
4% glucose where it shows an ~300 fold induction compared to transcript levels 
measured in galactose grown yeast cells (repressing) 167.  The expression levels 
of HXT3 (encoding a moderate to low affinity transporter) in response to glucose 
are more moderate, increasing ~10 fold at 1% glucose concentrations, again 
consistent with Hxt3 uptake kinetics, with induction observed at glucose levels 
between 0.1 and 1%.  It is also interesting to note that HXT3 expression varies 
the least of any functional glucose transporter with high expression observed 
over the broadest range of glucose concentrations 167.  The transcriptional 
expression of HXT1 and HXT3 are not subject to glucose repression and this fact 
along with their measured uptake kinetics suggest that they are the major 
transporters comprising the low affinity glucose uptake system that was initially 
detected for this Saccharomyces.   
The remaining functional glucose transporter genes (HXT2, HXT4, HXT6 
and HXT7) are subject to glucose repression with maximal expression observed 
at low glucose concentrations and thus together comprise the high affinity uptake 
system.  HXT2 and HXT4, encoding high affinity hexose transporters, show 
similar expression profiles, with HXT4 transcription showing greater sensitivity to 
glucose repression.  Gene expression profiles for these transcripts show 
induction between 0.1 and 0.5% glucose with reduction in expression observed 
at glucose concentrations greater than 0.75%.  Basal levels for HXT2 are 
reached at 4% glucose while HXT4 expression reaches basal level at 1% 
glucose 167.  The HXT6 and HXT7 genes encode for highly similar proteins that 
only differ at two amino acid residues (293 Val/Ile and 556 Thr/Ala) 176.  
Furthermore, these two genes are located in tandem on the right arm of 
chromosome IV and in some strains are fused into a single chimeric gene 176,177.  
Thus, HXT6 and HXT7 gene expression is strikingly similar as both are highly 
glucose repressible at glucose concentrations greater than 0.5%.  Interestingly, 
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HXT7 exhibits the strongest level of expression of any HXT gene during growth 
on extremely low levels of glucose or on non-fermentable carbon sources, 
suggesting that this transporter is critical for re-establishment of glucose 
fermentation after prolonged periods of non-fermentative growth 183. 
 
2.5.  Glucose Signaling and Control of Hexose Transporters by the Rgt2 
and Snf3 Pathway 
The extracellular nutrient composition in both nature and the laboratory 
environment is in a constant state of flux and thus in order to support growth in 
this, vacillating environment, organisms must be able to adapt accordingly.  S. 
cerevisiae, glucose transport capacity is adjusted to maintain an optimal influx of 
glucose in response to external glucose fluctuations.  As reviewed earlier, the 
ability of yeast to maintain adequate glucose transport as glucose concentrations 
vary is realized, in part, by the presence of multiple glucose transporters with 
varying affinities for glucose.  However, in order to maintain optimal glucose 
transport rates across a wide range of glucose concentrations, the subset of 
active transporters present at the plasma membrane must be coordinated in 
response to the external and internal glucose concentrations.  Coordination of 
hexose transporter gene expression with external glucose concentrations is 
partially realized through a regulatory pathway that monitors extracellular glucose 
concentrations utilizing two glucose sensors known as Snf3 and Rgt2.  These 
two glucose sensors initiate a signal that is propagated in a Grr1 dependent 
manner to ultimately alter the activity of a transcriptional repressor known as 
Rgt1 which binds the promoter region of a number of HXT genes. 
 
2.5.1.  The Snf3 and Rgt2 Extracellular Glucose Sensors 
Snf3 and Rgt2 are high and low affinity glucose sensors, respectively, that 
lack the ability to transport glucose 144 but nevertheless influence glucose 
transport by coordinating hexose transporter transcription in response to 
extracellular glucose concentrations.  Null mutations in SNF3 (sucrose non-
fermenting) were first isolated in screens searching for spontaneous mutations 
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that conferred the inability to grow on sucrose or raffinose 184.  These two 
polysaccharides are hydrolyzed in the periplasmic space by a secreted enzyme 
known as invertase, encoded by SUC2, which provides glucose to the cell.  It 
was found that snf3Δ cells show no aberrations in the amount of secreted 
invertase activity 185 but show drastic defects in growth on low glucose due to 
defective high affinity glucose uptake 186.  Originally, it was suspected that SNF3 
encoded a high affinity glucose transporter; a conclusion supported by the high 
degree of Snf3 protein sequence homology to hexose transporters (~48%), the 
presence in the Snf3 protein sequence of 12 predicted transmembrane domains 
161, and the fact that Snf3 localizes to the plasma membrane 187.  However, over-
expression of SNF3 in the hxtΔ mutant does not restore growth of this mutant on 
glucose 161 and thus, Snf3 possesses no glucose transport capacity of its own.  
Interestingly, snf3Δ cells are unable to induce transcriptional expression of the 
high affinity glucose transporters HXT2 and HXT4 in low glucose conditions 167.  
Also, in snf3Δ cells, expression of the low affinity glucose transporter, HXT3, is 
reduced by greater than threefold on low glucose (raffinose) but is fully induced 
on high glucose concentrations (~4% glucose).  However, the transcriptional 
expression of HXT1, another low affinity hexose transporter is only partially 
affected by the absence of SNF3 167.  Taken together, these results suggest that 
Snf3 functions as a high affinity glucose sensor that primarily influences the 
transcriptional expression of high affinity glucose transporters. 
The transcriptional expression of the low affinity glucose transporters 
(HXT1 and HXT3) on high glucose concentrations requires another plasma 
membrane localized protein known as Rgt2.  Rgt2 is 60% similar in sequence 
identity to Snf3 and also like Snf3 possesses 12 predicted transmembrane 
domains.  A dominant mutation in RGT2, named RGT2-1, was isolated as a 
suppressor that restores high affinity glucose uptake to snf3Δ cells 188.  This 
dominant RGT2 allele restored, through a glucose and SNF3 independent 
mechanism, the transcriptional expression of HXT2 and HXT4, and displayed 
constitutive expression of HXT1.  Interestingly, introduction of the same mutation 
into the SNF3 locus (known as SNF3-1) also caused constitutive transcriptional 
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expression of HXT2 and HXT1 144.  Strains deleted for RGT2 display normal 
induction of HXT2 and HXT4 on low levels of glucose but are unable to fully 
induce HXT1 transcription on high levels of glucose 144.  Taken together, these 
data suggest that Rgt2 and Snf3 coordinate the transcriptional expression of low 
and high affinity glucose transporter genes, respectively, in response to external 
glucose concentrations.  Consistent with a role for these two proteins in the 
positive regulation of HXTs in response to glucose, snf3Δrgt2Δ strains exhibit 
extremely slow growth on glucose media and no growth at all on glucose media 
in the presence of the respiratory inhibitor, Antimycin A 99. 
 
2.5.2.  Std1 and Mth1 
Though the precise mechanism by which glucose may be sensed through 
Snf3 and Rgt2 has not been elucidated, the molecular events initiated by these 
two sensors that ultimately coordinate hexose transporter transcription to 
external glucose levels have been revealed.  Unlike the other members of the 
hexose transporter family, Snf3 and Rgt2 possess an additional long C-terminal 
cytoplasmic tail of 218 and 303 amino acids, respectively.  Interestingly, deletion 
of these C-terminal tails abolishes the ability of these two sensors to induce the 
expression of their respective glucose transporter genes and chimeric Hxt1 and 
Hxt2 proteins with Snf3 and Rgt2 tails fused to their C-terminus restore this ability 
161.  These cytoplasmic tails have been found to mediate binding of two proteins 
known as Std1 and Mth1 189,190.  STD1 (Suppressor of TBP Deletion) was 
originally discovered as a high copy suppressor of the growth defect associated 
with over-expression of a dominant negative SPT15 (known as TBPΔ57; first 57 
amino acids on the N-terminus are deleted) allele that encodes a yeast TFIID 
protein 191.  Deletion of STD1 (aka MSN3) confers no observable phenotype on 
glucose media; however, a highly redundant functional paralog that shared 61% 
sequence similarity 192 with STD1 was discovered through low stringency cross 
hybridization to the STD1 coding sequence.  This gene was aptly named MTH1 
(MSN Three Homolog) 192.  Like std1Δ strains, mth1Δ strains have no observable 
phenotypic defects on glucose media; however, deletion of MTH1 in the 
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snf3Δrgt2Δ strain restores wild-type rates of growth to this strain on glucose as 
well as glucose/Antimycin A media 99.  Restoration of glucose based growth in 
the mth1Δrgt2Δsnf3Δ strain was subsequently shown to be a result of glucose 
insensitive transcriptional expression of HXT2, HXT3, and HXT4 in this strain but 
HXT1 expression was unaffected 99.  Deletion of STD1 does not restore HXT 
expression or wild-type growth rates to snf3Δrgt2Δ cells but only a 
std1Δmth1Δsnf3Δrgt2Δ strain exhibited glucose insensitive expression of HXT1 
99.  Together this data suggested that Std1 and Mth1 served to negatively 
regulate low and high affinity HXT expression, respectively, and that these two 
proteins are negatively regulated by the glucose sensors, Snf3 and Rgt2.   
 
2.5.3.  Rgt1 
Mth1 and Std1 together cause repression of HXT genes by activating the 
transcriptional repressor, Rgt1, in the absence of glucose.  Recessive mutations 
in RGT1 were discovered in the same screen as dominant mutations in RGT2 by 
their ability to restore growth on low glucose to snf3Δ strains 188.  It was 
subsequently shown that deletion of RGT1 also restored glucose transport to 
grr1Δ strains 69,166 and that this restoration was due to relief of the constitutive 
repression of HXT2, HXT3, and HXT4 observed in grr1Δ strains 167.  Rgt1 directly 
binds to the promoters of HXT1, HXT2, HXT3, and HXT4 when glucose is absent 
and DNA binding activity towards these promoters requires Rgt1 association with 
Mth1 or Std1 193-195,56,196.  Loss of either MTH1 or STD1 leads to glucose 
insensitive expression of HXT1, HXT2, HXT3, and HXT4 and increased 
expression correlates directly with loss of Rgt1 association at these promoters 
and with Rgt1 hyper-phosphorylation 56.  In the absence of glucose, Rgt1 has 
been found to physically associate with Mth1 and Std1 by two-hybrid and pull-
down assays and its association with Mth1 is required for DNA binding at HXT 
promoters 197.  Mth1 does not directly participate in transcriptional repression in 
conjunction with Rgt1 but is thought to prevent inhibitory phosphorylation of Rgt1 
by the cAMP dependent protein kinases (Tpk1-Tpk3) 143.  Interestingly, though 
Tpk phosphorylation is required for inhibition of Rgt1 repressor activity on low 
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glucose, it is also required for hyper-phosphorylation of Rgt1 on high glucose 
where it acts to induce HXT1 expression 198,199,143.  However, Rgt1 does not 
directly bind the HXT1 promoter on high glucose and thus the role of Rgt1 in 
HXT1 induction occurs through an indirect mechanism; possibly through 
induction of a transcription factor responsible for HXT1 induction on high glucose 
198. 
 
2.5.4.  The Role of Grr1 in the Snf3/Rgt2 Pathway 
Rgt1 repressor activity towards the HXT genes is inactivated through Grr1 
targeted ubiquitin dependent degradation of Mth1 and Std1in response to 
glucose.  Strains deleted for GRR1, like snf3Δrgt2Δ strains, exhibit slow growth 
on glucose and have defects in high affinity glucose transport that are attributable 
to the inability to de-repress HXT gene expression in response to glucose 
availability 162,198,48,66.  This defect, also like snf3Δrgt2Δ strains, is abrogated by 
deletion of RGT1 suggesting that Grr1 participates positively in conjunction with 
Snf3 and Rgt2 to negatively regulate Rgt1 repression of HXT genes 188,167,69.  It 
was originally posited that Grr1 mediates the degradation and/or sub-cellular 
localization of Rgt1 directly yet Rgt1 protein levels remain stable and nuclear 
regardless of glucose concentration.  However, Rgt1 is found to be hypo-
phosphorylated in grr1Δ cells and constitutively bound to HXT1, HXT2, HXT3, 
and HXT4 promoters 56.  Deletion of both STD1 and MTH1 restore expression of 
HXT genes in grr1Δ cells and this restoration correlates with hyper-
phosphorylation of Rgt1 and loss of Rgt1 association with HXT gene promoters 
56.  Mth1 protein levels are rapidly reduced when wild-type cells grown on 
galactose are exposed to glucose and this rapid loss of Mth1 is not observed in 
grr1Δ strains 56.  It was subsequently shown that Mth1 and Std1 are targeted for 
ubiquitin dependent degradation by Grr1 in response to glucose 48,162.  Glucose 
induced ubiquitylation of Mth1 and Std1 requires not only Grr1 but also Snf3 or 
Rgt2, and either of the membrane bound casein kinases, Yck1 and Yck2 162,142. 
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2.5.5.  Model for Control of Hexose Transporter Gene Transcription through 
Integration of the Snf3/Rgt2, Hxk2/Glc7/Snf1, and Ras/cAMP Pathways 
Considering all of the genetic and biochemical evidence regarding each of 
these elements influence on HXT gene expression, a model for how glucose 
stimulates de-repression of HXT genes through the Snf3/Rgt2 pathway has been 
proposed 200,163,197.  In the presence of low to moderate amounts of glucose (0.1-
1%) (Figure 2.2 B and C), it is thought that glucose binding to Snf3 or Rgt2 may 
induce a conformational change in these proteins that stimulates phosphorylation 
of cytoplasmic C-terminally bound Mth1 and Std1 by the membrane bound 
casein kinases, Yck1 and Yck2 142.  Phosphorylated Mth1 and Std1 are then 
recognized by Grr1 which facilitates their ubiquitylation and subsequent 
degradation by the 26S proteasome 56,48.  Degradation of Mth1 and Std1 inhibits 
their association with Rgt1 resulting in the exposure of inhibitory phosphorylation 
sites on Rgt1 that are targeted by cAMP dependent protein kinases (Tpks).  
Phosphorylated Rgt1 no longer associates with HXT promoters and thus 
repression is lifted in the presence of glucose.  In the absence of glucose or in 
grr1Δ strains (Figure 2.2 A), Std1 and Mth1 phosphorylation, ubiquitylation, and 
degradation is absent allowing Std1 and Mth1 to translocate to the nucleus and 
bind Rgt1 195.  Std1 and Mth1 mask Tpk phosphorylation sites on Rgt1 leading to 
Rgt1 hypo-phosphorylation.  This active complex is then free to bind the 
promoters of a number of HXTs resulting in their transcriptional repression.   
While this model provides a basic description of the events that occur along the 
Snf2/Rgt2 pathway to control HXT transcription, full control of HXT expression is 
actually achieved through the combined action of the Hxk/Glc7/Snf1, Ras/cAMP, 
and the Snf3/Rgt2 pathways.  Through integration of these pathways, expression 
of the appropriate subset of HXT genes is intricately coordinated in response to 
the external and internal glucose concentrations.  When no glucose is present, 
as indicated above, transcription of HXT1,2,3 and 4 is repressed by Rgt1 in 
association with Mth1 and Std1 201.  On high glucose, the high affinity 
transporters Hxt2, 4, and 6/7 are not needed and therefore are transcriptionally 
repressed.  However, repression of their respective genes is not exerted by Rgt1  
 43 
 
on high glucose but by another repressor known as Mig1 167.  Mig1 repressor 
activity is inactivated by Snf1 dependent phosphorylation 202,203.  On high 
glucose, Snf1 kinase activity is inactivated by a signaling mechanism that 
requires Hxk2 and the PP1 phosphatase, Glc7, in association with one of its 
targeting proteins, Reg1.  Through an unknown mechanism, Hxk2 
phosphorylation of glucose to glucose-6-phosphate promotes Glc7 association 
with Reg1 which targets Glc7 phosphatase activity to de-phosphorylate and 
subsequently inactivate Snf1 kinase 204.  Inactivation of Snf1 kinase on high 
glucose prevents Snf1 dependent inactivation of Mig1 which binds to the HXT2, 
HXT4, and HXT6/7 promoters 160.  On high glucose, full de-repression of the low 
affinity transporter genes, HXT3 and HXT1 is achieved because these two 
transporter genes are not subject to Mig1 mediated repression and Rgt1 
repressor activity is fully inactive due to Rgt1 hyper-phosphorylation by the cAMP 
dependent protein kinases 197,143.   
On low glucose, the intracellular signals which lead to high affinity 
transporter gene expression and low affinity transporter gene repression are only 
partially defined and the events that dictate full expression of HXT1 on high 
glucose and repression of HXT1 on low glucose remain unclear.  High glucose 
concentrations promote Tpk dependent hyper-phosphorylation of Rgt1 which 
leads to activation of HXT expression 198.  However, Rgt1 does not directly bind 
the HXT1 promoter under these conditions 198.  Additionally, Std1 exclusively 
inhibits HXT1 expression in conjunction with Rgt1 on low glucose, suggesting 
that Mth1 and Std1 function are not completely redundant 189.  A mechanism that 
completely describes how Rgt1 repressor activity is maintained at low affinity 
transporter gene promoters (specifically HXT1) but is inactivated on high affinity 
hexose transporter genes on low glucose has not been described.  Here we 
propose a new model based on our interpretation of the current literature.  On 
low glucose, the high affinity glucose sensor, Snf3, is activated, signaling for the 
Grr1 dependent degradation of Std1 and Mth1 which have both been found to 
bind the cytoplasmic C-terminal tail of Snf3.  However, we propose that signaling 
through the low affinity sensor, Rgt2, is not active on low glucose conditions and 
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Figure 2.2.  Transcriptional Regulation of Hexose Transport.  A.  On low 
glucose or in grr1Δ cells, degradation of Std1 and Mth1 is prevented and through and unknown 
mechanism Std1 and Mth1 translocate to the nucleus where they physically interact with the Rgt1 
repressor.  Association of Std1 and Mth1 with Rgt1 leads to repression of both low affinity (HXT1 
and HXT3) and high affinity (HXT2 and HXT4) hexose transporter genes.  At the same time 
Hxk2/Reg1-Glc7 inhibition of Snf1 kinase activity is prevented leading to phosphorylation and 
inhibition of the transcriptional repressor Mig1.  B.  Low extracellular glucose is sensed through 
the high affinity glucose sensor, Snf3, which promotes Yck1/2 (casein kinases) dependent 
phosphorylation of Snf3-C terminally bound Std1 and Mth1.  Phosphorylation of Std1 and Mth1 
leads to their ubiquitylation by SCFGrr1 which targets Std1 and Mth1 for proteasomal degradation.  
However, the low affinity glucose sensor, Rgt2, is not active and C-terminally bound Std1 is free 
to associate and activate the Snf1 kinase.  The active, nuclear localized, Std1-Snf1 kinase 
complex associates with Rgt1, preventing Rgt1 hyper-phosphorylation by the cAMP dependent 
protein kinases (Tpk1-3).  The Std1-Rgt1-Snf1 complex fully represses HXT1 expression, partially 
represses HXT3 gene expression, and inhibits Mig1 dependent repression of high affinity (HXT2 
and HXT4) hexose transporter expression.  C.  High glucose is sensed by both the high affinity 
glucose sensor, Snf3, and the low affinity glucose sensor, Rgt2, which leads to Yck1/2 dependent 
phosphorylation of both Snf3 C-terminally associated Std1 and Mth1 and Rgt2 C-terminally 
associated Std1.  Mth1 and Std1 are then ubiquitylated by SCFGrr1 which targets them for 
proteasomal degradation.  Degradation of Std1 and Mth1 leads to hyper-phosphorylation and 
inactivation of the Rgt1 transcriptional repressor which subsequently leads to inhibition of Rgt1 
dependent repression of the low affinity hexose transporters, HXT1 and HXT3.  Concurrently, the 
high rate of glucose transport leads to inactivation of Snf1 through Reg1-Glc7 de-phosphorylation 
of Thr210 in the Snf1 catalytic domain.  Inhibition of Snf1 kinase activity leads to Mig1 hypo-
phosphorylation promoting Mig1 dependent repression of the high affinity hexose transporters, 
HXT2, HXT4, and possibly HXT6/7 205-209.   
 
that only Std1 binds to its cytoplasmic C-terminal tail.  This hypothesis is based 
on a number of genetic and biochemical assays described here.  It was originally 
discovered through two-hybrid analysis that while Std1 interacted with both 
glucose sensors, Mth1, only interacted with the high affinity sensor, Snf3 189.  
Consistent with these observations, Snf3 contains two copies of a conserved, C-
terminal, 25 amino acid, sequence which serve as binding sites for Std1 and 
Mth1, whereas Rgt2 contains only one such sequence 161.  Furthermore, 
mutations in Rgt2 have been found to exclusively prevent high glucose activation 
of HXT1 expression 161 and glucose insensitive expression of HXT1 requires 
deletion of both STD1 and MTH1, whereas glucose insensitive expression of 
HXT2 and HXT4 only requires MTH1 deletion 189.  Interestingly, Std1 has been 
discovered to interact with Snf1 210,192 and Snf1 activity is required for HXT1 
repression on low glucose 189,210. 
Taking these observations into account; the following model for de-
repression of the high affinity hexose transporter genes and repression of the low 
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affinity hexose transporter, HXT1, on low glucose is proposed (Figure 2.2 B).  
Low external glucose concentrations activate the high affinity glucose sensor, 
Snf3, leading to Grr1 dependent ubiquitylation and degradation of Snf3 
associated, Std1 and Mth1.  On the other hand, low glucose does not lead to 
complete degradation of Std1 and it alone binds to Rgt2 which is not activated by 
low glucose.  Stabilized Std1 is free to interact with Snf1 preventing Snf1 
inactivation by Reg1-Glc7 and leading to the nuclear localization of a Std1-Snf1-
Gal83-Snf4 complex.  The absence of Mth1 bound Rgt1 leads to phosphorylation 
of Rgt1 by the cAMP dependent protein kinases (TPKs) which inhibits the 
repressor activity of Rgt1 towards the high affinity hexose transporter genes, 
HXT2, HXT4, and HXT6,7.  At the same time, Mig1 repression of these genes is 
relieved through inactivation of Mig1 by Std1-Snf1-Gal83-Snf4 dependent 
phosphorylation.  Full repression of HXT1 and partial repression of HXT3 is 
achieved through the Std1 dependent interaction of Rgt1 with the Snf1-Gal83-
Snf4 complex. 
 
2.6.  The Hxk/Glc7/Snf1 Dependent Intracellular Glucose Signaling Pathway 
2.6.1.  Hxk2 and Glucose Phosphorylation 
Once glucose has been transported into the cell by any of the functional 
hexose transporters it is quickly and irreversibly phosphorylated by one of three 
hexose kinases in yeast to form glucose-6-phosphate.  There are three hexose 
kinases in yeast that possess the ability to phosphorylate glucose including Hxk1, 
Hxk2, and Glk1 211.  Though each of these enzymes is capable of glucose 
phosphorylation, both transcriptional and protein expression studies suggest that 
Hxk2 provides most of the glucose phosphorylation activity in cells growing 
exponentially on glucose 212,213.  As the first and predominate enzyme in the 
metabolism of glucose, it is not surprising that Hxk2 plays a major regulatory role 
in glucose repression that cannot be ascribed to either Hxk1 or Glk1 154,155 Genes 
resistant to glucose repression in strains deleted for HXK2 include SUC2 153,152, 
HXK1 and GLK1 152,214, MAL and GAL genes 215-217, HXT2 and HXT4 218, and 
genes involved in respiratory metabolism 215,216,219.  The altered expression of 
 47 
 
 
 
Figure 2.3.  Control of Hxk2 Dimerization and Hxk2 Dependent 
Transcriptional Repression in Response to Glucose.  In the absence of glucose, 
Hxk2 is found primarily in a hyper-phosphorylated form that possesses a higher Km for glucose 
(indicated by thin green line).  The kinase acting to phosphorylate Hxk2 is currently unknown.  
Through an unknown signal, increased concentrations of glucose or glucose-6-phosphate induce 
Reg1-Glc7 dependent de-phosphorylation of Hxk2 (green dashed lines) which leads to Hxk2 
dimerization.  Dimerized Hxk2 possesses a lower Km for glucose and thus possibly supports 
greater glycolytic flux (thick green line).  It is presumed that the dimerized form of Hxk2 interacts 
with the Mig1 repressor which promotes nuclear localization of Hxk2.  Nuclear Mig1-Hxk2 binds 
directly to the SUC2, GLK1, and HXK1 promoters to repress these genes transcription in 
response to glucose.  Nuclear Hxk2-Mig1 also is required through an unknown mechanism to 
induce HXK2 transcription on high glucose.  Repression of MAL, GAL, respiratory, 
gluconeogenic, and glyoxylate cycle genes is inhibited through an Hxk2 and Reg1-Glc7 
dependent pathway that acts to inhibit Snf1 catalytic activity which is responsible for induction of 
these genes in response to glucose exhaustion.  (Figure 2.4)
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respiratory genes are commensurate with an increased respiratory capacity in 
this stain, since hxk2Δ strains have been shown to grow 30% slower on glucose 
as well as have a 41% decrease in ethanol yield 215,219.  Additionally, hxk2Δ 
strains have been shown to co-consume multiple sugars and ethanol in the 
presence of glucose 220.  Genes encoding gluconeogenesis enzymes are 
unaffected by HXK2 deletion 216,215. 
Recent evidence suggests that, in addition to the catalytic activity of Hxk2, 
Hxk2 serves a direct role in transcriptional regulation of glucose repressed 
genes.  Support for this role is supplied by a number of independent 
observations.  Though most of Hxk2 protein is localized in the cytoplasm, a 
significant fraction has been determined to be nuclear localized (~14%) on 
glucose media 221-223.  Translocation of Hxk2 to the nucleus requires a putative 
nuclear localization sequence within the N-terminal sequence, K7 –M16, since a 
strain containing an Hxk2 construct lacking these amino acids (HXK2Δ K7M16) 
does not localize to the nucleus 223.  The nuclear localization of Hxk2 has been 
shown to be induced by the presence of glucose and is dependent on Hxk2 
interaction with Mig1 which is a transcriptional repressor of many glucose 
repressed genes 222.  Nuclear localized Hxk2 is required for SUC2 repression 
and has been shown to associate with a complex of proteins in the upstream 
promoter of this gene that includes the transcriptional repressor Mig1 and the 
mediator protein Med8 222.  Taken together, the evidence supporting a direct role 
for Hxk2 in controlling transcriptional expression of at least SUC2, HXK1, GLK1, 
and itself is incontrovertible.   
Hxk2 has been shown to be phosphorylated in vivo on Serine 15 and 
enhanced phosphorylation of this site correlates to increased levels of the 
monomer form of Hxk2.  This monomer form of Hxk2 is more prevalent when 
cells are grown on non-repressive carbon sources such as galactose, raffinose, 
and ethanol.  The phosphorylation and dimerization state of Hxk2 has been 
shown to be affected by mutations in Grr1, Reg1, and Glc7 224.  While the 
increased phosphorylation of Hxk2 leading to the prevalence of the monomer 
form of Hxk2 has been shown to be attributable to reduced glucose transport in 
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grr1 strains, this is not the case for reg1 and glc7 mutations and thus the Reg1-
Glc7 phosphatase complex is proposed to regulate the phosphorylation state of 
Hxk2 directly.  In a subsequent study comparing the phospho-proteome of reg1Δ 
strains and reg1 mutant strains defective in the ability to bind Glc7 to wild-type 
strains; phosphorylation of Hxk2 was found to be enhanced and this was 
subsequently shown to be due to reduced de-phosphorylation of Hxk2 by Reg1-
Glc7 204. 
Given the mounting evidence for a direct role for Hxk2 in transcriptional 
control, it is now undeniable that Hxk2 has both a regulatory and metabolic 
functions in response to the presence of glucose (for an overview of the role of 
Hxk2 in glucose repression see Figure 2.2).  However, the inability to separate 
catalytic activity and regulatory modules of Hxk2 as well as the fact that Hxk1 
and Glk1 cannot substitute for Hxk2 to reduce respiratory metabolism, has led to 
a controversial debate over the role Hxk2 catalytic function plays in regulation of 
glucose repression.  Mutations in Hxk2 that abrogate glucose repression (as 
defined by the extent of SUC2 de-repression) while maintaining wild-type or 
increased levels of glucose phosphorylation activity have been isolated and thus 
Hxk2 catalytic activity is not sufficient for regulation 223.  However, whether Hxk2 
catalytic activity is necessary for exerting glucose repression is another question 
that remains to be answered.  The effect on glucose repression (again in the 
context of SUC2 repression) utilizing mutations which alter Hxk2 catalytic activity 
have been obtained with mixed results as multiple groups found catalytic activity 
to be required for eliciting glucose repression 156,225 while others have isolated 
Hxk2 mutants with low catalytic activity that retained the ability to induce glucose 
repression 226,227.  It should be noted that the effects on glucose repression for 
the various HXK2 mutants have been primarily performed using SUC2 
transcription as a reporter with little attention devoted to other Hxk2 repressed 
genes such as respiratory enzymes.  A role for Hxk2 catalytic activity in their 
repression and de-repression could be primarily dependent on Hxk2 catalytic 
activity since reduced phosphorylation of glucose would lead to an increased 
dependence on respiration to support the energy demands of the cell.  It is also 
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interesting that Hxk1 is 75% identical at the sequence level to Hxk2 and also 
possesses the K7-M16 sequence as well as other regulatory sequences that have 
been shown to be important for Hxk2 regulatory function 163.  The controversy is 
further compounded by the fact that the levels of sugar phosphates can be 
completely supplied by the glucose phosphorylation activity of Hxk1 and Glk1 in 
hxk2Δ strains 228,211,156.  For further review regarding the controversy surrounding 
the mechanism by which Hxk2 induces glucose repression see the following 
excellent reviews 229,230,163,165,164. 
 
2.6.2.  Reg1-Glc7 and Snf1 
In the absence of fermentable sugars, genes required for respiration, 
gluconeogenesis, and the glyoxylate cycle are relieved from repression in order 
to prepare the cell for growth on C2 and C3 carbon sources such as glycerol, 
ethanol, and acetate.  At the protein level, enzymes and transporters responsible 
for the metabolism of these alternative energy sources are activated through 
post-translational events that modify the enzymatic activity and cellular location 
of these proteins.  The integration of these processes requires a complicated 
coordination of multiple molecular signaling events that are all dependent to 
some degree on the activity of the Snf1 kinase.  As glucose is exhausted, Snf1 
kinase activity is elevated through an unknown intracellular signal.  Though the 
origin of this signal remains elusive, the molecular events that occur to regulate 
Snf1 activity and the consequences of Snf1 activation have been elucidated 
through eloquent genetic and biochemical studies.  Given the centralized role for 
Snf1 in the response to glucose limitation and the fact that grr1Δ mutants exhibit 
glucose independent changes in transcriptional and post-transcriptional events 
controlled by Snf1, what is known about Snf1’s regulation and the consequences 
of its activation will be reviewed in this section.   
Snf1 is the catalytic subunit of a serine/threonine kinase with significant 
homology to the mammalian AMP activated protein kinase (AMPK) 231-233.  As in 
mammals, Snf1 kinase functions in vivo within any of three hetero-trimeric protein 
complexes consisting of an α subunit (Snf1), a γ subunit (Snf4), and one of three 
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alternate β subunits (Gal83, Sip2, and Sip1) 234,235,163,164,229.  Snf1 is constitutively 
expressed and protein levels remain constant across diverse growth conditions 
236.  Thus, the catalytic activity of Snf1 towards its various substrates is regulated 
primarily through post-translational mechanisms.  Post-translational regulation of 
Snf1 is achieved through both regulation of its phosphorylation state on threonine 
210 237-241 and control of its sub-cellular localization through its interchangeable 
association with the β subunits 242-245.  Together these regulatory mechanisms 
differentially direct the kinase activity of Snf1 towards a myriad of intracellular 
substrates and these regulatory mechanisms are highly influenced by the 
presence or absence of glucose.  (Figure 2.4) 
 
2.6.3.  Glucose Dependent Control of Snf1 Catalytic Activity by Regulation of the 
Phosphorylation Status of Thr210 
Phosphorylation of threonine 210 found in the activation loop of the N-
terminal kinase domain of the Snf1 catalytic subunit is required for its catalytic 
activity and is regulated in a glucose dependent manner 239,238,246.  On high 
glucose, this phosphorylation site is masked through auto-inhibition by a motif 
present in the C-terminal domain of Snf1 known as the AIS (Auto-Inhibitory 
Sequence) 247,241.  Autoinhibition is counteracted by association of the β subunit, 
Snf4, with the C-terminal regulatory region of Snf1 241.  It is proposed that on low 
glucose, Snf4 binds to this regulatory region and inhibits interaction of the C-
terminal AIS with the kinase domain thereby maintaining Snf1 in an open 
configuration to allow uninhibited phosphorylation of threonine 210 by activating 
kinases 248-250.  Consistent with this reasoning is the fact that glucose strongly 
inhibits Snf4 and Snf1 association 241.  Though Snf4 is required for catalytic 
activity of full length Snf1 it is not required for activity of Snf1 lacking the C-
terminal regulatory domain 249,241.  However, in the absence of Snf4, in strains 
expressing truncated Snf1, the ability of glucose to modulate Snf1 
phosphorylation on threonine 210 is preserved, suggesting that the glucose 
dependent phosphorylation and/or de-phosphorylation of Snf1 at threonine 210 
do not require Snf4 for function 239,251,252.  Nevertheless, Snf4 is required for the 
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catalytic activation of Snf1 in the context of the functional hetero-trimeric 
complex. 
Phosphorylation of threonine 210 is carried out by any of three upstream 
kinases known as Elm1, Tos3, and Sak1 251.  With regard to Snf1 
phosphorylation at threonine 210 these three kinases seem to be redundant 
since Snf1 catalytic activity is completely abolished in only an elm1Δ tos3Δ 
sak1Δ triple deleted strain 251.  In addition, this strain, like snf1Δ strains, does not 
grow on raffinose or ethanol/glycerol medium 251,237.  Despite the functional 
redundancy of these kinases towards Snf1 activation, other non-redundant 
cellular functions for these kinases have been described.  Elm1 for instance 
localizes to the bud neck and is involved in regulating cytokinesis as well as cell 
morphogenesis 253-255.  Lack of TOS3, on the other hand, has been shown to 
lead to growth defects and reduced Snf1 catalytic activity after prolonged growth 
on ethanol-glycerol medium 256.  Due to their roles in discrete cellular functions, it 
seemed likely that each of these kinases was responsible for activating a specific 
hetero-trimeric Snf1 complex, specified by the particular β subunit of each 
complex.  However, this is not the case as both Sak1 and Elm1 were found to 
participate in phosphorylating Gal83-Snf1 and Sip2-Snf1 kinase complexes 
257,258.  The different hetero-trimeric Snf complexes do seem to exhibit kinase 
specific preferences dependent on the particular stress 257,258.  Interestingly, as of 
yet, there is no evidence that Snf1 activating kinase activity is regulated in 
response to glucose.  In fact, it has been determined that kinase activity towards 
threonine 210 of Snf1 may be constitutive and that the glucose specific signal 
regulating the phosphorylation state of Snf1 is dependent on the rate of de-
phosphorylation catalyzed by the Reg1-Glc7 phosphatase 237.   
 
2.6.4.  The Role of the Reg1-Glc7 Phosphatase in Regulating the Snf1 Kinase in 
Response to Glucose 
The Glc7 protein is the yeast equivalent of the PP1 phosphatase of 
mammalian cells and like its homologs has been found to regulate a multitude of 
intracellular functions 259-267.  Glc7 is a stable protein with a half life of ~180 
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minutes and regulation of Glc7 activity through transcriptional and/or translational 
mechanisms has not been observed 261,259.  The specificity and catalytic activity 
of the PP1 catalytic subunit is partially determined by controlling its physical 
association with one of a number of regulatory proteins 262,268,263,264,269,270,266,267, 
including Reg1 207.  Due to its central role in a number of critical cellular 
processes, null mutations in the GLC7 locus result in the loss of viability.  
However, mutations that do not inhibit total Glc7 catalytic activity but result in the 
inability for a particular targeting subunit to interact with Glc7 have been isolated 
271.  One such mutant, glc7-T 152K (known at that time as cid1-226), was 
isolated in a mutagenesis screen for mutants resistant to 2-deoxyglucose 272.  
This mutant also exhibited glucose repression resistant expression of SUC2 as 
well as the MAL genes which suggested that Glc7 may counteract the effects of 
Snf1 activity 273.  This mutation was later shown to cause a defect in the ability of 
Glc7 to associate with its regulatory subunit, Reg1 207.   
Strains lacking functional Reg1 were also isolated based on their 
resistance to 2-deoxyglucose (2-DOG) and show similar glucose repression 
resistant/Snf1 dependent gene expression as that observed for strains harboring 
the glc7-T152K allele 274.  It was later shown that Reg1 interacts strongly with 
protein phosphatase type 1 (Glc7) 207 through a PP1-binding motif found in Reg1 
with the sequence RHIHF468 275,276.  Genetic complementation tests indicated that 
Reg1-Glc7 acted upstream of the Snf1 kinase in the intracellular glucose 
signaling pathway since mutations in SNF1 are epistatic to REG1 mutations 
277,278.  Additionally, Reg1 physically interacts with Snf1 through a C-terminal 
sequence that is distinct from the Glc7 interaction domain 279.  This interaction 
requires phosphorylation of threonine 210 in the activation loop of the Snf1 
kinase.  Furthermore, reg1Δ strains exhibit glucose independent constitutive Snf1 
kinase activity, hyper-phosphorylation of Snf1 at threonine 210, and glucose 
independent Snf1 interaction with Snf4 241,280.  This data suggests that Reg1 
serves to target Glc7 phosphatase activity to de-phosphorylate Snf1 at threonine 
210 and that Reg1-Glc7 de-phosphorylation prevents activation of the Snf1-Snf4 
kinase complex in response to glucose availability. 
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Figure 2.4.  Regulation of Gal83-Snf4-Snf1 Kinase Activity.  A.  Glucose 
exhaustion results in activation and nuclear accumulation of the Gal83-Snf4-Snf1 kinase hetero-
trimer.  Through an unknown mechanism that is inhibited by glucose, Gal83 associates with and 
promotes formation of the active Snf1 kinase hetero-trimer (Molecular events which are active or 
increased are shown in Green, inactive or decreased molecular events are shown in Red, 
constitutive molecular events are shown in powder blue).  Activation is partially achieved through 
Snf4 association with the Snf1 auto regulatory domain (shown in powder blue on Snf1).  Snf4 
inhibits association of the auto regulatory domain with the kinase domain thereby exposing 
threonine 210 to phosphorylation by the Snf1 activating kinase Pak1.  Phosphorylation of Snf1 on 
Thr210 is required to activate Snf1 kinase activity and Pak1 kinase activity towards Snf1 is not 
regulated by glucose.  Phosphorylation and Gal83 association of Snf1 is also required for 
cytoplasmic to nuclear translocation of the complex.  Once nuclear, the Gal83-Snf4-Snf1 hetero-
trimer inhibits and activates transcription factors through phosphorylation which leads to de-
repression and induction of glucose repressed genes.  B.  In the presence of glucose.  Hxk2, 
glucose-6-phosphate, or increased glycolytic flux leads to activation of Reg1-Glc7 phosphatase 
activity through an unknown mechanism that either acts to promote Reg1/Glc7 interaction or to 
regulate Reg1-Glc7 catalytic activity directly through post-translational modification.  Through 
Reg1, Glc7 phosphatase activity is targeted to de-phosphorylate threonine 210 on Snf1 which 
inactivates Snf1 kinase activity and promotes formation of the Snf1 auto-inhibited state.  The 
auto-inhibited α subunit of Snf1 can no longer interact with Gal83 and therefore is retained in the 
cytoplasm.  Through an unknown mechanism, glucose-6-phosphate also inhibits Gal83 
dependent nuclear localization of Snf1. 
 
Notwithstanding the inability to decipher the precise mechanism through 
which Hxk2, Reg1, and Glc7 regulate Snf1 activity in response to glucose, a 
number of results emphasize that glucose regulation of Snf1 occurs by governing 
the complex interplay between Glc7- Reg1 and Snf1.  First, the phosphorylation 
state of Reg1 has been found to be regulated in a glucose dependent manner.  
On low glucose or in the absence of glucose, Reg1 is found in a hyper-
phosphorylated state that is dependent on Snf1 catalytic activity 209; whether 
Snf1 kinase phosphorylates Reg1 directly or through an indirect mechanism 
remains unanswered.  Second, de-phosphorylation of Reg1 in response to the 
presence of glucose is directly dependent on Glc7 phosphatase activity 209.  
Biochemical evidence suggests that Reg1 phosphorylation leads to its 
disassociation from Snf1 and thus is a mechanism for Snf1 to modulate its  
own activity.  Third, this phosphorylation event has also been shown to be 
influenced by Hxk2 since Reg1 was not found to be phosphorylated in an hxk2Δ 
strain 209.  Fourth, analysis of the phosphorylation state of threonine 210 utilizing 
phospho-specific antibodies has revealed that the glucose dependent 
phosphorylation of this residue is not a result of regulated kinase activity but 
phosphatase activity 237.  In vitro kinase assays conducted utilizing each of the 
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three SAKs isolated from cells grown on low and high glucose concentrations 
showed high activity regardless of the glucose concentration 281.  However, 
inhibition of Reg1-Glc7 activity through deletion of REG1 results in a tremendous 
increase in Snf1 phosphorylation, even at high glucose concentrations 
281,207,282,283.  Despite the lack of a precise mechanism describing how each of 
these events are carried out in response to glucose the evidence supporting that 
the glucose signal acts to modulate Reg1-Glc7 activity towards Snf1 is 
compelling. 
 
2.6.5.  Spatial Regulation of Snf1 
Among the postulated mechanisms for directing Reg1-Glc7 catalyzed 
inactivation of Snf1, the most probable involves modulation of Snf1 by controlling 
its sub-cellular localization and thus its exposure to Reg1-Glc7.  Strains deleted 
for any single β subunit exhibit no traceable phenotype, but a triple null mutant, 
sip1Δ gal83Δ sip2Δ, is unable to grow on glycerol-ethanol and raffinose-
Antimycin A medias and show slower growth than wild-type strains on rich 
glucose and galactose medias 242.  These phenotypes are indistinguishable from 
those exhibited by snf1Δ strains 231.  Consistent with the genetic data, each of 
the β subunits interact with both α and γ subunits of the Snf1 kinase complex, 
suggesting that the β subunits are important for formation of the Snf1 hetero-
trimer 284,285,242.  These data suggest that the β subunits may be redundant in 
function and that the sole purpose of the β subunit is to serve as a molecular 
scaffold for hetero-trimer formation.  However, genetic analysis of cells harboring 
various combinations of β subunit double mutations revealed that certain Snf 
negative phenotypes could be separated genetically.  For example, while the 
sip1Δ sip2Δ and sip1Δ gal83Δ strains exhibit normal wild-type growth on various 
media, a sip2Δgal83Δ strain grew normally on raffinose-Antimycin A media but 
grew slowly on glycerol-ethanol media 242.  Additionally, Snf1 interaction and 
phosphorylation of the Sip4 transcription factor, whose function is important for 
glycerol-ethanol based growth, is exclusively mediated by Gal83 244.   
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Utilizing GFP-fusion constructs of each of the β subunits Vincent et.al 
determined the intracellular location of each of these subunits, that nuclear 
localization of Snf1 was dependent on Gal83, and that Gal83 nuclear localization 
was controlled in a glucose dependent manner independent of Reg1-Glc7 and 
Hxk2 function 245.  In response to glucose availability and glucose 
phosphorylation by any one of the three hexose kinases, all β subunits are found 
predominately in the cytoplasm.  However, in the absence of glucose, on 
glycerol-ethanol media, the Sip1 subunit localizes predominately to the vacuole, 
the Sip2 subunit localizes predominately to the cytoplasm, and the Gal83 subunit 
is found predominately nuclear 245.  The fact that the Gal83 isoform is the most 
highly expressed of all Snf1 β subunits and the fact that Gal83 directs nuclear 
localization of Snf1 in response to glucose exhaustion 245 together suggest that 
the affects of Snf1 activity on transcriptional processes are primarily carried out 
by the Gal83-Snf1-Snf4 hetero-trimer.  Interestingly, while Glc7 is found in 
various sub-cellular compartments including the nucleus and nucleolus 286, Reg1 
is exclusively found in the cytoplasm 276, limiting Glc7 phosphatase activity 
towards Snf1 to the cytoplasmic fraction of Snf1.  Thus, the glucose dependent 
modulation of Gal83-Snf1 nuclear-cytoplasmic distribution may serve as another 
regulatory mechanism to control Snf1 kinase activity towards intracellular 
substrates. 
 
2.7.  Downstream Transcription Factors Directly Regulated by the 
Hxk2/Reg1-Glc7/Snf1 Glucose Signaling Pathway  
2.7.1.  Mig1  
The MIG1 gene was first isolated as a high copy suppressor of GAL1 
(glucose repressed gene encoding galactokinase catalyzing the first step in 
galactose catabolism) over-expression and was revealed to encode a C2H2 zinc 
finger type transcriptional repressor which binds to GC boxes (GC rich DNA 
sequences) present in the promoter regions of glucose repressed transcripts 287.  
Since that time the Mig1 repressor has been discovered to repress a number of 
genes subject to glucose repression, including GAL 288-290 , MAL 291-293, hexose 
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transporter 167,160,176, HXK1 294, respiratory 295, gluconeogenic 296-300, and 
glyoxylate cycle 301,302 genes 303.  Interestingly, many of the genes directly 
repressed by Mig1 are glucose signaling proteins or transcription factors which 
induce expression of glucose repressed genes.  The gluconeogenic transcription 
factor, Cat8 300,304, the respiratory transcription factor, Hap4 305,295,306,307, and the 
Snf3/Rgt2 pathway proteins, Snf3 and Mth1 308, are all repressed at the 
transcriptional level by Mig1 in the presence of glucose.  Thus, the Mig1 
repressor plays a major role in glucose repression by directly repressing 
metabolic and regulatory genes necessary for growth on alternative carbon 
sources. 
The regulatory mechanism acting to control Mig1 dependent repression 
has been partially revealed.  In the presence of glucose, the Mig1 protein is 
found predominately in the nucleus and upon glucose depletion Mig1 
translocates rapidly (~2 to 3 minutes) to the cytoplasm 309 which correlates with a 
rapid release of glucose repression of Mig1 transcriptional targets.  Removal of 
Mig1 from the nucleus in response to glucose depletion requires Mig1 
phosphorylation and the nuclear exportin, Msn5 310,311.  Re-establishment of 
nuclear localized Mig1 in response to glucose repletion requires Mig1 de-
phosphorylation 309.  It was subsequently revealed that Mig1 phosphorylation and 
nuclear localization is increased in the presence of glucose under conditions 
which lead to glucose insensitive activation of Snf1 kinase activity, including in 
reg1Δ and hxk2Δ cells 202.  Additionally, deletion of MIG1 in snf1Δ cells relieves 
gene de-repression defects of snf1Δ cells and thus, MIG1 deletion is epistatic to 
SNF1 deletion 312.  These observations led to the discovery that Snf1 directly 
phosphorylates and thus inactivates Mig1 repression in response to glucose 
depletion 313,203,314.  Thus, active Snf1 kinase activity has been found to directly 
modulate the transcriptional repressor Mig1 through phosphorylation and Mig1 
phosphorylation is a key regulatory event responsible for relieving glucose 
repression of a number of glucose repressed genes.  Though Snf1 dependent 
modulation of Mig1 repressor activity seems to be the primary mechanism  
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Figure 2.5.  Snf1/Mig1/Cat8/Sip4 Dependent Control of Respiratory, 
Gluconeogenic, and Glyoxylate Cycle Genes in Response to Glucose 
Exhaustion.  In the absence of fermentable sugars the Gal83/Snf4/Snf1 kinase complex 
traverses to the nucleus and catalyzes the phosphorylation of three transcription factors known as 
Mig1, Cat8, and Sip4 that together promote transcriptional activation of genes needed for growth 
on respiratory carbon sources.  Phosphorylation of Mig1 by Snf1 leads to deactivation of its 
transcriptional repressor activity which relieves Mig1 dependent repression of CAT8 and HAP4.  
HAP4 de-repression leads to transcription and production of Hap4, which is a transcription factor 
that activates transcription of respiratory and TCA cycle genes.  Additionally, Hap4 activates 
transcription of CAT8 and transcriptional activation of CAT8 by Hap4 leads to Cat8 synthesis.  
Cat8 dependent transcriptional activation of gluconeogenic and glyoxylate cycle genes is then 
activated through phosphorylation of Cat8 by the Snf1 kinase.  Phosphorylated Cat8 also 
activates SIP4 transcription leading to synthesis of Sip4.  Activation of transcription by Sip4 is 
also dependent on Sip4 phosphorylation by the Snf1 kinase and active Sip4 promotes further 
activation of gluconeogenic and glyoxylate cycle genes. 
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governing Mig1 dependent repression in response to glucose depletion, other 
regulatory events have been shown to regulate Mig1 repressor function.  First, 
Hxk2 directly interacts with Mig1 and this interaction is required for Hxk2 
sequestration in the nucleus 222.  Additionally, The Hxk2-Mig1 complex has been 
demonstrated to form a repressor complex on the SUC2 promoter 222.  It has 
been postulated that Hxk2 may inhibit Snf1 phosphorylation and nuclear export 
of Mig1 on high glucose (Figure 2.3) 315. 
 
2.7.2.  Cat8 and Sip4 
Genes encoding enzymes of the glyoxylate cycle and gluconeogenesis 
are among the most sensitive to glucose repression as their gene expression is 
only de-repressed and induced when glucose has been completely exhausted 
171,135.  The glucose sensitivity of gluconeogenic and glyoxylate cycle gene 
expression is conferred through the Hxk2/Reg1-Glc7/Snf1 glucose signaling 
pathway.  Snf1 kinase is responsible for modulating both de-repression and 
induction of gluconeogenic and glyoxylate cycle genes by inhibiting their glucose 
induced repression 300,299,298,297,296,304 and by activating the transcriptional activity 
of the transcriptional activators, Cat8 and Sip4 316-318.  In the presence of 
glucose, Mig1, and most likely other glucose controlled transcriptional repressors 
297,319, bind to and repress CAT8 transcription 316.  As indicated above, 
exhaustion of glucose leads to Snf1 activation and nuclear localization which 
subsequently leads to inactivation of Mig1 repression by Snf1 dependent 
phosphorylation.  Snf1 dependent inactivation of Mig1 as well as other glucose 
regulated repressors leads to de-repression of CAT8 gene expression which 
allows Hap2/3/4/5 (respiratory transcription factor complex) to activate CAT8 
gene expression 316.  Activation of Cat8 dependent transcription requires Cat8 to 
be phosphorylated and phosphorylation of Cat8 is also dependent on Snf1 
kinase activity 316,320.  Thus, Snf1 modulates Cat8 dependent transcription by 
controlling CAT8 gene expression and Cat8 transcriptional activity.  
Transcriptionally active Cat8 binds to an upstream activation sequence, known 
as the carbon source response element (CSRE with the consensus sequence 
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YCCRTTNRNCCG), present in gluconeogenic and glyoxylate cycle genes 321.  
Additionally, the CSRE element is present in SIP4 and SIP4 expression is also 
Cat8 dependent 318.  Like Cat8, Sip4 transcriptional activity is activated through 
phosphorylation by the Snf1 kinase and Sip4 dependent gene expression is also 
facilitated through Sip4 binding to CSRE sequences 318.  Together, Cat8 and  
Sip4 are primarily responsible for the induction of gluconeogenic and glyoxylate 
cycle genes possessing CSRE sequences in their promoters, including FBP1 322, 
ICL1 321, PCK1 323, MLS1 323, MDH2 324, ACS1 325, SFC1 326, IDP2 327 and the 
respiratory transcription factor, HAP4 328.  Thus, the exquisite sensitivity of 
gluconeogenic and glyoxylate cycle genes to glucose repression is in part 
conferred by the extensive role of the Snf1 kinase in modulating their expression 
at multiple stages.  Through modulation of Cat8 and Sip4 transcriptional activity, 
the Hxk2/Reg1-Glc7/Snf1 signaling pathway regulates the transcriptional re-
programming of carbon metabolism in response to glucose exhaustion.
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CHAPTER 3: MATERIALS AND METHODS 
 
3.1.  Global Proteomic Analysis  
3.1.1.  Strain Construction 
Two strains were utilized exclusively for both global proteomic as well as 
microarray experiments.  Strain DBY2059 (MATα leu2-3, 112) served as the 
comparative wild-type strain in these experiments and is derived directly from 
S288C.  Strain JH001 (MATα grr1Δ::NAT), also derived from S288C, was 
constructed by adaptamer mediated gene disruption as previously described 329.  
Briefly, forward (5’-CGTGAAATCTTGAAATTTCTCATTGATTTCGGCACAATAAT
TATCATTGGTAGTGAGGCTAAACAGTTTTGCGGTTTCCTTTATACTAAGAAG
GTCTATACAGCTGAAGCTTCGTAC-3’) and reverse (5’-TCAAAGTGAATGCAT
TATGTATTTATATGTAAATAAGTAGAAAAGTGGGATTTTGAAAATAAAGGTGT
AGTAGGACAGTAAGTATTCAATGAAATACAAGCATAGGCCACTAGTGGATCT
G-3’) adaptamers of ~120bp in length were designed and purchased from MWG 
Biotech™ with ~20bp of DNA sequence at the 3’ ends of each oligonucleotide 
complementary to flanking sequences of the gene conferring dominant 
resistance to the aminoglycoside, nourseothrycin (NATMX).  The remaining 
100bp of 5’ sequence on the forward and reverse oligonucleotides contains DNA 
sequence complementary to the 5’ and 3’ non-coding regions of the GRR1 locus, 
respectively.  Utilizing these adaptamers, a GRR1 specific disruption cassette 
was PCR-amplified from the plasmid pAG25, harboring the NATMX gene.  This 
cassette was then utilized to transform the S288c prototrophic strain, BL2, 
utilizing the lithium acetate method 330.  Following transformation, strains 
harboring the NATMX gene were selected by incubating transformed cells on 
YPD supplemented with 90ug/ml nourseothrycin at 30°C for 3 to 4 days.  Clones 
harboring a complete disruption of the GRR1 locus with this cassette were 
confirmed by PCR utilizing primer sets which flanked both the 5’ and 3’ ends of 
the cassette and the endogenous GRR1 gene.
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Strain Genotype 
DBY2059 Mat α leu2-3, 112 
JH001 Mat α grr1Δ::NAT 
CenPK113-7D Mat A MAL2-8c, SUC2, RHO+ 
JH015 Mat A MAL2-8c, SUC2, RHO+, grr1Δ::NAT 
BY4741 MATA his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
BY4741 (XXX:TAP) MATA his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 XXX::TAP::HIS3 
MT2112 mfα1Δ::MFα1pr-LEU2 can1Δ::MFA1pr-HIS3, his3Δ1, leu2Δ0, ura3Δ0, met15Δ0, lys2Δ0 
JH002 mfα1Δ::MFα1pr-LEU2 can1Δ::MFA1pr-HIS3, his3Δ1, leu2Δ0, ura3Δ0, grr1Δ::URA3, met15Δ0, 
lys2Δ0 
JH006 mfα1Δ::MFα1pr-LEU2 his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 grr1Δ::URA3 CAT8::TAP::HIS3 
JH007 mfα1Δ::MFα1pr-LEU2 his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 grr1Δ::URA3 GLC7::TAP::HIS3 
JH008 mfα1Δ::MFα1pr-LEU2 his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 grr1Δ::URA3 INO2::TAP::HIS3 
JH009 mfα1Δ::MFα1pr-LEU2 his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 grr1Δ::URA3 INO4::TAP::HIS3 
JH010 mfα1Δ::MFα1pr-LEU2 his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 grr1Δ::URA3 SOL1::TAP::HIS3 
 
Table 3.1.  S. cerevisiae Strains Utilized in this Volume 
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3.1.2.  Growth Conditions and Sample Preparation 
Mass labeling for MS analysis was performed using a customized SILAC 
approach 331.  S. cerevisiae strain DBY2059 (MAT α leu2-3) was cultured 
overnight to stationary phase in two replicate 10ml batches of modified SD media 
consisting of 2% glucose, 0.17% yeast nitrogen base minus amino acids and 
ammonium sulfate, 0.25% glutamine, 0.025% magnesium sulfate, and 0.05mg/ml 
C613 leucine (Cambridge Isotope Laboratories, Inc., Andover, MA, USA).  
Concurrently, strain JH001 (MAT α, grr1Δ::NATMX) was also cultured overnight 
to stationary phase in two replicate 10ml batches of the same media 
supplemented with C612 leucine.  Each 10ml culture was then used to inoculate a 
500ml culture of the same media and cells were grown for nine population 
doublings to mid-log phase (~5x106cells/ml).  Cell density was determined by cell 
counting using a hemacytometer (Reichert, Buffalo, NY, USA.).  Cells were 
harvested by centrifugation in a Beckman JA-14 rotor at 4000Xg for 10 minutes, 
washed three times in ice cold water, and immediately re-suspended in 5ml of 
extraction buffer (8M Urea, .1M ammonium bicarbonate).  Cells were then 
immediately flash frozen in liquid nitrogen and stored at -80°C overnight. 
Protein extract was prepared the following day by manual bead beating 
using 300μm acid washed glass beads (Sigma, St. Louis, MO.).  Specifically, 
samples were subjected to 10 cycles consisting of 30 seconds on ice and 30 
seconds of vortexing in the presence of glass beads.  Glass beads and cellular 
debris were then spun down at 2000Xg and the supernatant was placed in 15ml 
conical tubes.  Protein concentrations were determined using the Bradford 
protein assay and protein samples were mixed in a 1:1 ratio (DBY2059 C613 
leucine: JH001 C612 leucine) producing two replicate protein mixes from four 
independently grown batch cultures.   
 
3.1.3.  Reduction, Alkylation, and Trypsinization 
Each protein mixture was diluted with 100mM ammonium bicarbonate to a 
final urea concentration of 4M.  Protein disulfide bond reduction was carried out 
by adding a 40 fold molar excess of dithiothreitol (DTT) to each protein mixture 
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followed by a three hour incubation at 36°C.  Reduced protein mixtures were 
then alkylated using a 1:80 molar ratio of protein to iodoacetamide (IAM) followed 
by incubation on ice in complete darkness for 2 hours.  The reduced and 
alkylated protein mixture was then diluted to 2M urea using an equal volume of 
100mM ammonium bicarbonate and subjected to trypsin digestion using 2% 
(weight/weight) of TPCK-treated trypsin.  Digestion was carried out at 37°C for 
twenty four hours.  Peptide samples were then dried down in a speed vac and 
resuspended in a buffer consisting of 5% acetonitrile, 95% EMD water, 0.025% 
formic acid, and .0025% HFBA. 
 
3.1.4.  Peptide Separation and Mass Spectrometry 
 The two replicate peptide mixtures were analyzed 3 times each through 
an automated de-salt/2DLC/MS system.  Peptide de-salting and separation were 
performed in tandem using the Paradigm MG4 HPLC System (Michrom 
Biosciences, Inc.).  Initially, approximately 150μg of the tryptic peptide mixture 
was loaded directly onto a C-18 microtrap (Michrom Biosciences, Inc.) and 
desalted by flushing the trap with 20 column volumes of mobile phase A (2% 
acetonitrile, 98% water, 0.025% formic acid) at a flow rate of 50μl/min.  Peptides 
were then eluted onto an SCX microtrap (Michrom Biosciences, Inc.) using 20 
volumes of mobile phase B (98% acetonitrile, 2% water, 0.025% formic acid, 
0.001% HFBA).  Peptides were then eluted from the SCX microtrap in a stepwise 
fashion using increasing concentrations of ammonium formate.  Ten steps of 0, 
4, 8, 12, 15, 18, 21, 25, 50, and 100mM ammonium formate were used in our 
analysis followed by two identical steps of 1M ammonium formate.  Each 
population of peptides eluted off the SCX micro-trap onto a C8 nano-trap 
(Michrom Biosciences, Inc.) coupled directly to a hand packed C18 column with a 
hand pulled tip.  A homemade high pressure bomb was used to pack 15cm of 
5μm-100Å Magic C18 resin (Michrom Biosciences, Inc.).  Peptides were then 
eluted off this column at 500ηl/min using an acetonitrile gradient from 5-50% and 
analyzed by an LTQ Mass Spectrometer (Thermo Electron Corporation) on the 
fly. 
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The LTQ-MS was set for data dependent MS/MS acquisition with a total 
ion count threshold of 1000.  Dynamic exclusion was used to only collect two 
MS/MS spectra on a single parent ion every 45 seconds.  Two types of data 
collection were performed in this analysis termed gas phase fractionation and full 
scan analysis.  Typically, the LTQ-MS is set to scan across an m/z range from 
500-2000 throughout the course of the analysis.  This type of analysis was done 
in replicate for both replicate peptide mixtures culminating in four, 12 step full 
scan analyses.  Each of the peptide mixtures was also subjected to a single gas 
phase fractionation analysis.  This analysis is essentially equivalent to three full 
scan analyses but the mass spectrometer is set to scan 1/3 of the m/z scan 
range.  This allows for greater m/z resolution and increased peptide detection 
sensitivity due to the fact that MS/MS spectra are only being collected for a 
smaller fraction of the peptide population eluting from the column.  However, this 
process is time consuming given that three separate analyses must be 
performed to acquire data across the whole scan range and thus we only 
conducted a single gas phase analysis for each peptide mixture.  The scan 
ranges for gas phase fractionation were 500-1000m/z, 900-1500m/z, and 1400-
2000m/z.  In all, each of the two replicate peptide mixes were loaded and 
analyzed five times through the 2D-LC-MS system for a total of ten different runs.  
A schematic summarizing our analysis is shown in Figure 3.1. 
 
3.1.5.  Data Analysis and Validation 
Peptide assignments for experimental MS/MS spectra were made using 
the SEQUEST™ program (Thermo Electron Corporation).  Peptide assignments 
were then analyzed for validity using a suite of software available from the 
Institute for Systems Biology termed the Trans-Proteomic Pipeline.  This analysis 
toolkit provides computational tools that validate peptide assignments 
(PeptideProphetTM) 332, protein assignments (ProteinProphet) 333, and quantify 
relative peptide and protein abundance ratios (ASAPRatio) 334.  All SEQUEST™ 
.dta and .out files pertaining to an individual analysis were validated together 
through the ISB pipeline.  Thus, gas phase separations derived from the same 
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analysis were analyzed concurrently to provide the most accurate protein 
probabilities and ASAP ratios.  Following data processing through the ISB 
pipeline, a combined unified Protein Probability across all data sets was 
calculated using the following criteria.  If a protein is identified by k experiments, 
labeled r1, r2,…rk, then the summarized probability is calculated as: 
 
Pid =  1 −�(1−  PriKi=1 ) 
[1] 
 
Where Pri is the probability measure from experiment ri.  Final relative abundance 
ratios were calculated by taking the average abundance ratio (ASAPRatio) over 
all data sets for each protein. 
 
3.2.  Microarray Analysis 
3.2.1.  Growth conditions 
A grr1Δ strain (JH001) and a wild-type strain (DBY2059) were inoculated 
from stationary phase cultures into a synthetic defined minimal medium 
containing 2% dextrose, 0.17% yeast nitrogen base minus amino acids and 
ammonium sulfate, 0.25% L-glutamine, 0.025% magnesium sulfate and 
25.2mg/L L-leucine.  Four separate cultures of each strain were grown at 30°C, 
allowing between three and four doublings and cells were collected at 
approximately 8 x 106cells/ml.  Cells were centrifuged and immediately frozen in 
liquid nitrogen. 
3.2.2.  RNA extraction and cRNA construction 
 Cells were centrifuged and immediately frozen in liquid nitrogen.  Total RNA 
was extracted using a hot acid phenol-chloroform protocol as previously 
described 335.  RNA quality was verified with OD260/280 readings and a 1.5% 
agarose gel.  The following portion of this microarray study was carried out using 
the facilities of the Center for Medical Genomics at Indiana University School of 
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Medicine.  The Center for Medical Genomics is supported in part by the Indiana 
Genomics Initiative at Indiana University (INGEN®), which is supported in part by 
the Lilly Endowment, Inc.  Briefly, cDNA was synthesized from the original RNA 
template by single cycle labeling using a T7 promoter-dT24 oligonucleotide as 
primer with the Invitrogen Life Technologies SuperScript Choice system 
(Invitrogen, California, USA) per the manufacturer’s instructions.  Following 
second strand cDNA synthesis and incubation with T4 DNA polymerase, the 
products were purified using an Affymetrix Cleanup Module (Affymetrix, 
California, USA) per the manufacturer’s protocol.  The cDNA was converted to 
cRNA using the Affymetrix IVT kit, again following the manufacturer’s 
instructions.  The cRNA was purified with Qiagen RNAeasy columns (Qiagen, 
California, USA), quantitated and then fragmented by incubating at high 
temperature with magnesium.   
 
3.2.3.  cRNA Hybridization and Data Analysis 
Fifteen µg of biotinylated cRNA was added to a total hybridization cocktail 
of 300µl, and 200µl was hybridized to an Affymetrix Yeast 2.0 GeneChip after 
adding control oligonucleotides.  The cRNA was hybridized at 45°C for 17 hours 
with constant rotation.  The hybridization mixture was then removed and the 
Affymetrix Yeast 2.0 GeneChip were washed, stained with phycoerythrin-labeled 
streptavidin, washed, incubated with biotinylated anti-streptavidin, and then re-
stained with phycoerythrin-labeled streptavidin for signal amplification.  Balanced 
groups of samples were handled in parallel to reduce non-random error.  The 
arrays were then scanned using the dedicated scanner, controlled by Affymetrix 
GCOS software.  The Affymetrix Microarray Suite version 5 (MAS5) algorithms 
was used to analyze the hybridization intensity data from each array.  The 
average intensity on each array was normalized by globally scaling to a target 
intensity of 1000.  A student’s t-test of the log base 2 transformed data was used 
to establish p-values. 
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3.3.  Hxt3 and Hxt7 Western Blots 
3.3.1.  Strains, Growth Conditions, and Protein Extraction 
Strains DBY2059 and JH001 (See Table 3.1 for genotype) were grown in 
150ml of the same synthetic media described in Section 3.1.2 to a cell density of 
1 x 107cells/ml, allowing for four population doublings.  Cells were then spun 
down at 3,000 X g and immediately flash frozen utilizing liquid nitrogen.  The next 
day cells were thawed spun down and re-suspended in 1ml of lysis buffer (50mM 
Tris-HCL, pH 7.4, 250mM NaCl, 50 mM NaF, 5mM EDTA, .1% NP-40, 2mM 
EGTA, and proteasome inhibitors (Roche Diagnostics™).  Protein extract was 
prepared the following day by manual bead beating using 300μm acid washed 
glass beads (Sigma™, St. Louis, MO.).  Specifically, samples were subjected to 
10 cycles consisting of 30 seconds on ice and 30 seconds of vortexing in the 
presence of glass beads.  Glass beads and cellular debris were then spun down 
at 2000Xg and the supernatant was placed in 1ml Eppendorf tubes.  Protein 
concentrations were determined using the Bradford protein assay. 
 
3.3.2.  Western Blot Analysis and Antibodies 
Immediately following protein extraction, three 40μl (1μg/μl) aliquots of 
both DBY2059 and JH001 protein extract were mixed with 10μl of 5x Laemmli 
loading buffer, heated at 80°C for 5 minutes, and 20ul of each sample was 
loaded in replicate onto two hand cast 15% SDS-PAGE gels.  Each gel was run 
at 60V in a BIO RAD™ Mini-Protean® II Cell until the resolving gel was reached 
at which time the voltage was increased to 100V.  Each gel was cut in half and 
one side was stained with Coomassie to serve as a loading control while the 
other was wet transferred (25mM Tris-HCl, 192mM glycine, 15% methanol) onto 
a PVDF membrane for two hours at 28 Volts.  The PVDF membrane was cut in 
half and each membrane was washed in three times for five minutes in 1 x 
KPBS-T.  Membranes were blocked for one hour at room temperature in 5% dry 
milk dissolved in 1 X KPBS-T.  One membrane was incubated for two hours at 
room temperature with primary antibody from the day 35 bleed of rabbit PA0661 
(Hxt3; 1:2000 in 5% dry milk in 1X KPBST).  The other membrane was incubated 
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as above with primary antibody from the day 35 bleed of rabbit PA0651 (Hxt7; 
1:1000) (Table 3.2).  The membranes were washed as before and then 
incubated at room temperature for one hour with horseradish peroxidase-
conjugated goat anti-rabbit secondary antibody (1:10,000) (Santa Cruz 
Biotechnology, Santa Cruz, CA).  Blots were then washed three times for 5 
minutes with 1 X KPBST and then incubated for one minute at room temperature 
with ECL™ (Amersham™ Biosciences, Pittsburgh, PA).  Exposure shown for 
Hxt3 is two minutes while the Hxt7 exposure is 30 seconds.   
Polyclonal antibodies recognizing the Hxt3 protein and the Hxt7 protein 
were raised utilizing synthesized peptide antigens (35KGVQDDFQAEADQVL49 for 
Hxt3 and 33KAERDEIKAYGEGEEHE49 for Hxt7) unique to the Hxt3 and Hxt7 
protein sequences.  Antibody preparation was conducted by Open Biosystems™ 
by injecting each peptide antigen into two independent rabbit hosts each and raw 
serum was drawn at day 35, 58, and upon termination.  Crude antibody ELISA 
titers were measured pre-bleed and at the day 35 and 58 bleeds.  These titers 
are shown below (Table 3.2).  These titers are the reciprocal of the serum dilution 
at which the absorbance drops below 0.2 at OD 405.  These ELISAs are 
conducted utilizing the peptide antigen coated directly onto the plate and 
antibodies are detected utilizing indirect enzyme immune assay utilizing anti-IgG-
HRP and the ABTS substrate. 
 
3.4.  α-TAP Western Blots 
3.4.1.  Strain Construction 
TAP tagged constructs of Cat8, Ino2, Ino4, Glc7, and Sol1 were 
introduced into the grr1Δ strain using a mating and selection method derived 
from the synthetic genetic array methodology 336.  First, GRR1 was knocked out 
in strain MT2112 (See Table 3.1) obtained from Dr.  Mike Tyers using adaptamer 
mediated gene disruption as previously described 329.  Briefly, forward (5’-GGGA 
TTTTGAAAATAAAGGTGTAGTAGGACAGTAAGTATTCAATGAAATACAACACA
CCGCAGGGTAATAACTG-3’) and reverse (5’GGTAGTGAGGCTAAACAGTTTT
GCGGTTTCCTTTATACTAAGAAGGTCTATAGATTCGGTAATCTCCGAACA-3’)  
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Table 3.2.  Hxt3 and Hxt7 Antibody Titers 
 
adaptamers of  74 and 72 bp in length, respectively, were designed and 
purchased from MWG Biotech™ with ~20bp of DNA sequence at the 3’ ends of 
each oligonucleotide complementary to flanking sequences of the URA3 gene of 
plasmid PRS306.  The remaining ~50 bp of 5’ sequence on the forward and 
reverse oligonucleotides contains DNA sequence complementary to the 5’ and 3’ 
non-coding regions of the GRR1 locus, respectively.  PCR amplification of the 
URA3 containing disruption cassette, targeted to the GRR1 locus was then 
performed utilizing plasmid PRS306 as the template.  The disruption cassette 
was then transformed into strain MT2112 utilizing the lithium acetate method 330. 
Strains harboring the disruption cassette were isolated by plating transformed 
cells on SD-URA for six days.  Individual colonies were isolated a validated for 
GRR1 disruption by phenotypic verification of the elongated bud morphology and 
by PCR confirmation.  One strain was subsequently utilized in crosses with the 
TAP-tag library strains constructed by 337 and available through Open 
Biosystems™. 
Before any crosses are made each TAP tagged strain was placed on YPD 
by taking 5ul of the culture from the appropriate plate coordinate and placing 
within a single square of the grid on a YPD plate.  Strains were allowed to grow 
overnight at 30°C and were then replica plate onto each of the following medias.  
Animal/Antigen Pre-Bleed Day35 Day58 
PA0651/Hxt7 400 >204,800 >204,800 
PA0652/Hxt7 <50 >204,800 >204,800 
PA0661/Hxt3 <50 >204,800 >204,800 
PA0662/Hxt3 <50 >204,800 >204,800 
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SD (-ura), SD (-his), SD (-met), SD (-leu), YPD (+canavanine), SD (-lys) in order 
to verify auxotrophies and markers.  The parental phenotypes for every strain 
reported in this volume exactly matched the indicated markers. 
A lawn of JH020 cells was made on YPD media and allowed to grow three 
days until it was confluent.  Once the JH020 lawn was confluent, the BY4741 
(TAP tagged strains) strains from the SD (-his) selection plates were stamped 
onto a velvet.  These plates contained each TAP tagged strain to be crossed in 
patch format arranged in a grid.  The lawn of JH020 was then stamped onto the 
same velvet as the BY4741 stamp and this velvet was then replica plated onto 
YPD and allowed to grow overnight at 30°C.  The next day, each strain was 
picked from its corresponding grid location and then struck onto its own individual 
SD –ura –his –lys plate for single colonies.  This will allowed for selection of 
diploid colonies.  Each strain was incubated at 30°C for two days.  After two 
days, a single colony was picked from each diploid selection plate, patched on 
sporulation media (10g/L potassium acetate, 1g/L Bacto yeast extract, 0.5g/L 
glucose, 20g/L Bacto-agar, 1% adenine, 1% asparagine) in the same grid 
coordinate as before, and incubated at room temperature one week. 
The following week, MAT α spore progeny were selected by streaking 
each sporulated diploid patch onto its own SD-leu-ura-his-lys plate.  This plate 
was incubated at 30°C for three days.  Each spore plate was then replica plated 
onto SD +canavanine (50µg/ml), -his, -arg and incubated for two days at 30°C. 
This selection revealed clones that were not resistant to canavanine which 
indicates that the histidine prototrophy is not conferred by the presence of the 
mating type selectable marker but the ORF::TAP-HIS construct.  Canavanine 
sensitive colonies from each strain plate were individually and manually analyzed 
microscopically for the presence of the multiple elongated bud morphology of 
grr1Δ strains.  Three clones for each grr1Δ Orf::TAP strain with the 
aforementioned characteristics were isolated and placed in liquid SD –leu, -his, -
lys, -ura overnight at 30°C.  The next day, 200ul of this culture was spread on 
YPD and incubated at 30°C overnight.  The next day the cells were harvested 
and froze away at -80°C in 15% glycerol. 
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3.4.2.  Growth Conditions and Sample Preparation 
Protein extracts for western analysis of all ORF::TAP grr1Δ strains and the 
isogenic ORF::TAP containing wild-type strains were prepared from strains 
cultured as follows.  Each, of the three clones for each ORF::TAP grr1Δ and the 
parental clone utilized to construct the ORF::TAP grr1Δ strain was struck from 
glycerol stocks onto YPD and incubated for three days at 30°C.  A single colony 
was then picked and struck onto SD –leu, -ura, -his, -lys selection plates and 
incubated for two days at 30°C to verify auxotrophies and markers.  After two 
days, a single colony from the selection plate was inoculated into 10ml of YPD + 
0.5% glutamine and incubated at 30°C.  Once the 10ml cultures reached 
stationary phase (~2 x 108cells/ml), these cultures were utilized to inoculate a 
250ml culture of YPD + 0.5% glutamine to 2 x 106cells/ml.  This culture was 
incubated at 30°C on an Orbital shaker set to 200 rpm allowing for three 
population doublings (~1.6 x 107cells/ml or ~8hrs).  Once the cultures reached 
1.6 x 107cells/ml, they were immediately spun down at 3,000xg, immediately 
flash frozen utilizing liquid nitrogen, and stored at -80°C overnight.  The following 
day, protein extracts were prepared utilizing the protein extraction method of 338. 
 
 
 
3.4.3.  Western Blot Analysis and Antibodies 
The procedures for western analysis of each TAP-tagged containing strain 
differed slightly because of the different sizes and pKas inherent to each of the 
proteins under analysis.  For extracts prepared from Glc7::TAP, Ino2::TAP, 
Ino4::TAP, and Sol1::TAP containing strains, extracts were loaded onto a hand 
cast, large format, 10% SDS-Page gel model V16-2 (Bethesda Research 
Laboratories Life Technologies™).  SDS-Page gels were then transferred onto 
PVDF (polyvinylidene fluoride; Immobilon-P from Millipore Corporation™) 
membrane at 12 volts in CAPS pH 11 buffer (2.2g/L CAPS, 10% methanol) for 60 
minutes utilizing a semi-dry transfer apparatus (Fisher Biotech™).  For extracts 
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prepared from Cat8::TAP containing strains, all conditions were identical to those 
described above with a few exceptions.  First, 5% SDS-PAGE gels were utilized 
since the Cat8::TAP protein fusion has a predicted size of ~180,000 Da.  Second, 
wet transfers of Cat8::TAP protein extracts were conducted at 25 volts overnight 
in a 4°C old room utilizing CAPS pH11 transfer buffer.  All membranes were 
blotted utilizing a 1:2,000 dilution of rabbit polyclonal α-TAP primary antibody 
(Open Biosystems™) and a 1:5,000 dilution of polyclonal HRP-conjugated α-
Rabbit secondary antibody (Santa Cruz Biotechnology, Inc.). 
 
3.5.  Glc7 Western Blots using α-Glc7 Antibodies 
3.5.1.  Growth Conditions and Sample Preparation 
Antibodies raised against endogenous Glc7 protein were obtained from 
Dr. John F. Cannon and western blots using these antibodies are pictured in 
Figure 7.6.  For these blots, strains DBY2059 and JH001 were diluted to 
2 x 106cells/ml in 175mls of the synthetic media described in Section 3.1.2.  Cells 
were incubated at 32°C on an Orbital shaker at 175 rpm for three population 
doublings until cells reached an approximate cell density of 2 x 107cells/ml.  Cells 
were spun down at 3000Xg, washed twice with ice cold water, and immediately 
flash frozen in liquid nitrogen.  The next day cells were thawed and re-suspended 
in 300ul of RIPA lysis buffer (50mM Tris-HCL, pH 8, 0.1% SDS, 0.5% 
deoxycholate, 150mM NaCl, 1% Triton X100, 5mM EDTA, 50mM NaF, 10mM 
NEM) and cells were disrupted utilizing the bead beating method described in 
Section 3.3.1.  NEM was chelated using 30μl of 100mM cysteine.   
 
3.5.2.  Western Blot Analysis and Antibodies 
Immediately preceding protein extraction, protein extracts were diluted to 
equal concentrations of 2μg/μl using RIPA buffer minus NEM and 64μl of extract 
from each strain was mixed with 16μl of 5 x Laemmli sample buffer.  The 
samples were heated at 90°C for eight minutes and 40μg of extract from each 
strain was loaded in replicate onto a hand cast 10% SDS page gel.  The gel was 
run at 65 volts through the stacking gel at which time the voltage was increased 
to 105 volts.  Transfer conditions as well as washing and blocking conditions 
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were identical to those described in Section 3.3.2.  Primary antibody to Glc7 was 
obtained from Dr. John Cannon and supplied in purified form by Dr. Anna De-
Paoli-Roach.  The membrane was cut in half after blocking and one half was 
incubated with a 1:500 dilution of rabbit anti-Glc7 antibody overnight at 4°C.  The 
other membrane was incubated with a 1:20,000 dilution of purified α-Cdc34 
which served as the loading control.  The remaining procedures were identical to 
those described in Section 3.3.2.  Exposures shown in Figure 7.6 B are seven 
minutes.   
 
3.6.  Spot Dilution Assays 
3.6.1.  Glucose + Antimycin A 
Glucose concentration spot dilution assays conducted on grr1Δ and the 
representative wild-type strain (DBY2059) were carried out by first streaking for 
single colonies for both strains on YPD plates.  Single colonies were picked for 
each strain and re-struck on YPD.  After two days incubation at 30°C, four 
colonies were picked for each strain and struck on plates of the synthetic media 
described in Section 3.1.2 containing .02%, .2%, 1%, 2%, and 7% glucose, 
respectively.  After four days incubation of these plates at 30°C, single colonies 
were picked from each plate and inoculated in to liquid cultures of the same 
composition from which they were picked.  These liquid cultures were allowed to 
grow to mid-log phase at which time they were serial diluted in water to attain 
dilutions of the following cell concentrations (300, 30, 3, .3 cells/μl).  10μm of 
each dilution for each glucose concentration was then spotted onto plates of the 
same synthetic media with the same glucose concentration supplemented with 
3μg/L of the respiratory inhibitor, Antimycin A (Sigma Aldrich Corporation).  
Pictures were taken using a Canon EOS digital SLR camera at 24 and 48 hrs 
post-incubation at 30°C.   
 
3.6.2.  Ethanol 
Ethanol spot dilution assays conducted on strains, DBY2059, CenPK113-
7D, JH001, and JH015 were carried out by first streaking for single colonies for 
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all strains on YPD plates.  Single colonies were picked for each strain and re-
struck on YPD.  After two days incubation at 30°C, single colonies were picked 
for each strain and re-struck on YPE containing 3% ethanol.  After seven days 
incubation of these plates at 30°C, single colonies were picked from each plate 
and inoculated in to liquid cultures of synthetic media (See Section 3.1.2) 
supplemented with 3% ethanol in place of glucose.  These liquid cultures were 
allowed to grow to mid-log phase at which time they were serial diluted in water 
to attain dilutions of the following cell concentrations (6000, 600, 60, 6cells/ul).  
10μm of each dilution for each glucose concentration was then spotted onto 
plates of synthetic media supplemented with 3% ethanol in place of glucose.  
Pictures were taken using a Canon EOS digital SLR camera at 72 hours post-
incubation at 30°C. 
 
3.7.  Network Analysis 
 In order to facilitate physical and genetic network analyses, a database 
containing physical as well as genetic interaction data for all Saccharomyces 
cerevisiae proteins was constructed by importing the interaction data available 
through the Saccharomyces Genome Database ftp server.  
(http://downloads.yeastgenome.org/literature_curation/archive/) The following 
interaction file was utilized for all physical and genetic interaction networks; 
(interactions.tab.200606.gz).  Additionally, transcription factor gene targets were 
manually imported into our database from the curated transcription factor/target 
gene repository of YEASTRACT (Yea
 Interaction networks were generated utilizing the network analysis tool 
ProteoLens 1.06 340 which can be downloaded from the following URL.  
(
st Search for Transcriptional Regulators 
And Consensus Tracking) 339. 
http://bio.informatics.iupui.edu/proteolens/index.stm) Utilizing this tool we were 
able to overlay our proteomic and genomic expression information onto the 
interaction data from SGD and YEASTRACT in order to reveal nodes “proteins” 
possessing interactions with multiple proteins or genes observed to change at 
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either the gene or protein expression level.  Relevant interaction networks were 
then rendered for publication utilizing Adobe Illustrator® CS4. 
 
3.8.  GO Analysis 
 GO (Gene Ontology) 341 annotations were obtained from the 
Saccharomyces Genome Database ftp server 
(http://downloads.yeastgenome.org/literature_curation/archive/orf_geneontology.t
ab.200606.gz).  These annotations were utilized for GO component analysis as 
well as to direct our manual revised GO annotations for the genes and proteins 
with significantly altered expression in grr1Δ strains.  GO enrichment analysis 
was conducted utilizing GenGO 342 which is openly available for use at the 
following URL; (http://www.sb.cs.cmu.edu/GenGO/). 
 
3.9.  Figure and Table Construction 
 All figures were rendered utilizing Adobe Illustrator® CS4.  Scatter plots 
and bar graphs were generated utilizing the visual analysis and data visualization 
software, Tableau™.   
  
3.10.  Relational Database Tables  
The sheer volume of data collected between our global genomic and 
proteomic analyses necessitated the need for a highly organized and relatively 
robust data storage infrastructure.  Additionally, since many data processing 
steps and network analyses were to be carried out on these data, storage 
infrastructure had to be malleable allowing multiple queries and cross 
comparisons between many inter-related data sets.  For these reasons, all data 
was imported into the open source database, MySQL (available for download at 
http://dev.mysql.com/downloads).  A brief description of the data tables and the 
types of data stored in the “GRR1 Database” is provided as well as significant 
numbers and statistics for hand curated interaction and transcription factor 
tables. 
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3.10.1.  Mass Spectrometry Data Tables 
3.10.1.1.  Peptide Specific Data Tables 
All data describing each peptide detected and analyzed at any confidence 
level in our global proteomic analyses is captured in our database within the table 
“peptide_res”.  For each peptide instance, all results obtained from SEQUEST™, 
PeptideProphet™, and ASAPRatio™ are recorded here.  Additionally, the 
analysis (specified as “run_id”) as well as the specific MudPIT step and scan 
numbers that provided the MS/MS files for the peptides identification can be 
found within this table.  The peptide sequence and its corresponding ORF or 
ORFs (if redundant) can also be found in this table.  In all, this table consists of 
67,201 records. 
The number of peptides detected for a given protein utilizing MudPIT 
analysis has been shown to positively correlate with the number of protein 
molecules present within the cell 343,344.  Thus, more highly expressed proteins 
possess a greater number of positive peptide identifications in these analyses.  
Instances where a low protein molecule per cell estimate is accompanied by a 
high number of positive peptide identifications could convey biologically relevant 
information pertaining to differences between the media and/or strain utilized in 
our analysis compared to that utilized in the study where the protein molecule per 
cell estimates were made.  Additionally, bias toward identification of labeled 
(wild-type) and/or un-labeled (grr1Δ) proteins could also provide an additional 
rough indicator of relative protein abundance.  Total peptide counts across all 
analyses for non-redundant peptides with peptide probabilities greater than or 
equal to .75 for each ORF are provided in table “pepcount_protmolcell”.  
Additionally, the estimated protein molecules per cell as determined by 337 are 
provided alongside peptide counts for grr1Δ and wild-type specific peptides for 
each ORF.  In all, there are 2105 records in this table. 
 
3.10.1.2.  Protein Specific Data Tables 
All protein data generated across all six analyses, prior to application of 
the multiple algorithms to combine these data, can be found in summarized, 
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filtered, or individual formats within the “GRR1 Database”.  All protein data 
generated across all analyses as reported by ProteinProphet™ and 
ASAPRatio™ for proteins at all confidence levels can be found in the table 
“protein_total_res”.  Since data can be generated for a given protein in any one 
of the six analyses, multiple records for a single ORF may exist and in these 
instances the origins of the data can be distinguished by their “run_id” and 
“sample_id”.  Each record consists of the identified ORF, its protein probability as 
determined by ProteinProphet™, its percent coverage, its ratio and adjusted ratio 
mean with calculated standard deviations as determined by ASAPratio™, the 
number of unique and total number of peptides identified for the protein, the 
percent share of spectrum identifications for that protein relative to the total 
number of identifications in the analysis, a brief description of the ORF (gene 
name etc…), and whether the protein has redundant sequence with any other 
protein in the database (“alt_orf1”, if blank is not redundant).  An annotated and 
filtered version of this table is “protein_total_res_p75pp_filter_anno” and contains 
the same information as “protein_total_res” but only for those protein 
identifications with a protein probability greater than .75.  This table also contains 
the “SGD_ID” for the ORF in order to fuse this information with SGD 
(Saccharomyces Genome Database) specific information such as details about 
the proteins function, half-life, translational frequency, codon bias, codon 
adaptation index, and gene expression level.  This specific information has 
already been imported into this table to aid in elucidating relationships between 
protein characteristics and their ability to be detected and quantified by our 
analysis.  Finally, the summarized results provided by “protein_total_res” are also 
provided in individual, analysis specific, tables to allow for individual evaluation of 
the results from each analysis.  These tables are named “protein_analysis_(1_1-
2_3)_results”, respectively. 
The protein identifications and relative abundances from each analysis for 
each ORF were combined utilizing the algorithms described in Sections 3.11.4.6 
- 3.11.4.8 in order to generate proteomic data of higher confidence.  The data 
from each of these stages is captured in a series of tables starting with 
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“protein_combined_res_all” which contains the calculated combined probability 
(Section 3.11.4.6) of every ORF for which data was collected regardless of 
protein identification confidence.  A wealth of additional data is also provided in 
this table including all data collected from each individual analysis for a given 
ORF (in column format rather than rows) as well as the number of times the ORF 
was identified across the six analyses (“Orf_count_6”).  There is data for 3602 
ORFs within this table.  A filtered version of this table using a combined 
probability cutoff of .75 is named “protein_combined_res_detected” and contains 
data for the 1867 identified proteins in our analysis as reported in Section 4.1.3.   
The combined analysis protein table named “protein_combined_res_quan-
_anno” contains the final combined quantification data for the 1182 proteins 
quantitated in our analysis including “Gold”, “Silver”, and “Bronze” quantification 
categories (Section 3.11.4.7 and 3.11.4.8).  This table contains a wealth of data 
including all ProteinProphet™ and ASAPRatio™ data for every individual 
analysis for each ORF as well as summarized data from all of the analyses that 
may be utilized to assess the validity of the final relative abundance measure.  
For example, the number of total and unique peptides from which the protein was 
identified and quantified across all analyses is reported as well as the calculated 
quantification confidence and the z score.  Additionally, the inter- and intra-
analysis standard deviations are reported here.  The inter-analysis standard 
deviation is calculated by considering each final adjusted ratio mean for a 
particular ORF for each individual analysis and is an indicator of quantitative 
reproducibility between replicate analyses.  The intra analysis standard deviation 
is calculated by averaging the measured standard deviations from each analysis 
and is an indicator of peptide abundance measure variability across the six 
analyses. 
 
3.10.2.  Gene Expression Data Tables 
We conducted whole genome expression studies comparing grr1Δ and 
wild-type strains using the Affymetrix™ yeast gene chips.  These studies were 
conducted utilizing four replicates each of wild-type and grr1Δ RNA preps.  All 
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raw data generated for each of these replicate analyses is provided in the 
“microarray_raw” table in the “GRR1 Database”.  The term “raw data” refers to 
the numeric signal intensities, the presence or absence call, and the p-value for 
each gene in each replicate.  This raw data was consolidated by calculating the 
mean signal intensity and standard deviation of the four replicate measures for 
both the wild-type and grr1Δ samples.  The fold change was then determined by 
dividing the mean signal intensity for the grr1Δ samples by the mean signal 
intensity for the wild-type samples.  Fold changes below 1 were converted to 
negative scale by taking the negative inverse of the fold change.  Both the 
Welch’s t-test and the Students t-test were applied and normalized to the log2 
scale to determine the statistical relevance of the fold change.  These 
summarized measures are reported in the table “microarray_grr1_vs_wt-
_summary” and data for 5689 records is contained therein. 
 
3.11.  Development of the 2D-LC-MS/MS Based Quantitative Global 
Proteomics Approach:  From Sample Preparation To Data Processing 
The implementation of a liquid chromatography-mass spectrometry (LC-
MS) based proteomic analysis platform is a stepwise process with the successful 
execution of each step pertinent to achieving reliable and comprehensive 
proteomic data.  LC-MS based proteomics platforms can be divided into four 
main stages (Figure 3.1) defined generally as experimental design and sample 
preparation, chromatographic separation, mass spectrometric analysis, and data 
analysis and validation.  Though these general stages of analysis are common to 
virtually every LC-MS based proteomics platform, the strategies that define these 
stages are highly customizable and often consist of multiple stepwise 
procedures, themselves.  Additionally, these strategies can be utilized in multiple 
permutations; each with strengths and weaknesses specific to a given 
application.  Thus, the design of a given proteomic platform must be tailored to 
specific experimental goals.  In this regard, a great deal of effort was exerted in 
our laboratory to adopt and develop strategies that would allow an extensive and 
reliable quantitative analysis of a complex peptide mixture derived from a yeast 
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Figure 3.1.  Schematic Diagram of SILAC/2D-LC/MS-MS Proteomics 
Platform and Data Analysis Pipeline.  The proteomics platform employed in this study 
can be divided into four major components, each consisting of multiple stepwise procedures.  
Sample preparation A: Strains DBY2059 (Mat α leu2-3, 112) and JH001 (Mat α grr1::NAT) were 
grown in independent replicate batches of SD-Glutamine supplemented with 6-C13 leucine and 
6-C12 leucine respectively to facilitate peptide labeling.  Protein was extracted by bead beating 
for each culture and total protein concentration was determined utilizing a standard Bradford 
assay.  Proteins from each batch (JH001 + DBY2059) were then mixed in a 1:1 ratio and reduced 
alkylated and trypsinized.  Online de-salt/SCX/C18 peptide separation B: Approximately 150 
ugs of each mixture (2 mixtures total) were then injected, separated, and analyzed six separate 
times utilizing an online desalting trap in line with a strong cation exchange column and finally a 
reverse phase (C18) column.  Peptides from each injection (run) were sequentially fractionated 
utilizing the SCX trap by introducing Ammonium Formate concentrations of 0, 4, 8, 12, 15, 18, 21, 
25, 50, and 100mM followed by two 1M steps.  Each of these fractions was immediately 
separated on the C18 column utilizing a 90 minute Acetonitrile gradient from 5 to 50% at a 
500nl/min flow rate.  Electrospray ionization and Mass spectrometry C: As peptides eluted 
from the C18 column they were immediately ionized utilizing electrospray and analyzed utilizing 
an LTQ (Thermo Electron Corporation) mass spectrometer.  The first three injections for each 
mixture were analyzed utilizing defined m/z scan windows of 500-1000 m/z, 900-1500 m/z, and 
1400-2000m/z and together constituted one “gas phase” analysis.  The final two injections for 
each mixture were analyzed utilizing the full m/z scan range and each individually constituted a 
“full scan range” analysis.  In all, three analyses were performed on each mixture, one “gas 
phase” analysis and two “full scan range analyses”.  Data Processing D: Each injection (run) 
resulted in 12 ms.raw files that were each analyzed individually through SEQUEST (Thermo 
Electron Corporation) to facilitate peptide identification.  SEQUEST results were then analyzed for 
validity and relative peptide quantification was measured utilizing a suite of software known as the 
Trans Proteomics Pipeline (TPP) available as open source from the Institute for Systems Biology.  
Statistical rules utilized by the TPP were then applied to the TPP results to combine protein 
identification probabilities and relative abundance ratios across all analyses into a final list of 
statistically valid protein identities and relative abundance ratios. 
 
whole cell extract.  In this chapter the stages of our proteomics platform are 
described in detail with emphasis placed on critical components of these stages 
and how they drove our decisions to adopt certain technologies.  Additionally, 
suggestions for significant improvement of this system will be interjected. 
 
3.11.1.  Stage1:  Experimental Design and Sample Preparation 
3.11.1.1.  Experimental Question and Approach 
In order to drive the development of our customized proteomics platform 
we chose to characterize the proteomic response to deletion of the F-box protein, 
Grr1, in S. cerevisiae.  Proteomic profiling of GRR1 deleted S. cerevisiae strains 
was attractive for reasons both practical and biological.  Practically, the S. 
cerevisiae genome was the first fully sequenced genome and is the most 
extensively annotated with 4718 verified genes, 1077 uncharacterized genes, 
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and 812 dubious open reading frames 345.  This translates to more reliable 
protein sequence databases to facilitate protein identification.  Also, the yeast 
genome contains ~6000 open reading frames, offering a less complex eukaryotic 
protein mixture to analyze than its mammalian counterparts.  Additionally, LC/MS 
systems have limited sensitivity that is typically accounted for by loading large 
amounts of protein (~150-200ug) that is easily obtained from yeast cell culture.   
Biologically, our laboratory specializes in yeast genetics with particular 
interest in the SCF’s (Skp, Cullin, F-box) role in coordinating both transcriptional 
and post-transcriptional responses to nutrient status.  Thus, we were specifically 
interested in the discordance between transcript and protein levels in response to 
deletion of components involved in this regulatory pathway.  With this in mind, we 
chose to characterize the proteomic response to deletion of the F-box protein, 
Grr1.  Yeast deleted for GRR1 remain viable, unlike many of the other SCF 
components, and thus, grr1Δ strains are amenable to analysis.  Additionally, 
many substrates for the SCFGrr1 complex have been elucidated.  Therefore, the 
validity of data generated through our proteomics strategy could be ascertained 
since certain proteomic changes could be inferred from the known biological 
roles of Grr1.  Finally, the eclectic group of substrates targeted by Grr1 includes  
multiple nutrient responsive transcription factors 56,168,57, cell polarity proteins 
55,101, cell cycle regulators 346,347, and mitotic proteins 54,348.  We therefore 
predicted that a diverse array of proteins would be observed to have altered 
abundances in grr1Δ strains and that the inability of these strains to degrade 
Grr1 targeted transcription factors would lead to discordance between transcript 
and protein expression levels.  Evaluation of this discordance would lead to a 
greater understanding of the role that Grr1 plays in coordinating these regulatory 
mechanisms. 
In summary, our primary strategy pertaining to the development of the 
proteomics platform can be stated as follows.  We hypothesized that an 
application driven strategy for the development of a global quantitative 
proteomics platform utilizing grr1Δ mutants of S. cerevisiae would serve to 
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validate the utility of the platform and generate new biological insights into 
Grr1 function that could then be used to direct future experimentation. 
 
3.11.1.2.  Factors Influencing Strains and Media Conditions 
In order to provide a comprehensive and biologically relevant proteomic 
data set there were a number of considerations prior to sample preparation that 
influenced the strains and media conditions utilized.  First, both the strains and 
media are dependent to some extent on the labeling strategy to be implemented.  
While many labeling approaches impose no restrictions on strain or media, 
others, such as SILAC (Stable Isotope Labeling of Amino Acids in Cell Culture) 
349, in some circumstances, require specific strains and media to facilitate relative 
peptide quantification.  Secondly, due to the known roles that Grr1 plays in 
extracellular sensing of both glucose and amino acids, both the genotype of the 
strain and the specific media conditions were tailored to minimize biological 
variables that would obfuscate the assessment of proteomic changes that arise 
as a direct result of Grr1 absence.  In this section, I will briefly describe the 
labeling procedures that were available to us at the time of our analysis and 
detail the specific factors that led to the application of the chosen labeling 
procedure.  Additionally, the specific growth and genetic concerns associated 
with the grr1Δ strain affected how we implemented the labeling procedure and 
will also be described.   
The first strategic consideration that must be addressed when performing 
a quantitative proteomic analysis on a complex mixture is whether label free or 
isotopic labeling will be utilized.  Both these methods can be employed to 
facilitate the relative quantitative comparison of two or more peptide samples and 
offer comparably accurate quantification.  However, they differ remarkably in the 
degree of difficulty in reducing quantitative errors due to sample handling during 
preparation.  This degree of difficulty is directly related to the theory by which 
each of these strategies relies on to facilitate relative peptide and finally protein 
quantification and underlies the most critical consideration when choosing 
between quantitative methods when both strategies are equally pursuable. 
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Label free strategies rely on the theories that relative peptide 
quantification can be measured by comparative quantification of extracted ion 
chromatograms (comparative LC-MS) 350 or by comparing the number of spectral 
counts (spectral counting) 343,351,352 from individual LC-MS analyses performed on 
the samples to be compared.  In these procedures, samples are prepared and 
analyzed by HPLC-MS in parallel and as a result the reliability of the final 
quantitative results relies heavily on the ability to reproducibly prepare, 
chromatographically separate, ionize, detect, and measure peptides and their 
respective ion intensities across multiple HPLC-MS experiments.  Variances in 
peptide quantification can be reduced significantly through multiple replicate 
analyses and extensive statistical analysis of the data but implementation of 
these measures drives up the price and time for each analysis 353,350.  
Nevertheless, label free methodologies remain attractive and widely used for 
biological applications where label based strategies cannot be employed, such 
as the comparative analysis of more than three samples concurrently 354,355. 
Quantitative labeling strategies rely on the theory that relative peptide 
quantification can be measured by comparing the extracted ion chromatograms 
of isotopically light and isotopically heavy labeled peptide pairs derived from the 
two samples to be compared, respectively.  The introduction of an isotopic label 
to the peptides of one or possibly more samples allows for samples to be mixed 
prior to LC-MS analysis and analyzed concurrently 354,355, since the sample origin 
can now be distinguished by the shift in mass to charge ratio measured by the 
mass spectrometer.  Samples can be mixed at the cell, protein, or peptide level, 
and prepared as one sample; minimizing errors introduced during sample 
handling and data acquisition.  However, label based strategies, in some cases, 
vary in the degree of difficulty of performing the labeling reaction to completeness 
and thus suffer from incomplete labeling that compromises the accuracy of 
quantification 356,357.  Labels can also be costly and in most instances may only 
label a certain fraction of the protein or peptide mixture.  Despite these 
drawbacks, label based methods remain the predominate strategies for 
conducting quantitative analysis on complex peptide mixtures.   
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Many label based strategies are currently applied for peptide quantification 
and a thorough review of all the technical alternatives is far beyond the scope of 
this volume 358,352.  However, these strategies can be classified generally based 
on the stage during sample preparation that the label is introduced and as a 
result the degree to which systematic and non-systematic variations can be 
reduced.  Isotopic labels such as ICAT (Isotope Coded Affinity Tags) 359 are 
incorporated post cell lysis but before enzymatic digestion of the protein extract, 
enzyme facilitated labeling using trypsin or Glu-C in the presence of 18O 356 
incorporates the label during protein digestion, and chemical labels such as 
iTRAQ 355 are incorporated post-digestion.  Each methodology provides viable 
peptide quantification, however the earliest stage at which a label can be 
incorporated into the proteome is during cell culture using a strategy known as 
SILAC (Stable Isotope Labeling of Amino Acids in Cell Culture) 349.  SILAC 
labeled samples can be mixed before or after cell lysis and, as a result, SILAC 
offers perhaps the most reliable quantification method if performed appropriately. 
Due to the fact that our experiments were to be performed on yeast, the 
full toolkit of labeling strategies was available to facilitate relative peptide 
quantification.  However, the ability to label proteins in vivo before systematic 
errors could be introduced was attractive to us and thus, we chose to implement 
a derivation of SILAC 360,349.  The SILAC strategy relies on the incorporation of a 
non-radioactive isotope of an essential amino acid into the proteome of one of 
the strains to be compared.  This incorporation is engineered by supplementing 
the amino acid of choice into the growth medium of cultured cells for ~9-10 
doublings.  As a result, every instance of that amino acid in the proteome of the 
cultured cells occurs as the heavier isotopic version of the chosen amino acid.  
Samples can then be mixed after cell culture or after cell lysis and prepared and 
analyzed through HPLC-MS as a single sample.  Since the mass spectrometer 
can distinguish between unlabelled and labeled peptide pairs based on the 
imposed mass difference; relative peptide quantification is realized by comparing 
their respective ion intensities across their chromatographic elution time. 
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Typically, SILAC is performed utilizing C13 incorporated arginine and lysine 
residues 361,362.  The utilization of these amino acids for quantification of peptides 
generated from tryptic digestion is particularly attractive since trypsin cleaves at 
lysine and arginine residues which in theory would result in the incorporation of 
an isotopic label on every peptide.  However, many organisms and cell lines can 
synthesize arginine and more often than not, lysine, de novo 363.  This ability 
leads to under-labeling and if left un-addressed can lead to inaccuracies in 
peptide quantification.  Yeast, in particular, can synthesize every amino acid de 
novo and thus the successful implementation of SILAC in this organism relies on 
the construction of auxotrophic strains specific to the amino acid isotope to be 
utilized 364.  In addition, yeast will actively catabolize amino acids as primary 
sources of nitrogen and recycle the remaining carbon skeleton for the synthesis 
of other metabolites, including amino acids 365.  This can result in non-specific 
amino acid labeling through incorporation of 15N or 13C isotopes derived from 
catalysis of the isotopic amino acid.  Thus, for any isotopic amino acid to be a 
viable label in yeast for whole proteome labeling, pathways required for synthesis 
and breakdown of the amino acid must be disabled.   
The genetic engineering of yeast for the utilization of isotopic derivatives 
of arginine for relative peptide quantification is particularly challenging.  Arginine 
can be synthesized de novo and is also a moderate nitrogen source in yeast 
(Figure 3.2).  As a result, 15N and 13C isotopes incorporated into arginine can 
quickly become incorporated into other metabolites such as proline, and 
glutamate which lead to non-specific incorporation of isotopic labels into peptides 
(Figure 3.2).  Thus, the effective use of arginine isotopes as quantitative labels 
requires at least two gene deletions (arg4 and car1) that together result in the 
inability of Saccharomyces to synthesize arginine de novo and catabolize 
arginine as a source of nitrogen.  These gene deletions would not only affect 
arginine metabolism but the synthesis of proline and glutamate under certain 
nutrient conditions and as a result could introduce variations in protein or gene 
regulation that would be specific to the required gene deletions.  However, it has 
been shown that supplementation of low amounts of proline in the growth 
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Figure 3.2.  Engineering S. cerevisiae for SILAC Arginine Labeling.  The 
successful utilization of arginine isotopes for peptide labeling utilizing the SILAC (Stable Isotope 
Labeling of Amino acids in cell Culture) method for yeast cell culture requires at least two gene 
deletions (nodes shown in red).  The ARG2 gene encodes for acetylglutamate synthase which 
catalyzes the first step in de novo arginine biosynthesis.  Deletion of this gene is necessary to 
insure full incorporation of isotopically labeled arginine into newly synthesized proteins.  The 
CAR1 gene encodes for arginase and catalyzes the first step in arginine degradation.  Strains 
containing a functional CAR1 gene are able to utilize both the carbon skeleton and nitrogens of 
arginine for synthesis of other amino acids.  Thus, in order to prevent incorporation of isotopic 
elements derived from arginine into other protein residues, deletion of CAR1 is required.  Isotopic 
elements derived from arginine are shown in red.   
 
medium of cultured embryonic stem cells inhibits the conversion of arginine to 
proline 366 and thus proline supplementation in yeast medium could bypass the 
requirement for CAR1 deletion. 
To avoid the practical concerns associated with the utilization of arginine 
isotopes, we chose to utilize 13C-6 leucine (available from Cambridge Isotope 
Laboratories, Inc., Andover, MA, USA.) The utilization of isotopic derivatives of 
leucine to facilitate relative peptide quantification has been demonstrated 
recently 367 and is an extremely attractive alternative to arginine/lysine labeling 
for multiple reasons.  First, de novo synthesis of leucine is easily avoided in yeast 
through utilization of a leu2Δ strain 364.  These strains are widely available in 
multiple S. cerevisiae backgrounds due to their widespread use as genetic 
markers 368.  Second, branched chain amino acid carbon skeletons are not 
recycled by yeast for biosynthesis and are metabolized to fusel alcohols and/or 
fusel acids that are simply excreted from the cell 369,370 (See Figure 3.3).  No 
further gene deletions are required to remove leucine catabolic enzymes and 
thus, far less influence on nitrogen biosynthetic processes is exerted when 
implementing isotopic leucine derivatives as peptide labels.  Finally, leucine is 
the most common amino acid comprising on average 9.1% of the amino acid 
residues in yeast proteins 367 and by our laboratories calculations would result in 
the labeling of ~65% of all tryptic peptides detectable. 
In summary, the utilization of leucine isotopes to facilitate peptide labeling 
requires fewer gene deletions and influences central nitrogen metabolism to a 
much lesser extent than gene deletions required for utilization of arginine 
isotopes.  In contrast, the implementation of isotopic leucine for peptide labeling 
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imposes limitations on the number of quantifiable peptides.  We chose to error on 
the side of caution by utilizing isotopic leucine as a label due primarily to known 
issues that grr1Δ cells possess regarding nitrogen signaling and metabolism. 
It is interesting to stress that, like leucine, valine and isoleucine are 
degraded to non-metabolizable fusel alcohols in yeast.  Interestingly, an 
isoleucine/leucine/valine auxotrophic strain can be constructed through a single 
gene deletion at the ILV3 locus encoding dihydroxyacid dehydratase which 
catalyzes the third step in the common pathway required for biosynthesis of all 
three branched chain amino acids.  The utilization of isotopes of all three of these 
amino acids simultaneously would increase quantifiable tryptic peptide coverage 
to ~89%.  Additionally, leucine and isoleucine are isobaric and as a result 
undistinguishable by mass spectrometry; implementation of isotopic leucine and 
isoleucine labels of different mass would bypass this issue leading to greater 
peptide identification confidence. 
Additionally, when choosing between different amino acid labels 
containing elemental isotopes, it is wise to employ strictly 13C derivatives that 
produce a mass shift greater than 4 Daltons.  Labels with deuterated hydrogen 
impose chromatographic shifts in retention time that lead to difficulties in 
extracting ion chromatograms for quantification 371.  Due to the fact that primary 
amines on amino acids are often cleaved for nitrogen utilization and can 
ultimately be utilized for the anabolism of other amino acids 134, it is best to avoid 
15N incorporated labels when possible.  Finally, ion traps are robust mass 
spectrometers and for this reason are popular mass analyzers utilized for the 
analysis of complex mixtures.  However, these instruments have mass 
accuracies of approximately 1 Dalton and thus the ability to resolve isotopic 
envelopes of heavy and light peptide pairs becomes a greater challenge with 
labels less than 4 Daltons.  This is because mass spectrometers measure m/z 
and thus a 3 Dalton label on a peptide with a charge equal to 3 would only shift 
the heavy label peptide 1 Dalton. 
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Figure 3.3.  Engineering S. cerevisiae for SILAC Branched Chain Amino 
Acid Labeling.  The utilization of branched chain amino acid isotopes for SILAC labeling of 
peptides requires only a single gene deletion since the carbon skeleton of branched chain amino 
acids is not utilized for the synthesis of other amino acids.  Branched chain amino acids are 
broken down to form fusel alcohols that are not utilized for protein synthesis therefore; 
inactivation of these pathways is not required.  Utilization of isotopic leucine (utilized in our 
analysis) requires a single gene deletion of LEU2, which encodes for β-isopropylmalate 
dehydrogenase, or LEU1, which encodes for isopropylmalate isomerase.  Theoretically, yeast 
could be engineered for concurrent utilization of isotopic valine, leucine, and isoleucine by 
deletion of ILV5 or ILV3 in order to increase the number of peptides quantitated.  Intracellular, 
fates of isotopes derived from labeled valine, isoleucine, or leucine are shown in red. 
 
In summary, the decision to employ a label based method facilitated by 
13C-6 leucine SILAC was primarily driven by the concern to reduce systematic 
errors and their influence on data validity.  We identified two potential sources 
ofsystematic errors that could be resolved early in the sample preparation 
stages.  First, systematic errors due to sample handling are most easily 
minimized by preparing samples together in the same test tube at the earliest 
stages of sample preparation possible and the SILAC strategy is amenable to 
very early sample mixing.  Second, non-specific isotopic labeling of peptides 
utilizing isotopic arginine labels is a known factor contributing to systematic errors 
in peptide quantification 372,358,371.  To bypass possible issues that would arise 
with their use we chose to utilize isotopic leucine whose carbon skeleton is 
known not to be recycled for biosynthetic reactions.  The decision to implement 
this strategy imposed two restrictions on the media and strains that had to be 
utilized in our experiment.  First, at least one of the strains had to be a leucine 
auxotroph.  Thus, we chose to utilize strain DBY2059 (MAT α leu2-3, 112) as our 
comparative “wild-type” strain since a nonfunctional leu2-3 allele was already 
present.  Second, both strains culture media had to be supplemented with a 
significant amount of leucine and 13C-6 leucine, respectively, to facilitate peptide 
quantification.  The remaining strains and media conditions were influenced 
strictly by the nature of the biological experiment and will be discussed in the 
following section. 
Yeast requires a viable source of carbon, nitrogen, sulfur, and some 
essential vitamins to support growth and division.  Interestingly, Grr1 is known to 
participate in coordinating cellular responses to both carbon and nitrogen source 
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fluctuations in the extra-cellular environment (Sections 1.9, 1.10, and 2.2).  
Specifically, grr1Δ strains have been shown to have defects in both glucose and 
nitrogen signaling and transport.  This multi-faceted role for Grr1 in facilitating the 
intracellular response to these two critical metabolites presented an exceptional 
challenge to experimental design.  The primary goal of our global analyses was 
to characterize changes in protein and transcript levels that were attributable to 
differential responses to glucose between grr1Δ and wild-type strains.  Due to the 
role of Grr1 in both carbon and nitrogen signaling and the intimate relationship 
between these two nutrients in metabolism, it is difficult if not impossible to 
completely eliminate cross talk between the molecular responses that they elicit.  
Ergo, we sought to separate the molecular responses to carbon and nitrogen by 
choosing nitrogen and amino acid sources whose influence on grr1Δ physiology 
and transcriptional regulation had been previously defined. 
As mentioned previously, the deletion of GRR1 results in the inability to 
respond to extra-cellular amino acids through the SPS signaling pathway and 
therefore grr1Δ cells possess specific amino acid uptake deficiencies.  It is well 
known that ssy1Δ leu2Δ strains do not grow on complex media despite the 
presence of leucine112.  This phenotype has been attributed to the fact that Gap1 
facilitated amino acid transport is the predominant transport mechanism in ssy1Δ 
cells and that amino acids compete for import through this transporter when 
multiple amino acids are present.  Therefore, in the presence of multiple amino 
acids, the transport of leucine through Gap1in an ssy1Δ leu2Δ strain is 
insufficient to replace leucine biosynthesis.  Strains deleted for GRR1 share 
many of the attributes of ssy1Δ strains in regard to amino acid uptake.  Like 
ssy1Δ leu2Δ, the grr1Δ leu2Δ strain (our laboratory, data not shown) shows a 
dramatic growth defect when grown in complex media when leucine is not 
provided at greater concentrations.  Thus, we surmised that Gap1 was the 
predominant amino acid transporter in grr1Δ strains as well.  We therefore chose 
not to utilize a grr1Δ leu2Δ strain in our global genomic and proteomic profiling 
experiments to avoid the effects that leucine deficiency would impose on the 
transcriptional and proteomic profiles of grr1Δ cells.  The possible drawback of 
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this choice would be that the absence of leucine biosynthetic mutation in grr1Δ 
cells could lead to transcriptional and proteomic changes in leucine biosynthetic 
genes and proteins compared to “wild-type” (leu2-114) if leucine import was 
insufficient to supplement the intracellular leucine requirement in grr1Δ cells. 
Due to the aforementioned competitive transport of amino acids through 
Gap1 we were limited in the number of amino acids that grr1Δ cells could be 
cultured with to avoid transcriptional and proteomic changes caused by 
deficiency of a particular amino acid.  Furthermore, we wanted to culture grr1Δ in 
a media that was conducive to elicit nitrogen catabolite repression in order to 
avoid proteomic and transcriptional responses attributable to defective nitrogen 
signaling.  Nitrogen catabolite repression is analogous to glucose repression in 
that certain nitrogen sources are defined as “preferred” nitrogen sources since 
their transport and metabolism exerts repression on genes required for the 
utilization of other “non-preferred” nitrogen sources.  Leucine is a “non-preferred” 
nitrogen source and thus another nitrogen source that would elicit nitrogen 
catabolite repression was required.  Strains of the S288C background show 
deficiencies in nitrogen catabolite repression when grown in ammonium sulfate 
which is normally a “preferred” nitrogen source in other strain backgrounds.  
Thus, even though grr1Δ strains show no deficiencies in transport of ammonium 
sulfate, this nitrogen source had to be avoided.  Glutamine is a highly preferred 
nitrogen source in S. cerevisiae and has been shown in multiple studies to exert 
nitrogen repression 373.  Glutamine is also transported by the Gap1 amino acid 
transporter 121,374.  Due to these characteristics, we utilized glutamine as the 
primary source of nitrogen in our studies.   
 
3.11.1.3.  Protein extraction 
Following cell culture, total cellular protein is extracted utilizing any 
number of alternative methods specific to the particular experimental application.  
An extensive review as well as experimental protocols for cell lysis of 
mammalian, bacterial, and yeast cells for common applications such as 
immunoprecipitation, immunoblotting, and liquid chromatography/mass 
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spectrometry can be found in 375.  This review provides an extensive and well 
outlined description of the critical issues that must be addressed for successful 
protein extraction.  However, I will discuss some of the key issues I discovered, 
specifically for preparation of yeast whole cell lysates for LC-MS based global 
proteomic profiling experiments. 
The ability to identify and determine the quantity of all proteins and 
peptides present in an entire cell is the “Holy Grail” of global proteomic profiling 
analysis.  The comprehensiveness of these experiments completely relies on the 
ability to extract the entire set of proteins present in the cell.  In order to analyze 
a given protein or peptide, it must first be present in the sample.  There are two 
important factors that determine the thoroughness and applicability of a given 
extraction method.  First, the efficiency of cell lysis must be high since unlysed 
cells lead to less protein and as a result make it harder to detect peptides derived 
from low abundance proteins.  Second, and perhaps most importantly, lysis must 
be performed in a buffer that will solubilize the vast majority if not all proteins.  
This is particularly challenging given that cellular proteins exhibit radically diverse 
solubilities, pKas, hydrophobicity indices, and sub-cellular localizations. 
A relatively simple procedure utilizing glass beads and a vortex provides a 
robust and efficient method for yeast cell lysis.  Yeast cells are notoriously hard 
to lyse given the presence of a rigid cell wall in this organism and as a result 
require extraction methods that employ more “brute force” than procedures 
utilized for mammalian cell disruption.  A number of viable alternatives are 
available to facilitate yeast cell breakage including the utilization of high pressure 
induced disruption facilitated by a French pressure cell or nitrogen cavitation.  
However, the abrasive lysis of yeast cells utilizing 0.5mm glass beads offered a 
simple and efficient method (yields of up to 95% cell breakage) 375 of protein 
extraction.  Briefly, cells are suspended in an appropriate buffer and glass beads 
are added to the meniscus of this suspension.  Cells are disrupted by ten 
consecutive rounds of 30 second vortexing and 30 second incubations on ice.  
The degree of cell breakage can be ascertained by examining an 8ul sample of 
the suspension under a phase contrast microscope. 
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As stated previously, the lysis buffer utilized during the glass bead 
disruption must promote solubilization of a wide array of proteins.  Buffers 
containing 8M urea or 6M guanidinium chloride have been employed for quite 
some time for solubilizing notoriously insoluble proteins.  Urea and guanidinium 
chloride are chaotrophic agents that greatly promote denaturation and thus 
enhance protein solubility.  Therefore, we chose to utilize a lysis buffer comprised 
of 8M urea buffered to pH8.5 with 1mM ammonium bicarbonate. 
 
3.11.1.4.  Determination of Protein Concentration and Sample Mixing 
Following cell lysis, the total protein concentration for each sample is 
determined to evaluate extraction yield and facilitate equal sample mixing.  
SILAC allows for sample mixing prior to cell lysis; however we were concerned 
about the variability in cell breakage efficiency between different strains 
(communications with the Roach lab).  This was especially concerning given the 
gross morphological abnormalities observed in grr1Δ cells.  We therefore 
decided to error on the side of caution and perform the mixing step post lysis 
where a relatively accurate protein concentration for each mixture could be 
determined utilizing any one of a number of available protein concentration 
assays. 
The accuracy of relative peptide and protein concentration relies heavily 
on the ability to mix the samples to be compared in a 1:1 ratio during sample 
preparation.  Thus, the given protein assay utilized to determine total protein 
concentration after cell lysis must be both robust and reliable.  The protein 
concentration of each sample can be determined utilizing a number of 
techniques, including ultraviolet absorbance 376, the Lowry assay 377, the BCA 
assay 378,379, and the Bradford assay 380.  Each of these methods varies in 
sensitivity and the degree to which buffer constituents (i.e. salts and other 
biological materials) interfere with the measurement.  Our protein mixtures were 
prepared in 8M urea and 100mM ammonium bicarbonate (salt) and therefore the 
protein assay we employed had to be both sensitive and compatible with salt.  
Among the possible methods, the Bradford assay offered both a highly sensitive 
 98 
 
and buffer compatible means to determine protein concentration.  Briefly, this 
assay is conducted utilizing Coomassie Brilliant Blue G-250 dye which binds to 
arginine, tryptophan, tyrosine, phenylalanine, and histidine residues in anionic 
form with an absorbance maximum at 595nm.  An absorbance curve for a 
standard protein sample (normally Bovine Serum Albumin) at various 
concentrations is generated.  It is important to seed the solutions for generating 
the standard curve with the same concentrations and volumes of the sample 
buffer that will be utilized (in this case 8M urea, .1M ammonium bicarbonate) 
when measuring the sample absorbance in order to minimize variability in 
absorbance attributable to the buffer constituents.  The absorbance for the 
protein samples is then measured and protein concentration is calculated using 
the equation defining the standard curve.  After protein concentrations are 
determined for each sample, the samples to be compared are mixed in a 1:1 
ratio accordingly.  Thus, in our experiment two independent mixtures have been 
created with each consisting of protein extracts derived from DBY2059 and 
JH001 mixed in a 1:1 ratio. 
 
3.11.1.5.  Reduction, Alkylation, and Digestion 
Once the desired protein extracts have been mixed, these protein 
mixtures are prepared for proteolytic digestion.  At this stage the proteins in the 
mixture exist in a semi-denatured state where both the secondary and tertiary 
structure has been disrupted by the presence of 8M urea.  Secondary and 
tertiary structure is defined by non-covalent interactions, namely hydrophobic, 
hydrophilic, and Van der Waal’s forces which are easily disrupted by urea.  
However, covalent bonds are not affected by urea and as a result disulfide 
bridges between cysteine residues are still intact.  If these disulfide bridges are 
left intact, any reduction in the urea concentration could promote protein 
renaturation that would in some cases lead to protein aggregation and as a result 
sample loss.  Additionally, the presence of disulfide bonds obstructs the protease 
during digestion resulting in inefficient protein cleavage.  Proteolytic digestion 
cannot be conducted at urea concentrations exceeding 2M since the enzymes 
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utilized for digestion are themselves denatured and rendered inactive.  
Therefore, disulfide bridges must be disrupted and their reformation must be 
prohibited before the urea concentration can be reduced and digestion can 
proceed.  Disulfide bridges are disrupted through chemically induced reductive 
cleavage utilizing dithiothreitol (DTT) 381,382.  Briefly, a 1:40 molar excess of DTT 
is introduced into the sample mixture and incubated at 50°C for ~30 minutes.  
The molarity of the protein mixture can be calculated utilizing the concentrations 
measured by the Bradford assay and by assuming an average protein molecular 
weight of 66,000 Daltons. 
At this point the proteins present in the mixtures exist in a fully denatured 
state.  Cysteines have been fully reduced and now exist with thiol groups present 
on the side chains.  In order to prevent reformation of disulfide bridges that 
readily form from natural air oxidation reactions these thiol groups are alkylated 
utilizing iodoacetamide.  Briefly, iodoactamide is added in an 80 fold molar 
excess to the reduced protein mixture and incubated in complete darkness on ice 
for ~2 hours.  Reformation of disulfide bridges is now prohibited since the 
cysteines have been converted to S-carboxymethylcysteine 383,384. 
Reduction and alkylation is proceeded by digestion of the protein mixture 
and is facilitated by any number of proteolytic enzymes (proteases) and 
chemicals (for review see 375).  Each of these enzymes and chemicals possess 
varying degrees of selectivity and specificity that determine the ability of the 
enzyme or chemical to generate peptide fragment mixtures amenable to analysis 
by a given global proteomics platform.  The selectivity of a proteolytic enzyme or 
chemical is defined by the number of distinct sites (peptide bonds) that are 
recognized for hydrolysis.  For example, chymotrypsin (EC 3.4.21.1) is a broadly 
selective protease that hydrolyzes peptide bonds C-terminal to tryptophan, 
tyrosine, phenylalanine, leucine, and methionine, whereas endoproteinase Lys-C 
(EC 3.4.21.50) is a highly selective protease hydrolyzing peptide bonds C-
terminal to only lysine.  Specificity refers to the efficiency of the hydrolysis at the 
selected sites and the degree to which “non-specific” peptide bonds are 
hydrolyzed inadvertently.  Together, the selectivity and specificity of a particular 
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proteolytic enzyme or chemical determine the complexity of the final peptide 
mixture and the physical nature of the peptides generated.  Both of these 
properties must be optimized and tailored to the proteomics platform to achieve 
valid and comprehensive global profiling data. 
The comprehensiveness of a “global profiling” experiment is, in part, 
determined by the number of analyzable peptides generated during the digestion 
procedure: if more peptides are analyzable, then more proteins are detectable 
and quantifiable.  The number of analyzable peptides is influenced greatly by the 
degree to which the physical properties of the peptides generated from a 
particular digestion strategy are amenable to the downstream separation, 
ionization, and analysis systems.  Two important properties determine this 
amenability and are largely defined by the selectivity of the proteolytic enzyme or 
chemical.   
First, it is favorable to generate peptides that can retain a significant 
number of positive charges.  Most online two dimensional separation systems 
employ strong cation exchange chemistry to facilitate peptide separation in the 
first dimension 385.  This chemistry utilizes immobilized anions to retain positively 
charged peptides and therefore the generation of a peptide population containing 
a large number of peptides with anionic properties would decrease the efficiency 
of this separation step.  Additionally, electrospray ionization is typically utilized in 
these systems in positive ionization mode which selectively ionizes positively 
charged peptides for mass spectrometric analysis 386.  For these reasons, 
digestion strategies that cleave C-terminal to basic residues (arginine and lysine) 
generate peptides that are quite amenable to analysis through these types of 
platforms.  Second, ion trapping instruments are robust mass analyzers that are 
commonly employed in global profiling experiments.  These mass analyzers 
possess functional scan ranges from 500 to 2000m/z.  Scan limitations in this 
range would theoretically allow for the detection of peptides ranging from 500 to 
6000 Daltons since peptides can hold multiple charges, usually ranging from 1 to 
3.  For this reason, it is favorable to choose a digestion strategy that produces 
the largest number of peptides within this molecular weight range.  The optimal 
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proteolytic enzyme or chemical may vary for different proteomes since the 
average peptide size produced is a function of the number of cleavage sites the 
enzyme or chemical possesses and the frequency of these sites in a proteome. 
Proteolytic enzymes or chemicals with broad selectivity and/or specificity 
generate diversified peptide populations which require larger peptide databases 
to facilitate efficient peptide identification.  As the database gets larger and as a 
result more complex the statistical validity of peptide assignments made by 
database searching algorithms is adversely affected 387,388.  Thus, in order to 
increase the validity of peptide identifications it is wise to simplify the peptide 
mixture as much as possible to reduce database complexity but not at the 
detriment of proteome coverage.  This is easily achieved by utilizing proteolytic 
enzymes of moderate to low selectivity and high specificity.  Low selectivity and 
high specificity decreases the diversity of C-terminal and/or N-terminal amino 
acids which can be exploited when the peptide database is generated to reduce 
database size and complexity.  To elaborate, during the mass spectrometric 
analysis of a complex peptide mixture, thousands of experimentally acquired 
“peptide fingerprints” known as MS/MS spectra are generated.  Each of these 
spectra are unique to a given peptide sequence and as a result are utilized to 
reveal the peptides identity by comparing their pattern to theoretically derived 
MS/MS spectra generated from a protein sequence database (in our case the S. 
cerevisiae protein sequence database) 389.  The first step in the generation of 
theoretical MS/MS spectra is the computer assisted (in silico) digestion of the 
protein sequence database to generate the peptide database.  Thus, the greater 
the number of non-specific cleavage events or recognized amino acids by a 
particular proteolytic enzyme or chemical, the larger the peptide database must 
become.   
Tryptic digestion of protein mixtures generates a large number of peptides 
amenable to 2DLC-ESI-MS and is a highly selective and specific protease.  
Trypsin (EC 3.4.21.4) selectively hydrolyzes peptide bonds C-terminal to 
arginines and lysines which possess basic amine groups that increase the 
charge capacity of the peptides.  This cleavage is highly specific and cleavage is 
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only known to be inhibited by the presence of proline residues C-terminally 
adjacent to arginine or lysine residues.  For this reason, database searches can 
be performed utilizing a theoretical peptide database generated by specifying 
arginine and lysine cleavage with only two or three mis-cleavage events allowed.  
Furthermore, ~95% of the peptides generated from tryptic digestion of the yeast 
proteome fall within the mass window of ion trap instruments 390.  For these 
reasons, trypsin is utilized as the digestive enzyme for many “global profiling” 
experiments. 
Despite the wide spread use of trypsin as the digestive enzyme for “global 
profiling” experiments it is important to emphasize that the implementation of 
multiple complementary enzymes on identical but separate protein mixtures 
could theoretically enhance proteome coverage and data validity.  Thus, the 
same protein mixture would be digested by two separate digestive strategies and 
each of these peptide mixtures could then be analyzed separately to maintain 
database simplicity for each search.  Amino acid sequences that are not detected 
and quantified by utilizing one digestion strategy due to the recalcitrance of the 
peptide to the analysis may be detected and quantified from another digestion 
strategy since the peptide properties would more than likely have changed.  The 
results from these two analyses could then be combined to increase the 
statistical validity of protein identification and quantification as well as increase 
proteome coverage.  The utilization of multiple digestion strategies to enhance 
“global profiling” analyses has received little attention despite the predicted 
benefits and hence optimization of this step in the analysis could provide large 
dividends with regards to enhanced proteome coverage. 
In our experiment, for reasons described above, we chose to utilize trypsin 
to digest our protein mixture.  Trypsin activity is inhibited at urea concentrations 
greater than 2M and thus before proceeding with digestion our samples were 
diluted four fold with 100mM ammonium bicarbonate to 2M urea.  After dilution 
trypsin (TPCK treated to prevent autolysis) was added to achieve an enzyme to 
substrate ratio of 50:1.  This mixture was incubated overnight at 37°C to allow 
digestion to proceed to completion.   
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3.11.1.6.  Sample De-Salting and Concentration 
Following digestion, the peptide mixture must be concentrated and buffer 
components that are incompatible with the separation strategy must be removed 
to insure realistic sample loading times and efficient peptide separation.  The 
most effective liquid chromatography based separation strategies for complex 
peptide mixtures support low flow rates ranging from 100-300ηl/min.  With 150 to 
250μg of sample typically loaded per analysis, an 180μg peptide sample at 
10ug/ul would take ~1 hour at a flow rate of 300ηl/min.  The dilution steps 
needed to facilitate digestion typically dilute the peptide concentration to 
anywhere from 0.1-1μg/μl, thus these mixtures must be concentrated to minimize 
loading times.  Additionally, liquid chromatography based separation strategies 
for the analysis of complex mixtures employ orthologous separation strategies 
performed in tandem, known as two-dimensional liquid chromatography.  Strong 
cation exchange (SCX) chemistry comprises the first dimension of separation 
and retains peptides based on their positive charge.  Peptides are then 
separated by increasing salt concentrations to divide the peptide mixtures into 
fractions.  Thus, in order to retain the greatest number of peptides at the initial 
loading stage, the sample buffer must be largely devoid of salt and other buffer 
constituents that adversely affect peptide retention on SCX resin columns.  Urea 
and ammonium bicarbonate at high concentrations are incompatible with SCX 
chromatography as is electrospray ionization and therefore great care must be 
exerted to insure the removal of these buffer components. 
A number of methodologies can be employed to facilitate sample 
concentration and de-salting but solid phase extraction with a C18 or comparable 
micro-trap offers a simple strategy that is compatible with two dimensional 
chromatography separations consisting of SCX and reverse phase (RP) resins.  
In this procedure the peptide mixture is loaded onto a C18 micro-trap and 
peptides are retained on the column by hydrophobic interactions between the 
peptide and C18 stationary phase.  Urea and ammonium bicarbonate are 
removed through subsequent washing steps after which the peptides are eluted 
utilizing the resin manufacturer’s specifications.  Often, the elution buffer is not 
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ideal for 2DLC-ESI-MS experiments and eluted peptide concentrations may not 
be ideal.  In these instances the buffer can be exchanged and the peptide 
concentration increased by evaporating the elution buffer away from the peptides 
utilizing a speed vac.  The dried peptide sample can then be re-suspended in a 
2DLC-ESI-MS compatible buffer of appropriate volume. 
There are a number of solid phase extraction strategies that can be 
employed with manufacturers promising increased retention of peptides with 
diverse physical properties.  For instance, the OasisTM HLB (Hydrophylic-
Lypophylic Balance) cartridges from Waters Corporation employ N-
vinylpyrrolidone and divinylbenzene stationary phases in the same column to 
retain peptides of neutral, basic, and acidic properties.  However, the advantages 
of these preparatory columns are lost unless the same stationary phase 
chemistry is utilized in the second, reverse phase peptide separation.  Peptides 
that are specifically retained on the Oasis HLB column due to the enhanced resin 
will not be retained if another C18 resin is utilized in the reverse phase 
separation.  Therefore, to maintain peptide sample composition through all 
separation strategies it is wise to employ identical or similar stationary phases 
(typically C18) for de-salting and reverse phase separations. 
De-salting procedures can be performed off-line utilizing gravimetric flow 
or vacuum manifolds, independent of the HPLC platform, or on-line where de-
salting and two dimensional separations can be performed in tandem utilizing an 
HPLC system.  Solid phase extraction columns for off-line de-salting can be 
purchased from numerous vendors, including Waters, Varian, GE Healthcare, 
and 3M Bio-analytical Technologies.  Off-line de-salting strategies require more 
manual effort but reduce peptide sample cross-contamination problems and 
HPLC dead volumes that contribute to sample loss.  Additionally, off-line 
strategies are more amenable to protocol development since multiple procedures 
utilizing varying chemistries can be performed simultaneously to assess the most 
robust and efficient de-salting method for a given application.  On-line de-salting 
procedures, if implemented correctly, reduce manual sample preparation times 
through automation.  The initial implementation and optimization of these 
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systems can be tedious since back pressure, buffer compatibility, flow rate, 
system volume, and plumbing must all be seamlessly integrated with 
downstream separation components.  However, a carefully automated system 
can provide robust and sensitive analyses that require far less manual effort than 
off-line systems.  The data reported in this work was generated utilizing an on-
line de-salting and separation system and therefore the description of our de-
salting and separation procedures will be discussed together in the next section. 
 
3.11.2.  Stage 2:  Peptide Separation Strategies for the Analysis of Complex 
Peptide Mixtures 
The comprehensiveness of a global proteomic profiling experiment is 
largely defined by the efficacy of sample preparation and the capacity of the 
analysis platform to detect, identify, and quantify the peptides present in the 
sample peptide mixture.  These mixtures contain hundreds of thousands of 
peptides each present at specific concentrations that can vary by more than a 
thousand fold and therefore the complete analysis of every component in these 
mixtures presents a significant challenge to proteomic analysis platforms 337.  
Employed alone, mass spectrometers lack the analytical capacity to measure 
even a small fraction of peptides present in these highly complex mixtures.  To 
increase the analytical capacity of mass spectrometers, peptide separation 
strategies are implemented prior to mass spectrometric analysis.  Separation 
systems act to temporally and spatially disperse peptides based on their inherent 
chemical properties.  This serves to reduce the number of peptides available for 
analysis per unit of time in order to complement the analytical capacity of the 
ionization and analysis systems.  This ultimately allows for measurements of a 
greater number of peptides to be carried out over the course of a separation.  
Therefore, the comprehensiveness of a global proteomics platform relies heavily 
on the effectiveness to which the separation components resolve the greatest 
number of peptides prior to mass spectrometric analysis. 
The effectiveness of a given separation system to resolve the components 
of a mixture is primarily assessed by a metric termed peak capacity 391.  Peak 
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capacity in chromatographic separations is defined as the maximum number of 
peaks or separable components (in this case peptides) that can be sufficiently 
resolved within a given separation space.  The maximum peak capacity of a 
chromatographic separation can be described by 
 NC = L(4σ)Rs 
[2] 
 
where L is defined as the theoretical total separation time or space, 4σ  is the 
average time over which each peptide elutes or peak width, and RS is the desired 
resolution 392,393.  Thus, peak capacity can be increased by increasing separation 
space, by reducing the peak zone width, and/or by reducing the desired 
resolution.  (Figure 3.4)  
A number of peptide separation technologies have been developed in 
attempts to maximize peak capacity in order to provide complete proteomic 
coverage.  HPLC (High Performance Liquid Chromatography) 394, UPLC 
(UltraPerformance Liquid Chromatography) 391, CZE (Capillary Zone 
Electrophoresis) 395, and CIEF (Capillary Isoelectric Focusing) 396 have all been 
utilized to analyze significant fractions of the peptides present in whole proteome 
digests but all of these technologies fall short of providing comprehensive 
proteome coverage.  Nonetheless, these technologies allow for a substantial 
fraction of the proteome to be sampled and as a result can provide a wealth of 
biologically relevant proteomic measurements.Among these technologies, high 
performance liquid chromatography based separations have become the most 
widely employed.  The widespread availability and relatively low cost of HPLC 
solvent delivery systems, the ease that these systems can be interfaced with 
mass spectrometers through electrospray ionization (ESI) or matrix assisted 
laser desorption ionization (MALDI), and the high sensitivities and peak 
capacities achievable by these systems are attributes that have contributed to 
this popularity.  Within this category of liquid chromatography based separations 
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Figure 3.4.  Factors Defining Peak Capacity in Chromatographic 
Separations.  A.  Peak capacity in single dimension chromatographic systems is defined by 
the number of components (i.e. peptides) than can be separated in a given separation space (in 
this case length = time = L).  Peak capacity is a function of the length (L) divided by the resolution 
multiplied by the peak width (4σ).  Resolution is calculated by taking the difference in retention 
times between two adjacent peaks (ΔZ = retention time of second peak (Trb ) minus the retention 
time of the first peak (Tra)) and dividing by the sum of the half widths of each peak (2σ: sigma 
being a unit of time equal to 10 seconds in the left panel).  In the left panel the baseline widths of 
each peak are uniform with each peak width equal to 4σ or 40s.  Additionally, ΔZ, or the 
difference in retention time, is equal to 4σ and thus the resolution equals one (unit resolution).  
The separation space defined in this case by the length L in the left bottom panel is ~12σ  or 2 
minutes and thus the peak capacity of the example in the left panel is 3.  A number of 
chromatographic properties can be altered to favor increased resolution including increasing the 
temperature and pressure of the mobile phase and  decreasing the size and pore size of the 
chromatographic resin.  The effects of increased resolution on peak capacity are exemplified in 
the middle panel.  In the middle panel the peak width of each peptide has been reduced 
compared to the peak width observed in the left panel by altering one of the aforementioned 
chromatographic parameters (4σ now equal to 24s).  By reducing the peak width, the ΔZ value 
relative to the peak width has now increased to 6.4σ or 38.4s and thus the resolution now equals 
1.6.  This increase in resolution leads to an increase in the peak capacity to 5 within the same 2 
minute separation space.  Peak capacity can also be increased by increasing the effective 
separation space or in this case length.  If effective separation length can be achieved without a 
significant decrease in resolution, as can be achieved in certain types of chromatography, peak 
capacity can be increased as shown in the right panel.  By doubling the effective separation 
space the peak capacity was also doubled (Pc = 6).  B.  Separation space can more effectively 
be increased by utilizing orthogonal separations in tandem.  First, components (peptides) are 
separated utilizing a particular separation strategy that has a peak capacity of 12.  Each of the 
components (peptides) from the first separation are then subject to another orthogonal 
(separation of components in the first dimension is retained in the second) separation strategy 
that further separates the components into additional components.  This second separation 
strategy possesses a peak capacity of 6.  The peak capacity of the two separation strategies 
utilized in tandem can now be calculated by taking the product of their individual peak capacities 
which in this case would be 72. 
 
exists a multitude of configurations that employ unique separation chemistries in 
stand alone or tandem formats to enhance peptide detection.  A complete review 
of the many HPLC configurations designed for proteomics applications is beyond 
the scope of this volume but can be found in the following excellent reviews 
397,398.  HPLC strategies employing strong cation exchange (SCX) and reverse 
phase (RP) separation chemistries in tandem formats constitute the core of the 
most popular methodologies for shotgun based global proteomic profiling 
experiments and thus represent the mainstream class of global proteomics 
platforms.  For our analysis, we chose to implement an on-line two dimensional 
SCX-RP HPLC based separation strategy. 
The balance between high sensitivity, high peak capacity, and high 
resolution achievable utilizing capillary reverse phase HPLC on peptide mixtures 
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as well as the ease to which this separation can be coupled to mass 
spectrometric instrumentation through electrospray ionization (ESI) has made it a 
popular separation strategy for conducting global proteomic profiling 
experiments.  Reverse phase peptide separations are often carried out utilizing 
micro capillary columns ranging in diameter from 50-100μm with varying lengths 
of 20-75cm.  These small bore capillaries are densely packed with porous silica 
beads that are 5-10μm in size with pore sizes of ~300Å or greater and C18 
surface coatings serving as the stationary phase chemistry.  Initially, peptides are 
loaded onto the column dissolved in a predominately aqueous mobile phase 
environment that is continuously delivered through the column utilizing an HPLC 
pump at flow a rate ranging from 50-600ηl/min and pressures ranging from 500-
1100psi.  It is widely accepted that the water surrounding the dissolved peptides 
and the hydrophobic stationary phase must assume a highly structured lattice of 
unfavorable entropy 393.  The interaction of hydrophobic side chains present on 
peptides and the C18 stationary phase leads to a favorable increase in entropy 
for the system that leads to peptide retention on the column.  Once bound, 
peptides are eluted differentially utilizing an organic solvent (typically acetonitrile) 
delivered by an HPLC pump that gradually increases the organic concentration of 
the mobile phase over time.  As the organic concentration is increased, the 
increase in entropy associated with the peptides binding to the stationary phase 
C18 becomes minimized relative to the increase in entropy associated with the 
peptides interaction with the organic mobile phase.  The mobile phase 
composition eventually reaches a critical organic phase concentration where it is 
entropically more favorable for the peptide to completely desorb back into the 
mobile phase and elute from the column.  The organic phase concentration at 
which desorption occurs depends on the hydrophobic composition of each 
peptide and thus differential separation is achieved by exploiting the hydrophobic 
character of each peptide.  The wide range of hydrophobicities present in peptide 
digests and the ability to implement capillary scale separations utilizing gradient 
elution under high pressures are the primary attributes of capillary reverse phase 
HPLC that contribute to its widespread success in providing sensitive separations 
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at high peak capacity.  A more detailed and thorough treatment of separation 
theory by reverse phase chromatography can be found in the following volumes 
399,393,400-402.   
Initially, global proteomic profiling experiments were conducted utilizing 
one-dimensional capillary RP-HPLC, however due to the complexity of peptide 
mixtures generated from global proteome digests, the enhanced peak capacity 
achieved utilizing only one dimensional capillary RP- HPLC was insufficient to 
achieve comprehensive proteome coverage 403-405.  This insufficiency is best 
illustrated by computing the theoretical peak capacity of a one-dimensional RP-
ESI-MS analysis.  The peak capacity of a proteomics analysis platform is a 
product of the individual peak capacities of each orthogonal separation 
component.  Separations are orthogonal if the resolution of the components in 
one dimension is retained and further enhanced in the second dimension 406.  In 
a typical one-dimensional RP-ESI-MS experiment the reverse phase 
chromatographic resin and the mass spectrometer can be considered as two 
orthogonal separations.  Thus the peak capacity of the total proteomics platform 
is a product of the reverse phase separations peak capacity and the mass 
spectrometers peak capacity 393.  Assuming that the RP separation is performed 
utilizing a 90 min gradient run time and each peptide elutes over a 30 second 
time period (30s = 4σ) the ideal peak capacity at unit resolution (Rs =1) of this 
one dimensional separation would be 180 (in this case 180 peptides could be 
resolved at unit resolution) using equation (1) for maximum peak capacity.  The 
peak capacity of the mass spectrometer is determined by its duty cycle and the 
number of redundant peptide measurements that it is programmed to make.  The 
duty cycle of a typical linear ion trap instrument is ~1s and commonly two 
redundant measurements are allowed, therefore the peak capacity of the mass 
spectrometer over a typical 30s chromatographic peak width is ~15 (in this case 
peptides).  By multiplying the peak capacity of the reverse phase separation and 
the mass spectrometric analysis we arrive at a peak capacity of 2700 for a typical 
RP-ESI-MS proteomics analysis platform.  Thus, even an ideal one dimensional 
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separation and analysis would only provide the peak capacity to analyze a 
fraction of the peptides present in a complex mixture.   
In order to overcome the peak capacity limitations of one-dimensional 
separations, researchers have employed additional orthogonal separation stages 
prior to the RP-MS stage.  For each additional, truly orthogonal, separation 
strategy employed, the peak capacity has the potential to increase by an order of 
magnitude.  This concept is illustrated in (Figure 3.4 B) and is described here 
using 2D-gel electrophoresis as an example.  In this separation, proteins are first 
separated by their pI using a pH gradient gel strip.  This separation can be 
visualized with Coomassie stain which reveals that the proteins migrate in 
discrete zones along the gel (indicated as 12 peaks in Figure 3.4 B).  Each zone 
can be comprised of multiple proteins but this cannot be confirmed visually 
utilizing only one dimension of separation.  Application of a second orthogonal 
separation of the proteins by size reveals that each peak in fact consists of a 
myriad of proteins which can now be visually confirmed.  The peak capacity of 
both separation strategies when employed together has now increased by an 
order of 12 which if multiplied by the peak capacity of our single reverse phase 
separation system results in a rise in peak capacity from 2,700 to 32,400.  Most 
commonly, increases in peak capacity for global liquid chromatography based 
peptide separations are achieved utilizing an additional orthogonal peptide 
separation step prior to RP-ESI-MS.  Among the many separation strategies 
available, peptide separation utilizing strong cation exchange (SCX) 
chromatography prior to RP-ESI-MS has become the most popular.  Strong 
cation exchange (SCX) chromatographic separations, like reverse phase 
separations, are carried out in micro capillary columns densely packed with 
porous silica beads that are 5-10μm in size with pore sizes of ~300Å.  However, 
SCX resins contain hydrophilic, anionic surface coatings (i.e.  poly-(2-sulfoethyl 
aspartamide)) that retain peptides of net positive charge.  Peptide retention is 
enhanced by loading peptide mixtures with a buffer at low pH (between 2 and 3) 
in order to insure that both aspartic and glutamic acid residues are neutralized 
and the net charge on the peptide is positive.  Peptides can be eluted using a salt 
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Figure 3.5.  MudPIT (MultiDimensional Protein Identification Technology).  
Increased chromatographic peak capacity to facilitate more comprehensive proteomic coverage 
is achieved utilizing orthogonal Strong Cation Exchange (SCX) and Reverse Phase (RP) 
separations juxtaposed in a single 50-100um i.d.. capillary.  Initially, peptides are loaded onto the 
first 3-5cm of SCX packing utilizing mobile phase solvent A.  Positively charged peptides are 
retained through ionic interactions with the negatively charged stationary phase (Polysulfoethyl 
A).  During loading, a certain population of uncharged peptides will pass through the SCX packing 
and be retained by the RP packing through favorable hydrophobic interactions with the C18 
stationary phase.  This population of peptides is separated first utilizing a 70 minute acetonitrile 
gradient (Solvent B, Step1) and peptides are analyzed as they elute from the column using ESI-
MS (Electrospray Ionization Mass Spectrometry).  Populations of peptides are then eluted from 
the SCX packing based on their charge (peptides with less charge elute earlier) in a stepwise 
fashion onto the RP packing utilizing increasing salt (ammonium acetate) concentrations (Solvent 
C, Steps 2-11 and 12 yellow) (Solvent D, Step 13 green).  Peptide populations eluted onto the RP 
packing after each salt step are then immediately separated and analyzed by acetonitrile gradient 
elution and ESI-MS (Steps 2-11, 12, and 13 orange).   
 
(i.e. ammonium formate) gradient but are typically eluted using sequential 
isocratic (step-wise) elutions of increasing salt concentration. As the salt 
concentration increases peptides of greater net positive charge (acidic) are 
eluted from the column and thus, SCX chromatography separates peptides 
loosely by their inherent pIs with basic peptides eluting earlier than acidic.  SCX 
chemistries are typically employed prior to reverse phase separations due to their 
superior binding capacity (~4 times greater than reverse phase resins) and can 
be integrated seamlessly with downstream reverse phase separations because 
peptide retention on either column is not affected by the elution buffers utilized in 
the other separation.  These attributes led to the development of the popular two 
dimensional peptide separation strategy termed MudPIT (Multidimensional 
Protein Identification Technology) 407-409.  A version of this technology was 
utilized for our analysis and thus will be described further to illustrate the theory 
behind the peptide separation approach we employed.   
The MudPIT separation strategy is schematically represented in (Figure 
3.5).  At the core of this technology is the separation column which consists of a 
50-100μm diameter fused silica capillary possessing a hand pulled tip.  This 
capillary is first packed with 15cm of C18 reverse phase resin followed by 3 -5cm 
of polysulfoethyl aspartamide SCX resin.  The tandem juxtaposition of the two 
separation resins eliminates dead volumes that can greatly increase separation 
times and sample loss.  Initially, the peptide sample, suspended in a low pH 
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buffer (~pH 2-3) is loaded directly onto the SCX resin phase of the column.  
During this initial sample loading stage, a large number of peptides with net 
positive charge are retained on the SCX phase while a small number of neutral 
or basic peptides slip through and are retained on the reverse phase column.  
Immediately after loading, a 90 minute reverse phase gradient from 5 to 50% 
acetonitrile is conducted to elute and analyze this fraction of peptides.  Following 
the initial reverse phase separation, a pulse of 4mM ammonium formate is 
delivered across the column to elute the next fraction of peptides onto the 
reverse phase resin; another 90 minute gradient is run.  This cycle proceeds for 
12 steps consisting of 0, 4, 8, 12, 15, 18, 21, 25, 50, 100mM and finally two, 1M 
ammonium formate pulses.  The application of MudPIT to global peptide 
separations has been reported to have a conservative theoretical peak capacity 
of 23,000 using an LCQ Deca 407,408 and would be at least 2 times higher if not 
more using the faster scanning LTQ for a peak capacity of 46,000.   
 
3.11.3.  Stage 3: Electrospray Ionization and Mass Spectrometry  
Throughout each reverse phase separation, peptide ions eluting from the 
tip of the chromatographic column are immediately ionized using electrospray 
ionization.  This ionization procedure utilizes a high voltage potential (~3 kV) 
between the tip of the chromatographic column and the capillary orifice of the 
mass spectrometer to release peptide ions from the mobile phase into the gas 
phase.  This step is absolutely necessary for peptide ions to be amenable to 
mass spectrometric analysis and remained one of the last barriers preventing the 
application of mass spectrometry to large biomolecules until John Fenn and 
colleagues developed the procedure 410; a feat for which he earned the Nobel 
prize in chemistry 411,412.  The mechanism by which peptides are liberated from 
the mobile phase solvent utilizing electrospray ionization is reviewed in the 
following volumes 411,413-415 and briefly described here. 
In order to promote protonation of peptides the mobile phase normally 
contains a small amount of organic acid (0.0025%) and thus the mobile 
phase/peptide solution contains an excess of positive charge.  As the 
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Figure 3.6.  Overview of Mass Spectrometric Analysis Utilizing the Thermo 
Finnigan™ LTQ Linear Quadrupole Ion Trap (LTQ).  A. As peptides elute from the 
MudPIT column they are exposed to an electric field which promotes their conversion from liquid 
phase ions to gas phase ions.  This process is known as electrospray ionization.  These gas 
phase peptide ions enter into a heated capillary and are then guided through a series of ion optics 
into the linear quadrupole ion trap.  B. 1.  A discrete packet of ions of a specific mass to charge 
ratio range is trapped in the ion trap in a dynamic state of axial and radial motion between the 
quadrupoles of the trap through the combined application of direct-current (DC) and radio 
frequency (RF) fields.  B. 2 and 3.  Once trapped, the magnitude of the radio frequency amplitude 
and direct current voltage is ramped at a fixed ratio to eject peptide ions sequentially, based on 
their mass to charge ratio, towards the electron multipliers. The radio frequency and direct current 
ratio at which a particular peptide becomes unstable in the trap and hits the electron multiplier is 
utilized to determine the mass to charge ratio of the ion.  The abundance of that ion in the trap is 
determined by the extent of the electric current produced from the ion populations bombardment 
of the electron multiplier.  B. 4.  The final output of the mass spectrometer is a two dimensional 
graph with the m/z ratio plotted on the x-axis and the ion intensity plotted on the y-axis.  This is 
known as a parent ion mass spectrum.  C. 1.  If the abundance of the ion is larger than a pre-
defined cutoff, the computerized control system will set the ratio of the RF and DC fields in the 
quadrupole trap to only allow for stability of that ion in the trap.  Thus, the next packet of ions 
entering the trap will be effectively filtered to isolate only the peptide ion of interest.  In terms of 
sequence, if multiple different ions are present in abundance above the cutoff, the most abundant 
ion will be isolated first and the remaining ions will be isolated in subsequent cycles of the trap.  
C. 2.  Once isolated, the peptide ion is electrically accelerated in the presence of an inert gas 
such as argon.  The accelerated ion collides with the argon molecules which leads to what is 
known as collision induced dissociation of the ion into ion fragments.  C. 3.  These ion fragments 
are then scanned as in the collection of the parent mass spectrum and their m/z ratios as well as 
their abundance are collected.  C. 4.  The final output of the mass spectrometer is a two 
dimensional graph with the m/z ratio plotted on the x-axis and the ion intensity plotted on the y-
axis.  This is known as the tandem mass spectrum or MS/MS spectrum.  The pattern of a MS/MS 
spectrum is specific to the peptide ion sequence and can be utilized to determine the identity of 
the peptide by searching the MS/MS spectra against a library of theoretical MS/MS spectra 
generated computationally utilizing a protein sequence database. 
 
peptide/mobile phase solution elutes from the capillary tip it is immediately 
exposed to the electric field and, due to the excess positive charge of the mobile 
phase/peptide solvent droplet, is pulled towards the lower potential mass 
spectrometer entrance orifice.  As the peptide/mobile phase solvent droplet 
traverses toward the heated mass spectrometer capillary orifice, the thermal 
energy as well as the electric field promote solvent evaporation and the solvent 
droplet reduces in size.  However, since ions are relatively involatile, the ions are 
retained in the droplet.  The reduction in droplet size and the retention of positive 
ions within the droplet leads to an increase in charge density until the repulsive 
forces between the positive ions become greater than the cohesive forces acting 
to keep the solvent molecules together (known as the Rayleigh limit).  Once the 
Rayleigh limit is reached, the solvent droplet begins to release peptide ions into 
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the gas phase.  Peptide ions produced from electrospray ionization can possess 
multiple charges and peptides of +1, +2, +3 and even +4 charge are possible.  
Peptides are continuously ionized by electrospray ionization during the 
course of each reverse phase separation and are analyzed “on the fly” utilizing 
mass spectrometry.  Numerous mass spectrometers employing technologies in 
various formats exist and each possesses its own subset of characteristics that 
make it amenable for specialized applications (for review see 415,414).  The 
robustness and relatively fast scan rate of the linear ion trap mass spectrometer 
makes it particularly amenable to global shotgun based proteomic analyses.  
This type of instrument was utilized in our analysis and a basic schematic of the 
Thermo Finnigan™ LTQ linear ion trap that we utilized is depicted in Figure 3.6 
A.  An LTQ mass spectrometer is a complicated instrument consisting of a 
multitude of parts including pumping systems, electronic circuit boards, system 
gauges, and computer interfaces.  Therefore, a thorough description of each of 
these systems is beyond the scope of this volume.  However, the instrument can 
be broken down into three basic parts; the ion optics, the mass analyzer (in this 
case the linear quadrupole ion trap), and the detector (in this case the electron 
multiplier).  In the following section, I will describe the processes that each of 
these parts facilitate in order to convey at a conceptual level how the mass  
spectrometer manipulates ions in order to measure their abundances and mass 
to charge ratios and to determine their identities. 
Ionized peptides enter the mass spectrometer through a heated capillary 
tube which guides the peptides to a series of ion optics.  The type and 
configuration of ion optics vary between mass spectrometers but in most 
instances serve to focus, accelerate, or de-accelerate the ion stream before the 
ions are subjected to analysis in the mass analyzer.  The mass analyzer in this 
instance is the linear quadrupole ion trap which is comprised of four parallel rods 
spaced equidistant to form a hyperbolic cross section.  In the Thermo Finnigan™ 
LTQ pictured in Figure 3.6 A, these four parallel rods are electrically and 
physically divided into three sections.  The end sections (shown in yellow) are 
connected to a static DC voltage supply which is dynamically switched to gate 
 118 
 
the ion stream from the ion optics into the central section of the mass analyzer 
(shown in green) and to trap ions within the centralized quadrupole region.  Each 
pair of diagonal rods of the central quadrupole are connected together electrically 
and to RF and DC voltage sources and thus each pair of diagonal rods is 
oscillating between negative and positive polarity 180° out of phase.  By 
modulating the amplitude of the RF and DC voltages at a fixed ratio, ions can be 
selectively trapped or excited out of the trap radially based on their mass to 
charge ratio.  Ions that have been selectively excited from the trap hit either of 
the electron multipliers that are positioned perpendicular to the longitudinal axis 
of the linear ion trap.  The collision of an emitted ion with the electron multiplier 
causes a chain reaction of electronic events that ultimately measure the 
presence and abundance of the emitted ion.  Finally, the mass to charge ratio of 
the ion is determined by the RF amplitude at which the ion was ejected from the 
trap and hit the electron multiplier. 
Throughout the course of the chromatographic separation peptides are 
continuously being ionized and injected in to the entrance of the mass 
spectrometer.  However, it is important to emphasize that peptide ion analysis in 
the mass analyzer is not continuous but cyclic.  Additionally, two types of cycles 
are carried out by the mass analyzer in order to facilitate ion detection (full scan 
or MS cycle) and to collect measurements to determine the identity of the peptide 
ion (product ion or MS/MS cycle).  During the full scan analysis, peptide ions are 
accelerated into the linear ion trap by the ion optics for a specified amount of 
time.  Once this time has been reached (trapping time), the end quadrupoles 
positive DC voltage is activated to trap the injected ions in the central 
quadrupole.  Additionally, the amplitude of the central quadrupole's RF frequency 
is set to selectively stabilize all ions present in the trap (Figure 3.6 B panel 1).  
Once trapped the ions are in a dynamic state of motion; oscillating axially and 
radially but within the confines of the quadrupole trap.  Each ion is then 
sequentially de-stabilized and emitted radially to the electron multiplier by linearly 
increasing the amplitude of the RF frequency but at a constant RF:DC ratio 
(Figure 3.6 B, panels 2 and 3).  Peptide ions of smaller m/z ratio are emitted from 
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the mass analyzer first.  This produces a single full MS parent scan which is 
represented on a graph with m/z on the x-axis and ion abundance (intensity) on 
the y-axis (Figure 3.6 B panel 4).  These scans are collected continuously 
throughout the course of a given chromatographic separation. 
If an ion is present in the full scan analysis at an abundance above a 
manually defined preset threshold, the mass spectrometer will perform two 
MS/MS (tandem MS) cycles on the selected ion (aka parent ion).  (Note: The 
number of MS/MS cycles performed on a given ion (level of redundancy) is 
manually defined and subject to individual operator discretion.) Immediately 
following the acquisition of the full or “parent” ion spectrum, the end quadrupoles 
of the mass analyzer once again open to allow injection of a new packet of ions.  
However, the central quadrupole is now set to allow only the selected ion from 
the “parent” spectrum to be trapped and thus the linear ion trap fills with only the 
selected ion (Figure 3.6 C panel 1).  Once filled, the selected ion is cooled or in 
other words the dynamic motion of the ion in the trap is slowed in preparation for 
fragmentation of the ion and a neutral gas is injected into the trap (Figure 3.6 C 
panel 2, yellow).  Fragmentation or collision induced dissociation of the ion is 
achieved by heating the ion in the radial direction through application of a 
resonance excitation voltage to all rod sections on the x-axis of the quadrupoles.  
This excitation causes the parent ion to dissociate into fragments as it collides 
with the inert gas within the trap (Figure 3.6 C panel 2, yellow).  These fragments 
are then selectively emitted from the trap as was described for the full scan MS 
analysis and detected (Figure 3.6 C panel 3).  This scan produces what is known 
as an MS/MS (tandem MS) spectrum or peptide mass fingerprint (Figure 3.6 C 
panel 4) which can be utilized to identify the amino acid sequence of the peptide 
(Section 3.11.4.1).  As indicated above, two of these spectra are collected for 
each ion of sufficient abundance.  After two MS/MS spectra have been collected, 
the parent ion is placed on an exclusion list for 2 minutes to prevent further 
analysis of the same parent ion. 
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3.11.4.  Data Analysis and Validation 
A brief overview of the data generated from each of the individual 
analyses conducted comparing grr1Δ to wild-type yeast as well as the software 
analysis pipeline utilized to process these data is shown in Figure 3.1 D.  In order 
to provide a tangible assessment of the comprehensiveness and efficiency of our 
analysis, to describe the details of this analysis pipeline, and to describe the data 
analysis stages that we utilized to generate our final quantified list of proteins, I 
will briefly describe each of these stages and the specific tasks that each of the 
algorithms perform. 
 
3.11.4.1.  Peptide Identification Utilizing SEQUEST™ 
The first stage of data analysis requires the assignment of each tandem 
MS file and its respective parent ion to the correct peptide and thus the correct 
protein.  Manual assignment of peptides to tandem mass spectra remains the 
most accurate method for assigning peptide identities but is tedious and time 
consuming and the vast number of MS and MS/MS files generated by our 
analysis required that a robust and accurate automated system be employed.  
Though multiple algorithms exist which will perform this process, we chose to 
utilize SEQUEST™ (Thermo Finnigan™, the manufacturer of the LTQ mass 
spectrometer that we utilized for data acquisition).  SEQUEST™ employs a four 
step process to match experimentally acquired tandem MS spectra with their 
respective peptides.  However, before these steps can be performed a protein 
sequence database must be available for theoretical generation of tandem MS 
files.  The details of SEQUEST™ analytical capabilities have been eloquently 
described in the following papers 416 and will be briefly reviewed here.   
The most popular search algorithm for peptide assignment from data 
generated from trap instruments, SEQUEST™ uses a correlation algorithm to 
match experimentally derived tandem mass spectra to the appropriate 
theoretically derived spectra; a process termed descriptive modeling 417. 
Algorithms that employ descriptive models generate theoretical tandem MS files 
from a specified protein sequence database.  In our case, a hand annotated 
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Saccharomyces protein sequence database was constructed utilizing the 
unaltered sequence database obtained through SGD (Saccharomyces Genome 
Database) by consolidating redundant protein sequences and removing some 
manually assessed dubious ORFs. 
 Theoretical tandem MS spectra were generated from this database in-
silico utilizing the SEQUEST™ algorithm by first generating a theoretical tryptic 
digestion of all protein sequences, allowing for two mis-cleavage events.  
Additionally, at this stage, parameters specific to an experimental method are 
also specified when generating the theoretical peptide tandem MS database.  
The molecular mass of each of the hundreds of thousands of peptides generated 
is calculated for each of the three probable charge states (+1,+2, and +3) that 
may exist for each peptide during the experimental analysis.  This calculation 
also includes any user specified parameters specific to the experiment that would 
influence the peptides mass.  For instance, we utilized a 6-C13-leucine label to 
distinguish between peptides derived from wild-type and grr1Δ strains.  Thus, 
when generating the peptide database, additional peptide tandem MS files with 
this mass shift incorporated were also generated for every peptide containing a 
leucine residue to enable assignment of peptides derived from the wild-type 
strain.  In addition, static carboxyamidomethylation of cysteine and dynamic 
carboxyamidomethylation of methionine residues is also specified.  These 
modifications occur as a result of the iodoacetamide treatment of the peptides 
prior to analysis.  Iodoacetamide, as discussed in Section 3.11.2.2, is an 
alkylating agent used to prevent disulfide bond formation at cysteine residues; 
however, this compound can also randomly modify methionine residues as well.  
The molecular mass of peptides containing a single modified version of these 
residues increases by ~57 Daltons. 
Once the experiment specific peptide database has been generated, 
SEQUEST™ proceeds by processing the tandem MS files into a more usable 
form that accelerates database searching.  First, replicate tandem MS spectra 
are consolidated into one final higher quality tandem MS spectra for a given 
parent ion.  The LTQ was configured during all of our analyses to collect replicate 
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tandem MS files for every parent ion that was selected for collision induced 
dissociation.  Consolidation of these replicate measures increases the quality of 
the tandem MS spectra for a given parent ion since aberrations that may occur in 
the first collision reaction event may be reconciled by the second.  After these 
replicate measures are consolidated the tandem MS spectra is reduced.  This 
reduction step removes all fragment ion signals except the 200 most abundant 
for a given spectra.  These 200 remaining fragment ion signals are then 
normalized to 100 and rounded to the nearest integer.  A number of additional 
processing steps are also implemented in order to reduce the complexity of the 
tandem MS spectra and facilitate more expedient database searching.  After 
these two processing steps are conducted SEQUEST™ generates files known 
as DTA files that contain the consolidated and reduced tandem MS spectra 
information.  As can be seen in Figure 3.1 the number of DTA files produced by 
this processing step is, as expected, approximately one half of the number of 
tandem MS files collected. 
After the DTA files are generated, the SEQUEST™ algorithm then 
sequentially searches the peptide database for peptides with masses (taking into 
account possible charge states as well) that match the experimentally acquired 
parent ion mass within a user specified mass tolerance.  This tolerance is 
typically set between ± 0.05% and was the tolerance utilized in our analyses.  All 
peptides with masses falling within this tolerance are then processed to produce 
theoretical tandem MS spectra using an algorithm based on empirical knowledge 
of peptides fragmentation during collision induced dissociation.  These theoretical 
tandem MS spectra are then scored (Sp) utilizing the following formula taken from 
418. 
 Sp =  �� im�ni(1 + β)(1 + ρ)/nt 
[3] 
 
where (ni) is the number of theoretical fragment ions matching within ± 1 amu of 
the experimentally acquired fragments, (im) is the abundances of these ions, (β) 
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is a 0.075 increment rewarded for every ion consecutive fragment ion matched, 
(ρ) is a 0.15 increment rewarded for every immonium ion matched between 
spectra, and (nt) is the total number of predicted ions.  Examination of this 
equation illustrates the specific characteristics of tandem MS spectra that are 
deemed to be important when determining the spectral match utilizing 
SEQUEST™.  SEQUEST™ reports the Sp score and the Sp rank for each 
theoretical tandem MS spectra matched to a given experimental spectra. 
The Sp score provides an initial measure of the validity of a given spectral 
match.  It was found that a number of experimentally acquired tandem MS 
spectra are not matched to the correct peptide because the correct theoretical 
tandem MS spectra do not produce the highest Sp score in a list of possible 
matches.  Therefore SEQUEST™ employs a cross correlation algorithm to 
further assess the top 500 theoretical tandem MS spectra matching a given 
experimental tandem MS spectra.  The cross-correlation process utilized by 
SEQUEST™ is described in the following references 419,417 and is briefly 
summarized here.  During collision induced dissociation, peptides fragment 
primarily along the peptide backbone to produce ions of a b and y ion distinction 
(For review see 420,375,421).  The b-and y- ions for the theoretical spectra are first 
generated with each of the primary ion series products assigned an intensity of 
50.  Any ions within a 1 amu mass window of these main fragments is assigned 
an abundance of 25 while the predicted water and ammonia ions are assigned 
an abundance value of 10.  The theoretical and experimental tandem mass 
spectra are then cross-correlated using the following algorithm: 
 
Rt =  � x[i]y[i + τ]n−1i=0  
[4] 
 
In essence, this algorithm measures the coherence of the experimental x[i] and 
theoretical y[i] discrete Fourier transforms utilizing fast Fourier transformation 
which superimposes the two functions across multiple displacement values (τ) 
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ranging from -75 -75.  A positive match has the highest correlation score at zero 
displacement and the final score (known as Xcorr) is calculated by subtracting 
the mean correlation value from all displacements from the 0 displacement value 
418,416.  This Xcorr value is also reported by SEQUEST™ and Xcorr cutoffs that 
are charge state specific are commonly utilized to filter positive identifications 
from less reliable matches.  It is worth noting that the Xcorr value is database 
size independent and thus reflects the quality of the spectral match. 
Another value of significance when assessing data validity generated from 
SEQUEST™ is the ΔCn value.  A Cn value is calculated by normalizing the Xcorr 
value to 1 for a given spectral match.  The difference of the Cn values from each 
theoretical spectral match to the next best theoretical spectral match for a given 
experimental spectra are calculated and reported as ΔCn.  Thus, the ΔCn of the 
highest ranking spectral match can be used as an indication of its uniqueness in 
the database.  The more unique (or greater the ΔCn) the match is, the greater 
the confidence that the experimental spectra is assigned to the correct theoretical 
spectra and the correct peptide. 
 
3.11.4.2.  Statistical Analysis of SEQUEST Results using the Trans Proteomic 
Pipeline 
The accurate assignment of experimentally acquired tandem mass 
spectra (MS/MS) to the correct peptide and thus the correct protein is critical if 
the results of an LC-MS based experiment are to be valid.  This necessitates the 
need for an automated analysis system that is both robust and accurate.  The 
SEQUEST™ algorithm has been used extensively in global proteomics studies 
and has proven to be robust and is highly automated 419,417.  However, 
SEQUEST™, not unlike any other peptide identification software, reports multiple 
scoring parameters (i.e. Xcorr, Sp, RSP, and ΔCn) that individually assess a 
given attribute of the quality of the spectral match.  Additionally, scores are 
biased by MS/MS quality, peptide mass, and charge state 332.  Thus, we sought 
to employ an additional layer of data evaluation that would serve to assess these 
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individual scores and derive an unbiased unified scoring parameter that we could 
use to assess the validity of our data systematically. 
There are multiple data analysis algorithms available that will increase or 
assess the validity of peptide matches generated from SEQUEST™ including LIP 
(Logistic Identification of Peptides)4, AMASS (Advanced Mass Spectrum 
Screener)5, QSCORE 6, SEQUEST-NORM 7, and many more 8-12.  However, 
since we required programs that could facilitate relative peptide quantification as 
well as validate peptide search results we were drawn to utilize an analysis 
pipeline known as the TPP (Trans Proteomic Pipeline).  The TPP, available as 
open source software from the Institute for Systems Biology 
(http://tools.proteomecenter.org/software.php), is a suite of software that was 
developed to provide a systematic analysis pipeline for global quantitative 
proteomic studies.  Briefly, SEQUEST™ results for each peptide match are first 
analyzed by PeptideProphet™ which utilizes discriminate function analysis to 
combine the multiple scores generated by SEQUEST™ into a single unified 
probability that is based off of machine learning techniques from training data 
sets 332.  Peptide probabilities generated by PeptideProphet™ are then 
transferred into the program ProteinProphet™ which calculates a unified 
probability that a protein was successfully identified based on the probabilities of 
its representative peptides 333.  Finally, relative quantification is facilitated by 
ASAPRatio™ which utilizes rigorous numerical and statistical tests to assess 
peptide abundance ratios and their associated errors.  Peptide ratios from 
peptides derived from the same protein are then weighted by their error and a 
protein abundance ratio is calculated using statistical methods for weighted 
samples 334.   
In practice, SEQUEST™ can be utilized independently of the TPP (Trans 
Proteomic Pipeline) or within the TPP software pipeline.  In order to process 
“.RAW” files produced by Xcaliber (the software package utilized to run and 
process mass spectrometric results generated from Thermo Finnigan mass 
spectrometers) through the TPP, these files must first be converted to what is 
known as the mzXML format by a program known as ReAdW (available from 
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http://tools.proteomecenter.org/wiki/index.php?title=Software:ReAdW) .  The 
mzXML format was developed by the Seattle Proteome Center (SPC) at the 
Institute for Systems Biology to provide an open source file format for transfer 
and storage of mass spectrometry based proteomic data 422.  Like ReAdW, a 
number of file converters are available for many of the most popular instruments 
utilized for proteomic data analysis including, mzWiff (Analyst by ABI/MDS 
Sciex), massWolf (Water Masslynx), and trapper (Agilent MassHunter).  
Additionally, mzXML files can be viewed utilizing Pep3D (bundled with the TPP) 
which produces a graphical 2D gel type image that can be utilized for evaluating 
chromatographic separation efficiency and for interfacing with CID data and 
peptide probability information.  It is important to note that the SPC’s mzXML 
data format and the exclusive mzData format of the Proteomics Standards 
Initiative are in the process of consolidation, creating a new mzML format 
established by the HUPO Proteomics Standards Initiative 
(http://psidev.info/index.php?q=node/257) with participation by the ISB. 
 
3.11.4.3.  Peptide Prophet 
 Once the “.Raw” files are converted to mzXML they are processed 
utilizing SEQUEST™ within the TPP and passed to the PeptideProphet ™ 
algorithm.  A thorough treatment of the statistical theories employed by this 
algorithm can be found in the following reference 332.  However, I will provide a 
brief, albeit surface level, review of the algorithm in order to convey some 
understanding of the process.  Peptide Prophet™ was developed utilizing 
experimentally acquired data sets acquired from 22 LC/MS/MS runs on a sample 
of 18 purified and trypsinized proteins.  These data sets were utilized to create 
training data sets where the attributes (SEQUEST™ scores) of known correct 
and incorrect spectral assignments could be defined.  From these defined 
attributes, a discriminate function can be derived that can be utilized to combine 
the multiple scores generated by SEQUEST™ into a single discriminate score.  
Bayes law can then be applied to calculate the probability that a given peptide 
assignment is correct.  This algorithm adjusts for changes in scores attributable 
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to charge state and peptide length.  The algorithm also can be utilized to 
calculate peptide probabilities from data sets generated not utilizing enzymatic 
constraints on peptide identifications.  For example, an unconstrained search is 
sometimes utilized to identify non-tryptic peptides in an experiment where trypsin 
was utilized.  Additionally, error and sensitivity values are calculated across all 
probabilities in order to provide a means for users to specify a peptide 
acceptance cutoff.  In short, PeptideProphet™ generates a single unified 
probability for each peptide assignment indicating the confidence of the spectral 
match.  Error and sensitivity cutoffs are then applied to generate a user specified 
list of high confidence assignments.  Thus, PeptideProphet™ provides a robust, 
fast, efficient, and unbiased means to filter peptide assignments generated by the 
SEQUEST™ algorithm. 
 
3.11.4.4.  Protein Prophet 
The statistical results generated by PeptideProphet™ for each peptide of 
a given protein are then utilized by another algorithm named ProteinProphet™ to 
calculate a unified protein probability.  The statistical theorems utilized by 
ProteinProphet™ have been described previously 333.  Using Bayesian statistics, 
ProteinProphet™ utilizes the highest probability of each unique peptide 
assignment for a given protein to calculate the probability that the protein was 
identified.  Unique peptides are defined as those identified with distinctive amino 
acid sequence or charge state.  This algorithm adjusts, in a data set specific 
manner, peptide probabilities obtained from PeptideProphet™ to account for the 
fact that the probability that a given peptide is correct is increased by the number 
of “sibling” peptides identified.  This parameter, termed NSP (for Number of 
Sibling Peptides) is calculated by summing the individual probabilities of each 
distinct correct peptide assignment for a given “multi-hit” protein.  Thus, peptides 
of “multi-hit” proteins have increased confidence adjusted according to the 
probabilities of its “sibling” peptides.  De-generate peptides or peptide sequences 
identified that occur in multiple proteins are also accounted for and protein 
probabilities are adjusted accordingly.  The final output of the ProteinProphet™ 
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analysis for each protein is a final probability that a particular protein was 
identified correctly based on the individual probabilities of its peptides.  Error and 
sensitivity data across all probabilities is also provided to allow user defined 
probability cutoffs to be assessed and applied. 
 
3.11.4.5.  Determination of Peptide and Protein Relative Abundance Using 
ASAPratio 
The calculation of relative abundance ratios for peptides and proteins is 
facilitated in the TPP by an algorithm called ASAPratio™ (Automated Statistical 
Analysis of Protein ratios).  The relative abundance of peptides labeled by a wide 
variety of chemical, enzymatic, or metabolic means can be determined utilizing 
this algorithm.  The details of the calculations performed by ASAPratio™ have 
been described previously 334.  First, a single ion chromatogram is constructed 
across the entire elution time by summing the intensities of the first three isotopic 
peaks of the parent ion for a given tandem MS spectra (peptide).  This process is 
repeated for the calculated labeled peptide pair as well as all charge states 
identified for each peptide.  The chromatograms are then smoothed utilizing the 
Savitzky-Golay method and background noise is estimated based on the average 
of the signals measured outside the elution peak.  A peak is accepted if the 
centered intensity is two fold higher than the background noise.  If a peak is not 
accepted it is given a value of 0 however, the respective peptide partner is not 
excluded from measurement based on this assignment.  In the cases where only 
one peptide of a pair is measured the final abundance ratio output is either 0 or 
999 depending on which was quantified and which sample was set to be the 
numerator of the ratio (in our analysis a ratio of 0 would indicate that only the 
wild-type peptide was quantitated while a ratio of 999 would indicate the 
quantification of only the peptide derived from grr1Δ).  Peptide ratio abundance 
errors are calculated based on the difference in area between the raw and 
smoothed chromatograms.  This algorithm additionally accounts for the 
identification of multiple charge states and the phenomena that a peptide is often 
found at different retention times and sometimes in different reverse phase 
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fractions during two dimensional analyses.  Dixon’s test is applied in these cases 
to omit outliers where three or more abundance ratios exist for the same peptide.  
The result of this analysis is the generation of a final weighted abundance ratio 
with a calculated error for every peptide identified and quantitated.  The peptide 
abundance ratios corresponding to a given protein are then weighted by their 
errors and a final protein abundance measure with standard deviation is then 
calculated using statistical methods for weighted samples.  P values are 
generated for each protein whose relative abundance was measured and provide 
a statistical means to evaluate significant abundance changes between samples. 
 
3.11.4.6.  Generation of a Final Combined Protein Probability and Relative 
Abundance Ratio Utilizing Data Collected from All Analyses 
Though the TPP was designed to allow individual analyses to be 
combined and analyzed, we failed to get ten, twelve step, two dimensional, LC 
MS analyses through the pipeline simultaneously, presumably due to insufficient 
computational power.  We therefore sought to combine the results from each 
analysis into a single high quality protein list using a multi-step processing 
scheme derived from algorithms utilized within the TPP computing architecture.  
Utilizing this processing scheme a final protein probability based off of the 
individual protein probabilities assessed in each analysis is calculated for every 
protein identified.  Additionally, a unified relative abundance ratio with error 
analysis is also determined.  The details of the processing steps utilized to 
generate these final scores are explained in the following section. 
Since some proteins are identified in multiple analyses, the reliability and 
accuracy of multiple probability measures can be improved by combining the 
probability measures from each analysis.  If a protein is identified by k analyses, 
labeled r1, r2,…rk, then the summarized probability is calculated as: 
 
Pid = 1 −�(1−  Pri )ki=1  
[5] 
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Where Pri is the probability measure from analysis ri.  Thus, utilizing this 
calculation, a protein identified in two separate analyses at 0.5 protein probability 
would have a final probability of 0.85.  We deemed that a protein possessing a 
combined protein probability of 0.9 was successfully identified and valid.  For 
example, using this cutoff for multiply sampled proteins this list, for example, 
would capture proteins whose confidence was assessed at 0.69 at least twice, at 
0.6 at least three times, 0.5 at least four times, and 0.4 at least six times.   
  
3.11.4.7.  Calculation of Combined Adjusted Ratio Means and Standard Errors 
We next wanted to combine the individual relative abundance ratios as 
well as their errors from each analysis into a single highly confident relative 
abundance measure for each protein.  However, the confidence of the relative 
abundance ratio is determined by multiple factors and though the final calculation 
is relatively straightforward, consideration of all parameters contributing to its 
validity is not.  First, a protein may be identified across multiple analyses at 
varying probabilities and it is possible for the relative abundance ratio to be 
derived from a low confidence protein identity despite the fact that the final 
protein probability is quite high.  Second, though the extent of our analyses was 
quite substantial there still remain a number of proteins quantified by only a 
single peptide.  Though these relative abundance ratios are deemed to be 
accurate for the single peptide, it is more difficult to assess the protein 
abundance ratio since multiple peptides ratios cannot be utilized for the 
calculation.  Additionally, differential post-translational modifications occurring on 
a quantified peptide can create significant peptide abundance ratio changes that, 
if not accounted for, can be misinterpreted as protein abundance changes.  In 
actuality, single peptide derived relative abundance ratios can be indicative of 
protein abundance changes or a change in the post-translational state of the 
peptide and nevertheless could represent significant biological changes 
attributable to the studied perturbation.  Third, the error of the relative abundance 
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ratios within analyses as well as between multiple analyses must be assessed if 
a high confidence list of quantified proteins is to be constructed. 
In order to construct a list of quantified proteins with tangible confidence 
parameters that could be assessed by the user, we first divided quantified 
proteins from all analyses into three different confidence groups termed “Gold”, 
“Silver” and “Bronze”.  To construct the Gold list, we first filtered all protein 
assigned a probability across the six analysis by removing any proteins with 
probabilities less than our defined cutoff of 0.75.  Proteins with no calculated 
abundance ratio or an abundance ratio of 0 or 999 were also removed.  Thus, 
only protein identifications that possessed a valid relative abundance ratio and 
were highly confident were included in this list of quantified proteins.  A combined 
relative abundance ratio and error was then determined in collaboration with Dr.  
Changyu Shen (Division of Biostatistics, IUSM) for the proteins within the “Gold” 
list using the procedure described in the next section.  The “Silver” list includes 
those proteins that may not have possessed a single quantified instance where 
the protein probability was greater than 0.75 but were nevertheless quantified 
across multiple analyses below this cutoff threshold.  To construct this list the 
combined abundance ratio was calculated as described in the next section by 
only considering those proteins with a valid abundance ratio and a combined 
protein probability of at least 0.9.  There was no probability cutoff applied to the 
protein identification utilized for the quantified value and thus any quantification of 
a protein derived from this list is more suspect than the “Golden” list.  It is 
important to justify the need for both the “Golden” list and the “Silver” list since 
both lists capture different types of high quality data.  The “Golden” list, though 
highly confident, used alone would fail to consider any proteins that were 
detected reproducibly at moderate to high confidence which lends to an overall 
higher confidence that the protein was identified correctly.  On the other hand, if 
the “Silver” list were used solely any protein identified and quantified only once at 
a probability below 0.9 would not be considered.  Thus, the two lists together 
encapsulate distinct instances, leading to a more comprehensive quantified list of 
proteins.  The final “Bronze” list includes the remainder of the proteins for which a 
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relative abundance ratio was determined and thus contains the lowest quality 
data with a presumed high false positive rate.  Though this last list is indeed 
comprised of what is deemed low quality data we felt that it nonetheless should 
be included in the final results since some measures are indeed correct and 
could fortify significant changes in protein functional groups. 
In order to combine the individual relative abundance ratios measured for 
a given protein across multiple analyses we employed the following method.  The 
final relative abundance ratio as well as the associated error for proteins 
quantified in only one analysis is utilized for the final abundance ratio and error in 
the combined list.  However, the determination of a final protein abundance ratio 
for proteins quantified multiple times presents a small dilemma.  Each time a 
relative abundance ratio is determined for a given protein, the number of 
peptides that this ratio is based on most certainly varies.  This is due to the 
stochastic process of obtaining valid parental mass spectra as well as tandem 
mass spectra for a given peptide each time an analysis is performed.  Due to 
variations in the number of peptides contributing to a given abundance ratio, the 
standard deviation of the ratio varies as a function of the congruence observed 
across multiple peptide ratios.  It is fair to make the assumption that a protein 
ratio with a low standard deviation provides a more accurate representation of 
the actual protein ratio than one containing a high standard deviation.  Thus, the 
standard deviation associated with an abundance ratio can be utilized to weigh 
the significance of each independent measurement as well as the final protein 
ratio.  With this in mind, final protein ratios as well as their standard deviations 
were calculated by combining multiple independent ratios across all analyses.  
The individual steps in this method are described below. 
First, the adjusted ratio mean and the associated standard deviation for 
each independent measurement is logarithmically transformed by taking the 
natural logarithm of the adjusted ratio mean (denoted as lnRi) and dividing the 
standard deviation by the original adjusted ratio mean, respectively (denoted as 
lnSDi).  Second, a weight is calculated for each adjusted ratio mean based on the 
standard deviation of the given adjusted ratio mean, using the following formula: 
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Wi = 1(ln SDi)2
∑ �
1(lnSDi)2�Ni=1  
[6] 
 
Where Wi is the weight score for each adjusted ratio mean determined for a 
given protein.  Third, the final combined ratio in the natural log scale (denoted as 
lnR) is calculated using this weight score as follows: 
 
lnR =  �Wi Ni=1 ∗ lnRi 
[7] 
 
where Wi is the weight calculated in equation 1 for a given ratio (lnRi).  Using this 
equation to sum each weighted instance of an adjusted ratio mean attained for a 
given protein; the final adjusted ration mean (R) for that protein is calculated and 
converted back to the normal scale.  Finally, the final standard deviation (lnSD) is 
determined utilizing the following equation:  
 
lnSD =  � 1
∑ 1(lnSDi)2Ni=1  
[8] 
 
The final standard deviation (SD) is then calculated by multiplying the combined 
ratio (R) and the above calculated lnSD. 
 
3.11.4.8. Determination of Proteins with Significantly Altered Relative Abundance 
Changes 
We next sought to isolate those proteins whose relative abundance was 
altered either positively or negatively by GRR1 deletion.  To do this, a z-score 
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was calculated by dividing the final abundance ratio by its standard error for each 
protein.  The local false discovery approach proposed by Effron (REF) is applied 
to the z-score to calculate the probability that the relative abundance ratio is 
different from 1- (PR).  Finally, we solve P =  Pid xPratio  where Pid  is the combined 
protein probability that the protein is identified correctly and Pratio  is the 
probability that the change in relative abundance is significant.  In other words, to 
be claimed as “differentially expressed” in our analysis, a protein needs to have 
high confidence in its identification and high confidence in its differential 
abundance. 
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CHAPTER 4: GLOBAL PROTEOMIC AND MICROARRAY RESULTS 
 
4.1.  Mass Spectrometry Analysis Numbers and Proteome Coverage 
4.1.1.  Raw Data and SEQUEST™ Totals 
The completion of our LC/LC-MS analysis resulted in the production of 12 
mass spectrometric raw files (denoted with a .RAW file extension) for each run.  
A total of 10 runs were performed ( 3 runs for each of two gas phase analyses as 
well as four single run full scan analyses) resulting in the generation of 120 
“.RAW” files.  Each of these “.RAW” files contains a file for every MS and MS/MS 
scan collected for the peptides eluting from one 90 minute reverse phase 
gradient from one salt step.  Thus, not including wash steps, down time in 
between runs, and injection times; the entire LC/LC-MS procedure of the 
experiment took roughly 8 days of instrument time.  Over one million scans (both 
MS and MS/MS scans as well as redundant scans), 500,716 of which were MS 
full scans, and 638,853 of which were MS/MS (tandem MS) scans were collected 
over the course of all six analyses (Figure 4.1).  Comparison of the number of 
MS and MS/MS files generated from each analysis revealed, as expected, that 
the ample gas phase analysis (1.1), which consists of three runs with the mass 
spectrometer scanning a different third of the full scan range each run, generates 
~ 3 times more MS and MS/MS files than a full scan single MS run (Figure 4.1).  
Also, as expected, consolidation of the redundant tandem MS scans by 
SEQUEST™ resulted in the production of approximately half the number of DTA 
files compared to the number of tandem MS files acquired for each analysis.  In 
all, approximately 300,000 DTA files were generated and searched utilizing 
SEQUEST™. 
We were curious to assess the proteome coverage achieved in our 
analysis by comparing our data to that of other global proteomic studies being 
performed on yeast at the time.  Just prior to our proteomic analysis, a global 
analysis of the yeast proteome was reported 409.  At the time, this study 
represented the gold standard for protein identifications and their analyses most 
closely resembled our own, barring a few differences (i.e. we utilized more 
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analyses but did not fractionate and they utilized a less automated/more sensitive 
LC/LC separation). 
Thus, we sought to compare our peptide and protein identifications totals 
utilizing their cutoff scores to validate the quality of our data.  At that time, data 
was filtered using SEQUEST™ cutoffs and thus we utilized the same cutoffs 
applied by Washburn et.al to facilitate comparison of our data set with theirs.  
Washburn et.al deemed that peptides possessing the following criteria were 
valid.  Peptides of +1, +2, and +3 charge states had to possess ΔCn values 
greater than or equal to 0.1 and the Xcorr value had to be greater than or equal 
to 1.9, 2.2, or 3.75, respectively 409.  In this study, Washburn et al. analyzed three 
fractions of a yeast whole cell lysate in three separate analyses.  Utilizing this 
technique and these cutoffs they were able to identify 5,540 unique peptides 
corresponding to the identification of 1,484 proteins.  In our analysis utilizing their 
SEQUEST™ filtering criteria we were able to successfully identify 19,861 total 
peptides (includes redundancies) corresponding to 5,200 unique peptide 
identifications and 1,722 non-redundant protein identifications.  Surprisingly, we 
identified fewer unique peptides but more proteins than Washburn et al. (Figure 
4.3).This would suggest that we successfully matched fewer peptides per protein 
or in other words increased protein coverage at the expense of the depth of 
coverage.  Interestingly, on average the proteins we detected possessed over 10 
peptide identifications per protein and we postulate that the replicate analyses 
greatly increased the depth of coverage for the most abundant proteins while the 
increase in coverage afforded to less abundant proteins was much more modest.  
However, given the added depth to which the gas phase analyses probe the 
proteome, it could be that we extended proteome coverage by detecting a new 
subset of peptides afforded by the added separation step in the gas phase 
analyses.  Nevertheless, we believe that our analysis was at least as extensive 
as that of Washburn et al. if not more. 
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Figure 4.1.  Mass Spectrometry Scans and File Totals for All grr1Δ vs wild-type Proteomic Analyses.  The total 
number of scans, MS, tandem MS (MS/MS), and SEQUEST™ processed MS/MS (Dta) files generated per analysis as well as across all analyses 
are plotted and displayed.
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4.1.2.  Peptide Totals from Peptide Prophet™ and ASAPratio™ 
As indicated previously, all SEQUEST™ search results were immediately 
processed using peptide prophet to statistically assess the validity of the peptide 
matches.  Subsequently, relative peptide abundance ratios were then determined 
using ASAPratio™.  Our results as processed through these two algorithms are 
shown in Figure 4.2.  PeptideProphet™ successfully calculated a peptide 
probability of at least 0.1 or greater for 67,201 of the 299,954 DTA files 
generated by SEQUEST™ (22.4%).  Interestingly, 17,637 peptides were 
assigned a probability of at least 0.9 or higher.  This represents 26% of all 
peptides for which a peptide probability was assigned and contains the most 
peptides of any probability bin.  Interestingly, this number is 2224 peptides fewer 
than the total number of peptides detected using the SEQUEST™ cutoffs of 
Washburn et al., indicating that a 0.9 probability cutoff may eliminate a number of 
positive identifications.  Additionally, the greatest number of peptides for which 
ASAPratio™ determined a relative abundance ratio also possessed peptide 
probabilities of at least 0.9 with 5,743 peptides quantitated at or above this 
probability.  Thus, ~1/3 of the 17,637 peptides identified with probabilities greater 
than or equal to 0.9 were quantified as well.  In summary, the high number of 
identified, as well as quantified, peptides assigned high probabilities in our 
analysis is a testament to the quality of the data generated. 
Once again, as shown in Figure 4.2, the gas phase analysis (1.1 shown in 
orange) contributed greatly to both the number of identified and quantified 
peptides at all probabilities.  This analysis alone accounted for ~66% of all the 
peptide identifications with probabilities greater than or equal to 0.9 across all 
runs.  Given the fact that a single gas phase analysis consists of three 
independent runs, it can be presumed that one gas phase analysis would 
produce at least three times the number of peptide identifications as a normal full 
scan analysis.  However, though the gas phase analysis produced approximately 
three times the number of DTA files as the other analyses (Figure 4.1), it 
produced approximately ten times the number of high quality peptide 
identifications (pep prob >= .9) (Figure 4.2).  Thus, the increase in data 
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generated utilizing the gas phase analysis is not simply a byproduct of increased 
data acquisition but can be attributed, for the most part, to an increase in the 
quality of data collected.  This increase in data quality is most likely due to the 
decreased number of ions that need to be trapped per MS scan due to the preset 
scan range limitations.  Reduction of the number of ions that are trapped 
presumably leads to less space charge effects in the ion trap which allows for 
greater scan resolution and sensitivity.  This disproportionally high contribution of 
the first gas phase analyses to the generation of high quality peptide data 
provides large support for the implementation of these type analyses on a greater 
scale. 
 
4.1.3.  Protein Results from Protein Prophet™ and ASAPratio™ 
Peptide probabilities as well as peptide relative abundance ratios are 
utilized by ProteinProphet™ and ASAPratio™ to arrive at the final protein 
probability and protein relative abundance ratio for each analysis.  A summary of 
the final protein results from these algorithms can be seen in Figure 4.3.  Utilizing 
a probability cutoff of .75 where the estimated average error and sensitivity 
across all six analyses was 5.6% and 60.1% respectively (Figure 4.4), we were 
able to successfully identify 1,810 proteins.  Among those proteins identified at 
this probability, approximately 44% were quantified (796).  Utilizing the 
ProteinProphet™ error and sensitivity estimates to determine the 0.75 protein 
probability cutoff, we were able to successfully include 88 statistically valid 
protein identifications that were not included utilizing the SEQUEST™ cutoff 
scores of Washburn et al.  In summary, we were able to successfully identify 
22% more proteins than that identified in the Washburn et al. analysis.  
Presently, other proteomic analyses are out performing our own, but given the 
time at which our data was collected this represented a significant achievement 
and is again a testament to the validity of the data collected. 
As was the case for the peptide identifications and quantifications, the 
number of protein identifications and quantifications was facilitated by the gas
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Figure 4.2.  PeptideProphet™ and ASAPratio™ Analysis Totals for Peptides 
Measured in all grr1Δ vs. wild-type Analyses.  (Top) Peptides assigned a peptide 
probability (Identified) by PeptideProphet™ as well as peptides whose relative abundance ratio 
was determined by ASAPratio™ (Quantified) across all grr1Δ vs. wild-type analyses were 
separated into ten bins based on their assigned peptide probabilities and plotted.  The number of 
peptides contributed by each analysis for each bin is indicated by color and presented in the inset 
table.  (Bottom) Total peptides as well as unique peptides using no probability cutoff as well as a 
probability cutoff of .75 (error = 6%) are plotted. 
 
phase analysis (1.1 in orange) and exceeded the number acquired by any other 
analysis.  However, the degree to which the number of protein identifications in 
analysis 1.1 exceeded the others on average (~2.8X the number of protein 
identifications at a protein probability of 0.9) was not as pronounced as the 10X 
improvement observed for peptide identifications.  The decreased performance 
at the protein level most likely resulted from increased protein coverage in 
analysis 1.1 for proteins of high abundance that are commonly identified by 
multiple peptides at high probability.  The identification of more high quality 
peptides for these proteins would only increase their protein probability 
incrementally since only one peptide of high probability is required to identify a 
protein at the same high probability.  Thus, the accumulation of high quality 
peptide identifications for a single protein is not reflected strongly in the protein 
probability calculation and as a result those proteins identified by only a single 
peptide of high probability are not penalized.  This assumption is supported by 
the fact that the average percentage of protein coverage in analysis 1.1 as well 
as 2.1 (also a gas phase analysis but 2.1 suffered from column clogging) for 
proteins possessing a 0.9 protein probability is approximately 21% and 18%, 
respectively, compared to the approximately 10% coverage obtained in the other 
full scan analyses. 
The bias of global LC-MS based proteomic analyses towards proteins of 
high cellular abundance is well documented 423,424,389,425-427 and is illustrated 
utilizing our data in Figure 4.5.  Utilizing the estimated proteins molecules per cell 
as determined by 428 we plotted the total number of proteins assigned a protein 
probability in each of fifteen protein abundance bins and visually overlaid the 
calculated average protein probability for each of those bins for each analysis  
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(Figure 4.5 A, the thicker and more red the bar, the greater the average protein 
probability determined for that bin). A couple of observations can be made from 
this graph.  First, the average protein probability increases as the estimated 
number of protein molecules/cell increases across all analyses and this increase 
is directly correlated to an increase in the number of peptides identified per 
protein for all analyses (Figure 4.5 B).  Second, the gas phase analyses (1.1 and 
2.1) contain higher average protein probabilities across all bins.  This indicates 
that these analyses greatly increase the dynamic range of the proteomics 
platform as proteins of lower abundance become more confidently identified.  
Again, this increase in dynamic range is a direct result of the increase in protein 
coverage at lower protein molecules/cell bins as the average number of peptides 
identified per protein is increased in lower abundance bins for the two gas phase 
analyses.  Thus, as observed in other studies, our proteomics platform also is 
biased towards proteins of greater abundance and as a result possesses a 
limited dynamic range.  However, the dynamic range is increased greatly by 
conducting “gas phase” analyses and would presumably increase to a greater 
extent as the number of replicate analyses of this type increased.  Additionally, 
the gain in dynamic range conferred by this type of analysis utilizing newer 
separation technologies such as ultra high pressure liquid chromatography 
coupled to newer mass analyzers such as the Orbitrap may be immense. 
 
4.1.4.  Identification and Quantification Totals for the Final Combined Protein List 
Until this point, our results have been reported regarding each analysis 
individually with final peptide and protein numbers calculated as the sum of the 
identifications obtained in each analysis.  Additionally, we have assessed a 
probability cutoff of 0.75 based off of the average error and sensitivities achieved 
across all six analyses.  Though the application of this cutoff alone is sufficient for 
individual analyses, it fails to consider those proteins that may have been 
identified in multiple analyses just below this cutoff.  Since some proteins are 
identified in multiple analyses, the reliability and accuracy of multiple probability 
measures can be improved by combining the probability measures from each  
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Figure 4.3.  ProteinProphet™ and ASAPratio™ Analysis Totals for Proteins 
Measured in all grr1Δ vs. wild-type Analyses.  (Top) Proteins assigned a protein 
probability (Identified) by ProteinProphet™ as well as proteins whose relative abundance ratio 
was determined by ASAPratio™ (Quantified) across all grr1Δ vs. wild-type analyses were 
separated into eight bins based on their assigned protein probabilities and plotted .  The number 
of proteins contributed by each analysis for each bin is indicated by color and presented in the 
inset table (Note: Redundant protein measures are included).  (Bottom) Total non-redundant 
proteins detected using no probability cutoff as well as a probability cutoff of .75 (error = 6%) are 
plotted.  Additionally, total proteins identified using the SEQUEST™ cutoffs specified by 
Washburn et al. for this analysis as well as their analysis are also plotted for comparison 
purposes.  Finally, the totals for our combined probability and adjusted ratio means calculations 
are provided as the final protein list.   
 
analysis.  Thus, we sought to utilize the data processing scheme described in 
Section 4.4.6 to combine the protein probabilities of proteins identified multiple 
times in order to provide a more accurate unified probability.  Utilizing a 
combined protein probability cutoff of 0.9 for multiply sampled proteins as well as 
the 0.75 cutoff for single analysis protein identifications we were able to increase 
the number of successfully identified proteins from 1810 to 1867.  This list will be 
referred to as the final protein list throughout the rest of this volume. 
The accuracy of the measured adjusted ratio mean for a given protein can 
also be improved by combining the multiple independent ratios obtained across 
all analyses into a single unified adjusted ratio mean.  For proteins whose 
adjusted ratio mean was determined in more than one analysis we applied the 
data processing scheme described in Section 4.4.7.  Through this process, a 
single adjusted ratio mean as well as its standard deviation is calculated from 
each individual relative abundance weighted by it standard deviation.  Each 
protein for which an adjusted ratio mean was calculated was then categorized 
into one of three categories termed ‘Gold’, ‘Silver’, and ‘Bronze’ based on the 
confidence of the calculated ratio.  “Gold” categorized proteins are considered 
the most reliable measures because they possess combined relative abundance 
ratios calculated from individual ratios whose corresponding protein probability 
was at least 0.75 or greater.  This “Golden” protein list contained 797 quantified 
proteins.  “Silver” categorized proteins possess a combined final protein 
probability greater than 0.9 but were not detected in any single analysis at a 
probability greater than 0.75.  Thus, the relative abundance ratio is based off 
measurements from lower confidence protein identifications and as a result is 
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considered less reliable than those in the “Gold” list.  This “Silver” list contained 
an additional 117 quantified proteins.  The third and final list, denoted the 
“Bronze” list, contains the remainder of proteins for which an adjusted ratio mean 
was determined regardless of protein probability.  This list contains 267 proteins 
and is expected to contain a high number of false positives.  However, it most 
certainly contains a number of true positives that could provide useful biological 
evidence and was therefore included in the final protein list.  The “Bronze” list is 
not included in any of the reported numbers for quantified proteins.  Together, 
these categories indicate the confidence that a protein in our experiment was 
quantified correctly and can be utilized at the individual researcher’s discretion 
when interpreting the final results.  Considering only the “Gold” and “Silver” lists 
we successfully quantified 914 proteins in a S. cerevisiae whole cell extract 
utilizing our proteomics analysis platform (Table 4.3).  If the “Bronze list” is 
included in the total, 1181 proteins were quantified with the last 267 “Bronze” 
proteins containing many false positives. 
Now that we had combined the data from all analyses into a unified list of 
proteins with unified confidence and relative abundance metrics we next wanted 
to isolate those proteins whose relative abundance changed significantly due to 
GRR1 deletion.  To do this, as described in Section 4.4.8, we calculated a 
“probability of change” that is calculated by taking the product of the combined 
probability that the protein was identified correctly and the probability that the 
relative abundance changed significantly (Pratio).  This second probability was 
calculated using the local false discovery approach of Effron 429 applied to the 
calculated z-score of the relative protein abundance.  Thus, in order to possess a 
high “probability of change” in our analysis the protein had to both be identified at 
high confidence and its differential abundance had to be at high confidence.  In 
order for a protein to be deemed “differentially expressed” in our analysis its 
“probability of change” had to be at least 0.9, the protein category had to be at 
least “Gold” or “Silver”, and the magnitude of its abundance change had to be at 
least 2.5X.  Utilizing these cutoffs, 187 proteins were determined to be 
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Figure 4.4.  Estimated Average Error and Sensitivity Plots from All Analyses.  Protein Prophet™ calculates an error and 
sensitivity estimation for each probability for each analysis.  Utilizing these individual error and sensitivity estimates we calculated the average 
error and sensitivity across all six analyses (shown above with average sensitivity plot on top and average error plotted on bottom).  Utilizing these 
averages we assessed a probability cutoff of .75 (red line) where the error was approximately 5.7% and the sensitivity was around 60% across all 
analyses.  This cutoff was applied to those proteins only identified in a single analysis whereas those observed in multiple analyses were 
subjected to additional data processing (see text).
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significantly changed due to GRR1 deletion.  Ninety one proteins have increased 
relative abundances in grr1Δ strains compared to wild-type while 96 proteins 
showed lower relative abundances in grr1Δ.  Altogether, ~ 20.5 % of the proteins, 
for which we attained a relative abundance, were found to be “differentially 
expressed” due to GRR1 deletion (Figure 4.6). 
 
4.2.  Micro-Array Totals 
Our interests did not rest solely on determining the proteomic response to 
GRR1 deletion but in comparing the correlation or lack thereof between 
transcriptional and proteomic changes attributable to loss of this gene.  
Microarray analyses have previously been reported for grr1Δ strains; however 
these analyses were conducted utilizing strains of the CenPK background which 
displays major differences with the S288C background regarding growth and 
nitrogen source preference.  With this in mind, a genome wide transcriptional 
analysis (microarray) was conducted utilizing the same strains, media, and 
growth conditions as those utilized in our proteomic analysis.  The details 
pertaining to how our microarray analysis was performed is described in detail in 
Section 3.2 and the results are summarized briefly here.  Utilizing four biological 
replicates for each strain, we determined the relative levels of 5,593 gene 
transcripts including ~99% of the genes assayable on the microarray chip (Figure 
4.6).  A Welch significance test was applied to each measurement and only those 
transcripts possessing a Welch log 2 value equal to or below 0.05 as well as a 2 
fold change in either direction were considered “differentially expressed”.  
Utilizing these cutoffs we were able to measure 267 significant changes in gene 
expression of which, 197 were observed to increase and 70 were observed to 
decrease in grr1Δ strains.  Altogether, ~ 4.8% of those genes whose relative 
expression level was measured were found to change significantly in the grr1Δ 
strain. 
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4.3.  GO Enrichment Analyses for Proteomic and Genomic Data Sets 
4.3.1.  GO Component Enrichment Analysis of Global Proteomic Data 
Global shotgun based proteomic analyses have previously displayed 
systematic biases against the identification of membrane proteins and/ or 
proteins of different sub-cellular locations 430.  This bias is attributable to both the 
inherent hydrophobicity of these proteins, which limits their solubility during 
extraction, and to the low abundance of these proteins within the cell.  In order to 
assess whether this bias or if any other bias was present in our own analysis we 
determined the enrichment or lack thereof for proteins from different sub-cellular 
compartments.  To do this, we individually categorized proteins detected, 
quantified, and changed in our analysis by their assigned GO (Gene Ontology) 
Slim component ontologies ("Saccharomyces Genome Database" ftp://genome-
ftp.stanford.edu/pub/yeast/data_download/literature_curation/go_slim_mapping.t
ab (9/16/2009)).  A percentage of protein coverage within a particular ontology 
was then determined by dividing our detected and quantified total by the total 
number of proteins in SGD assigned to the particular ontology.  Additionally, 
given the bias already described towards proteins of higher abundance within the 
cell, we also calculated the average protein abundance as determined by 428 for 
each Saccharomyces GO Slim component category.   
Empirical evaluation of each component in conjunction with the calculated 
enrichments for our analysis as well as the average protein abundance revealed 
that a high percentage of proteins annotated to the ribosome were detected 
(14.65% points above the mean) and quantified (15.26% points above the mean) 
and that this bias correlates with the increased average abundance of proteins 
annotated to the ribosomal component (Figure 4.7).  Consistent with other 
analyses, proteins annotated to membranes as well as the nucleolus (7.35% 
below mean coverage) are observed to be underrepresented in our analysis 
including the plasma membrane (5.4% below), endoplasmic reticulum (10.76% 
below), membrane (10.18% below), membrane fraction (7.67% below), 
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Figure 4.5.  Assessment of the Inherent Bias Toward Proteins of Higher 
Abundance in the grr1Δ vs. wild-type Proteomic Analysis.  A.  All proteins 
assigned a protein probability by Protein Prophet™ were divided by analysis and grouped into 
one of fifteen bins based on their estimated protein molecules per cell as determined by 428 The 
number of proteins within a given bin for a given analysis is represented by the height of the bar 
and annotated by the number at the top of the bar.  The bars are colored by the average protein 
probability within that bin for that analysis.  Higher average protein probability is represented by 
darker shades of red and thicker bars while lower average protein probability is represented by 
lighter shades of red and thinner bars.  B.  The average number of peptides identified for proteins 
within a given protein molecule per cell bin are plotted and separated by analysis. 
 
mitochondrial envelope (10.46% below), and cytoplasmic membrane bound 
vesicle (5.42% below).  This under enrichment does not correlate directly with the 
average protein abundance calculated for proteins within these components, 
suggesting that either the extraction procedure or our LC-LC-MS procedure 
possesses an inherent bias against the isolation or detection of proteins linked to 
these sub-cellular locations.  This bias is most likely greater for proteins located 
in the endoplasmic reticulum, membrane, and membrane fraction since an 
exaggerated bias against their quantification is observed with values below the 
means of 5.58%, 12.26%, and 7.63%, respectively.  Since our extraction 
procedures were not designed to include extracellular or excreted proteins, the 
lack of coverage for proteins annotated to extracellular region is expected.  In 
summary, the bias of our proteomic analyses towards the detection and 
quantification of high abundance proteins is exemplified further in the GO 
component analysis due to the apparent preference for analyzing ribosomal 
proteins which are usually very abundant.  Furthermore, the observed bias 
against membrane protein analysis for our platform is consistent with previous 
reports 431,432 and stresses the need for implementing extraction procedures ideal 
for membrane protein enrichment. 
While the GO component enrichments discussed above are most likely 
due to systematic bias, the increased enrichment in the number of differentially 
expressed proteins annotated to cellular bud, cytoskeleton, and mitochondrial 
envelope most likely reflects biological differences between grr1Δ and wild-type 
strains.  The percentage of proteins with significantly altered protein 
expression in these categories were 3.86% (cellular bud), 
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Figure 4.6.  Proteomic and Micro-array Analysis Totals for grr1Δ vs. wild-
type Cells.  Top.  Our hand annotated Saccharomyces Database contained 5,483 non-
redundant protein entries of which 1867 were successfully identified in the grr1Δ vs. wild-type 
proteomic analysis utilizing our Protein Prophet™ cutoffs (see text).  Of these 1867 identified 
proteins, 914 were quantified utilizing leucine SILAC™ and the ASAPRatio™ algorithm.  Protein 
expression of 187 of these proteins was measured to significantly change in grr1Δ strains 
compared to wild-type with 91 proteins exhibiting increased expression and 96 exhibiting 
decreased expression.  Bottom.  A total of 5,642 non-redundant genes were represented on the 
Affymetrix Yeast 2.0 GeneChip.  The relative expression of 5,593 of these genes was determined 
and 267 were measured to significantly change using a fold change cutoff of 2 and a Welch t-test 
cutoff of .05.  The expression level of 197 genes was measured to increase in grr1Δ strains while 
70 were measured to decrease.
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9.56% (mitochondrial envelope), and 5.49% (cytoskeleton) above the mean 
percentage of significantly altered proteins across GO component categories.  
Phenotypically, grr1Δ strains exhibit an elongated bud morphology that requires 
altered regulation of bud and cytoskeletal proteins.  Thus, the increased number 
of proteins annotated to these components that are observed to change is 
consistent with phenotypical manifestations of the GRR1 deletion.  This also 
holds true for proteins annotatedto the mitochondrial envelope as grr1Δ strains 
have been characterized by multiple laboratories to require enhanced 
mitochondrial function to support growth on glucose media 70,66,67.  Together, the 
observed enrichments attributable to lack of Grr1 function provide rudimentary 
validation of our proteomic analysis ability to measure relevant biological 
perturbations of protein expression. 
 
4.3.2.  GO Process Enrichments Achieved Utilizing GenGO on Changes in 
Global Gene Expression are Consistent with Previous Gene Expression 
Analyses of grr1Δ Cells  
Given the fact that the GO component analysis was successful in 
revealing enrichments in protein groups that could be ascribed to Grr1 function; 
we next sought to identify more specific biological processes that GRR1 deletion 
may perturb by extending  this type of enrichment analysis to the entire “Process” 
category of GO ontologies 433.  Additionally, we were interested in comparing the 
enrichments achieved at the protein level to those at the transcriptional level in 
order to begin to evaluate the continuity between the transcriptional and post-
transcriptional responses to GRR1 deletion.  To facilitate this analysis we first 
subjected our list of significantly changed proteins and transcripts to GO process 
analysis using the GenGO (GENerative GO analysis) algorithm 434.  This 
algorithm is available as a web based application 
(http://www.sb.cs.cmu.edu/GenGO) and utilizes a global likelihood function to 
identify a small subset of descriptive categories that together represent the major 
processes enriched in the supplied list of genes or proteins.  We felt that a 
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Figure 4.7.  GO Slim Component Analysis of Proteins Detected, 
Quantitated, and Significantly Changed between grr1Δ and wild-type Cells.  
The total number of proteins detected, quantitated, and measured to significantly change in 
protein expression between grr1Δ and wilt type strains were determined for each of 19 Go-Slim 
component annotations obtained from the "Saccharomyces Genome Database" ftp://genome-
ftp.stanford.edu/pub/yeast/data_download/literature_curation/go_slim_mapping.tab (9/16/2009).  
Utilizing these totals the percent coverage within a given GO-Slim component category was 
calculated by dividing the total number of yeast genes in SGD annotated to the term.  The total 
genes in SGD annotated to a given GO-Slim component are provided in the bar graph to the far 
left.  The percent coverage for detected, quantitated, and changed proteins for the 19 GO-Slim 
component categories is plotted in the middle three bar graphs.  The vertical black line in each of 
these graphs represents the mean percent coverage across all 19 GO-Slim Component 
categories.  Deviations below or above the mean represent under-represented or enriched 
components in our proteomic analysis, respectively.  The bar graph on the far right contains the 
average protein molecules per cell for proteins annotated to the given GO-Slim component.  The 
average protein molecules per cell were calculated utilizing the individual protein molecule per 
cell estimates of 428. 
 
comparison of the enriched GO processes generated by GenGO for the 
differentially expressed protein and transcript lists would provide a basic initial 
characterization of the discordance between transcript and protein in grr1Δ 
mutants.  
In order to validate the ability of GenGO to elucidate biologically 
meaningful GO enrichments we first applied this algorithm to our grr1Δ gene 
expression data.  The effects of GRR1 deletion on gene expression have been 
eloquently revealed through the concerted effort of multiple laboratories 
67,435,159,56,167 and thus the application of GenGO to our list of differentially 
expressed genes should reveal enriched GO processes consistent with these 
studies.  To conduct our GenGO analysis we utilized three different lists of genes 
discriminated by the degree to which their expression level changed due to 
GRR1 gene deletion.  The implementation of the GenGO analysis in this way 
provides not only a more comprehensive list of enriched GO processes but also 
provides a hierarchy of the degree to which processes are most influenced by the 
absence of Grr1.  As can be seen in Table 4.1, GenGO analysis of the list of 
gene transcripts differentially expressed by at least five fold in either direction 
revealed that the processes of “carboxylic acid transport”, “nitrogen utilization”, 
“glyoxylate metabolism”, “monosaccharide transport”, and “gluconeogenesis” 
were the most affected at the transcriptional level by GRR1 deletion.  The effects 
of GRR1 deletion on the transcription of amino acid transporters as well as 
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nitrogen utilization genes through the SPS (Ssy1, Ptr3, Ssy5) signaling pathway 
436,111,72,437 and the transcription of hexose transporters through the Snf3/Rgt2 
signaling pathway 159,438,69,56 are well established.  Thus, the enrichment of 
differentially expressed genes annotated to “carboxylic acid transport”, 
“monosaccharide transport”, (which encapsulates amino acid transport and 
hexose transport respectively) and “nitrogen utilization” is consistent with well 
characterized roles for Grr1.  Genes annotated to “glyoxylate metabolism” and 
“gluconeogenesis” had also been measured to change in a previous grr1Δ micro-
array 159.  Additionally, as the relative abundance cutoff was dropped from five 
fold, to three fold, and finally to two fold the list of GO enrichments expanded to 
include more processes known to be affected by GRR1 deletion including, 
among others, heterocycle catabolic process (includes genes involved in 
allantoin metabolism) 63,159, siderophore transport (iron chelation for iron 
scavenging) 71, and disaccharide catabolic process 184.  Based on the ability of 
GenGO to isolate GO process ontologies from our genome wide expression data 
that are consistent with previous grr1Δ gene expression studies, we concluded 
that GenGO provided a very accurate and descriptive GO process enrichment 
analysis for our whole genome expression data. 
 
4.3.3.  Protein GO Process Enrichment Analysis Utilizing GenGO Reveals 
Previously Characterized Roles for Grr1 that are not Reflected at the 
Transcriptional Level 
In order to reveal processes affected at the proteomic level, we applied 
the GenGO algorithm to lists of significantly altered proteins utilizing the fold 
change cutoffs applied to the transcriptional data (fold difference >= 2, 3, or 5) 
and the protein data validity cutoffs utilized to report our analysis totals (i.e.  
Probability of change >= 0.9, Category = Gold or Silver).  Like the GenGO 
analysis of gene expression, the protein expression analysis also revealed GO 
process enrichments that correlate to known grr1Δ phenotypes.  However, many 
of the processes enriched at the protein expression level were not significantly 
enriched at the gene expression level suggesting that these processes are 
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Table 4.1.  GenGO Process Enrichment Analysis of Significant Gene and Protein Expression Changes 
Attributable to GRR1 Deletion.  See page 158 for description.
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Table 4.1.  GenGO Process Enrichment Analysis of Significant Gene and Protein Expression Changes 
Attributable to GRR1 Deletion.  Continued.  See page 158 for description.
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Table 4.1.  GenGO Process Enrichment Analysis of Significant Gene and 
Protein Expression Changes Attributable to GRR1 Deletion.  Table 4.1,  Page 
155 (Blue).  GO “process” enrichment analysis was conducted on three different lists of proteins 
measured to exhibit significantly altered expression in grr1Δ cells relative to wild-type cells.  The 
three protein lists are distinguished by the minimal fold change cutoff applied and thus were 
divided to include proteins whose expression level changed by greater than or equal to five fold 
(Blue/Top), greater than or equal to three fold (Blue/Middle), and greater than or equal to two fold 
(Blue/Bottom).  A significance p-value for each enrichment is calculated by GenGO and reported 
here as “Score”.  The number of proteins in our experimental list is provided under “Present” as 
well as the total number of proteins in SGD annotated to the term (“total”).  The common gene 
names for the proteins annotated to each term along with their protein and gene expression fold 
changes are provided in the final column in the following format (gene name (protein FC grr1/WT, 
transcript FC grr1/WT)).  The existence of only one number in parentheses denotes that only the 
transcriptional fold change was measured and is reported in Table 4.1,  Page 156 (Pink).  GO 
“process” enrichment analysis was conducted on three different lists of transcripts measured to 
exhibit significantly altered expression in grr1Δ cells relative to wild-type cells.  The three protein 
lists are distinguished by the minimal fold change cutoff applied and thus were divided to include 
proteins whose expression level changed by greater than or equal to ten fold (Pink/Top), greater 
than or equal to five fold (Pink/Middle), and greater than or equal to two fold (Pink/Bottom). 
 
predominately regulated through post translational mechanisms.  Significant 
GenGO process enrichments at the protein expression level that correlated with 
known grr1Δ phenotypes include “budding cell apical bud growth” (p-value = 
0.01), “response to osmotic stress” (p-value = 2E-4), and “purine nucleoside 
mono-phosphate biosynthetic process” (p-value = 4E-3).  Consistent with the 
enrichment of altered proteins annotated to the GO component of “cellular bud”, 
the GenGO determined enrichment of “budding cell apical bud growth” is 
reflective of the role of Grr1 in negatively regulating hyperpolarized growth 
through ubiquitin targeted degradation of the cyclins, Cln1 and Cln2 78,74, as well 
as the Cdc42 effectors, Gic1 and Gic2 101,102.  Strains deleted for GRR1 were 
originally characterized to exhibit enhanced sensitivity to osmotic stress 66.  Thus, 
altered protein expressions for proteins participating in the “response to osmotic 
stress” also correlate to a known phenotype of grr1Δ strains.   
Evidence indicating that purine metabolic processes are altered in grr1Δ 
strains has also been previously detected.  In metabolic profile experiments 
conducted on grr1Δ strains, xanthosine-5’-monophosphate, an important 
intermediate in purine and nucleoside metabolism, was determined to be the top 
reporter metabolite 67.  Also, in another global proteomic experiment utilizing GFP 
tagged proteins and microscopy, Ade17, which along with its redundant isozyme, 
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Ade16, catalyzes the penultimate step of purine biosynthesis (the metabolic 
synthesis of IMP from AICAR) was found to be increased at the protein level by a 
little over two fold 77.  Consistent with this observation, we measured Ade16 
protein levels to increase by approximately six fold in our analysis.  Together 
these results are not only a testament to the ability of our proteomics platform to 
determine relevant biological perturbations attributable to GRR1 deletion but also 
a testament to the ability of GenGO to isolate these processes through GO 
analysis. 
In addition to the observed enriched processes that can be directly 
ascribed to previously defined phenotypes of grr1Δ strains, a number of 
previously uncharacterized processes affected by GRR1 deletion were observed 
to be enriched in the GenGO analysis of differentially expressed proteins.  
Multiple lines of evidence suggest that at least some if not all of these processes 
are indeed perturbed in grr1Δ cells.  For instance, the second most affected 
process in grr1Δ strains was “spindle pole body organization and biogenesis” and 
a role for Grr1 in this process is supported by multiple lines of evidence.  First, 
GRR1 deletions are synthetically lethal with gene deletions of PAC10 and TUB3 
439.  The PAC10 gene encodes Pac10/Gim2, a co-chaperone component of the 
GimC/prefoldin complex partially responsible for the proper folding of β-tubulin.  
The TUB3 gene encodes α-tubulin.  Deletion of either of these genes leads to 
increased levels of un-dimerized β-tubulin which is toxic to the cell and as a 
result causes growth defects in strains harboring either of these deletions 440,441.  
The fact that deletion of GRR1 exacerbates this growth defect suggests that 
grr1Δ strains may already be stressed by defects in microtubule function.  This 
hypothesis is further supported by the fact that grr1Δ cells are observed to be 
hypersensitive to the microtubule destabilizing agent, benomyl 442.  Evidence that 
these defects in microtubule function are directly related to spindle pole body 
complications is provided by another independent study showing that ~ 23%  of 
grr1Δ cells exhibit aberrant microtubules not connected to the spindle pole body 
or nucleus for that matter 442.   
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Interestingly, though they were not revealed in the GenGO process 
analysis, additional changes in protein abundance for other proteins involved in 
microtubule function and mitotic spindle migration were also measured in our 
analysis.  Dyn1 and Kar3 which are microtubule motors found to be concentrated 
at spindle pole bodies and function in mitotic spindle migration 443-446 were found 
to be increased by ~39 and 6 fold, respectively.  Additionally, components of the 
dynactin complex, Arp10 and Nip100, which are believed to participate in 
tethering microtubules to the spindle pole body as well as dynein (Dyn1) to 
endomembrane compartments 447, were found to increase by 4 fold and 
decrease by 10 fold, respectively.  Taken together, these data provide compelling 
evidence for the presence of a previously undefined role for Grr1in spindle pole 
body and microtubule dynamics.  The mechanistic role for Grr1 in these 
processes cannot be deduced utilizing These data alone but the fact that a 
number of proteins within the dynein/dynactin complex were observed to change 
suggests that Grr1 may be directly involved in regulating its function or the 
activity of a functionally redundant complex.  This line of experimentation was not 
further explored in our research but nevertheless remains an exciting and 
extremely fertile experimental path. 
The GO processes of membrane invagination (endocytosis) as well as 
purine metabolism are also most likely perturbed in grr1Δ cells.  Grr1 was found 
by two hybrid analysis to bind to Bzz1 448, which was measured to increase 6.39 
fold in grr1Δ cells by our proteomic analysis.  Bzz1 has been found to localize to 
actin paches and is implicated in the regulation of actin polymerization and 
endocytosis through its association with the yeast homolog to the human 
Wiskott-Aldrich syndrome protein (WASP), Las17 449.  Interestingly, the Bzz1 
protein is comprised of a N-terminal FCH bar domain, PEST sequences, and a 
C-terminal SH3 domain that are all present in a known Grr1 substrate, Hof1 54.  
Based on these observations it has been suggested that Bzz1 is a substrate for 
SCFGrr1 mediated ubiquitylation and the increase in Bzz1 protein levels measured 
in our analysis is consistent with this hypothesis.  Together these data support 
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that the altered protein levels measured for proteins involved in endocytosis are 
indeed representative of changes due to GRR1 deletion. 
Taken together the GO process enrichments as determined by GenGO 
analysis provide a biologically valid snapshot of transcriptional and proteomic 
processes affected by GRR1 deletion, yet many of the processes most affected 
at the transcriptional level were not observed to be enriched at the protein level 
and visa versa.  Interestingly, of the forty two proteins within a significantly 
enriched GenGO process whose protein abundance level was observed to 
change greater than three fold, only two showed concomitant changes in the 
included bronze categorized proteins under the assumption that a large number 
of significant changes in protein expression observed within a given expression 
of their encoding genes (Hsp12 and Cit1) (Tables 4.2 and 4.3).  The expression 
level of genes encoding the remaining proteins either remained unaltered or 
significantly changed in the opposite direction.  The enriched processes at both 
the transcriptional and proteomic levels reflect biological processes known to be 
perturbed in grr1Δ strains.  This suggests that Grr1 may influence the molecular 
biology of the cell through both transcriptional and post-transcriptional 
mechanisms that in some instances are mutually exclusive.  However, this 
analysis only provides a preliminary characterization of this phenomenon and by 
no means reflects the degree to which discordance is observed across the 
genome for grr1Δ cells since only 16.7 % of the proteome was quantitatively 
measured.  Nevertheless, the instances of discordance observed in our GenGO 
analysis provide compelling support for the implementation of concurrent global 
genomic and proteomic profiling experiments to describe phenotypic 
manifestations of the molecular response to GRR1 deletion. 
 
4.3.4.  Manual Curation and Comparative Analysis of the Transcriptional and 
Proteomic Response to GRR1 Deletion 
In order to provide a more intricate analysis of the transcriptional and 
proteomic discordance occurring in response to GRR1 deletion, we manually 
annotated each gene and protein observed to change and utilized these manual 
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Figure 4.8.  Manually Curated GO Process Enrichments for Gene and 
Protein Expression Changes Measured between grr1Δ and wild-type Yeast.  
Manually assessed GO enrichments for Gene(A) and Protein(B) expression changes listed in 
tables 4.2 and 4.3 are presented.  Genes and proteins annotated to a given process were totaled 
(found in parentheses next to the process name) and the percentage of genes or proteins within a 
given process was calculated by dividing this total by the total number of genes or proteins which 
were measured to change.  Processes such as Carbon/Energy Regulation and Metabolism can 
be further subdivided into more granular processes and the percentages of genes or proteins in a 
particular sub-process within some select processes are also presented as expanded pie charts. 
 
annotations to group genes and proteins by shared function and process.  
Additionally, in order to capture both the relevant changes in gene and protein 
expression in a format that allowed for the most facile comparison between the 
two we chose to present the data in two separate tables with one containing both 
proteomic and transcriptional information for relevant gene changes and the 
other containing the same information for relevant protein changes.  The results 
of this work are presented in Table 4.2 (transcriptional changes) and Table 4.3 
(proteomic changes).  Together these tables contain all of the changes in gene 
and protein expression we measured as well as relevant results from our 
statistical analyses of each of these data sets.  Within the proteomic table we 
process/function category would serve to strengthen the validity of those proteins 
quantitated within the same category at lower confidence.  Genes and proteins 
were grouped by relevant shared processes and functions as curated by hand.  
Changes in gene expression are accompanied by the measured changes in 
protein expression where applicable and visa versa to allow comparison of 
transcriptional and proteomic information when both have been measured.  Each 
table also contains annotated function/process and component descriptions 
collected from descriptions found in the Saccharomyces Genome Database as 
well as our own manual literature searches.  Within the gene expression table is 
a field listing known transcription factors associated with each gene that were 
based off of annotations contained in the YEASTRACT database 339 and our own 
literature searches.  Additionally, the protein expression table contains 
information allowing for individual discretion to be utilized when considering the 
validity and nature of each measured proteomic change.  For instance, proteins 
changes determined by a single peptide could actually be indicative of a change 
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in a post-translational modification on the peptide being measured.  
Nevertheless, these instances still represent significant changes in the post-
translational state of the protein and thus these instances are retained in our final 
analysis.  However, in these instances the peptide sequence for the measured 
peptide is included to guide further inquiry.   
As indicated in the GenGO analysis of the transcriptional response to 
GRR1 deletion, our measured changes in gene expression are consistent with 
previous grr1Δ gene expression profiles.  As reported in Figure 4.6, 267 genes 
were measured to change by two fold or more, of these, 132 (49.4%) could be 
ascribed to functions or processes involved in carbon or nitrogen metabolism 
while 51 (20.6%) of the transcriptional changes were in genes encoding for 
nutrient transporters.  As indicated in the description of the GenGO analysis, the 
affect that GRR1 deletion has on these processes has been previously 
characterized to be manifestations of defects in Snf3/Rgt2 signaling and SPS 
(Ssy1, Ptr3, Ssy5) signaling, respectively.  The remainder of the genes observed 
to be altered in grr1Δ strains participate in eclectic cellular processes.  These 
include “cell and spore wall organization and biogenesis /meiosis” (17 genes), 
“mating” (9 genes), “mitochondrial function” (5 genes), “protein trafficking” (7 
genes), “pseudohyphal growth” (4 genes), “stress” (16 genes), “transport of small 
molecules” (20 genes), “lipid metabolism” (4 genes), “ubiquitin” (3 genes), and a 
small group of “protein phosphatase one (PP1) regulators” (3 genes).  The 
majority of these processes are consistent with either known molecular roles for 
Grr1 or grr1Δ phenotypes.  For instance, defects in mating and small molecule 
transport have been previously reported for grr1Δ cells 71,74.  Grr1 is also known 
to negatively regulate cell polarity through targeted degradation of the cyclins, 
Cln1 and Cln2 346,74, and the Cdc42 effectors, Gic1 and Gic2 55,101.  Additionally, 
the known Grr1 substrate, Ime2 53,450, is a transcriptional regulator of meiotic 
genes and thus it is likely that Grr1 can influence meiotic gene expression 
through Ime2.  Additionally, the known Grr1 substrate, Ime2 53,450, is a 
transcriptional regulator of meiotic genes and thus a mechanism of Grr1’s 
influence on meiotic gene expression through Ime2 is likely. 
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Comparison of the list of manually categorized changes in protein 
abundance (Tables 4.2 and 4.3 and Figure 4.8) with the categorized changes in 
gene expression revealed accordance and discordance between and within the 
processes enriched in each list.  The processes of carbon and energy 
metabolism (32), nitrogen metabolism (13), small molecule transport (4), mating 
(6), mitochondrial function (22), stress (10), ubiquitin (12), and trafficking (60), 
which were all found to be enriched at the transcriptional level were also enriched 
at the proteomic level.  However, the extent to which these processes were 
enriched at each molecular level varied to a large degree.  For instance, changes 
in gene expression for carbon and energy metabolism genes represented 38% of 
the transcriptional changes while they only represented 10.4% of the proteomic 
changes.  Additionally, within this group the sub process of respiration 
represented 40% of all changes at the transcriptional level but only 25% of the 
changes observed at the proteomic level.  Changes in gene expression for 
nitrogen metabolism related genes represented 12% of the transcriptional 
changes observed at the genetic level with changes in nitrogen/amino acid 
transporters representing 46.7% of all nitrogen related changes in gene 
expression.  At the proteomic level, changes in nitrogen metabolism related 
proteins only constituted 4.2% of all proteomic changes and only one of the 
proteins (Put4) was an amino acid transporter.  Interestingly, the expression level 
of proteins involved in “protein and vesicle trafficking” (60 proteins in this 
category representing 19.5% of all protein changes) process were highly 
influenced by GRR1 deletion and yet only modestly reflected at the gene 
expression level (7 representing 3% of all transcriptional changes).  Other 
processes, such as “mitosis and cytokinesis”, “transcriptional regulation” 
(constituted of chromatin remodeling and polymerase holo-enzymes as well as a 
handful of transcription factors), “protein synthesis/ribosome”, “nucleotide 
metabolism”, “DNA repair / meiotic recombination”, and “splicing / mRNA 
processing” were among a number of processes only observed to be influenced 
at the proteomic level (Figure 4.8). 
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Though these paradoxes distinguishing enriched processes in the 
proteomic and transcriptional data sets are striking, at least some of them are 
reflective of reduced proteomic coverage (16.7% of the proteome quantitated) 
relative to the coverage obtained at the genetic level (~99% of the genome 
quantitated).  Fifty four of the two hundred and sixty seven (20.2%) changes in 
gene expression were measured at the protein level and, excepting Put4, no 
quantitative measurements for amino acid transporters were obtained.  Thus, the 
influence that GRR1 deletion has on amino acid transporters post-
transcriptionally could not be assessed.  However, contrary to nitrogen 
metabolism, 15 of the 40 significant changes in gene expression within the sub-
process of respiration were measured at the protein level and only three (5%) 
were measured with significant changes in protein abundance.  This would 
indicate a high level of discordance within the sub-process of respiration.  Thus, 
the enrichments pictured in Figure 4.8 for changes in gene expression must be 
scrutinized when comparing our manually annotated processes that are highly 
enriched at the genetic level but underrepresented at the proteomic level. 
 
4.3.5.  Characterization of Discordance between Protein and Gene Expression 
Levels in grr1Δ Cells 
In order to reveal valid instances of discordance systematically between 
perturbed processes at the genetic and proteomic levels, we plotted the log2 
mRNA and protein expression ratios for the 914 genes where a measured 
protein expression ratio was acquired at high confidence (“Gold” or “Silver” 
category).  Since all of the changes observed at the proteomic level were 
accompanied by transcriptional measurements, this analysis enabled a more 
thorough investigation of transcriptional and proteomic discordance.  This 
analysis (Figure 1 A) revealed that a large majority of loci (664 of 914 “Gold” and 
“Silver”; ~73%) exhibited no significant change in protein or gene expression.  
Strikingly, only a handful of loci exhibiting significantly altered expression at the 
protein and mRNA levels showed positive correlation (perfect positive correlation 
is represented by the diagonal line).  Loci exhibiting positive correlation between 
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Figure 4.9.  Scatter Plots Reveal Discordance between Gene Expression 
and Protein Expression in grr1Δ Cells.  A.  Scatter plot of the log2 of protein 
expression (y-axis) versus the log2 of gene expression (x-axis) among 914 loci of “Gold and 
Silver” confidence (black) and “Bronze” confidence (grey).  The diagonal line represents perfect 
positive correlation.  Discordance among the GO (Gene Ontology) “process” clusters of “mitosis”, 
“trafficking”, and “carbon/energy metabolism” are shown in panels B., C, and D., respectively.  
 
changes in gene expression and their products included CIT1, HSP12, GOR1, 
NSE5, and PDH1.  In each case increase was observed, both transcriptionally 
and proteomic ally.  Furthermore, both Snz1 and Ari1 and their products 
decreased significantly.  The remaining loci showed either little or no positive 
correlation between protein and mRNA expression levels and can be categorized 
into three groups based upon the nature of their discordance.  The majority of 
discordant loci (176 of 914 quantitated “Gold” or “Silver”) displayed either 
significantly increased (86) or decreased (90) protein expression with no 
significant change in gene expression measured.  This type of discordance was 
exhibited by the majority of gene/proteins in all annotated GO processes 
enriched at the proteomic level (Figure 4.8) but the processes of “trafficking” 
(Figure 4.9 C), “carbon/energy metabolism” (Figure 4.9 D), “mitosis/cytokinesis” 
(Figure 4.9 B), “transcriptional regulation”, “protein synthesis/ribosome”, and 
“mitochondrial function” together contained over 54% of loci within this category.  
This suggests that GRR1 deletion influences these particular processes almost 
exclusively through post-transcriptional mechanisms.  The second type of 
discordance included loci that exhibit significantly increased or decreased gene 
expression with no concomitant change in protein expression and contained 26 
of 914 loci quantitated at the proteomic level with “Gold” or “Silver” confidence.  
Though instances of this type of discordance are observed within a number of 
processes they are most highly enriched in “Carbon/energy metabolism” (Figure 
4.9 D) genes/proteins as 15 of the 26 proteins within this category of discordance 
were annotated to this process.  The last discordant category describes 
instances where the proteomic and genomic expression levels exhibit inverted 
responses.  Interestingly, this type of inverse correlation was only observed for a 
handful of loci (7) which all displayed a significant decrease in protein expression 
despite a significant increase in their encoding genes.  Once again the majority of 
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the loci within this group were those annotated to “carbon/energy metabolism” 
(Figure 4.9 D) (Ach1, Idh2, Hxt7, Ndi1, and Atp19) with one loci annotated to 
“trafficking” (Emp46) and the final loci annotated to “ergosterol metabolism” 
(Mcr1).  Taken together, these data suggest not only that a number of processes 
are influenced by GRR1 deletion exclusively at the protein expression level but 
also that many gene expression changes observed in response to GRR1 deletion 
are not reflected in the expression of their products.
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Table 4.2.  Categorized List of Gene Expression Level Changed Between grr1Δ and wild-type Yeast.  See page 180 
for details.
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Table 4.2.  Categorized List of Gene Expression Level Changes Between 
grr1Δ and wild-type Yeast.  Significant changes in gene expression (Welch log2 <=.05 
and fold change >= 2 or <=-2) were categorized manually utilizing information obtained from the 
Saccharomyces Genome Database (SGD) or through manual literature curation.  Genes are 
grouped at the highest level by shared process (highlighted in Peach).  In some instances genes 
under a given process are further grouped into sub-classes (highlighted in Grey bars) and sub-
sub classes (highlighted in Taupe).  Under the process of metabolism within the sub-class of 
carbon/energy metabolism, genes involved in sugar fermentation are highlighted in blue, genes 
involved in storage carbohydrate metabolism are highlighted in green, and genes involved in 
respiratory metabolism are highlighted in red.  For each gene, the ORF name (ORF) and 
common gene name (Gene) is provided when one has been assigned.  Additionally, the Welch 
log2, the Student’s T-test log2, and the measured fold change (+ = up in grr1, - = down in grr1) is 
provided for each measurement.  When a measured protein expression level was attained for the 
gene product, information regarding the validity and degree of its fold change is provided.  
Relevant metrics pertaining to protein expression data include the “category” which contains the 
“Gold”, “Silver”, and “Bronze” designations as determined by the parameters (outlined in Section 
3.11.4.7), the “final protein probability (detected)” which contains the combined protein probability 
across all analyses (calculation outlined in Section 3.11.4.6), the “quan confidence” which 
captures the calculated confidence of the measured protein fold change (calculation outlined in 
Section 3.11.4.8), and the “final protein ratio (grr1/wt)” and the “SD (±)” which hold the combined 
relative protein expression and it’s associated standard deviation, respectively (calculations 
outlined in Section 3.11.4.7).  Significant fold changes for both protein and gene expression data 
are colored red when expression was increased in grr1 cells and green when expression was 
decreased in grr1 cells.  Proteins for which an expression level was measured but the expression 
level change was not significantly different between grr1 and wild-type cells are colored blue.  
Each gene is also annotated with notes obtained from SGD as well as manual literature curation 
that pertain to the genes function and process as well as its localization and this information is 
captured in the “Functions/GO Terms” and “Localization” columns, respectively.  Known 
transcription factors which contribute to the genes regulation were also obtained utilizing 
YEASTRACT and manual literature curation and are provided in the “Transcription Factor” 
column.
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Table 4.3.  Categorized List of Protein Expression Changes Between grr1Δ and wild-type Yeast. See page 195 for 
details.
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Table 4.3.  Categorized List of Protein Expression Level Changes Between grr1Δ and wild-type Yeast.  Changes in 
protein expression (including “Gold”, “Silver”, and “Bronze” categories; Fold changes >= 2.5 or <=.4) were categorized manually utilizing 
information obtained from the Saccharomyces Genome Database (SGD) or through manual literature curation.  Descriptions for the semantics of 
the table structure as well as the data descriptions for the proteomic and transcriptional data presented can be found in the Table 4.2 legend.  
Proteins identified and quantitated from a single peptide are denoted with an asterisk within the “category” field and in these instances the peptide 
sequence, its’ charge, and the predicted mass shift of the labeled peptide are provided. Inter-experimental standard deviation is also reported and 
indicates the deviation between protein abundance ratios determined between separate analyses for the same protein. An interexperimental 
standard deviation of 0 is reported for proteins that were only quantitated in one analysis. Additionally, intra-experimental standard deviation 
indicates the average standard deviation among peptides whose relative abundance ratios were utilized to calculate the final protein abundance 
ratio across all analyses.  Proteins which participate in mitotic processes are highlighted in brown.
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CHAPTER 5:  PROTEIN AND GENE EXPRESSION DISCORDANCE IN grr1Δ 
CELLS AND ITS IMPLICATIONS FOR GRR1’S ROLE IN GLUCOSE 
REPRESSION 
 
5.1  Introduction  
In the previous sections we determined that 22% of the loci where protein 
expression was determined exhibited discordance between gene and protein 
expression in grr1Δ strains.  Each occurrence of measured discordance 
potentially represents an instance where protein steady state levels cannot be 
inferred from gene expression data.  Thus, inferences made by whole genome 
expression analyses may either be inaccurate or fail to detect perturbations in 
processes that may be strictly regulated post-translationally.  Since analysis of 
each individual locus remains a practical challenge, we implemented a GO 
enrichment analysis to determine the processes exhibiting the highest degree of 
discordance in terms of the number of proteins with measured discordance 
annotated to a given process.  The GO process of “Carbon and Energy 
Metabolism” was found to be highly enriched among discordant loci in our 
analysis with 44 discordant loci annotated to this process.  Discordant loci among 
the “Carbon and Energy Metabolism” cluster could be grouped into each of the 
three discordance types with 4 loci exhibiting type 1 discordance, 23 loci 
exhibiting type 2 discordance, and 21 loci exhibiting type 3 discordance.   
As indicated previously, Grr1 plays a predominate role in the regulation of 
the cellular response to glucose and grr1Δ strains exhibit glucose repression 
resistant expression of a number of glucose repressed genes.  However, much of 
what is known about the role for Grr1 in glucose repression and the effects of 
GRR1 deletion on glucose dependent signaling and metabolism have been 
limited to transcriptional and phenotypic studies with little attention devoted to the 
proteomic response to GRR1deletion.  From these studies, the effects of GRR1 
deletion on metabolic and signaling processes can only be inferred which could 
lead to inaccurate descriptions of the actual state of grr1Δ cells.  The extent of 
discordance between gene and protein expression that we measured among loci 
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annotated to “Carbon and Energy Metabolism” processes suggests that 
descriptions of the role for Grr1 in glucose repression based solely off 
transcriptional studies may indeed be inaccurate or incomplete.  In this chapter, 
we present a thorough analysis of the discordances measured among loci 
annotated to the “Carbon and Energy Metabolism” cluster in grr1Δ strains.  
Through this analysis we reveal a number of relevant instances of discordance 
that necessitate the re-assessment of the role for Grr1 in glucose repression. 
 
5.2.  Expression Levels for the Hexose Transporters, Hxt3 and Hxt7, are 
Discordant with HXT3 and HXT7 Gene Expression Levels in grr1Δ Strains 
Strains harboring deletions of GRR1 have been extensively characterized 
to possess defects in high affinity glucose transport that lead to severely reduced 
growth on low glucose or raffinose media.  Additionally, grr1Δ strains display 
increased doubling times on high glucose media (~2%) with reported increases 
ranging from 75-100% of that of wild-type strains 159,66,67.  Consistent with these 
phenotypes, high affinity transport has been found to be completely absent in 
grr1Δ cells while defects in low affinity glucose uptake have been reported to be 
reduced 35% of that of wild-type strains 69,70.  These defects in grr1Δ strains are 
a consequence of the inability to de-repress transcription through the Snf3/Rgt2 
dependent inactivation of the transcriptional repressor Rgt1 in response to 
glucose availability 56,167,160.  Thus, despite the presence of glucose, Rgt1 
remains constitutively bound to HXT gene promoters and as a result a number of 
hexose transporter genes, including both low (HXT1 and HXT3) and high (HXT2, 
and HXT4) affinity transporter genes, remain constitutively repressed in grr1Δ 
cells 167.  While the constitutive repression of glucose transporters genes 
certainly contributes to the glucose growth defects of grr1Δ cells, it does not 
completely account for a number of phenotypes.  First, while the high affinity 
hexose transporter genes, HXT2 and HXT4, are constitutively repressed in grr1Δ 
cells, the gene expression of the remaining functional high affinity hexose 
transporter gene(s), HXT6/7, has been measured in multiple independent 
experiments to be higher in grr1Δ strains by approximately four fold (159 and 
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present study).  This is inconsistent with the lack of high affinity glucose transport 
in grr1Δ strains.  Second, despite significant large decreases in low affinity 
(HXT1 and HXT3) 167 hexose transporter gene expression, grr1Δ cells grow more 
robustly on high concentrations of glucose with only a decrease in glucose 
uptake at these concentrations of ~35% 69,70. 
In the experiments described above, we compared the gene expression 
and protein expression profiles of grr1Δ and wild-type cells on a system wide 
level.  As noted, a high degree of discordance was observed between gene 
expression and protein expression, especially among genes and proteins 
annotated to the GO process of “carbon and energy metabolism”.  Among the 
loci within this category, discordance between gene expression and protein 
expression for hexose transporters and the encoding genes was observed.  
Interestingly, despite significant large decreases in gene expression for the low 
affinity hexose transporters, HXT1 (-209.98) and HXT3 (-19.86), the protein 
expression level of these transporters remained relatively unaltered (1.12 ± 0.01 
and 1.09 ± 0.01, respectively) (Figure 5.1 middle) in grr1Δ cells.  Additionally, 
while expression of the high affinity transporter gene, HXT7, was observed to 
increase in grr1Δ cells relative to wild-type (4.62), the relative expression of Hxt7 
was observed to decrease (0.39 ± .44).   
In order to confirm that the protein expression ratios obtained by our 
proteomic analysis for Hxt3 and Hxt7 were indeed reflective of changes in the 
steady state level of these proteins, we performed western analysis of Hxt3 and 
Hxt7 protein levels in grr1Δ strains utilizing rabbit polyclonal antibodies raised 
against synthesized peptide sequences unique to Hxt3 and Hxt7 (Open 
Biosystems™) (Section 3.3.2).  Western blots were performed utilizing raw sera 
from these antibody preparations on protein extracts obtained from both wild-type 
and grr1Δ cells grown on defined medium containing 2% glucose.  As can be 
seen in Figure 5.1 (right), western analysis confirmed that the relative protein 
expression measurements obtained in our global proteomic analysis were in fact 
reflective of the steady state protein level of both Hxt3 and Hxt7.  Hxt7 steady 
state levels were observed to decrease while Hxt3 steady state protein levels 
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remained unaltered in grr1Δ strains.  These data are in contrast to the 
transcriptional regulation of each of these transporters.  The steady state protein 
levels for Hxt3 and Hxt7 in grr1Δ strains are consistent with both the glucose 
transport defects as well as the growth defects observed on glucose media for 
grr1Δ strains.  Since our strains and media condition were slightly different than 
those utilized previously, we sought to confirm that our grr1Δ strain exhibited 
these same growth properties on the synthetic medium we utilized in our global 
analyses.  To do this, we utilized spot dilution assays to compare grr1Δ and wild-
type growth on the synthetic defined media utilized in our global analyses 
supplemented with glucose concentrations of 0.02, 0.2, 1, and 2% in the 
presence of the respiratory inhibitor, Antimycin A.  As can be seen in Figure 5.1 
(left), consistent with previous studies, defects in glucose based growth were 
exhibited at all concentrations of glucose assayed.  However, growth of grr1Δ 
cells deteriorated precipitously as the glucose concentration decreased.  These 
data are consistent with the growth phenotypes of grr1Δ cells reported by others.  
Together these data suggest that glucose transport and as result growth on high 
glucose concentrations is supported by Hxt3 and possibly Hxt1 mediated glucose 
transport despite large decreases in their transcriptional expression.  At the same 
time, the severe growth defect of grr1Δ cells on low glucose seems to be a 
consequence of constitutive repression of HXT2 and HXT4 (Hxt2 protein 
expression was measured to decrease in accordance with its reduced gene 
expression (Figure 5.1)) and the reduced protein steady state levels of Hxt6/7. 
 
5.3.  Analysis of Discordance between Gene and Protein Expression for 
Mitochondrial Function in grr1Δ Cells 
Previous genetic analyses monitoring the effect that GRR1 deletion has 
on gene expression on high glucose media (~2%) have revealed widespread de- 
repression of a number of enzymes and transporters required for the utilization of 
an eclectic array of alternative energy sources.  Genes necessary for growth on 
other fermentable sugars such as maltose, sucrose, and galactose as well as  
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Figure 5.1.  HXT3 and HXT7 Gene Expression is Discordant with Hxt3 and 
Hxt7 Protein Expression in grr1Δ Cells.  Left: Spot dilution assays were performed at 
various concentrations of glucose in the presence of the respiratory inhibitor, Antimycin A (3 
μg/L), comparing growth of grr1Δ and the representative wild-type strain, DBY2059.  Pictures 
were taken at 24 and 48 hours post incubation at 30°C.  Middle:  The hexose transporters 
facilitating the majority of glucose transport at the glucose concentrations utilized in the spot 
dilution assays was inferred from gene expression 167 and kinetic studies 173,451 and indicated by 
black bars.  The Km values (Kma) for each hexose transporter as determined by 173, the relative 
gene expression levels (grr1Δb) and their respective p-values (Welch p-valueb) as measured in 
this study and by 159 (grr1Δc), and the relative protein expression levels as measured in our 
proteomic analysis (W_Ratio) are indicated .  Red denotes significant increased expression in 
grr1Δ strains, blue indicates no significant change in expression, and green indicates significant 
decreased expression in grr1Δ strains.  Right:  Western blots utilizing rabbit polyclonal antibody 
raised against synthetic peptides unique to Hxt3 and Hxt7 confirm the mass spectrometry based 
protein expression data.   
 
genes needed for respiratory growth on C2 and C3 carbon sources such as 
pyruvate, lactate, acetate, glycerol and ethanol have all been measured to have 
increased gene expression in grr1Δ cells grown on high glucose concentrations 
(~2%) 159.  The changes we measured in gene expression for grr1Δ cells under 
our media conditions (synthetic media containing 2% glucose and 5mg/ml 
glutamine) were consistent with these analyses.  Figure 5.2 and table 5.1 show 
the significant relative gene and protein expression changes measured in our 
global profiling experiments of grr1Δ cells for select metabolic processes 
including glycolysis, ethanol fermentation, the TCA cycle, the electron transport 
chain, gluconeogenesis, the glyoxylate cycle, and the pentose phosphate shunt 
as well as glycerol, ethanol, acetate, pyruvate, lactate, and maltose metabolism.  
Proteins are represented as ovals with the color of the oval filling indicating the 
change in protein expression measured and the color of the oval border 
representing the change in gene expression measured for the specific enzyme or 
transporter encoding gene (Red = up in grr1, Green = down in grr1, Blue = 
unchanged, and Black = not measured).  As can be seen in Figure 5.2, glucose 
insensitive expression of a number of genes within these processes was 
measured including genes necessary for the utilization of maltose (MAL11, 
MAL31, MAL32, and MAL33), sucrose (SUC2), galactose (GAL3), ethanol and 
acetate (SFC1, DIC1, ADY2, ACS1, ACH1, ADH2, and ALD4), fatty acids (YAT1, 
YAT2, CRC1, POT1, and POX1), glycerol (GPP2 and GUT2), and lactate and 
pyruvate (JEN1 and CYB2).  Additionally, glucose insensitive expression of 
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respiratory and TCA cycle genes (AAC1, PDH1, CIT1, CIT3, ACO1, LSC2, 
SDH1, SDH2, SDH3, SDH4, IDH1, IDH2, MDH1, PET10, ATP3, ATP21, ATP17, 
ATP14, ATP20, ATP19, STF1, INH1, RIP1, COR1, QCR6, QCR10, QCR2, NDI1, 
CYT1, SUE1, CYC1, COX4, COX6, COX12, COX13, and COX7) as well as 
glyoxylate cycle and gluconeogenesis genes (CIT2, ICL1, IDP2, AGX1, FBP1, 
PCK1, MLS1, and PYC1) were also measured in grr1Δ strains.
The increased expression of respiratory genes has been suggested to 
result in increased respiratory metabolism in grr1Δ cells grown on glucose as the 
sole carbon source 70.  However, recent glucose fermentation profiles of grr1Δ 
cells have measured no significant decrease in overall ethanol yield 67.  This 
suggests that, despite increased expression of TCA cycle and respiratory genes, 
respiration rate remains unaltered in grr1Δ strains.  The measured discordance 
between gene and protein expression among loci of the TCA cycle and 
respiratory chain as well as loci involved in mitochondrial function support the 
metabolic data and further suggest that though flux through the TCA cycle is 
increased in grr1Δ cells respiratory capacity is decreased in grr1Δ cells (Figure 
5.2 and table 5.1).  Discordance among TCA cycle and respiratory chain 
genes/proteins can be categorized into three types based on the nature of the 
discordance.  The majority of loci exhibited increased gene expression with no 
concomitant change in protein expression and included ACO1/Aco1 (+2.41 gene 
expression in grr1Δ, +1.06 protein expression in grr1Δ), IDH1/Idh1 (+3.31, -1.12), 
SDH2/Sdh2 (+3.02, -1.5), MDH1/Mdh1 (+2.24, -2.1), ATP3/Atp3 (+2.26, -1.25), 
QCR2/Qcr2 (+2.35, -1.9), COR1/Cor1 (+2.34, +1.11), CYC1/Cyc1 (+3.09, +1.52), 
COX4/Cox4 (+2.51, +1.59), and COX6/Cox6 (+2, -1.14).  A smaller group of 
proteins, including Pet9 (+1.37, +4.67) and Coq2 (+1.2, +5.83), were measured 
to significantly increase in expression with no significant change in the 
expression of their encoding.  Finally, Ach1 (+4.03, -5.6), Ndi1 (+3.76, -2.86), 
Idh2 (+3.03, -6.25), and Atp19 (+2.5, -2.5) were measured to significantly 
decrease in protein expression despite significant increases in the expression of 
their encoding genes.  With the exception of Pet9 and Coq2, the measured 
protein expression levels of the remainder of TCA cycle and respiratory enzymes 
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Figure 5.2.  Metabolic Map of grr1Δ Cells Grown on 2% Glucose.  (Previous 
page) Gene and protein expression measurements were overlaid onto a metabolic map of S. 
cerevisiae metabolism.  Enzymes are represented by nodes with the color of the node denoting 
increased (red), decreased (green), unchanged (blue), or un-measured (black) protein 
expression.  Changes in gene expression are represented by the color of the ring or edge around 
each node utilizing the same color scheme as that used for protein expression.  Reactions are 
denoted with solid lines with the direction of the reaction denoted by the arrowhead (bi-directional 
reactions contain an arrowhead at both ends).  The color of the reaction line denotes whether the 
flux through the reaction is presumed to be increased (red), decreased (green), or unchanged 
(blue).  Flux through a particular reaction is presumed based off of gene expression data when no 
protein expression data is present.  However, if protein expression is measured for an enzyme of 
a particular reaction it is utilized over gene expression data to infer flux through the reaction.  
Dotted reaction lines represent multiple metabolic steps.  Increased line weight for the reaction 
catalyzed by Gdh1 is utilized to denote that maximum flux capacity for this reaction is catalyzed 
by Gdh1 whereas Gdh3 catalyzes the reaction at a much slower rate.  Proteins bound by yellow 
bordered squares are mitochondrial localized proteins whereas those bound by a yellow bordered 
hexagon are peroxisomal.  Proteins highlighted in grey with the green boarder represent proteins 
involved in glycolysis and fermentation.  Transcriptional targets of Cat8 are also indicated (black 
dotted line with double arrow heads).  For protein expression and gene expression values see 
Table 5.1. 
 
and acetyl-CoA (Cit1).  Thus, it is possible that the increases in these enzymes 
are sufficient to suggest that respiratory rate may not be significantly altered in 
grr1Δ cells.  However, it is likely that the discordances measured of the last type, 
where decreased protein expression was measured despite an increase in gene 
expression, may be attributable to noise in the proteomic measurements 
contributed by differential post-translational modification of the peptides analyzed 
since these proteins were only quantified by single peptide hits.  Nevertheless, 
disregarding these instances of discordance, Aco1, Sdh2, Qcr2, Cor1, and Cox4 
were quantified utilizing 19, 3, 8, 9, and 6 peptides, respectively.  Each of these 
proteins expression has been found to increase as respiratory capacity increases 
452 and thus the absence of an observed increase in their protein expression 
suggests that respiratory capacity may be unaltered in grr1Δ cells.   
It must be noted that while many of the TCA cycle genes and proteins 
exhibited discordance, citrate synthase (Cit1) and the E1 alpha subunit of the 
pyruvate dehydrogenase complex (Pda1) were measured to have an accordant 
increase in protein expression and of the encoding gene of approximately three 
fold each.  Together these two proteins catalyze the initial, rate limiting, reactions 
of the TCA cycle; the synthesis of acetyl Co-A from pyruvate (Pda1 in 
conjunction with the pyruvate dehydrogenase complex) and the synthesis of 
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citrate from oxaloacetate increase flux through the TCA cycle without 
concomitant increases in the remaining TCA cycle enzymes.  Concurrent with 
this hypothesis, increased flux through the TCA cycle has been observed during 
13C-labeled glucose experiments monitoring metabolic flux through the TCA cycle 
in grr1Δ cells 174.  Together these data suggest that despite increases in flux 
through the TCA cycle, respiration rate is unaltered in grr1Δ cells. 
In addition to proteins involved in metabolic processes of the mitochondrial 
TCA cycle and respiratory chain, fourteen proteins involved in various aspects of 
maintaining mitochondrial integrity were also measured to be discordant with the 
expression of their encoding genes (Table 5.2).  All fourteen of these proteins 
exhibited either increased or decreased protein expression with no significant 
change observed in the expression of the encoding genes, suggesting that these 
proteins may be regulated post-transcriptionally in grr1Δ cells.  Proteins within 
this group included the mitochondrial porin, Por1 (+1.53, -2.78), six proteins 
involved in mitochondrial protein import, Hsp60 (-1.03, -2.56), Phb1 (+1.22, -
2.78), Mia40 (-1.02, -2.56), Tim15(+1.17, -4.55), Tom70 (-1.01, -9.09), and 
Mdm38 (+1.53, -16.67), three proteins involved in mitochondrial translation, Msk1 
(+1.01, +4.11), Tuf1 (+1.59, -9.09), and Cbs1 (+1.18, -6.67), and four proteins 
involved in other aspects of mitochondrial function, Mir1 (+1.53, +3.24), Rpo41 
(+1.42, -2.56), Fmp26 (+1.51, +3.13), and Mmr1 (+1.17, +2.70).  All of these 
proteins were quantified by multiple discrete peptides with the exception of Phb1.  
Msk1 (lysine-tRNA synthetase), Mir1 (mitochondrial phosphate carrier), Mmr1 
(localizes exclusively to mitochondria in the bud), and Fmp26 (unknown) 
displayed increased protein expression levels.  Among these proteins, the protein 
expression level of the mitochondrial porin, Por1, has been measured to increase 
with increased respiratory capacity 452 and this protein plays a central role in 
regulating respiratory capacity 453.  Por1 or the TOM complex both mediate the 
permeability of the outer mitochondrial membrane to NADH and have roles in 
mediating mitochondrial protein import.  Interestingly, Tom70, the receptor 
component of the TOM complex, was also shown to decrease in protein  
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Table 5.1.  Gene and Protein Expression Levels in grr1Δ Cells for Select Loci of Central Metabolism.  See page 213 
for details.
  
208 
Table 5.1.  Continued.
  
209 
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Table 5.1.  Gene and Protein Expression Levels in grr1Δ Cells for Select 
Loci of Central Metabolism.  Protein and gene expression data for loci of central carbon 
and energy metabolism from the comparative analysis of wild-type and grr1Δ cells is captured in 
this table.  Fields are as described in Tables 4.2 and 4.3. 
 
expression by ~9fold in grr1Δ strains.  Taken together, this further suggests that 
respiratory capacity may be decreased in strains lacking Grr1 function.  
Interestingly, the degree to which many of the mitochondrial import proteins 
decrease in protein expression (-2.78, -2.56, -2.78, -2.56, -4.55 for Por1, Hsp60, 
Phb1, Mia40, and Tim15, respectively) correlate well with the degree to which 
increases in gene expression for many of the TCA cycle and respiratory genes 
changed (+2.4 average increase). 
In order to empirically assess the respiratory competence of grr1Δ cells 
we performed spot dilution assays comparing wild-type and grr1Δ cells of the 
S288C and the CenPK genetic backgrounds on ethanol medium.  The S288C 
background possesses known respiratory defects 454 and thus we included wild-
type and grr1Δ cells of the CenPK background, which does not possess these 
defects, in our spot dilution analysis.  Cells for each strain were grown on YPD to 
mid log phase and then spotted onto SD-3% ethanol plates at cell counts of 
60,000, 6,000, 600, and 60 and incubated at 32°C for 40hrs.  As can be seen in 
Figure 5.3, both the wild-type and grr1Δ strains of the CenPK background, as 
predicted, grew much more robustly on ethanol medium than the respective 
strains of the S288C background.  Little growth was observed for grr1Δ 
 (S288C), confirming that respiratory growth on ethanol is indeed compromised.  
Additionally, though growth was far more robust for grr1Δ strains of the CenPK 
background on ethanol, slower growth was observed for this strain compared to 
the isogenic wild-type strain.  These data further suggest that, though the 
respiratory deficiencies of the S288C background exacerbate the growth defect 
of grr1Δ strains, they cannot completely account for all of the growth deficiencies 
of grr1Δ strains on ethanol based medium.  The discordance between gene and 
protein expression on glucose medium as well as the growth defects of grr1Δ 
cells on ethanol together provide compelling evidence for a reduced respiratory 
capacity inherent in grr1Δ cells. 
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5.4.  Glycerol Metabolism in grr1Δ Cells 
As indicated previously, ethanol production is not affected during 
fermentations with grr1Δ cells, however, the production of glycerol has been 
measured to be significantly decreased during fermentive growth of these strains.  
In this same experiment glycerol-3-phosphate was identified as a “reporter 
metabolite” based on a genome scale metabolic model 67.  Additionally, 
metabolic flux during the conversion of glycerol-3-phosphate to glycerol has been 
found to be reduced in grr1Δ cells 174.  Concurrent with these data, we were able 
to detect significant increases and decreases among genes and proteins 
required for glycerol metabolism.  The transcriptional and post-transcriptional 
regulation of glycerol metabolic enzymes measured in our genomic and 
proteomic analysis correlate well with the previously measured changes in 
metabolic flux through this pathway in grr1Δ cells.  Together these data suggest 
that this pathway is regulated to increase NADH oxidation via the glycerol-3-
phosphate shuttle.  The first step in glycerol biosynthesis is catalyzed by two 
isoforms of NAD-dependent glycerol-3-phosphate dehydrogenase, known as 
Gpd1 and Gpd2 455.  Together these two enzymes catalyze the rate limiting step 
of glycerol biosynthesis, glycerol phospholipid biosynthesis, and the glycerol-3-
phosphate shuttle (NADH oxidation to NAD) which entails the conversion of the 
glycolytic intermediate dihydroxy-acetone-phosphate to glycerol-3-phosphate 
accompanied by the re-oxidation of excess NADH to NAD.  Interestingly, Gpd1 
has been shown to play a major role in osmoadaptation 456,457 and we measured 
no significant changes in either the protein or its encoding gene.  On the other 
hand, Gpd2, whose proteins levels were measured to significantly increase in 
grr1Δ cells by ~3 fold, plays a different physiological role as its production is 
stimulated by anoxia or excess NADH 456.  The increase in Gpd2 protein 
expression suggests that the production of glycerol-3-phosphate is increased in 
grr1Δ cells in order to enhance oxidation of NADH to NAD. 
Glycerol-3-phosphate can be further metabolized to produce either 
glycerol for osmoadaptation, to produce phospholipids, or oxidized back to 
dihydroxy-acetone-phosphate by the glycerol-3-phosphate dehydrogenase, Gut2, 
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Figure 5.3.  Respiratory Deficiency in grr1Δ Cells.  Due to conflicting reports, we 
determined the respiratory competence of grr1Δ cells of the CenPK genetic background and the 
S288C genetic background.  Wild-type  and grr1Δ CenPK  and wild-type and grr1Δ S288C strains 
were spot diluted onto synthetic defined medium containing 3% ethanol as the carbon source and 
incubated at 32° C .  At 40 hours pictures were taken using a Canon EOS digital SLR camera.  
The S288C background contains a ty1 insertion in the gene encoding the respiratory transcription 
factor HAP1 454 and thus differences in strain background could explain the respiratory deficient 
phenotype of grr1Δ cells reported by some labs 68 .  While the S288C strains did exhibit 
decreased respiratory growth on ethanol media compared to the CenPK strains, the grr1Δ strains 
exhibited deficient respiratory growth in both strain backgrounds compared to the isogenic wild-
type strains.  Thus, GRR1 deletion does confer a respiratory deficiency to both strain 
backgrounds.
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which couples glycerol-3-phosphate oxidation to the electron transport chain and 
along with Gpd1 and Gpd2 comprises the glycerol-3-phosphate shuttle 453,456,458.  
A number of observations suggest that glycerol metabolism may be regulated in 
grr1Δ strains to increase flux through the latter pathway.  Both glycerol 
production and flux from glycerol-3-phosphate to glycerol have been measured to 
decrease in grr1Δ strains by approximately 2.4 fold 67 and 4.6 fold 174, 
respectively.  Together our proteomic and genomic data suggest a possible 
mechanism for this decreased flux.  Glycerol-3-phosphate is metabolized to 
glycerol by two isoforms of glycerol-3-phosphatase, Gpp1 and Gpp2.  We 
measured a significant increase in GPP2 expression (+2.55 fold), however Gpp1 
has been shown to be the major isoform contributing to greater than 70% of 
glycerol-3-phosphatase activity in this S. cerevisiae and deletion of GPP1 leads 
to significant increases in glycerol-3-phosphate accordingly 459.  Interestingly, we 
measured no significant change in GPP1 expression in grr1Δ cells compared to 
wild-type, yet Gpp1 protein expression decreased to the same extent that Gpd2 
protein expression increased; approximately 3 fold.  These measurements are 
strikingly similar to the fold decreases in glycerol output and flux between 
glycerol-3-phosphate and glycerol suggesting that the glycerol pathway has been 
modulated in grr1Δ cells at the post-transcriptional level to increase glycerol-3-
phosphate concentration.  Finally, we measured a significant ~3 fold increase in 
GUT2 expression as well, but failed to measure its product expression level.  
This is not surprising given the fact that it is an integral mitochondrial inner 
membrane protein and our proteomic analysis was slightly biased against the 
detection of membrane proteins.  Nevertheless, based off of the measurements 
acquired for the other glycerol pathway enzymes it is highly likely that Gut2 
protein expression is indeed increased in grr1Δ cells.  These data suggest that 
flux through the glycerol-3-phosphate shuttle is increased by at least 3 fold in 
grr1Δ cells.  Furthermore, this increase in flux implies that grr1Δ strains differ 
from wild-type strains regarding glycerol metabolism; choosing to utilize glycerol-
3-phosphate for respiration instead of the production of glycerol. 
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5.5.  Flux through Gluconeogenesis and the Glyoxylate Cycle May be 
Increased in grr1Δ Cells on Glucose Media 
Previously, GenGO enrichment analysis of our grr1Δ global gene 
expression analysis revealed that the processes of “gluconeogenesis” (p-value = 
8E-4) and “glyoxylate metabolism” (pvalue = 4E-4) were among the most 
affected processes at the transcriptional level in grr1Δ cells grown on 2% 
glucose.  Large transcriptional increases in the gluconeogenesis genes encoding 
for fructose-1,6-bisphosphatase (FBP1, +136.6), pep carboxy kinase (PCK1, 
+38.64), cytosolic NADP dependent isocitrate dehydrogenase (IDP2, +12.96), 
and pyruvate carboxylase (PYC1, +7.29) as well as the glyoxylate cycle genes 
encoding for isocitrate lyase (ICL1, +13.29) and malate synthase (MLS1, +88.33) 
were measured.  Increases in gene expression for these genes were measured 
in a previous grr1Δ microarray 159 but were not analyzed further.   
Despite these large increases in transcriptional expression we were 
unable to successfully measure the protein steady state levels for these 
enzymes.  However, a number of independent observations suggest that the 
transcript levels for these genes may reflect the steady state level of their 
respective encoded proteins.  First, previous analyses have found that the steady 
state level of Fbp1 is controlled by two distinct proteolytic pathways; one which is 
active after prolonged periods of glucose starvation (1-3 days) and another that is 
active after short term glucose starvation (~24 hrs) 460.  Glucose addition to cells 
exposed to long periods of glucose starvation induces degradation of Fbp1 by 
targeting Fbp1 to vacuolar import and degradation vesicles (Vid vesicles) which 
results in its’ degradation in the vacuole 461.  Our cells were not exposed to long 
term glucose starvation (see materials and methods) and thus Fbp1 degradation 
through this pathway is unlikely.  The second pathway targets Fbp1 for 
proteasomal degradation after glucose is added to cells starved for glucose less 
than 24 hours.  This pathway requires Grr1 and as a result Fbp1 protein levels 
are stabilized in grr1Δ cells 462.   
Second, we measured significant increases and decreases in proteins of 
metabolic pathways that suggest increased flux through gluconeogenesis and 
 218 
 
the glyoxylate cycle.  Both Ser3 and Shm2 were measured in our proteomic 
analysis of grr1Δ strains to decrease by ~8 and 7 fold, respectively.  Ser3 is one 
of two isoforms of 3-phosphoglycerate dehydrogenase in yeast 463 whereas 
Shm2 is the mitochondrial isoform for serine hydroxymethyltransferase 464.  Both 
of these enzymes contribute to the biosynthesis of glycine and serine on glucose 
grown cells 463.  On ethanol or other respiratory carbon sources, glycine and 
serine are synthesized via the glyoxylate pathway.  Thus, the decrease in Ser3 
and Shm2 protein levels are consistent with a decreased need to synthesize 
serine and glycine from 3-phosphoglycerate which can be supplied via the 
glyoxylate pathway. 
We also measured differential regulation of the cytosolic NADP+ 
dependent glutamate dehydrogenases, Gdh1 and Gdh3.  These two proteins 
together form a hetero-hexameric enzyme that catalyzes the synthesis of 
glutamate from ammonia and α-ketoglutarate 465,466.  It has been shown that the 
enzymatic rate of α-ketoglutarate utilization is much higher for Gdh1 than Gdh3 
and the ratio of these two enzymes is intricately controlled by post-transcriptional 
modification of Gdh1 467 and regulation of GDH3 expression 466, in a carbon 
source dependent manner.  On glucose or ethanol, the transcriptional expression 
of GDH1 is unaltered; however the ratio of Gdh1 to Gdh3 protein decreases as 
glucose is depleted from the media.  On the other hand, GDH3, transcriptional 
expression is low on glucose and markedly higher on ethanol.  This 
transcriptional increase corresponds to an ethanol dependent increase in Gdh3 
protein.  Taken together, these data suggest that during fermentive growth, when 
energy contributed via the TCA cycle is minimal, a higher rate of α-ketoglutarate 
utilization for the synthesis of glutamate can be supported and is facilitated 
predominately by Gdh1.  However, as glucose becomes limiting and aerobic 
growth on ethanol becomes the major energy providing pathway, the metabolic 
flux of α-ketoglutarate to glutamate is reduced by increasing the abundance of 
the less active isoenzyme, Gdh3, through transcriptional de-repression of its 
encoding gene.  The decrease in flux through this pathway most likely leads to 
higher cytosolic α-ketoglutarate levels which can serve as a source of cytosolic 
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isocitrate for the glyoxylate cycle and gluconeogenesis since the gluconeogenic, 
cytosolic, NADP dependent, isocitrate dehydrogenase, Idp2, is a bi-directional 
enzyme that catalyzes the interconversion of isocitrate and α-ketoglutarate in a 
substrate concentration dependent manner 468.  Our data is consistent with the 
mode of regulation for the two isozymes as Gdh1 protein expression in grr1Δ 
cells was decreased ~3 fold (Table 5.1) with no significant change in GDH1 
expression measured, while GDH3 expression increased ~8 fold (Table 5.1 and 
Figure 5.2).  We were unable to successfully measure Gdh3 expression level, 
however Gdh3 expression has been shown to correlate with GDH3 expression 
and thus it is likely that Gdh3 protein expression is increased in grr1Δ cells.  The 
differential regulation of Gdh1 and Gdh3 observed in grr1Δ cells is consistent 
with the differential regulation of these two proteins observed in wild-type strains 
grown on a respiratory carbon source where the glyoxylate cycle and 
gluconeogenesis are needed for metabolism.  Thus, these data further suggest 
that metabolic flux through these two pathways is increased in grr1Δ cells despite 
the fact that glucose is actively fermented in these strains. 
Finally, perhaps the most compelling piece of evidence supporting 
increased flux through gluconeogenesis and the glyoxylate cycle is supplied by a 
significant and correlated increase in both the gene and protein expression of the 
glyoxylate reductase encoded by YPL113C 469.  In our global transcriptional and 
proteomic analysis, YPL113C expression was measured to increase by ~2.6 fold 
with an accordant increase in protein expression of 5.1 fold also measured.  The 
YPl113C protein has been shown to be an isoform of a number of glyoxylate 
reductases in yeast that may be differentially localized 469.  The increased protein 
expression of YPL113C suggests that grr1Δ cells are producing excess 
glyoxylate through the glyoxylate cycle. 
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5.6.  Network Analysis of the Transcripts Observed to Increase in grr1Δ 
Cells Reveals that Direct Targets of the Gluconeogenic Transcription 
Factors, Cat8 and Adr1, are Significantly Increased in grr1Δ Cells 
Prior to glucose exhaustion, glucose exerts repression on genes 
necessary for utilizing of C2 carbon sources such as glycerol, ethanol and 
acetate.  Growth on these carbon sources requires the enzymes of both the 
glyoxylate cycle and gluconeogenesis which together catalyze the biosynthesis 
of four carbon compounds which are subsequently utilized to synthesize sugars 
such as glucose and other essential compounds.  These enzymes however, are 
dispensable for fermentive growth and thus the genes encoding these enzymes 
as well as the enzymes themselves are highly sensitive to glucose repression 
and glucose dependent inactivation, respectively.  In fact, glucose repression of 
gluconeogenic genes has been shown to be triggered on glucose concentrations 
as low as 0.005% 170 and glucose induced degradation of gluconeogenic 
mRNA’s has been found to occur at glucose concentrations as low as 0.001% 
171.  Additionally, gene expression profiles of fermentive metabolism have shown 
that the gluconeogenic and glyoxylate cycle genes are among the last to be de-
repressed; requiring almost complete depletion of glucose before increases in 
gene expression are detected 135.  In our analysis of grr1Δ cells the glucose 
concentration when we isolated our cells was well above 1% glucose; a 
concentration at which only a 30% deficiency in glucose transport is measured in 
grr1Δ cells470.  Despite these conditions, we measured significant increases in 
gene expression for the gluconeogenic genes, FBP1, PCK1, PYC1, and IDP2 as 
well as the glyoxylate cycle genes, MLS1 and ICL1.  Furthermore, a number of 
observations suggest that these transcripts indeed reflect the protein expression 
level of their respective products in grr1Δ cells (see Section 5.5).  Together, 
these data suggest that glucose repression of gluconeogenic and glyoxylate 
cycle genes and glucose induced inactivation of gluconeogenic proteins is 
inactive in grr1Δ cells despite the presence of glucose and glucose transport.  
Interestingly, studies monitoring FBP1 gene expression in yeast strains defective 
to varying degrees for glucose transport have shown that the complete absence 
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of glucose transport is required to eliminate glucose repression of FBP1 140.  
Thus the glucose insensitive expression of gluconeogenic and glyoxylate cycle 
genes in grr1Δ cells is unlikely to be an indirect consequence of the glucose 
transport deficiency of this strain. 
In order to determine the mechanism by which gluconeogenic and 
glyoxylate cycle genes are induced in grr1Δ cells, we first sought to determine 
the specific transcription factor(s) responsible for their expression.  Interestingly, 
we determined the expression of the gluconeogenic and glyoxylate cycle 
transcription factor genes ADR1, CAT8, and SIP4 to increase in gene expression 
by 3.4, 18.9, and 6.2 fold, respectively in grr1Δ cells.  Together Adr1, Cat8, and 
Sip4 are responsible for the induction of gluconeogenic and glyoxylate cycle 
genes after glucose exhaustion 471-473.  Recently, Tachibana et al. conducted an 
extensive analysis where they identified those genes that exhibit both Adr1 
and/or Cat8 binding to their promoter regions and showed significant decreases 
in transcriptional expression due to ADR1 or CAT8 deletion 474.  Thirty three 
genes were identified as direct targets of Adr1 of which 18 (55%) were 
significantly increased (as determined by Welchlog2 t-test < 0.05) in grr1Δ cells.  
Strikingly, 28 out of 34 (82%) of those genes found to be direct targets of Cat8 
were significantly up-regulated in the grr1Δ cells.(Figure 5.4) Together these two 
transcription factors account for 32% of all genes up-regulated in response to 
GRR1 deletion at least 3 fold with a Welch log2 t-test <= 0.05.  Thus, these data 
suggest that the glucose insensitive transcription of gluconeogenic and 
glyoxylate cycle genes is due to increased Adr1 and Cat8 dependent 
transcription. 
 
5.7.  Cat8 and Phosphorylated Cat8 Protein Levels are Increased in grr1Δ 
Strains 
The extent to which Cat8 dependent genes are induced in grr1Δ cells 
despite the presence of high concentrations of extracellular glucose, prompted us 
to confirm if Cat8 protein levels were indeed higher in grr1Δ cells under these 
same conditions.  To do this, we constructed grr1Δ cells containing a 
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Figure 5.4.  Glucose Insensitive Transcription of Gluconeogenic and 
Glyoxylate Cycle Genes in grr1Δ Cells is Due to Increased Cat8 and Adr1 
Dependent Transcription.  Genes directly regulated by the gluconeogenic transcription 
factors Cat8 (A.), Adr1 (B.), or both (C.) as determined by 474 are displayed as nodes connected 
to their respective transcription factors by black edges.  Protein and gene expression 
measurements from global analysis of grr1Δ cells are denoted by the color of the node (protein) 
and the color of the ring around the node (gene) as indicated.  D.  The protein expression level of 
Cat8 in wild-type and grr1Δ cells grown on glucose media is shown utilizing wild-type and grr1Δ 
cells containing the Cat8::TAP fusion construct and α-Tap antibodies obtained from Open 
Biosystems™.  The transcriptionally active, phosphorylated species are indicated. 
 
CAT8::TAP::HIS3 construct that could then be detected utilizing α-TAP 
antibodies available commercially through Open Biosystems™.  In order to 
construct this strain as well as grr1Δ strains containing other TAP tagged protein 
constructs in a high throughput manner we implemented a derivative of the 
selective screening procedure utilized to perform high throughput synthetic lethal 
screens 336.  Briefly, the GRR1 locus was deleted by adaptamer mediated gene 
disruption by inserting the URA3 gene into the GRR1 locus of the mating type 
selectable marker strain, MT2112, to construct strain JH020 (mfα1Δ::MFα1pr-
LEU2 can1Δ::MFA1pr-HIS3, his3Δ1, leu2Δ0, ura3Δ0, grr1Δ::URA3, met15Δ0, 
lys2Δ0).  This strain was then crossed to a BY4741 strain containing the 
CAT8::TAP::HIS3 (MATA his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 CAT8::TAP::HIS3) 
fusion construct that was obtained from the Open Biosystems™ TAP-tagged 
yeast strain library.  Diploids were then selected on synthetic media lacking 
uracil, histidine, and lysine.  Diploids were sporulated and MAT α spore progeny 
were selected by streaking spore tetrads on synthetic medium lacking leucine, 
uracil, histidine, and lysine.  Finally, grr1Δ cells containing the CAT8::TAP::HIS3 
construct were isolated by replica plating the MAT α strains onto synthetic 
medium containing canavanine and lacking histidine and arginine.  Colonies 
exhibiting no resistance to canavanine are positive for growth on media 
containing histidine due to the presence of the CAT8::TAP::HIS3 construct.  Each 
colony, exhibiting canavanine sensitivity, was examined for the characteristic 
elongated bud morphology of grr1Δ strains by microscopic examination and 
isolated (strain = JH006). 
Cat8 protein levels were determined by western blotting utilizing α-TAP 
antibodies against protein extracts from strain JH006 
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(grr1Δ::URA3 CAT8::TAP::HIS3) and the original progenitor BY4741 
(CAT8::TAP::HIS3) strain utilized to construct JH006.  As can be seen in Figure 
4.1 D we measured a drastic increase in Cat8 protein levels in grr1Δ strains 
grown on high glucose (~2%) media compared to the progenitor wild-type strain.  
Additionally, we observed two slower migrating species of Cat8 protein 
reminiscent of the phosphorylated species characterized by 320.  In this study, it 
was determined that the amount of hyper-phosphorylated Cat8 (Cat8 pIII) 
correlated with the gene expression as well as the enzymatic levels of PEPCK 
and FBPase.  Also, Cat8 hyper-phosphorylation is regulated by the carbon 
source as hyper-phosphorylation is lost upon introduction of glucose to cells 
growing on ethanol.  Together, the glucose insensitive expression of the CAT8 
gene, the glucose insensitive expression of gluconeogenic genes directly 
controlled by Cat8 dependent transcriptional induction, the measured increase in 
Cat8 protein levels on glucose media, and the prevalence of hyper-
phosphorylated Cat8 pIII on glucose media in grr1Δ cells confirm that the glucose 
repression mechanism acting to repress CAT8 gene expression as well as the 
catabolite inactivation mechanism responsible for inhibition of Cat8 dependent 
transcriptional activation are compromised in grr1Δ cells.       
 
5.8.  Network Analysis of Significantly Changed Proteins in grr1Δ Strains 
Reveals Enrichment for Glc7/Reg1 Interactors 
It has been well established that Cat8 transcriptional expression as well as 
Cat8 transcriptional activity both require Snf1 catalytic activity 316,320,317,475.  Thus, 
the increased expression of CAT8, the increased protein expression of Cat8, and 
the existence of hyper-phosphorylated Cat8 in grr1Δ cells suggest that Snf1 
catalytic activity must be active in this strain despite the presence of glucose and 
glucose transport.  With this in mind, we were curious to reveal the particular 
mechanism by which Snf1 could be activated in grr1Δ cells.  In order to do this 
we utilized the genetic and physical interaction data available through SGD to 
populate a relational database that could be interfaced with the network analysis 
tool ProteoLens™ 340.  Utilizing ProteoLens™ we then overlaid the protein and 
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Figure 5.5.  Network Analysis of Gene and Protein Expression Changes in 
grr1Δ Cells Reveals Enrichment among Proteins Associated with the PP1 
Targeting Subunit, Reg1.  A Reg1 protein interaction network was constructed utilizing the 
protein interaction data available through SGD and the network visualization tool ProteoLens™ 
340.  Utilizing ProteoLens™, global gene and protein expression data from our analysis of grr1Δ 
strains was overlaid onto the yeast interaction map and manually assessed for “hot spots” where 
a high degree of expression changes were observed surrounding particular nodes.  Utilizing this 
method, many proteins directly (first degree) and indirectly (second degree) associated with Reg1 
were revealed to exhibit changes in protein expression.  The legend for edges and nodes is 
provided (inset) as well as western blots confirming the protein expression level changes for Ino2 
and Sol1. 
 
gene expression data from our global grr1Δ genomic and proteomic data sets 
onto the Saccharomyces interaction network and looked for enrichment of protein 
or gene expression level changes among interactors of known Snf1 regulatory 
proteins.  Interestingly, we measured no enrichment for protein or gene 
expression changes among interactors of the activating gamma subunit of the 
Snf1 kinase complex, Snf4, or the beta subunits; Gal83, Sip1, and Sip2.  
Additionally, we observed no enrichments of protein or gene expression level 
changes among interactors of the upstream Snf1 activating kinases Elm1, Tos3, 
or Sak1.  However, a number of significant alterations in protein expression were 
observed among first degree and second degree interactors of the Glc7 
regulatory subunit Reg1 including Glc7 (Figure 5.5). 
Significant changes in protein expression measured in grr1Δ cells for 
proteins directly (first degree) interacting with Reg1 included components of the 
Ras/cAMP (Ras1 and Cyr1) pathway, enzymes involved in nucleotide 
biosynthesis (Ade16 and Sol1), the inositol transcription factor, Ino2, fructose-bis-
phosphatase (Fbp1), and the catalytic subunit of the Reg1-Glc7 phosphatase, 
Glc7.  Indirect interactions (second degree = separated by at most one shared 
node) with measured changes in protein expression included the splicing 
components, Spp41, Spp381, and Rat1, a number of Cdc48 interactors including 
Cdc53, Cln2, Pac10, Ubx2, Hmg2, and Shp1, and finally the downstream targets 
of Snf1, Cat8 and Sip4, which regulate gluconeogenic and glyoxylate cycle 
genes.  Together, the multiple changes in protein expression measured among 
proteins with first or second degree interactions with Reg1 suggested that 
aspects of Reg1-Glc7 function were indeed altered in grr1Δ cells.   
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5.9.  Western Analysis of Glc7 Reveals the Presence of a Modified Form of 
Glc7 that is Significantly Reduced in Abundance in grr1Δ Strains 
The measured protein expression level changes among proteins exhibiting 
either genetic or physical interactions with Reg1 suggested that Reg1 function 
was somehow altered in grr1Δ cells.  Interestingly, we measured increased 
protein expression of Glc7 whose phosphatase activity is required for the majority 
of Reg1 functions.  This alteration in Glc7 expression is perplexing given the fact 
that Glc7 is a stable protein whose abundance has not been measured to change 
in any conditions previously assayed.  However, Glc7 was quantitated in our 
global proteomic analysis by only one peptide (pep sequence) and thus the 
measured change in Glc7 abundance could either be due to the absence of an 
unknown modification of Glc7 on this peptide in grr1Δ cells or indeed reflect Glc7 
protein expression levels.  We therefore sought to resolve this discrepancy by 
constructing a grr1Δ strain harboring a Glc7::TAP fusion construct which could 
then be assayed by western analysis using anti-TAP antibodies.  This strain 
(JH007) was constructed utilizing the same method utilized to construct JH006 
(grr1Δ Cat8::TAP). 
Strain JH007 and its progenitor wild-type strain were grown to early mid-
log phase in liquid YPD+N media (see materials and methods) and whole cell 
protein extracts were prepared.  Interestingly, western analysis of these extracts 
utilizing the α-Tap antibodies obtained from Open Biosystems ™revealed that 
while Glc7::TAP in grr1Δ strains migrated at the predicted size ~36, the 
Glc7::TAP fusion in the progenitor wild-type strain displayed a much slower 
migrating form and no signal was measured at the predicted size of Glc7 in wild-
type strains.  In order to confirm that these bands were indeed the Glc7 protein 
and that the altered migration in wild-type was not a consequence of the 
presence of the Tap tag fusion construct we obtained antibodies raised against 
the endogenous Glc7 protein from two independent laboratories.  We first 
conducted western analysis on protein extracts isolated from strains DBY2059 
(leu2-3) and JH001 (grr1Δ::NAT) grown on the SD+N media utilized in the global 
genomic and proteomics experiments with purified α-Glc7 antibodies obtained 
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Figure 5.6.  Glc7 Western Blots Comparing grr1Δ and wild-type Cells  A. 
Western analysis of wild-type and grr1Δ strains grown on YPD+N (see materials and methods) 
harboring the Glc7::Tap construct using rabbit polyclonal antibodies against the Tap protein 
reveal the presence of a slower migrating form of Glc7 (Glc7 (f1)) that is estimated to be 10-
15kDa bigger than the Glc7 unmodified form found in grr1Δ strains (Glc7 (u)).  B:  Western 
analysis of wild-type and grr1Δ strains grown on SD+N (see materials and methods) using 
antibodies against the endogenous Glc7 protein (α-Glc7P) reveals the presence of multiple forms 
of Glc7 all of which are differentially expressed in grr1Δ strain.  Glc7(f1) represents the 
endogenous unmodified form of Glc7 and this form seems to migrate slightly slower in wild-type 
strains perhaps representing a phosphorylated form of Glc7 (Glc7(f1M)).  A slower migrating form 
of Glc7 ( Glc7 (f2))  which is estimated to be 10-15kDa bigger than the predicted 36kDa form, 
Glc7 (f2), is detected in the grr1Δ and the wild-type strain.  However, once again the wild-type 
Glc7 (f2m) seems to slightly migrate slower and is much more prevalent than in grr1Δ strains.  
Finally, a third , slower migrating form of Glc7 estimated to be at least 30 kDa larger than Glc7(f1) 
is found in wild-type strains but absent in grr1Δ strains.  C:  Western analysis of wild-type and 
grr1Δ strains on various concentrations of glucose and on ethanol media (see materials and 
methods) using another antibody raised against endogenous Glc7 (Glc7*) reveals that the 
presence of the different forms of Glc7 are differentially regulated according to carbon source.  
On 7% glucose forms f1m,f2, and f3 are measured to be equally present and the unmodified form 
of Glc7 (Glc7 (f1)) is absent in both wild-type and grr1Δ strains.  Both the f2 and f3 forms of Glc7 
are present in wild-type strains grown on 2% glucose but the f1m and the f1form is absent.  In 
grr1Δ strains all forms except the f1 form are present on 2% glucose.  On .02% glucose only the 
f1 form of Glc7 is present in wild-type and grr1Δ strains.  Finally, as on .02% glucose, on 3% 
ethanol media the wild-type strain contains only the f1 form.  However, the grr1Δ strain contains 
much more of the f1 form and both the f2 and f3 forms can be detected. 
 
from Dr. John Cannon.  As can be seen in Figure 5.6 B utilizing these antibodies 
we were able to detect Glc7 at the normal migration size in both the wild-type 
and grr1Δ strains which was in contrast to the pattern observed utilizing the α-
TAP antibodies against the Glc7::TAP fusion construct in wild-type and grr1Δ 
strains.  We were also able to detect the slower migrating form of Glc7 (Glc7 (f2)) 
in both strains under these conditions.  However, this form was much more 
prevalent in the wild-type strain than in the grr1Δ strain indicating that this form 
was differentially regulated in grr1Δ strains.  Additionally, another even slower 
migrating form of Glc7 was also detected in the wild-type utilizing these 
antibodies and this form was completely absent in grr1Δ strains.  This same 
banding pattern was also observed utilizing raw sera from another independent 
Glc7 antibody preparation obtained from Dr. Ron Wek (α-Glc7*).  Together, these 
data prove the existence of multiple forms of Glc7, the identity of which remains 
to be elucidated.  These data also suggests that the measured change in relative 
abundance of Glc7 in our mass spectrometric analysis of grr1Δ and wild-type 
strains may in fact reflect a difference in the relative abundance of different forms 
of the Glc7 protein between these two strains. 
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Due to the fact that grr1Δ strains display increased expression of genes 
directly controlled by the Snf1 kinase, that grr1Δ strains show changes in protein 
expression among Reg1 interactors, and that these changes are coincident with 
reduced expression of the second and third forms of Glc7, we speculated that the 
predicted faster migrating form of Glc7 may not interact with Reg1 and that Glc7 
interaction with Reg1 may be facilitated by the increased expression of either of 
the second and/or third forms of Glc7.  Additionally, the fact that these forms 
showed reduced expression in grr1Δ strains suggested that the expression of 
these forms may not be directly controlled by Grr1 but a consequence of reduced 
glucose transport in grr1Δ cells.  If this is indeed the case then the expression of 
these alternative forms would likely respond to the concentration of glucose 
provided to the cell and thus the regulation of these alternative forms may be a 
novel mechanism to control glucose repression of Snf1 dependent genes.   
In order to determine if these alternative forms were differentially regulated in 
response to glucose we grew the wild-type and grr1Δ strains on YPD media 
containing 7%, 2%, and .02% glucose as well as YP ethanol media.  We then 
compared the expression level of these alternative forms of Glc7 through western 
analysis utilizing the Glc7* antibodies.  As can be seen in Figure 5.6 C, on 7% 
glucose, we detected both the second and third forms of Glc7 in both the grr1Δ 
and wild-type strains.  Interestingly the predicted 36kDa from of Glc7 was not 
detected and yet another slower migrating form of Glc7 with an estimated 
molecular weight of 38-40kDa was detected in both strains.  On 2% glucose the 
expression of the second and third forms of Glc7 was reduced but present in 
both strains.  Once again the predicted 36kDa form of Glc7 was absent in both 
strains.  Interestingly, the 38-40kDa from of Glc7 was absent in wild-type cells 
but present in the grr1Δ cells at this glucose concentration.  We currently have no 
explanation for this difference other than the wild-type lane may be under loaded.  
Remarkably, when both the wild-type and the grr1Δ cells were grown on glucose 
de-repressing media (0.02% glucose and ethanol media), the second and third 
forms of Glc7 were absent as well as the 38-40kDa form in both strains.  In fact 
the only form of Glc7 observed on 0.02% glucose in both strains was the 
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predicted 36 kDa form of Glc7.  This form was also only present in the wild-type 
on ethanol media, however the grr1Δ strain displayed a tremendous increase in 
expression of this from on ethanol and additional forms of Glc7 were also 
observed in grr1Δ cells on ethanol media.  Together this data provides 
compelling evidence that multiple forms of Glc7 exist in Saccharomyces and that 
the expression of these forms is differentially regulated by the concentration and 
type of carbon source. 
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CHAPTER 6:  DISCUSSION:  THE ROLE OF GRR1 IN GLUCOSE 
REPRESSION 
  
6.1.  Glucose Transport in grr1Δ Cells 
 In our analysis of discordance among loci annotated to the “carbon and 
energy metabolism” cluster, discordance among hexose transporters was 
measured.  Multiple studies have eloquently revealed that grr1Δ cells are 
defective in high affinity glucose transport; however low affinity glucose transport 
has not been shown to be affected in grr1Δ cells.  This phenotype is counter to 
the changes in gene expression measured in grr1Δ cells among hexose 
transporter genes.  In previous studies, the affect that GRR1 deletion had on the 
high affinity transporter, HXT6/7, was either undetermined or not discussed.  
Interestingly, despite the lack of high affinity hexose transport in grr1Δ cells, we 
as well as others detect increased expression of HXT6/7.  In our analysis, we 
reveal that despite increases in Hxt6/7 gene expression, Hxt6/7 protein 
expression is significantly decreased in grr1Δ cells.  Though the origins of the 
discordance between gene and protein expression of Hxt6/7 in grr1Δ cells are 
not revealed by our analysis, network analysis of nutrient transporters post-
translationally controlled by Grr1 suggests that Grr1 may regulate trafficking of 
these transporters through a Las17 dependent mechanism (Section 5.4.3.1).  In 
the case of Hxt6/7, Grr1 would presumably promote the stability of Hxt6/7 at the 
membrane.   
Changes in gene expression measured for the low affinity hexose 
transporters are also inconsistent with the glucose transport phenotype of grr1Δ 
cells.  In grr1Δ cells, the expression of the low affinity hexose transporters, HXT1 
and HXT3, are fully and partially repressed, respectively.  Once again, these 
decreases in low affinity gene expression are inconsistent with the lack of a 
deficiency in low affinity glucose transport in grr1Δ cells.  We revealed that, 
despite a significant decrease in HXT3 gene expression, Hxt3 protein levels are 
not measured to change significantly in grr1Δ cells at the growth phase we 
measured.  Thus, the decreased gene expression of HXT3 is compensated in 
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grr1Δ cells by a currently unknown mechanism that most likely influences either 
the translational rate of Hxt3 synthesis or the trafficking and stability of Hxt3.  We 
therefore conclude that low affinity glucose transport in grr1Δ cells is, in part, 
facilitated by Hxt3. (Figure 8.1 for model) However, the presence of Hxt3 
facilitated glucose transport in grr1Δ cells does not completely provide wild-type 
levels of glucose transport as a 30-40% deficiency in glucose transport is 
measured at high glucose concentrations.  This would suggest that either a 
fraction of glucose transport at high glucose levels is provided by one or more 
high affinity glucose transporters, whose expression is defective in grr1Δ cells, 
and/or that Hxt1 facilitated glucose transport may be compromised in grr1Δ cells.  
Interestingly, our quantitative proteomics analysis measured no significant 
change in protein expression of Hxt1 in grr1Δ cells. 
 
6.2.  Discordance among Carbon and Energy Metabolism Genes and its 
Implications for Grr1 Metabolism 
Our discovery that Hxt3 protein levels are unaffected in grr1Δ cells despite 
a significant decrease in HXT3 expression provides a mechanistic explanation for 
the sustainability of glucose based growth in grr1Δ cells.  However, it also 
presents a perplexing paradigm regarding the role of Grr1 in glucose repression.  
Recently, utilizing an array of S. cerevisiae strains expressing individual hexose 
transporters with different glucose transport rates, it was shown that the 
transcriptional expression (and thus release from glucose repression) of the 
gluconeogenic gene, FBP1, required the complete lack of glucose transport 140.  
Additionally, a number of other studies have revealed that gluconeogenic and 
glyoxylate cycle genes are extremely sensitive to glucose repression 476,170,172,135.  
We presented multiple lines of evidence that indicate gluconeogenic and 
glyoxylate cycle genes are expressed, that their gene products are expressed, 
and that the enzymatic activity of these proteins is active in grr1Δ cells despite 
the presence of glucose and Hxt3 facilitated glucose transport.  These data pose 
the question; what causes glucose insensitive expression of gluconeogenic 
genes and their products in grr1Δ cells? Our data and that of others suggests
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Figure 6.1.  Model for Post-Transcriptional Regulation of Hxt3 and Hxt6/7 in 
grr1Δ Cells.  In grr1Δ cells the transcriptional repressor, Rgt1, is free to associate with both 
Mth1 and Std1. This leads to constitutive and full repression of the hexose transporter gene HXT1 
while HXT2, HXT4, HXT3 are repressed but not to the full extent.  Rgt1’s influence on HXT6,7 
has not been determined but must not be repressing since HXT6,7 expression is increased 4.6 
fold in grr1Δ cells.  On glucose media, the inability to fully de-repress HXT3 transcription leads to 
a lag in the accumulation of Hxt3 protein and a deficiency in Hxt3 mediated glucose transport. An 
increase in the translational rate or decrease in the vacuolar degradation of Hxt3 acts to 
compensate for this deficiency in HXT3 transcription in order to facilitate glucose transport in 
grr1Δ cells.  At the same time, despite the fact that HXT6,7 transcription is increased by almost 5 
fold in grr1Δ cells the protein expression level of Hxt6,7 is decreased in grr1Δ cells by greater 
than 3 fold.  This decrease in Hxt6,7 may be due to either a decrease in the rate of synthesis of 
the protein or an increase in the vacuolar degradation of the protein.  These data are consistent 
with the ability of grr1Δ cells to grow on moderate to high glucose concentrations where Hxt3 
facilitates glucose transport and the inability of grr1Δ cells to grow on low glucose concentrations 
where Hxt6,7 facilitate glucose transport. 
 
that flux through gluconeogenic and glyoxylate cycle pathways may be needed in 
grr1Δ cells to provide TCA cycle intermediates to the mitochondria in response to 
a deficiency in respiration in grr1Δ cells.  This respiratory deficiency may be 
caused by the inability to permeabilize the mitochondrial outer membrane to 
NADH and is remedied utilizing the less energy efficient glycerol-3-phosphate 
shuttle. 
  Comparison of protein and gene expression levels among loci annotated 
to the “carbon and energy metabolism” cluster revealed multiple instances of 
discordance which were subsequently overlaid onto a metabolic map of central 
carbon and energy metabolism.  Comparison of this metabolic map with previous 
analyses of metabolic flux in grr1Δ cells together suggested that despite 
increased flux through the TCA cycle, respiratory capacity is decreased in grr1Δ 
cells.  These conclusions are supported by multiple lines of evidence.   
In our proteomic and genomic analysis of grr1Δ cells we measured a 
significant amount of discordance between gene and protein expression of a 
number of mitochondrial proteins.  Significant increases in gene expression were 
measured for a number of TCA cycle genes yet correlative increases in protein 
expression were only observed for CIT1/Cit1 (2.70, 3.12).  These two enzymes 
catalyze the rate limiting steps of the TCA cycle and thus increased flux through 
the TCA cycle is likely despite the measured insignificant changes in the 
remaining TCA cycle proteins.  Consistent with this interpretation is the fact that 
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increased flux through the TCA cycle has been measured for grr1Δ cells 
previously 477,174.   
Despite increased flux through the TCA cycle in grr1Δ cells, our data as 
well as that of others supports that respiratory capacity in grr1Δ cells is 
compromised.  While some labs report normal growth of grr1Δ cells on 
respiratory carbon sources 66 others have found that GRR1 is required for 
respiratory growth 68.  We postulated that these discrepancies may be due to 
differences between strains backgrounds as cells of the S288C lineage are 
known to possess an inactivating Ty1 insertion in the respiratory HAP1 gene 454.  
However, while defects in respiratory growth for grr1Δ cells of the S288C 
background were more severe than those of the Cen.PK background a 
noticeable defect in respiratory growth was still present in Cen.PK grr1Δ cells.   
Consistent with a decreased respiratory capacity of grr1Δ cells, we also 
measured that expression of a number of proteins necessary for respiratory 
growth were observed to decrease.  The decreases in protein expression 
measured for mitochondrial proteins combined with the changes in protein 
expression for proteins involved in glycerol metabolism suggest that redox 
metabolism in grr1Δ cells is drastically altered.  The most notable of 
mitochondrial protein expression changes supporting an altered redox 
metabolism in grr1Δ cells are the mitochondrial porin, Por1, and the 
mitochondrial protein import receptor, Tom70.  Together, these two proteins, 
among other functions, serve to regulate the flux of NADH through the outer 
mitochondrial membrane 478,479,453,480, thus controlling the accessibility of NADH 
to the mitochondrial inner membrane NADH dehydrogenases, Nde1 and Nde2.  
The catalytic sites of these two dehydrogenases face the inter membrane space 
and thus these two enzymes couple the oxidation of cytosolic NADH to the 
mitochondrial electron transport chain.  Thus, reduction of Por1 and Tom70 
protein levels would suggest that the permeability of the mitochondrial outer 
membrane to NADH was reduced and that NADH oxidation through Nde1 and 
Nde2 is also coordinately reduced.  Interestingly, it has been found that the 
enzymatic activity of Nde1 and Nde2 inhibits the glycerol-3-phosphate 
 237 
 
dehydrogenase, Gut2 458, which was measured to increase in gene expression in 
grr1Δ cells.  Gut2 enzymatic activity is required for glycerol utilization and the 
glycerol-3-phosphate shuttle, which serves as an alternative pathway to couple 
NADH oxidation to the electron transport chain.  Interestingly, this pathway does 
not require NADH but glycerol-3-phosphate to traverse the mitochondrial outer 
membrane.  It has been reported that glycerol production in grr1Δ cells grown on 
glucose is reduced 67 and our protein expression data suggest that this reduction 
in glycerol production may be a consequence of increased flux through the 
glycerol-3-phosphate shuttle as Gpd2, whose protein expression is stimulated by 
excess cytosolic NADH 456, was measured to increase by 3 fold in grr1Δ cells.  
Additionally, we also measured decreased protein expression of Gpp1 in grr1Δ 
cells, which is the major isoform of glycerol-3-phosphatase catalyzing the 
biosynthesis of glycerol from glycerol-3-phosphate.  Together, this data suggests 
that decreased glycerol production in grr1Δ cells is a consequence of increased 
flux through the glycerol-3-phosphate shuttle in grr1Δ cells. 
The origins of decreased respiratory capacity in grr1Δ cells are difficult to 
ascertain from our present analysis.  However, a number of potential roles for 
Grr1 in regulating respiratory capacity are supported by various lines of evidence.  
Interestingly, Grr1 as well as the cullin protein of the SCF, Cdc53, have been 
discovered to physically interact with the Por1 protein in a large scale mass 
spectrometry based screen for protein interactions 481.  This data suggests that 
altered redox metabolism may be a consequence of some as of yet to be defined 
role for the SCFGrr1 complex in directly regulating the mitochondrial porin.  
Additionally, cells deleted for GRR1 have been shown to possess defects in the 
transport of divalent cations including, Ni2+, Co2+, Zn2+, and Mn2+ 71.  
Furthermore, significant increases in gene expression for transporters involved in 
iron import were measured in grr1Δ cells, including Fre7, Fit2, Fit3, and Fre5.  
Together, this data suggests that grr1Δ cells are depleted of intracellular cations.  
Decreased intracellular iron, in particular, would decrease the formation of iron-
sulfur cluster proteins which decreases respiratory capacity and activates the 
retrograde response pathway. 
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It has been previously discovered that Grr1 is required for activation of 
mitochondrial retrograde signaling in response to mitochondrial respiratory 
dysfunction by catalyzing the degradation of the negative regulator of retrograde 
signaling, Mks1 57.  Retrograde signaling is an adaptive response to deficiencies 
in mitochondrial respiration arising from changes in intracellular cation dynamics 
or defects in enzymes of the TCA cycle and/or respiratory chain 123,122.  The TCA 
cycle fails to function as a full cycle in respiratory deficient mitochondria since 
succinate would fail to be oxidized to fumarate.  Thus, through the retrograde 
signaling pathway, mitochondria can induce changes in nuclear gene expression 
to enhance production of enzymes of anapleurotic metabolic pathways that serve 
to provide TCA cycle intermediates to the mitochondria.  Utilizing the 
gluconeogenic and glyoxylate cycle pathways, the oxidation of succinate to 
fumarate in the TCA cycle can be bypassed to allow production of essential TCA 
cycle metabolites such as glutamate in the absence of respiratory function.  In 
grr1Δ cells the retrograde response is inactive and thus up-regulation of CAT8 
gene expression, which is not under retrograde control but Snf1 and 
Hap2/Hap3/Hap4/Hap5 control, may serve as a compensatory pathway to 
defects in retrograde response.  Nevertheless, the need for increased respiratory 
capacity in grr1Δ strains grown on glucose is not explained by these phenomena 
and a direct role for Grr1 in modulating Cat8 and Cat8 dependent transcription 
cannot be eliminated at this time.   
 
6.3.  Glc7 Regulation in grr1Δ Cells 
The intracellular signal that leads to Cat8 dependent transcriptional 
induction of gluconeogenic and glyoxylate cycle genes in grr1Δ cells remains a 
mystery but our data suggests that this signal acts to regulate Snf1 kinase 
activity through inhibition of Reg1-Glc7 activity.  We presented data that strongly 
suggests that transcriptional activation of gluconeogenic genes in grr1Δ cells is 
facilitated through Cat8 dependent transcriptional induction as CAT8 expression 
was increased in grr1Δ cells, Cat8 dependent genes were significantly increased 
in grr1Δ cells, and accumulation of the hyper-phosphorylated transcriptionally 
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active form of Cat8 was measured to increase in grr1Δ cells.  Since CAT8 gene 
expression and phosphorylation of Cat8 requires Snf1 kinase activity we 
deduced that the Snf1 kinase was indeed active in grr1Δ cells.  Finally, we 
presented evidence suggesting that grr1Δ cells possess alterations in the activity 
of the Reg1-Glc7 phosphatase, possibly through post-translational modification 
of Glc7, which most likely lead to increased Snf1 catalytic activity.  These data 
suggest that the signal acting to de-repress gluconeogenic and glyoxylate cycle 
genes in grr1Δ cells acts to modulate Reg1-Glc7 activity by controlling the levels 
of the alternative forms of Glc7.   
The identity of the alternative forms of Glc7 detected in our analysis is 
presently unknown but one promising possibility can be conceived.  The 
migration shift between form one of Glc7 and form two of Glc7 is estimated to 
correlate to a difference in protein size between 10-15 kDa.  Though many post-
translational modifications cause slower migration of proteins through SDS-Page 
gels the extent to which the migratory shift occurs is in most cases is more subtle 
than that observed for Glc7.  However, sumo, which is a protein that is covalently 
attached to protein substrates like ubiquitin, has a molecular weight of 11,597 
Da.  Thus, it is possible that Glc7 may be sumoylated and that Glc7 form three 
may possess two of these modifications since the difference in migration 
between form two and form three is roughly equal to the difference in migration 
between form one and form two.  It is also interesting to note that the SUMO 
peptidase, Ulp2, which de-conjugates SUMO modifications from proteins, was 
measured to increase in expression in grr1Δ cells by 5 fold.  Additionally, Uls1, 
which is a RING finger protein involved in ubiquitin dependent proteolysis of 
SUMO conjugated proteins, is also measured to increase in expression by ~10 
fold.  Together, these data provide preliminary evidence that the processes 
mediating sumoylation may be affected in grr1Δ strains and that Glc7 may be a 
target for sumoylation in response to glucose availability and/or increased 
glycolytic flux.  However, further investigation is required to confirm or deny this 
hypothesis. 
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6.4.  Final Model for Hexose Transport in grr1Δ Cells 
The results pertaining to post-transcriptional control of hexose 
transporters, the decreased respiratory capacity, and the regulation of 
gluconeogenic and glyoxylate cycle genes through modulation of Glc7 in grr1Δ 
strains together provide an in depth analysis of the regulatory and metabolic 
state of grr1Δ cells grown on glucose.  However, the direct cause of the glucose 
insensitivity of these alterations is not apparent in our analysis.  Previous 
analyses have provided compelling evidence that the resistance to glucose 
repression observed in grr1Δ strains is an indirect consequence of decreased 
glucose transport and as a result decreased glycolytic flux in this strain.  Our 
results do not refute this explanation but provide a possible explanation for the 
absence of glucose repression of the highly glucose sensitive gluconeogenic and 
glyoxylate cycle genes.  Considering these prior analyses as well as our own, we 
propose the following model for the glucose repression resistant phenotype of 
grr1Δ strains.   
During the initial phases of glucose based growth when stationary phase 
cells have just been diluted in fresh glucose medium there is a measurable lag in 
cell replication until the cells adjust the external environment as well as their own 
intracellular environment to support efficient utilization of the available nutrients.  
Once adjusted, the yeast cell enters logarithmic growth where the rate of cellular 
replication is increased substantially.  Depending on the metabolic and regulatory 
state of the cell this adjustment phase varies in length.  For example, if the 
inoculated cells were from stationary phase cultures, the transport and metabolic 
state of the cell is most likely adjusted for growth on low glucose or even ethanol 
depending on how long the cells were allowed to incubate in stationary phase.  
Thus, inoculation of these cells into fresh (2% glucose) cultures would require a 
more extensive remodeling of the transport and metabolic state of the cell.  
However, if the inoculated cells were from cultures of cells in mid-log phase, the 
transport and metabolic state of the cell is adjusted for fermentive growth on 
glucose (glucose concentrations ranging from 0.5-1.5%).  Thus, the amount of 
transport and metabolic remodeling required to adjust to fermentive growth on 
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the higher glucose concentration present in the fresh medium would be far less 
extensive.   
With this in mind, we believe that the glucose repression resistant 
phenotype of grr1Δ strains is a manifestation of two independent defects.  First, 
the relief from glucose repression in grr1Δ strains is a manifestation of the 
decreased ability of grr1Δ strains to adjust their glucose transport capacity in 
response to changes in extracellular glucose concentration.  When grr1Δ 
stationary phase cells are inoculated into fresh, 2% glucose media, there is a 
significant lag in the onset of logarithmic growth compared to wild-type cells.  We 
believe this lag is at least partially caused by the inability to de-repress hexose 
transporter transcription in response to glucose availability through the Snf3/Rgt2 
pathway.  However, the expression of the low affinity hexose transporter gene, 
HXT3, is not fully repressed in grr1Δ strains and therefore its protein product can 
be synthesized albeit at a much slower rate.  This slower rate of Hxt3 synthesis 
contributes to the lag in the onset of logarithmic growth of grr1Δ cells since 
glycolytic flux would presumably be decreased coordinately with the glucose 
transport capacity supplied by Hxt3.  Once Hxt3 protein levels reach wild-type 
levels in grr1Δ cells, we presume that glucose transport capacity would be 
sufficient for logarithmic growth on glucose to begin.  It is critical to emphasize 
that in our analyses we adjusted for the lag in the onset of logarithmic growth by 
allowing grr1Δ cells to grow for approximately 6 hours longer than wild-type (this 
was the point where cell densities were equal) before protein extraction.  Thus, at 
the time points where we measured Hxt3 and Hxt7 levels the grr1Δ strain had 
entered logarithmic growth and thus, under our model, differences in Hxt3 protein 
levels at this point would be absent.  Considering the above model for the 
decreased rate of glucose transport capacity adjustment in grr1Δ strains, the 
need for increased respiratory capacity in grr1Δ strains is an indirect 
consequence of this delay.  The slow response to the availability of glucose in 
grr1Δ strains would lead to an increased dependence of these strains to support 
the energy demands of the cell through respiration during the prolonged 
adjustment phase. 
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Second, the glucose insensitive expression of the highly glucose sensitive 
gluconeogenic and glyoxylate cycle genes is most likely a consequence of the 
need for increased respiratory capacity in grr1Δ strains and the inability to 
effectively increase respiratory capacity in grr1Δ strains due to an undefined role 
for Grr1 in regulating respiration.  As indicated previously, the glyoxylate cycle 
provides metabolic intermediates to the TCA cycle and can serve to bypass the 
oxidation of succinate to fumarate in respiratory deficient cells in order to support 
synthesis of essential metabolites such as glutamate and glutamine.  Our data 
suggests that grr1Δ cells possess defects in respiration that may be due to one 
or more roles for Grr1 in respiratory function.  Thus, gluconeogenic and 
glyoxylate cycle enzymes may be needed in grr1Δ cells to provide anapleurotic 
pathways in order to compensate for the respiratory defect of grr1Δ strains. 
 The patterns of Glc7 modification throughout our various experiments 
also provide support for the increased lag phase model.  We showed that that the 
levels of the modified forms of Glc7 were reduced considerably as wild-type and 
grr1Δ cells were grown on decreasing glucose concentrations.  However, in this 
set of experiments, we did not measure differences in the levels of the modified 
forms of Glc7 between wild-type and grr1Δ strains.  This is in contrast to the 
previous two blots (Figure 5.6 A and 5.6 B) where a difference in the expression 
levels of the modified forms of Glc7 was observed between wild-type and grr1Δ 
cells.  We believe that these differences can be explained by the differences in 
the way in which these experiments were conducted.  In the first experiments 
(Figure 5.6 A and B), cells were grown to stationary phase, inoculated into fresh 
culture and protein extraction was carried out at the indicated cell density.  In the 
second set of experiments (Figure 5.6 C) each culture was grown to mid-log 
phase in media of the appropriate glucose concentration, inoculated into fresh 
media of the same glucose concentration, and protein was extracted at the 
indicated cell density.  Thus, we believe that the grr1Δ cells in the second set of 
experiment were not compromised by their inability to re-adjust to the change in 
media conditions because these cultures were inoculated from mid-log phase 
cultures.  Therefore, the difference in expression of the modified forms of Glc7 
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Figure 6.2.  Final Model for Intracellular Glucose Signaling Through the 
Hxk2/Reg1-Glc7/Snf1 Dependent Pathway in wild-type and grr1Δ Cells.  A 
model for intracellular glucose signaling through the Hxk2/Reg1-Glc7/Snf1 dependent pathway in 
grr1Δ and wild-type strains is proposed based off of data from our present analysis as well as the 
current literature regarding regulation of this pathway.  Increased and decreased pathways are 
indicated by solid red lines and green lines, respectively.  Constitutively, active pathways are 
indicated in blue.  Unknown regulatory events are indicated by dashed lines and the presumed 
activity of these regulatory events are indicated by color with red indicating increased activity and 
green indicating decreased activity.  Decreased expression of a particular gene or protein is 
indicated by the color of the gene (bent arrow) or protein (node) with red indicating increased 
expression, green indicating decreased expression, and blue indicating no change in expression.  
The circled question mark indicated as a modification of Glc7 represents the modified forms of 
Glc7 detected in our analysis.  See text for description. 
 
between wild-type and grr1Δ strains is dependent on the precise phase at which 
the protein extracts are taken.  Though we presently favor this model, it is 
possible that one or a number of the pleiotrophic nutrient defects inherent in 
grr1Δ strains leads to the differential expression of modified forms of Glc7.  Thus, 
further analysis is needed to determine the specific conditions that lead to 
differential expression of the modified forms of Glc7.  Nevertheless, the 
expression levels of these modified forms decreases as the glucose 
concentration decreases suggesting that the intracellular signal modulating the 
presence of these forms is in some way influenced by glucose. 
Given these data the following model is proposed for intracellular glucose 
signaling through the Hxk2/Reg1/Glc7/Snf1 pathway in grr1Δ and wild-type 
strains grown on glucose.  In the presence of glucose, in wild-type strains, 
glucose is transported through any one of the hexose transporters, Hxt1, 2, 3, 4, 
and/or 6/7 depending on the external glucose concentration.  Transport of 
glucose in wild-type strains is of sufficient capacity to support high glycolytic flux 
which through an unknown mechanism (possibly increased glucose-6-
phosphate) leads to increased expression of the modified forms of Glc7.  
Presumably, the modified forms of Glc7 would interact more favorably with Reg1.  
Reg1-Glc7 then catalyzes the de-phosphorylation of Hxk2 leading to Hxk2 
dimerization which supports higher glycolytic flux and thus serves as a positive 
feedback loop promoting further Reg1-Glc7 interaction.  Reg1-Glc7 also de-
activates Snf1 kinase through de-phosphorylation of threonine-210 in the 
activation loop of Snf1.  De-phosphorylation of Snf1 leads to auto-inhibition as 
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the regulatory domain of Snf1 is now free to mask threonine-210 preventing 
phosphorylation by the Snf1 activating kinase, Pak1.  Inactivation of Snf1 also 
prevents its Gal83 dependent nuclear translocation thus preventing Snf1 
dependent phosphorylation and de-activation of the nuclear localized Mig1 
repressor.  Active Mig1 represses expression of the respiratory transcription 
factor gene, HAP4, as well as the gluconeogenic and glyoxylate cycle 
transcription factor genes, CAT8 and SIP4. 
In the presence of glucose, in grr1Δ cells, glucose based growth is 
facilitated predominately by the low affinity glucose transporter, Hxt3.  However, 
glucose transport through Hxt3 is insufficient to support a high glycolytic flux.  
Reduced glycolytic flux in grr1Δ strains leads to an increased dependency on 
respiration to fulfill the energy demands of the cell but grr1Δ strains possess a 
respiratory deficiency and thus cannot appropriately increase respiratory 
capacity.  The combination of decreased glycolytic flux in the presence of 
decreased respiratory capacity leads to reduced expression of the modified 
forms of Glc7 (again through an unknown mechanism).  The reduced expression 
of the modified forms of Glc7 reduces Reg1-Glc7 interaction which subsequently 
reduces the accumulation of dimerized Hxk2.  The presence of monomeric Hxk2 
reduces the glycolytic flux in accordance with the reduced transport capacity.  At 
the same time, the reduction of Reg1-Glc7 interaction leads to enhanced Snf1 
phosphorylation and Gal83 dependent nuclear localization.  Catalytically active 
nuclear localized Snf1-Gal83-Snf4 phosphorylates Mig1, inhibiting Mig1 
repression of the respiratory transcription factor gene, HAP4, as well as the 
gluconeogenic and glyoxylate cycle transcription factor genes, CAT8 and SIP4.  
Additionally, catalytically active nuclear localized Snf1-Gal83-Snf4 
phosphorylates and activates the transcriptional activity of Cat8 and Sip4 leading 
to gluconeogenic and glyoxylate cycle gene expression.  Gluconeogenic and 
glyoxylate cycle enzymes are then actively expressed in grr1Δ cells to provide 
metabolic intermediates to the TCA cycle to support supplementation of 
respiratory capacity through glycerol based growth.  
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CHAPTER 7:  DISCUSSION: GENE AND PROTEIN DISCORDANCE AND ITS 
IMPLICATIONS IN grr1Δ CELLS 
 
7.1.  Reasons for Discordance between Protein Expression and Gene 
Expression   
While the high degree of discordance between mRNA and protein 
expression levels in our analysis is counter-intuitive, the lack of accordance 
between protein and mRNA expression levels has been observed in other 
studies.  Several studies have been conducted comparing transcriptional 
expression levels to protein expression levels with only weak positive correlations 
observed 482-487.  This absence of correlation is perplexing and raises a number 
of questions.  First, what are the origins of discordance? Are they biological or 
are they simply a byproduct of the inherent noise of our analyses? If biological, 
from what molecular regulatory level does most discordance arise? These and 
many other questions must be addressed in order to begin to predict protein 
expression levels from transcriptional expression levels.  However, based on the 
primary type of discordance observed in our analysis (no change in gene 
expression despite large changes in protein expression) it seems doubtful that 
extrapolation from gene expression for a large percentage of the proteome will 
ever be able to be achieved, thus necessitating the need for independent protein 
measurements.   
Regarding the origins of discordance, at least four sources can be 
hypothesized.  Perhaps the most obvious factors contributing to protein and gene 
expression discordance is the existence of independent regulation of protein 
synthesis and protein degradation.  Early investigators showed that dynamic 
regulation of both of these processes serves as an important mechanism 
governing the activity of enzymes, transporters, and regulatory proteins, and 
multiple examples illustrating uncoupled regulation of transcriptional and post-
transcriptional regulation exist.  For instance, regulation of the transcriptional 
activator, Gcn4, is almost exclusively controlled by translational rate and the rate 
of protein degradation 488 and regulated proteolysis of cell cycle regulators such 
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as the cyclins and cyclin dependent kinase inhibitors is critical to proper cell cycle 
progression 489,80,490,491.  Furthermore, numerous nutrient transporters and 
enzymes are rapidly inactivated by protein degradation in response to changes in 
the extracellular nutrient composition 492-496.  Thus, if any model for extrapolating 
gene expression levels to determine protein expression levels is to be viable, 
rates of both protein synthesis and degradation under the conditions utilized must 
be taken into account.   
A number of computational analyses have been conducted in an effort to 
corroborate the discordance between protein and gene expression by taking into 
account protein synthesis and degradation rates.  While insightful, these 
analyses have had limited success.  Independent studies have provided 
estimates for translation rate 497, ribosome density 498, and protein half life 499 
across the yeast genome.  In order to account for differences in translational rate 
that most likely contribute to discordance, correlations of protein and mRNA 
abundance have been conducted by accounting for ribosome density (distribution 
of ribosomes on a mRNA)  and ribosome occupancy (number of ribosomes 
bound to an mRNA) of yeast mRNA concertedly.  Higher correlations were 
observed for ORFs possessing high levels of ribosomal occupancy and lower 
correlations observed for those transcripts possessing low occupancy 482,486; 
however, even considering these attributes the increase in correlation was subtle 
and only applied to a fraction of the genome.  In a more extensive analysis, 
conducted by 486, these measurements as well as other parameters such as 
protein abundance, mRNA abundance, and transcript length were utilized to 
calculate a protein half life descriptor (PHD) measure.  This value was 
constructed to provide a calculated protein half life measure that could be utilized 
to corroborate the lack of correlation between protein and mRNA expression 
levels.  However, while the “PHD” measure correlated well with known half-lives 
and underscored the tremendous variability between individual proteins with 
regards to protein turnover rate, it was not utilized to correct for discordance 
observed between individual transcripts and their respective proteins.  
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Nevertheless, the authors noted that protein turnover as well as protein synthesis 
rates are the most correlative predictors of steady state protein levels in the cell. 
The third and perhaps most under appreciated contributor to discordance 
is the mRNA degradation rate of the transcript.  A number of transcripts including  
SDH2  which encodes the iron protein subunit of succinate dehydrogenase 500, 
CYC1 which encodes cytochrome c 501,502,  MAL62 which encodes maltase 503, 
SUC2 which encodes invertase 504, PCK1 which encodes pep carboxy-kinase, 
FBP1 which encodes fructose-1,6-bisphosphatase 476, and the meiotic mRNA of 
SPO13 505 are promoted for rapid degradation when glucose is introduced to 
cells growing on respiratory carbon sources.  Though examples of control of 
mRNA degradation are limited to transcripts subject to glucose repression, it 
seems reasonable to think that more mRNAs in yeast will be found subject to this 
type of regulation.  If so, the steady state level of the mRNA abundance 
contributed to by both mRNA synthesis (transcription) and mRNA degradation 
could be potential regulatory points where discordance could be elicited. 
  A fourth factor potentially contributing to mRNA/protein discordance is 
the presence of manufactured systematic noise in global gene and protein 
expression data sets.  Systematic noise in protein expression data sets is most 
likely much greater than noise present in genomic data sets given the relative 
immaturity of the experimental processes utilized to attain quantitative protein 
measurements.  In my descriptions of our proteomic analyses I mentioned that 
differential post-translational modifications on peptides for a given protein could 
contribute to inaccurate estimates of the protein steady state level.  I believe that 
these phenomena may be the most important factor contributing to what would 
be considered experimental noise in shotgun based proteomic analyses.  Here I 
will describe the technical origins of this problem and provide biological support 
for the existence of this phenomena in the grr1Δ proteomic data set.    
Differential modification of peptides (i.e. phosphorylated in one sample but 
not the other) can lead to differences in chromatographic retention times between 
the modified (i.e. phosphorylated) and unmodified peptide.  In shotgun based 
proteomic analyses, proteins are digested utilizing proteolytic enzymes to 
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produce more readily analyzable peptide fragments and these peptides are then 
separated utilizing any number of chromatographic separation techniques.  In 
this study we utilized a two dimensional separation system known as MudPIT 
(For review see Section 3.11.3).  The first phase of this separation system 
utilizes a strong cation exchange stationary phase to retain peptides based on 
their charge.  The more positive the charge the higher the affinity the peptide has 
for the stationary phase.  The total yeast peptide population bound to the SCX 
column is then separated into 12 discrete populations by utilizing isocratic 
elutions of increasing salt concentration.  Thus, the average positive 
charge/peptide between peptide populations would increase as the salt 
concentration increases in later elutions.  The presence of a modification of either 
negative or positive polarity substantially alters the peptides charge state and 
thus the affinity of that peptide for the SCX stationary phase.  For instance, a 
phosphorylated serine or threonine would decrease the net positive charge of the 
peptide compared to the un-phosphorylated version of the peptide.  This 
phosphopeptide would thus, in most instances, elute in an earlier isocratic salt 
fraction than its respective un-phosphorylated version 506.  Each isocratic salt 
elution is followed by a 90 minute reverse phase separation which resolves 
peptides based on their hydrophobicity.  Peptide modifications such as 
phosphorylation have been found to decrease or increase a peptides retention 
time in reverse phase columns as well 507.   
As peptides elute from the reverse phase column their mass to charge 
ratio as well as their CID (collision induced dissociation) spectra are acquired 
through mass spectrometric analysis.  Identification of the peptide is facilitated by 
searching the experimentally acquired CID spectra against a theoretically 
determined CID spectral library.  This theoretical library is generated 
computationally utilizing protein sequence information obtained for the 
appropriate organism (in our case S. cerevisiae) obtained from the appropriate 
protein sequence database (in our case the Saccharomyces Genome Database 
ftp://ftp.yeastgenome.org/yeast/(July 2006)).Theoretical digestion of the protein 
sequences is performed by specifying the particular enzymatic protease.  Each 
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protease targets defined sites for proteolytic cleavage (i.e.  trypsin cleaves C-
terminal to arginine and lysine residues) and thus proteins from the sequence 
database can be computationally digested based upon these specificities.  The 
particular algorithm then calculates the theoretical mass to charge ratio of the 
theoretical, in this case, tryptic peptide.  At this stage, since post-translational 
modifications alter the mass to charge ratio of the peptide, post-translational 
modifications must be specified a priori.  Thus, in order to identify a modified 
peptide, knowledge of its modification would have to be known in order generate 
an in silico theoretical library that included the specific modification on the 
peptide with the correct mass to charge ratio.  Given the large number of different 
types of modifications as well as the combinations and number of modifications 
that could occur on a particular peptide, a theoretical library containing these 
permutations would be immense and practically unsearchable.  As a result, most 
searches are performed utilizing only a few modifications and thus many 
modified peptides remain unidentifiable.  Additionally, post-translational 
modifications greatly alter the experimentally acquired CID pattern of the peptide 
further complicating the ability to successfully identify these modified forms 508.   
The altered chromatographic retention time, mass to charge ratio, and CID 
spectra of modified forms of a particular peptide together lead to relative 
quantitative peptide measures that are not reflective of the relative protein 
abundance but of the extent of post-translational modification of the peptide 
between the samples being compared.  Typically, due to the aforementioned 
complications, only the unmodified peptide is detectable.  Once a peptide has 
been detected, its chromatographic elution profile is reconstructed using the ion 
intensities for the parent ion across multiple MS scans.  This typically creates a 
bell shaped curve whose area is determined through integration.  The 
chromatographic elution profile of the peptide partner from the other sample is 
then also reconstructed by utilizing the same steps.  However, if the peptide 
partner was not identified, the partner is assumed to elute with the identified 
peptide at a mass to charge ratio calculated by the size of the label utilized.  A 
relative quantitative measure of the particular peptide is then generated by 
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dividing the area of one peptide elution profile by the other.  Thus, if a peptide 
were differentially modified and thus undetectable, quantification utilizing these 
methods would lead to a relative peptide measure that would indicate that the 
peptide is more abundant in the sample containing the unmodified version of the 
peptide.  This would therefore either completely bias the relative protein measure 
(if it was one of only a few peptides measured for a given protein) or skew the 
relative protein abundance (if it was one of multiple peptides identified for a given 
protein) toward a higher or lower relative abundance difference. 
In order to reduce the bias contributed by peptide modifications to relative 
protein expression measures, analysis of shotgun based proteomic data must be 
restricted to only those proteins for which multiple distinct peptide sequences 
were identified and  quantitated.  However, these restrictions severely reduce 
proteomic coverage due to the dynamic range (sensitivity) limitations of these 
analyses and eliminate potentially valuable biological information pertaining to 
differential post-translational regulation of the protein.  A solution to the dynamic 
range problem inherent in shotgun based whole proteome analyses known as 
SRM, for selected reaction monitoring, can be applied to increase coverage of a 
predetermined set of proteins and offers a valuable follow up method to global 
analyses.  Recently, a variation of this technique was applied to successfully 
detect and quantify low abundance proteins of the TCA cycle, gluconeogenesis, 
glycolysis, and the glyoxylate cycle with extremely accurate results 509. 
  
7.2.  Type 1 Discordance: Instances of Inverted Gene and Protein 
Expression Levels are Likely Due to Manufactured Systematic Noise from 
Peptide Modifications in Proteomic Data Sets  
Our comparative analysis of global gene and protein expression levels 
revealed a large degree of discordance between these two regulatory levels in 
grr1Δ cells.  The discordance measured can be grouped into three different types 
depending upon the nature of the discordance.  The first type includes those loci 
where mRNA was observed to significantly increase and the change in the gene 
product expression level was measured to show an inverse correlation, 
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decreasing in abundance.  This group of loci was smallest among discordant loci 
and included  EMP46 and its product involved in COPII ER to Golgi transport 
protein (mRNA +2.1 in grr1Δ, protein -5.9 in grr1Δ), MCR1 and its product, the 
mitochondrial NADH-cytochrome b5 reductase (+2.04, -12.5), ATP19 an its 
product, the k subunit of the F1F0 ATP synthase (+2.5, -2.5), NDI1 and its 
product, the NADH:ubiquinone oxidoreductase (+3.76, -2.86), IDH2 and its 
product, the mitochondrial NAD(+)-dependent isocitrate dehydrogenase (+3.03, -
6.25), ACH1 and its product, the mitochondrial acetate detoxification enzyme 
(+4.03, -5.56), and HXT7 and its product, the high affinity hexose transporter 
(+4.62, -2.56).  Though in the instance of Hxt7, the measured discordance is 
indeed true, as shown in our results (Figure 5.1), the other instances for the most 
part likely represent discordance attributed to systematic noise due to possible 
post-translational modifications.  Idh2 was quantified as bronze by one peptide 
(KTFGLFANRVPAK) with a peptide probability of 0.59.  However, it is interesting 
to note that another peptide (pTGDLAGTATTSSFTEAVIK) for this protein was 
also identified and quantitated in our analysis with a relative abundance of 0 
(these are not included in our analysis due to a high degree of noise among 
proteins quantitated with 0 or 999 values).  The peptide phosphorylation 
(indicated by the lowercase p) was identified in a mass spectrometry screen 
mapping sites of phosphorylation on mitochondrial proteins 510.  Thus our data 
suggest that it is phosphorylated in grr1Δ cells.  The remaining proteins Ndi1 
(ARPVITDLFK), Emp46 (QGNEGDSTELFGGSSK), Ach1 (AIAGHLVEFFR), 
Mcr1 (GSNVVRPYTPVSDLSQK), and Atp19 (AIPPHQLAIGTLGLLGLLVVPNPF-
K) were all quantified by a single peptide (indicated in parentheses).  Taken 
together the majority of the instances of discordance measured within this group 
are probably false positives for significant changes in protein abundance as the 
relative peptide abundances are most likely due to differential modification of the 
quantitated peptide.  Nevertheless, these data may indeed reflect the actual 
steady state protein level or may indicate important regulatory modifications of 
these proteins on these peptide sequences.  Therefore, these data were included 
in the analysis. 
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7.3.  Type 2 Discordance:  Changes in Protein Expression Occurring in the 
Absence of Significant Changes in Gene Expression  
The second type of discordance measured included loci where no change 
in gene expression was measured while protein expression was measured to 
significantly increase or decrease.  This type of discordance was the most 
prominent in our analysis including 86% (286 of 333) of all discordant loci.  Loci 
within this discordance group were closely split between proteins measured to 
significantly increase (48.6%) and proteins measured to significantly decrease 
(51.4%).  These data suggest that a large number of proteins may be exclusively 
controlled through post-transcriptional mechanisms and that these post-
transcriptional regulatory mechanisms are affected by the absence of Grr1.   
Given the role that Grr1 plays in regulating protein stability through 
ubiquitin dependent degradation, a number of the proteins measured to increase 
could in fact be direct targets of Grr1 mediated ubiquitylation.  At the same time, 
a number of the alterations in protein steady state levels within this category of 
discordance could be affected in grr1Δ strains indirectly as part of a 
compensatory response to correct for deficiencies that are directly caused by 
GRR1 deletion.  Distinguishing between these two possibilities for each 
discordant locus poses a significant challenge, since extensive scientific 
analyses must be implemented to unravel the direct cause of each perturbation 
individually.  However, biological insight pertaining to the role that Grr1 plays in 
the biology of the cell can be extracted from large scale datasets by determining 
the processes most affected by the absence of GRR1.  To this end, we 
implemented an automated as well as a manual GO (Gene Ontology) annotation 
strategy to group proteins with significantly altered expression in grr1Δ strains by 
shared molecular processes.  The enrichment for each process among 
significantly changed protein was then determined.  Enrichment of several 
molecular processes was found among proteins exhibiting discordance of the 
second type described above and the role of Grr1 in several processes is 
supported by previous analyses.   
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7.3.1.  Type 2 Discordance among Trafficking Proteins in grr1Δ Cells  
Manual GO analysis of enriched processes revealed that the process 
“trafficking” encompassed 19.9% (60 total proteins) of all discordant loci of the 
second type.  This was the most highly enriched process within this group and 
included proteins involved in the dynamics of actin, microtubule, vesicle, and 
glycosylation function.  Thus our definition of “trafficking” encompassed a diverse 
array of processes that all affect the movement of proteins and vesicles within 
the cell.  GenGO analysis revealed more specifically that the processes 
“membrane invagination” and “budding cell apical bud growth”, which fall under 
our manual annotation of “trafficking” proteins, were significantly enriched among 
these discordant loci.  As can be seen in Figure 1.4, grr1Δ cells exhibit multiple 
elongated buds which is a phenotype attributed to the role of Grr1 in degrading 
the G1 cyclins, Cln1 and Cln2, as well as the Cdc42 effectors Gic1 and Gic2.  
Given this role for Grr1, the enrichment observed for proteins annotated to 
“budding cell apical bud growth” is well substantiated.  In fact, the majority of 
protein expression changes within the enriched process of “trafficking” may be 
attributable to downstream events initiated from stabilization of the Clns and the 
Gics in grr1Δ cells as drastic alterations in actin, microtubule, and secretory 
processes are necessary to promote polarized growth 511. 
The role of Grr1 in “trafficking” is not strictly limited to its function in 
regulating Cln and Gic stability.  The glucose induced inactivation of the maltose 
transporter, Mal61 512, and the galactose transporter, Gal2 512, has been shown 
to require Grr1.  In response to glucose both of these proteins are ubiquitylated 
by the HECT type ubiquitin ligase, Rsp5, which promotes their internalization and 
vacuolar degradation 513,514.  Therefore, Grr1 does not catalyze the ubiquitylation 
of these transporters directly, suggesting an indirect mechanism for Grr1 
mediated control of maltose and galactose transporter stability.   
Interestingly, the GO process of membrane invagination (endocytosis) 
was found to be enriched by GenGO analysis of protein expression changes in 
grr1Δ cells.  Grr1 was found by two hybrid analysis to bind to Bzz1 448, which was 
measured to increase 6.39 fold in grr1Δ cells by our proteomic analysis. Bzz1 
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has been found to localize to actin patches and is implicated in the regulation of 
actin polymerization and endocytosis through its association with the yeast 
homolog to the human Wiskott-Aldrich syndrome protein (WASP), Las17 449.  
Interestingly, the Bzz1 protein contains a N-terminal FCH bar domain, PEST 
sequences, and a C-terminal SH3 domain that are all present in a known Grr1 
substrate, Hof1 54.  Based on these observations it has been suggested that 
Bzz1 may be a substrate for SCFGrr1 mediated ubiquitylation and the increase in 
Bzz1 protein levels measured in our analysis is consistent with this hypothesis.  It 
is tempting to speculate that the role of Grr1 in glucose dependent de-activation 
of the maltose and galactose permeases is through de-stabilization of Bzz1 or 
another Bzz1 or Hof1-like protein. 
We were curious to determine through network analysis whether a link 
could be made between Las17/Bzz1 function and the maltose and galactose 
transporters (Figure 7.1).  Interestingly, physical interactions have been detected 
between Las17 and only two transporters, Gal2 and Hxt6/7.  No interaction 
between Las17 and the maltose transporter is in our database.  Nevertheless, 
since Gal2 inactivation is known to be Grr1 dependent, since Hxt6/7 may be 
differentially trafficked in Grr1 strains, and since these two proteins interact 
physically with Las17 suggests that Grr1 influences Las17 function to control 
endocytosis of these proteins.  This control may be exerted through Grr1 
dependent degradation of the Las17 effector, Bzz1, or through another unknown 
protein.  Interestingly, Yck2, which is involved in several Grr1 dependent 
processes, most notably the Snf3/Rgt2 pathway and the SPS pathway, also has 
biochemical activity towards Las17 and Bzz1 515.  Additionally, a 
Las17/Bzz1/Vrp1 complex has been found to regulate cortical actin patch 
assembly by activating the Arp2/3 complex 516.  This complex is recruited to 
Cdc42 and activated by a Cdc42 dependent mechanism 517.  Grr1 controls 
Cdc42 activity by controlling Cln2 stability 346,104  and Gic1 and Gic2 stability 
55,101.  Together, this data suggests that Grr1 may play a multifaceted role in 
regulating membrane dynamics through regulation of cortical actin patches in a 
Cdc42/Las17 dependent manner. 
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Figure 7.1.  Interaction Network Linking Las17/Bzz1 to Transporter Proteins 
Affected in grr1Δ Cells.  An interaction network was constructed utilizing interaction data 
from the Saccharomyces Genome Database (July, 2006 version) and the network visualization 
tool, ProteoLens™.  Physical interactions between the Las17 and the transporters Gal2 and 
Hxt6/7 were found in previous analyses.  Trafficking of the Gal2 transporter has been shown to 
be effected in grr1Δ cells through an unknown mechanism leading to Gal2 stability *495,518.  In our 
analysis, Hxt6/7 stability is also affected in grr1Δ strains (see Section 5.2).  Hof1 is a known Grr1 
substrate 54 and Bzz1 contains many of the protein domains present in Hof1 (see text).  Bzz1 is a 
known Las17 effector that is thought to recruit actin polymerization machinery during endocytosis 
449.  Given these facts and the fact that a number of proteins which interact with Bzz1 and Las17 
are measured to have increased (red) or decreased (green) protein levels, a role for Grr1 in 
endocytosis through Bzz1 is highly likely.
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7.3.2.  Type 2 Discordance among Proteins Annotated to “Mitosis” or “M phase of 
the Meiotic Cell Cycle”  
An interesting observation from the gene expression data is that, despite 
the well studied role for Grr1 in mediating the proteasomal degradation of the G1 
cyclins Cln1 and Cln2 to regulate G1/S phase progression, no changes in cell 
cycle genes are measured as significantly changed.  In fact, no evidence of 
Grr1’s role in cell cycle regulation is apparent at the transcriptional level with the 
exception of the 2 fold increase in CLN1 expression.  Overall, these data are 
commensurate with previous gene expression studies performed on grr1Δ cells 
159.   
Interestingly, 8.6% of the significant changes in protein expression in 
grr1Δ strains possessed known roles in mitosis.  Our manual GO annotation and 
GenGO analysis revealed that the process “M phase of the meiotic cell cycle” 
was significantly enriched among proteins with significant changes in protein 
expression in grr1Δ cells.  Proteins within this GO process of “Gold” or “Silver” 
confidence included proteins involved in regulating microtubule and spindle 
dynamics (Myo1 (-3.45 fold change in protein expression in grr1Δ cells), Inn1 (-
6.67), Src1 (-16.67), Slk19 (-2.70), Ady3 (-3.33), Bbp1 (+12.35), Dyn1 (+39.24), 
Arp10 (+4.03), Kar3 (+5.97), YNL313 (+14.43), and YJL051 (+28.31)), proteins 
involved in regulating actin dynamics (Sds23 (-3.57), Sds24 (-5.00), Rga2 (-
5.26), Bnr1 (-4.00), Ady4 (+6.19), Pan1 (+8.87), and Cla4 (-10.00)), transcription 
factors regulating mitotic genes (Hcm1 (-10.00) and Sum1 (+2.80)), the 
APC/Cyclosome activating protein Cdh1 (-4.35), and various other proteins 
involved in some capacity in mediating mitosis (Ulp2 (+5.03), Cdc37 (-5.26), Glc7 
(+4.35), Tor1 (+23.10), Hop1 (+3.05), Scp160 (+3.60), Msh5 (+5.69), and 
Mec1(+4.20)).  Interestingly, of these proteins, no significant change in gene 
expression was measured for any.  Together this data suggests that the cell 
cycle defects associated with grr1Δ strains manifest at the post-transcriptional 
level in M phase of the cell cycle. 
It has been previously established that a significant fraction of grr1Δ cells 
possess a 2N DNA content (92% compared to 55% of wild-type) 78,77 which has 
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been suggested to be a consequence of premature entry into S phase.  This 
hypothesis is based on the fact that premature advancement through the G1-S 
phase transition is observed in cells expressing stabilized versions of Cln2 82 and 
that Cln2 stability is increased in grr1Δ cells from a half life of 10 minutes to over 
30 minutes 78.  Stabilization of Cln1 and Cln2 promote premature phosphorylation 
and degradation of the Clb-Cdc28 inhibitor Sic1 which promotes early entry into 
S phase.  Interestingly, many of the mitotic proteins with significantly altered 
protein expression have been found to be potential substrates of the Sic1 
inhibited Clb2-Cdc28 kinase (Figure 4.9 B) suggesting that hyperactive Clb2-
Cdc28 kinase activity may contribute to many of the protein expression level 
changes in mitotic proteins measured in grr1Δ cells.  Additionally, Grr1 has been 
shown to mediate the timely degradation of the Hof1 protein required for 
cytokinesis and a fraction of cells harboring stabilized versions of Hof1 arrest in 
cytokinesis.  Thus, the mother and the daughter cell continue to share the same 
cytoplasm 54.  Therefore, it is possible that many of the measured changes in 
protein expression are a consequence of Grr1’s role in degrading the Clns and 
Hof1.  However given the extent to which mitotic protein expression levels are 
altered and the number measured to change it seems likely that additional roles 
for Grr1 in regulating mitosis remain to be uncovered; specifically with regards to 
regulating spindle dynamics. 
 
7.4.  Type 3 Discordance:  Changes in Gene Expression Occurring in the 
Absence of Significant Changes in Protein Expression 
The third type of discordance measured in our analysis included 
significant changes in gene expression with no concomitant change in the gene 
products expression.  This type of discordance was observed exclusively among 
loci annotated to “carbon and energy metabolism”.  The biological relevance of 
this discordance was studied in Chapter 5 and discussed in Chapter 6. 
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